diff --git "a/combinations.csv" "b/combinations.csv"
--- "a/combinations.csv"
+++ "b/combinations.csv"
@@ -1,1655 +1,1655 @@
-"{'pbs_code': '13308K', 'drug': 'etanercept', 'brand': 'Enbrel', 'formulation': 'Injections 50 mg in 1 mL single use pre-filled syringes, 4', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Continuing treatment', 'streamlined_code': '14154', 'online_application': True, 'authority_method': 'STREAMLINED', 'hospital_type': 'Public', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '13757C', 'drug': 'tofacitinib', 'brand': 'Xeljanz', 'formulation': 'Tablet 5 mg', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Transitioning from non-PBS to PBS-subsidised supply - Grandfather arrangements', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9034L', 'drug': 'adalimumab', 'brand': 'Abrilada', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled syringe', 'indication': 'psoriatic arthritis', 'treatment_phase': 'Continuing treatment - balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9034L', 'drug': 'adalimumab', 'brand': 'Idacio', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled syringe', 'indication': 'psoriatic arthritis', 'treatment_phase': 'Continuing treatment - balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9034L', 'drug': 'adalimumab', 'brand': 'Hadlima', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled syringe', 'indication': 'psoriatic arthritis', 'treatment_phase': 'Continuing treatment - balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9034L', 'drug': 'adalimumab', 'brand': 'Hyrimoz', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled syringe', 'indication': 'psoriatic arthritis', 'treatment_phase': 'Continuing treatment - balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9034L', 'drug': 'adalimumab', 'brand': 'Amgevita', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled syringe', 'indication': 'psoriatic arthritis', 'treatment_phase': 'Continuing treatment - balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9034L', 'drug': 'adalimumab', 'brand': 'Abrilada', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled syringe', 'indication': 'psoriatic arthritis', 'treatment_phase': 'First continuing treatment', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9034L', 'drug': 'adalimumab', 'brand': 'Idacio', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled syringe', 'indication': 'psoriatic arthritis', 'treatment_phase': 'First continuing treatment', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9034L', 'drug': 'adalimumab', 'brand': 'Hadlima', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled syringe', 'indication': 'psoriatic arthritis', 'treatment_phase': 'First continuing treatment', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9034L', 'drug': 'adalimumab', 'brand': 'Hyrimoz', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled syringe', 'indication': 'psoriatic arthritis', 'treatment_phase': 'First continuing treatment', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9034L', 'drug': 'adalimumab', 'brand': 'Amgevita', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled syringe', 'indication': 'psoriatic arthritis', 'treatment_phase': 'First continuing treatment', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9034L', 'drug': 'adalimumab', 'brand': 'Abrilada', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled syringe', 'indication': 'psoriatic arthritis', 'treatment_phase': 'Subsequent continuing treatment', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9034L', 'drug': 'adalimumab', 'brand': 'Idacio', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled syringe', 'indication': 'psoriatic arthritis', 'treatment_phase': 'Subsequent continuing treatment', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9034L', 'drug': 'adalimumab', 'brand': 'Hadlima', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled syringe', 'indication': 'psoriatic arthritis', 'treatment_phase': 'Subsequent continuing treatment', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9034L', 'drug': 'adalimumab', 'brand': 'Hyrimoz', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled syringe', 'indication': 'psoriatic arthritis', 'treatment_phase': 'Subsequent continuing treatment', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9034L', 'drug': 'adalimumab', 'brand': 'Amgevita', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled syringe', 'indication': 'psoriatic arthritis', 'treatment_phase': 'Subsequent continuing treatment', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '11516D', 'drug': 'golimumab', 'brand': 'Simponi', 'formulation': 'Injection 50 mg in 0.5 mL single use pre-filled syringe', 'indication': 'non-radiographic axial spondyloarthritis', 'treatment_phase': 'Continuing treatment - balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '11516D', 'drug': 'golimumab', 'brand': 'Simponi', 'formulation': 'Injection 50 mg in 0.5 mL single use pre-filled syringe', 'indication': 'non-radiographic axial spondyloarthritis', 'treatment_phase': 'Continuing treatment', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '10767Q', 'drug': 'ustekinumab', 'brand': 'Stelara', 'formulation': 'Injection 45 mg in 0.5 mL', 'indication': 'psoriatic arthritis', 'treatment_phase': 'Continuing treatment - balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '10767Q', 'drug': 'ustekinumab', 'brand': 'Stelara', 'formulation': 'Injection 45 mg in 0.5 mL', 'indication': 'psoriatic arthritis', 'treatment_phase': 'Continuing treatment', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '13720D', 'drug': 'tocilizumab', 'brand': 'Actemra ACTPen', 'formulation': 'Injection 162 mg in 0.9 mL single use pre-filled pen', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'Subsequent continuing treatment', 'streamlined_code': '14499', 'online_application': True, 'authority_method': 'STREAMLINED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '13065P', 'drug': 'infliximab', 'brand': 'Remsima SC', 'formulation': 'Solution for injection 120 mg in 1 mL pre-filled syringe', 'indication': 'ankylosing spondylitis', 'treatment_phase': 'Balance of supply (including switching formulation) where the full duration of treatment available under a particular treatment phase was not requested in the preceding prescription', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12217B', 'drug': 'ixekizumab', 'brand': 'Taltz', 'formulation': 'Injection 80 mg in 1 mL single dose pre-filled pen', 'indication': 'ankylosing spondylitis', 'treatment_phase': 'Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12217B', 'drug': 'ixekizumab', 'brand': 'Taltz', 'formulation': 'Injection 80 mg in 1 mL single dose pre-filled pen', 'indication': 'ankylosing spondylitis', 'treatment_phase': 'Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12217B', 'drug': 'ixekizumab', 'brand': 'Taltz', 'formulation': 'Injection 80 mg in 1 mL single dose pre-filled pen', 'indication': 'ankylosing spondylitis', 'treatment_phase': 'Initial treatment - Initial 1 (new patient), Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years) - balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12217B', 'drug': 'ixekizumab', 'brand': 'Taltz', 'formulation': 'Injection 80 mg in 1 mL single dose pre-filled pen', 'indication': 'ankylosing spondylitis', 'treatment_phase': 'Initial treatment - Initial 1 (new patient)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '3428K', 'drug': 'golimumab', 'brand': 'Simponi', 'formulation': 'Injection 50 mg in 0.5 mL single use pre-filled syringe', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'First continuing treatment', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '3428K', 'drug': 'golimumab', 'brand': 'Simponi', 'formulation': 'Injection 50 mg in 0.5 mL single use pre-filled syringe', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'First continuing treatment - balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '11375Q', 'drug': 'golimumab', 'brand': 'Simponi', 'formulation': 'Injection 50 mg in 0.5 mL single use pre-filled pen', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'First continuing treatment - balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '11375Q', 'drug': 'golimumab', 'brand': 'Simponi', 'formulation': 'Injection 50 mg in 0.5 mL single use pre-filled pen', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'First continuing treatment', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '3449M', 'drug': 'etanercept', 'brand': 'Enbrel', 'formulation': 'Injections 50 mg in 1 mL single use pre-filled syringes, 4', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Continuing Treatment - balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '3449M', 'drug': 'etanercept', 'brand': 'Enbrel', 'formulation': 'Injections 50 mg in 1 mL single use pre-filled syringes, 4', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Continuing treatment', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '13223Y', 'drug': 'adalimumab', 'brand': 'Yuflyma', 'formulation': 'Injection 40 mg in 0.4 mL pre-filled pen', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Subsequent continuing treatment', 'streamlined_code': '11604', 'online_application': True, 'authority_method': 'STREAMLINED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '13223Y', 'drug': 'adalimumab', 'brand': 'Adalicip', 'formulation': 'Injection 40 mg in 0.4 mL pre-filled pen', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Subsequent continuing treatment', 'streamlined_code': '11604', 'online_application': True, 'authority_method': 'STREAMLINED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '11498E', 'drug': 'infliximab', 'brand': 'Inflectra', 'formulation': 'Powder for I.V. infusion 100 mg', 'indication': 'psoriatic arthritis', 'treatment_phase': 'Subsequent continuing treatment', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Private', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '11498E', 'drug': 'infliximab', 'brand': 'Renflexis', 'formulation': 'Powder for I.V. infusion 100 mg', 'indication': 'psoriatic arthritis', 'treatment_phase': 'Subsequent continuing treatment', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Private', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '11498E', 'drug': 'infliximab', 'brand': 'Remicade', 'formulation': 'Powder for I.V. infusion 100 mg', 'indication': 'psoriatic arthritis', 'treatment_phase': 'Subsequent continuing treatment', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Private', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '11197H', 'drug': 'etanercept', 'brand': 'Enbrel', 'formulation': 'Injection set containing 4 vials powder for injection 25 mg and 4 pre-filled syringes solvent 1 mL', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'Subsequent continuing treatment', 'streamlined_code': '14499', 'online_application': True, 'authority_method': 'STREAMLINED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '6448J', 'drug': 'infliximab', 'brand': 'Remicade', 'formulation': 'Powder for I.V. infusion 100 mg', 'indication': 'ankylosing spondylitis', 'treatment_phase': 'Initial treatment - Initial 1 (new patient), Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years) - balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Private', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '6448J', 'drug': 'infliximab', 'brand': 'Inflectra', 'formulation': 'Powder for I.V. infusion 100 mg', 'indication': 'ankylosing spondylitis', 'treatment_phase': 'Initial treatment - Initial 1 (new patient), Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years) - balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Private', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '6448J', 'drug': 'infliximab', 'brand': 'Renflexis', 'formulation': 'Powder for I.V. infusion 100 mg', 'indication': 'ankylosing spondylitis', 'treatment_phase': 'Initial treatment - Initial 1 (new patient), Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years) - balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Private', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '6448J', 'drug': 'infliximab', 'brand': 'Remicade', 'formulation': 'Powder for I.V. infusion 100 mg', 'indication': 'ankylosing spondylitis', 'treatment_phase': 'Initial treatment - Initial 1 (new patient)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Private', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '6448J', 'drug': 'infliximab', 'brand': 'Inflectra', 'formulation': 'Powder for I.V. infusion 100 mg', 'indication': 'ankylosing spondylitis', 'treatment_phase': 'Initial treatment - Initial 1 (new patient)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Private', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '6448J', 'drug': 'infliximab', 'brand': 'Renflexis', 'formulation': 'Powder for I.V. infusion 100 mg', 'indication': 'ankylosing spondylitis', 'treatment_phase': 'Initial treatment - Initial 1 (new patient)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Private', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '6448J', 'drug': 'infliximab', 'brand': 'Remicade', 'formulation': 'Powder for I.V. infusion 100 mg', 'indication': 'ankylosing spondylitis', 'treatment_phase': 'Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Private', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '6448J', 'drug': 'infliximab', 'brand': 'Inflectra', 'formulation': 'Powder for I.V. infusion 100 mg', 'indication': 'ankylosing spondylitis', 'treatment_phase': 'Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Private', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '6448J', 'drug': 'infliximab', 'brand': 'Renflexis', 'formulation': 'Powder for I.V. infusion 100 mg', 'indication': 'ankylosing spondylitis', 'treatment_phase': 'Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Private', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '6448J', 'drug': 'infliximab', 'brand': 'Remicade', 'formulation': 'Powder for I.V. infusion 100 mg', 'indication': 'ankylosing spondylitis', 'treatment_phase': 'Continuing treatment - balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Private', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '6448J', 'drug': 'infliximab', 'brand': 'Inflectra', 'formulation': 'Powder for I.V. infusion 100 mg', 'indication': 'ankylosing spondylitis', 'treatment_phase': 'Continuing treatment - balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Private', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '6448J', 'drug': 'infliximab', 'brand': 'Renflexis', 'formulation': 'Powder for I.V. infusion 100 mg', 'indication': 'ankylosing spondylitis', 'treatment_phase': 'Continuing treatment - balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Private', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '6448J', 'drug': 'infliximab', 'brand': 'Remicade', 'formulation': 'Powder for I.V. infusion 100 mg', 'indication': 'ankylosing spondylitis', 'treatment_phase': 'Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Private', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '6448J', 'drug': 'infliximab', 'brand': 'Inflectra', 'formulation': 'Powder for I.V. infusion 100 mg', 'indication': 'ankylosing spondylitis', 'treatment_phase': 'Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Private', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '6448J', 'drug': 'infliximab', 'brand': 'Renflexis', 'formulation': 'Powder for I.V. infusion 100 mg', 'indication': 'ankylosing spondylitis', 'treatment_phase': 'Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Private', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '6448J', 'drug': 'infliximab', 'brand': 'Remicade', 'formulation': 'Powder for I.V. infusion 100 mg', 'indication': 'ankylosing spondylitis', 'treatment_phase': 'First continuing treatment', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Private', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '6448J', 'drug': 'infliximab', 'brand': 'Inflectra', 'formulation': 'Powder for I.V. infusion 100 mg', 'indication': 'ankylosing spondylitis', 'treatment_phase': 'First continuing treatment', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Private', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '6448J', 'drug': 'infliximab', 'brand': 'Renflexis', 'formulation': 'Powder for I.V. infusion 100 mg', 'indication': 'ankylosing spondylitis', 'treatment_phase': 'First continuing treatment', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Private', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '13228F', 'drug': 'adalimumab', 'brand': 'Humira', 'formulation': 'Injection 40 mg in 0.4 mL pre-filled syringe', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Continuing treatment', 'streamlined_code': '14136', 'online_application': True, 'authority_method': 'STREAMLINED', 'hospital_type': 'Public', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '13228F', 'drug': 'adalimumab', 'brand': 'Yuflyma', 'formulation': 'Injection 40 mg in 0.4 mL pre-filled syringe', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Continuing treatment', 'streamlined_code': '14136', 'online_application': True, 'authority_method': 'STREAMLINED', 'hospital_type': 'Public', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '13228F', 'drug': 'adalimumab', 'brand': 'Adalicip', 'formulation': 'Injection 40 mg in 0.4 mL pre-filled syringe', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Continuing treatment', 'streamlined_code': '14136', 'online_application': True, 'authority_method': 'STREAMLINED', 'hospital_type': 'Public', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '13315T', 'drug': 'tocilizumab', 'brand': 'Actemra', 'formulation': 'Concentrate for injection 80 mg in 4 mL', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Continuing treatment', 'streamlined_code': '14179', 'online_application': True, 'authority_method': 'STREAMLINED', 'hospital_type': 'Private', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '13047Q', 'drug': 'infliximab', 'brand': 'Remsima SC', 'formulation': 'Solution for injection 120 mg in 1 mL pre-filled syringe', 'indication': 'psoriatic arthritis', 'treatment_phase': 'Continuing treatment with subcutaneous form or switching from intravenous form to subcutaneous form', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '6397Q', 'drug': 'infliximab', 'brand': 'Remicade', 'formulation': 'Powder for I.V. infusion 100 mg', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Private', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '6397Q', 'drug': 'infliximab', 'brand': 'Renflexis', 'formulation': 'Powder for I.V. infusion 100 mg', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Private', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '6397Q', 'drug': 'infliximab', 'brand': 'Inflectra', 'formulation': 'Powder for I.V. infusion 100 mg', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Private', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '6397Q', 'drug': 'infliximab', 'brand': 'Remicade', 'formulation': 'Powder for I.V. infusion 100 mg', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 24 months) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months) - balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Private', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '6397Q', 'drug': 'infliximab', 'brand': 'Renflexis', 'formulation': 'Powder for I.V. infusion 100 mg', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 24 months) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months) - balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Private', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '6397Q', 'drug': 'infliximab', 'brand': 'Inflectra', 'formulation': 'Powder for I.V. infusion 100 mg', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 24 months) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months) - balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Private', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '6397Q', 'drug': 'infliximab', 'brand': 'Remicade', 'formulation': 'Powder for I.V. infusion 100 mg', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'First continuing treatment', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Private', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '6397Q', 'drug': 'infliximab', 'brand': 'Renflexis', 'formulation': 'Powder for I.V. infusion 100 mg', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'First continuing treatment', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Private', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '6397Q', 'drug': 'infliximab', 'brand': 'Inflectra', 'formulation': 'Powder for I.V. infusion 100 mg', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'First continuing treatment', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Private', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '6397Q', 'drug': 'infliximab', 'brand': 'Remicade', 'formulation': 'Powder for I.V. infusion 100 mg', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 24 months)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Private', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '6397Q', 'drug': 'infliximab', 'brand': 'Renflexis', 'formulation': 'Powder for I.V. infusion 100 mg', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 24 months)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Private', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '6397Q', 'drug': 'infliximab', 'brand': 'Inflectra', 'formulation': 'Powder for I.V. infusion 100 mg', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 24 months)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Private', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '6397Q', 'drug': 'infliximab', 'brand': 'Remicade', 'formulation': 'Powder for I.V. infusion 100 mg', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'First continuing treatment - balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Private', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '6397Q', 'drug': 'infliximab', 'brand': 'Renflexis', 'formulation': 'Powder for I.V. infusion 100 mg', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'First continuing treatment - balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Private', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '6397Q', 'drug': 'infliximab', 'brand': 'Inflectra', 'formulation': 'Powder for I.V. infusion 100 mg', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'First continuing treatment - balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Private', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '6397Q', 'drug': 'infliximab', 'brand': 'Remicade', 'formulation': 'Powder for I.V. infusion 100 mg', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'Initial treatment - Initial 1 (new patient)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Private', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '6397Q', 'drug': 'infliximab', 'brand': 'Renflexis', 'formulation': 'Powder for I.V. infusion 100 mg', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'Initial treatment - Initial 1 (new patient)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Private', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '6397Q', 'drug': 'infliximab', 'brand': 'Inflectra', 'formulation': 'Powder for I.V. infusion 100 mg', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'Initial treatment - Initial 1 (new patient)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Private', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '11675L', 'drug': 'tofacitinib', 'brand': 'Xeljanz', 'formulation': 'Tablet 5 mg', 'indication': 'psoriatic arthritis', 'treatment_phase': 'Continuing treatment', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '11675L', 'drug': 'tofacitinib', 'brand': 'Xeljanz', 'formulation': 'Tablet 5 mg', 'indication': 'psoriatic arthritis', 'treatment_phase': 'Continuing treatment - balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12094M', 'drug': 'tocilizumab', 'brand': 'Actemra ACTPen', 'formulation': 'Injection 162 mg in 0.9 mL single use pre-filled pen', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Balance of supply for Initial treatment - Initial 1 (new patient) or Initial 2 (retrial or recommencement of treatment after a break of less than 12 months) or Initial 3 (recommencement of treatment after a break of more than 12 months) - in a patient of any weight being administered a subcutaneous form of this biological medicine', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12355G', 'drug': 'adalimumab', 'brand': 'Abrilada', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled pen', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Continuing treatment', 'streamlined_code': '14136', 'online_application': True, 'authority_method': 'STREAMLINED', 'hospital_type': 'Public', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12355G', 'drug': 'adalimumab', 'brand': 'Amgevita', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled pen', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Continuing treatment', 'streamlined_code': '14136', 'online_application': True, 'authority_method': 'STREAMLINED', 'hospital_type': 'Public', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12355G', 'drug': 'adalimumab', 'brand': 'Hyrimoz', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled pen', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Continuing treatment', 'streamlined_code': '14136', 'online_application': True, 'authority_method': 'STREAMLINED', 'hospital_type': 'Public', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12355G', 'drug': 'adalimumab', 'brand': 'Hadlima', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled pen', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Continuing treatment', 'streamlined_code': '14136', 'online_application': True, 'authority_method': 'STREAMLINED', 'hospital_type': 'Public', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12355G', 'drug': 'adalimumab', 'brand': 'Idacio', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled pen', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Continuing treatment', 'streamlined_code': '14136', 'online_application': True, 'authority_method': 'STREAMLINED', 'hospital_type': 'Public', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '13723G', 'drug': 'infliximab', 'brand': 'Inflectra', 'formulation': 'Powder for I.V. infusion 100 mg', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months)', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Public', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '13723G', 'drug': 'infliximab', 'brand': 'Renflexis', 'formulation': 'Powder for I.V. infusion 100 mg', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months)', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Public', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '13723G', 'drug': 'infliximab', 'brand': 'Inflectra', 'formulation': 'Powder for I.V. infusion 100 mg', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 24 months) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months) - balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Public', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '13723G', 'drug': 'infliximab', 'brand': 'Renflexis', 'formulation': 'Powder for I.V. infusion 100 mg', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 24 months) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months) - balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Public', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '13723G', 'drug': 'infliximab', 'brand': 'Inflectra', 'formulation': 'Powder for I.V. infusion 100 mg', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 24 months)', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Public', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '13723G', 'drug': 'infliximab', 'brand': 'Renflexis', 'formulation': 'Powder for I.V. infusion 100 mg', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 24 months)', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Public', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '13723G', 'drug': 'infliximab', 'brand': 'Inflectra', 'formulation': 'Powder for I.V. infusion 100 mg', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'Initial treatment - Initial 1 (new patient)', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Public', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '13723G', 'drug': 'infliximab', 'brand': 'Renflexis', 'formulation': 'Powder for I.V. infusion 100 mg', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'Initial treatment - Initial 1 (new patient)', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Public', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '13305G', 'drug': 'tocilizumab', 'brand': 'Actemra', 'formulation': 'Concentrate for injection 200 mg in 10 mL', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Continuing treatment', 'streamlined_code': '14164', 'online_application': True, 'authority_method': 'STREAMLINED', 'hospital_type': 'Public', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '13735X', 'drug': 'certolizumab pegol', 'brand': 'Cimzia', 'formulation': 'Injection 200 mg in 1 mL single use pre-filled syringe', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'Subsequent continuing treatment', 'streamlined_code': '14499', 'online_application': True, 'authority_method': 'STREAMLINED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12775J', 'drug': 'tocilizumab', 'brand': 'Actemra', 'formulation': 'Concentrate for injection 80 mg in 4 mL', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'Initial treatment - Initial 4 (Temporary listing - change of treatment from another biological medicine to tocilizumab after resolution of the critical shortage of tocilizumab)', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Public', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '13704G', 'drug': 'adalimumab', 'brand': 'Adalicip', 'formulation': 'Injection 40 mg in 0.4 mL pre-filled syringe', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 24 months)', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '13704G', 'drug': 'adalimumab', 'brand': 'Yuflyma', 'formulation': 'Injection 40 mg in 0.4 mL pre-filled syringe', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 24 months)', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '13704G', 'drug': 'adalimumab', 'brand': 'Adalicip', 'formulation': 'Injection 40 mg in 0.4 mL pre-filled syringe', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'Initial treatment - Initial 1 (new patient)', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '13704G', 'drug': 'adalimumab', 'brand': 'Yuflyma', 'formulation': 'Injection 40 mg in 0.4 mL pre-filled syringe', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'Initial treatment - Initial 1 (new patient)', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '13704G', 'drug': 'adalimumab', 'brand': 'Adalicip', 'formulation': 'Injection 40 mg in 0.4 mL pre-filled syringe', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months)', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '13704G', 'drug': 'adalimumab', 'brand': 'Yuflyma', 'formulation': 'Injection 40 mg in 0.4 mL pre-filled syringe', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months)', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '10137M', 'drug': 'certolizumab pegol', 'brand': 'Cimzia', 'formulation': 'Injection 200 mg in 1 mL single use pre-filled syringe', 'indication': 'ankylosing spondylitis', 'treatment_phase': 'Continuing treatment', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '10137M', 'drug': 'certolizumab pegol', 'brand': 'Cimzia', 'formulation': 'Injection 200 mg in 1 mL single use pre-filled syringe', 'indication': 'ankylosing spondylitis', 'treatment_phase': 'Continuing treatment - balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '5757B', 'drug': 'infliximab', 'brand': 'Inflectra', 'formulation': 'Powder for I.V. infusion 100 mg', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 24 months)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Public', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '5757B', 'drug': 'infliximab', 'brand': 'Renflexis', 'formulation': 'Powder for I.V. infusion 100 mg', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 24 months)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Public', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '5757B', 'drug': 'infliximab', 'brand': 'Remicade', 'formulation': 'Powder for I.V. infusion 100 mg', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 24 months)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Public', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '5757B', 'drug': 'infliximab', 'brand': 'Inflectra', 'formulation': 'Powder for I.V. infusion 100 mg', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 24 months) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months) - balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Public', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '5757B', 'drug': 'infliximab', 'brand': 'Renflexis', 'formulation': 'Powder for I.V. infusion 100 mg', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 24 months) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months) - balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Public', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '5757B', 'drug': 'infliximab', 'brand': 'Remicade', 'formulation': 'Powder for I.V. infusion 100 mg', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 24 months) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months) - balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Public', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '5757B', 'drug': 'infliximab', 'brand': 'Inflectra', 'formulation': 'Powder for I.V. infusion 100 mg', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'Initial treatment - Initial 1 (new patient)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Public', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '5757B', 'drug': 'infliximab', 'brand': 'Renflexis', 'formulation': 'Powder for I.V. infusion 100 mg', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'Initial treatment - Initial 1 (new patient)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Public', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '5757B', 'drug': 'infliximab', 'brand': 'Remicade', 'formulation': 'Powder for I.V. infusion 100 mg', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'Initial treatment - Initial 1 (new patient)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Public', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '5757B', 'drug': 'infliximab', 'brand': 'Inflectra', 'formulation': 'Powder for I.V. infusion 100 mg', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'First continuing treatment - balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Public', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '5757B', 'drug': 'infliximab', 'brand': 'Renflexis', 'formulation': 'Powder for I.V. infusion 100 mg', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'First continuing treatment - balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Public', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '5757B', 'drug': 'infliximab', 'brand': 'Remicade', 'formulation': 'Powder for I.V. infusion 100 mg', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'First continuing treatment - balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Public', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '5757B', 'drug': 'infliximab', 'brand': 'Inflectra', 'formulation': 'Powder for I.V. infusion 100 mg', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Public', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '5757B', 'drug': 'infliximab', 'brand': 'Renflexis', 'formulation': 'Powder for I.V. infusion 100 mg', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Public', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '5757B', 'drug': 'infliximab', 'brand': 'Remicade', 'formulation': 'Powder for I.V. infusion 100 mg', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Public', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '5757B', 'drug': 'infliximab', 'brand': 'Inflectra', 'formulation': 'Powder for I.V. infusion 100 mg', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'First continuing treatment', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Public', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '5757B', 'drug': 'infliximab', 'brand': 'Renflexis', 'formulation': 'Powder for I.V. infusion 100 mg', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'First continuing treatment', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Public', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '5757B', 'drug': 'infliximab', 'brand': 'Remicade', 'formulation': 'Powder for I.V. infusion 100 mg', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'First continuing treatment', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Public', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9103D', 'drug': 'adalimumab', 'brand': 'Hyrimoz', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled pen', 'indication': 'ankylosing spondylitis', 'treatment_phase': 'Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years) - balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9103D', 'drug': 'adalimumab', 'brand': 'Hadlima', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled pen', 'indication': 'ankylosing spondylitis', 'treatment_phase': 'Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years) - balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9103D', 'drug': 'adalimumab', 'brand': 'Amgevita', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled pen', 'indication': 'ankylosing spondylitis', 'treatment_phase': 'Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years) - balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9103D', 'drug': 'adalimumab', 'brand': 'Idacio', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled pen', 'indication': 'ankylosing spondylitis', 'treatment_phase': 'Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years) - balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9103D', 'drug': 'adalimumab', 'brand': 'Abrilada', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled pen', 'indication': 'ankylosing spondylitis', 'treatment_phase': 'Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years) - balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9103D', 'drug': 'adalimumab', 'brand': 'Hyrimoz', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled pen', 'indication': 'ankylosing spondylitis', 'treatment_phase': 'Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9103D', 'drug': 'adalimumab', 'brand': 'Hadlima', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled pen', 'indication': 'ankylosing spondylitis', 'treatment_phase': 'Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9103D', 'drug': 'adalimumab', 'brand': 'Amgevita', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled pen', 'indication': 'ankylosing spondylitis', 'treatment_phase': 'Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9103D', 'drug': 'adalimumab', 'brand': 'Idacio', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled pen', 'indication': 'ankylosing spondylitis', 'treatment_phase': 'Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9103D', 'drug': 'adalimumab', 'brand': 'Abrilada', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled pen', 'indication': 'ankylosing spondylitis', 'treatment_phase': 'Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9103D', 'drug': 'adalimumab', 'brand': 'Hyrimoz', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled pen', 'indication': 'ankylosing spondylitis', 'treatment_phase': 'Initial treatment - Initial 1 (new patient)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9103D', 'drug': 'adalimumab', 'brand': 'Hadlima', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled pen', 'indication': 'ankylosing spondylitis', 'treatment_phase': 'Initial treatment - Initial 1 (new patient)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9103D', 'drug': 'adalimumab', 'brand': 'Amgevita', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled pen', 'indication': 'ankylosing spondylitis', 'treatment_phase': 'Initial treatment - Initial 1 (new patient)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9103D', 'drug': 'adalimumab', 'brand': 'Idacio', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled pen', 'indication': 'ankylosing spondylitis', 'treatment_phase': 'Initial treatment - Initial 1 (new patient)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9103D', 'drug': 'adalimumab', 'brand': 'Abrilada', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled pen', 'indication': 'ankylosing spondylitis', 'treatment_phase': 'Initial treatment - Initial 1 (new patient)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9103D', 'drug': 'adalimumab', 'brand': 'Hyrimoz', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled pen', 'indication': 'ankylosing spondylitis', 'treatment_phase': 'Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9103D', 'drug': 'adalimumab', 'brand': 'Hadlima', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled pen', 'indication': 'ankylosing spondylitis', 'treatment_phase': 'Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9103D', 'drug': 'adalimumab', 'brand': 'Amgevita', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled pen', 'indication': 'ankylosing spondylitis', 'treatment_phase': 'Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9103D', 'drug': 'adalimumab', 'brand': 'Idacio', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled pen', 'indication': 'ankylosing spondylitis', 'treatment_phase': 'Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9103D', 'drug': 'adalimumab', 'brand': 'Abrilada', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled pen', 'indication': 'ankylosing spondylitis', 'treatment_phase': 'Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '3448L', 'drug': 'etanercept', 'brand': 'Enbrel', 'formulation': 'Injection set containing 4 vials powder for injection 25 mg and 4 pre-filled syringes solvent 1 mL', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Continuing Treatment - balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '3448L', 'drug': 'etanercept', 'brand': 'Enbrel', 'formulation': 'Injection set containing 4 vials powder for injection 25 mg and 4 pre-filled syringes solvent 1 mL', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Continuing treatment', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '11690G', 'drug': 'tofacitinib', 'brand': 'Xeljanz', 'formulation': 'Tablet 5 mg', 'indication': 'psoriatic arthritis', 'treatment_phase': 'Initial treatment - Initial 1 (new patient)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '11690G', 'drug': 'tofacitinib', 'brand': 'Xeljanz', 'formulation': 'Tablet 5 mg', 'indication': 'psoriatic arthritis', 'treatment_phase': 'Initial treatment - Initial 2 (change or recommencement of treatment after a break in in biological medicine of less than 5 years)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '11690G', 'drug': 'tofacitinib', 'brand': 'Xeljanz', 'formulation': 'Tablet 5 mg', 'indication': 'psoriatic arthritis', 'treatment_phase': 'Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years) - balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '11690G', 'drug': 'tofacitinib', 'brand': 'Xeljanz', 'formulation': 'Tablet 5 mg', 'indication': 'psoriatic arthritis', 'treatment_phase': 'Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12329X', 'drug': 'adalimumab', 'brand': 'Hadlima', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled pen', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'Subsequent continuing treatment', 'streamlined_code': '14499', 'online_application': True, 'authority_method': 'STREAMLINED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12329X', 'drug': 'adalimumab', 'brand': 'Hyrimoz', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled pen', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'Subsequent continuing treatment', 'streamlined_code': '14499', 'online_application': True, 'authority_method': 'STREAMLINED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12329X', 'drug': 'adalimumab', 'brand': 'Amgevita', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled pen', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'Subsequent continuing treatment', 'streamlined_code': '14499', 'online_application': True, 'authority_method': 'STREAMLINED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12329X', 'drug': 'adalimumab', 'brand': 'Abrilada', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled pen', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'Subsequent continuing treatment', 'streamlined_code': '14499', 'online_application': True, 'authority_method': 'STREAMLINED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12329X', 'drug': 'adalimumab', 'brand': 'Idacio', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled pen', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'Subsequent continuing treatment', 'streamlined_code': '14499', 'online_application': True, 'authority_method': 'STREAMLINED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12763R', 'drug': 'tocilizumab', 'brand': 'Actemra', 'formulation': 'Concentrate for injection 400 mg in 20 mL', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'Initial treatment - Initial 4 (Temporary listing - change of treatment from another biological medicine to tocilizumab after resolution of the critical shortage of tocilizumab)', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Public', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '14285W', 'drug': 'adalimumab', 'brand': 'Abrilada', 'formulation': 'Injection 20 mg in 0.4 mL pre-filled syringe', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Continuing treatment', 'streamlined_code': '14107', 'online_application': True, 'authority_method': 'STREAMLINED', 'hospital_type': 'Private', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '13686H', 'drug': 'adalimumab', 'brand': 'Amgevita', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled pen', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'First continuing treatment', 'streamlined_code': '14567', 'online_application': True, 'authority_method': 'STREAMLINED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '13686H', 'drug': 'adalimumab', 'brand': 'Abrilada', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled pen', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'First continuing treatment', 'streamlined_code': '14567', 'online_application': True, 'authority_method': 'STREAMLINED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '13686H', 'drug': 'adalimumab', 'brand': 'Hadlima', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled pen', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'First continuing treatment', 'streamlined_code': '14567', 'online_application': True, 'authority_method': 'STREAMLINED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '13686H', 'drug': 'adalimumab', 'brand': 'Idacio', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled pen', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'First continuing treatment', 'streamlined_code': '14567', 'online_application': True, 'authority_method': 'STREAMLINED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '13686H', 'drug': 'adalimumab', 'brand': 'Hyrimoz', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled pen', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'First continuing treatment', 'streamlined_code': '14567', 'online_application': True, 'authority_method': 'STREAMLINED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '13299Y', 'drug': 'tocilizumab', 'brand': 'Actemra', 'formulation': 'Concentrate for injection 400 mg in 20 mL', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Continuing treatment', 'streamlined_code': '14093', 'online_application': True, 'authority_method': 'STREAMLINED', 'hospital_type': 'Public', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '6367D', 'drug': 'etanercept', 'brand': 'Enbrel', 'formulation': 'Injection set containing 4 vials powder for injection 25 mg and 4 pre-filled syringes solvent 1 mL', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 12 months)', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Private', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '6367D', 'drug': 'etanercept', 'brand': 'Enbrel', 'formulation': 'Injection set containing 4 vials powder for injection 25 mg and 4 pre-filled syringes solvent 1 mL', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial treatment - Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 12 months) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 12 months) - balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Private', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '6367D', 'drug': 'etanercept', 'brand': 'Enbrel', 'formulation': 'Injection set containing 4 vials powder for injection 25 mg and 4 pre-filled syringes solvent 1 mL', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial treatment - Initial 1 (new patient)', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Private', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '6367D', 'drug': 'etanercept', 'brand': 'Enbrel', 'formulation': 'Injection set containing 4 vials powder for injection 25 mg and 4 pre-filled syringes solvent 1 mL', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 12 months)', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Private', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '13687J', 'drug': 'etanercept', 'brand': 'Brenzys', 'formulation': 'Injection 50 mg in 1 mL single use auto-injector, 4', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 24 months)', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '13687J', 'drug': 'etanercept', 'brand': 'Brenzys', 'formulation': 'Injection 50 mg in 1 mL single use auto-injector, 4', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 24 months) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months) - balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '13687J', 'drug': 'etanercept', 'brand': 'Brenzys', 'formulation': 'Injection 50 mg in 1 mL single use auto-injector, 4', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months)', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '13687J', 'drug': 'etanercept', 'brand': 'Brenzys', 'formulation': 'Injection 50 mg in 1 mL single use auto-injector, 4', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'Initial treatment - Initial 1 (new patient)', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '10058J', 'drug': 'tocilizumab', 'brand': 'Actemra', 'formulation': 'Concentrate for injection 200 mg in 10 mL', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Continuing treatment', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Public', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '10058J', 'drug': 'tocilizumab', 'brand': 'Actemra', 'formulation': 'Concentrate for injection 200 mg in 10 mL', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial treatment - Initial 1 (new patient)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Public', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '10058J', 'drug': 'tocilizumab', 'brand': 'Actemra', 'formulation': 'Concentrate for injection 200 mg in 10 mL', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Public', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '10058J', 'drug': 'tocilizumab', 'brand': 'Actemra', 'formulation': 'Concentrate for injection 200 mg in 10 mL', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Continuing Treatment - balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Public', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '10058J', 'drug': 'tocilizumab', 'brand': 'Actemra', 'formulation': 'Concentrate for injection 200 mg in 10 mL', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 24 months)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Public', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '10058J', 'drug': 'tocilizumab', 'brand': 'Actemra', 'formulation': 'Concentrate for injection 200 mg in 10 mL', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial treatment - Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after break of less than 24 months) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months) -  balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Public', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12090H', 'drug': 'tocilizumab', 'brand': 'Actemra ACTPen', 'formulation': 'Injection 162 mg in 0.9 mL single use pre-filled pen', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Continuing treatment in a patient weighing less than 30 kg', 'streamlined_code': '14084', 'online_application': True, 'authority_method': 'STREAMLINED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '14235F', 'drug': 'adalimumab', 'brand': 'Abrilada', 'formulation': 'Injection 20 mg in 0.4 mL pre-filled syringe', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 12 months) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 12 months) - balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Public', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '14235F', 'drug': 'adalimumab', 'brand': 'Abrilada', 'formulation': 'Injection 20 mg in 0.4 mL pre-filled syringe', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 12 months)', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Public', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '14235F', 'drug': 'adalimumab', 'brand': 'Abrilada', 'formulation': 'Injection 20 mg in 0.4 mL pre-filled syringe', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial treatment - Initial 1 (new patient)', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Public', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '14235F', 'drug': 'adalimumab', 'brand': 'Abrilada', 'formulation': 'Injection 20 mg in 0.4 mL pre-filled syringe', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 12 months)', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Public', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '10079L', 'drug': 'tocilizumab', 'brand': 'Actemra', 'formulation': 'Concentrate for injection 200 mg in 10 mL', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial treatment - Initial 1 (new patient)', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Private', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '10079L', 'drug': 'tocilizumab', 'brand': 'Actemra', 'formulation': 'Concentrate for injection 200 mg in 10 mL', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial treatment - Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 12 months) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 12 months) - balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Private', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '10079L', 'drug': 'tocilizumab', 'brand': 'Actemra', 'formulation': 'Concentrate for injection 200 mg in 10 mL', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 12 months)', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Private', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '10079L', 'drug': 'tocilizumab', 'brand': 'Actemra', 'formulation': 'Concentrate for injection 200 mg in 10 mL', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 12 months)', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Private', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '11202N', 'drug': 'etanercept', 'brand': 'Brenzys', 'formulation': 'Injection 50 mg in 1 mL single use auto-injector, 4', 'indication': 'psoriatic arthritis', 'treatment_phase': 'Subsequent continuing treatment', 'streamlined_code': '9156', 'online_application': True, 'authority_method': 'STREAMLINED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12566J', 'drug': 'infliximab', 'brand': 'Remsima SC', 'formulation': 'Solution for injection 120 mg in 1 mL pre-filled pen', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'Balance of supply for Initial treatment, Continuing treatment - subcutaneous form', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '3430M', 'drug': 'golimumab', 'brand': 'Simponi', 'formulation': 'Injection 50 mg in 0.5 mL single use pre-filled syringe', 'indication': 'psoriatic arthritis', 'treatment_phase': 'Initial treatment - Initial 1 (new patient)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '3430M', 'drug': 'golimumab', 'brand': 'Simponi', 'formulation': 'Injection 50 mg in 0.5 mL single use pre-filled syringe', 'indication': 'psoriatic arthritis', 'treatment_phase': 'Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '3430M', 'drug': 'golimumab', 'brand': 'Simponi', 'formulation': 'Injection 50 mg in 0.5 mL single use pre-filled syringe', 'indication': 'psoriatic arthritis', 'treatment_phase': 'Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years) - balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '3430M', 'drug': 'golimumab', 'brand': 'Simponi', 'formulation': 'Injection 50 mg in 0.5 mL single use pre-filled syringe', 'indication': 'psoriatic arthritis', 'treatment_phase': 'Initial treatment - Initial 2 (change or recommencement of treatment after a break in in biological medicine of less than 5 years)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '8778B', 'drug': 'etanercept', 'brand': 'Enbrel', 'formulation': 'Injection set containing 4 vials powder for injection 25 mg and 4 pre-filled syringes solvent 1 mL', 'indication': 'ankylosing spondylitis', 'treatment_phase': 'Initial treatment - Initial 1 (new patient)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '8778B', 'drug': 'etanercept', 'brand': 'Enbrel', 'formulation': 'Injection set containing 4 vials powder for injection 25 mg and 4 pre-filled syringes solvent 1 mL', 'indication': 'ankylosing spondylitis', 'treatment_phase': 'Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '8778B', 'drug': 'etanercept', 'brand': 'Enbrel', 'formulation': 'Injection set containing 4 vials powder for injection 25 mg and 4 pre-filled syringes solvent 1 mL', 'indication': 'ankylosing spondylitis', 'treatment_phase': 'Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '8778B', 'drug': 'etanercept', 'brand': 'Enbrel', 'formulation': 'Injection set containing 4 vials powder for injection 25 mg and 4 pre-filled syringes solvent 1 mL', 'indication': 'ankylosing spondylitis', 'treatment_phase': 'Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years) - balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12349Y', 'drug': 'adalimumab', 'brand': 'Amgevita', 'formulation': 'Injection 20 mg in 0.4 mL pre-filled syringe', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Continuing treatment', 'streamlined_code': '14107', 'online_application': True, 'authority_method': 'STREAMLINED', 'hospital_type': 'Private', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12792G', 'drug': 'tocilizumab', 'brand': 'Actemra ACTPen', 'formulation': 'Injection 162 mg in 0.9 mL single use pre-filled pen', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'Initial treatment - Initial 4 (Temporary listing - change of treatment from another biological medicine to tocilizumab after resolution of the critical shortage of tocilizumab)', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12796L', 'drug': 'tocilizumab', 'brand': 'Actemra', 'formulation': 'Concentrate for injection 200 mg in 10 mL', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial treatment - Initial 4 (Temporary listing - change of treatment from another biological medicine to tocilzumab after resolution of the critical shortage of tocilizumab)', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Public', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12796L', 'drug': 'tocilizumab', 'brand': 'Actemra', 'formulation': 'Concentrate for injection 200 mg in 10 mL', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial treatment - Initial 4 (Temporary listing - change of treatment from another biological medicine to tocilizumab after resolution of the critical shortage of tocilizumab)', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Public', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '13295R', 'drug': 'etanercept', 'brand': 'Enbrel', 'formulation': 'Injection set containing 4 vials powder for injection 25 mg and 4 pre-filled syringes solvent 1 mL', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Continuing treatment', 'streamlined_code': '14155', 'online_application': True, 'authority_method': 'STREAMLINED', 'hospital_type': 'Private', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '11489Q', 'drug': 'infliximab', 'brand': 'Remicade', 'formulation': 'Powder for I.V. infusion 100 mg', 'indication': 'ankylosing spondylitis', 'treatment_phase': 'Subsequent continuing treatment', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Private', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '11489Q', 'drug': 'infliximab', 'brand': 'Inflectra', 'formulation': 'Powder for I.V. infusion 100 mg', 'indication': 'ankylosing spondylitis', 'treatment_phase': 'Subsequent continuing treatment', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Private', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '11489Q', 'drug': 'infliximab', 'brand': 'Renflexis', 'formulation': 'Powder for I.V. infusion 100 mg', 'indication': 'ankylosing spondylitis', 'treatment_phase': 'Subsequent continuing treatment', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Private', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '13339C', 'drug': 'tocilizumab', 'brand': 'Actemra', 'formulation': 'Concentrate for injection 400 mg in 20 mL', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Continuing treatment', 'streamlined_code': '14164', 'online_application': True, 'authority_method': 'STREAMLINED', 'hospital_type': 'Public', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '13699B', 'drug': 'golimumab', 'brand': 'Simponi', 'formulation': 'Injection 50 mg in 0.5 mL single use pre-filled syringe', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'Subsequent continuing treatment', 'streamlined_code': '14604', 'online_application': True, 'authority_method': 'STREAMLINED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '13722F', 'drug': 'adalimumab', 'brand': 'Abrilada', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled syringe', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 24 months)', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '13722F', 'drug': 'adalimumab', 'brand': 'Hadlima', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled syringe', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 24 months)', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '13722F', 'drug': 'adalimumab', 'brand': 'Idacio', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled syringe', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 24 months)', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '13722F', 'drug': 'adalimumab', 'brand': 'Amgevita', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled syringe', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 24 months)', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '13722F', 'drug': 'adalimumab', 'brand': 'Hyrimoz', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled syringe', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 24 months)', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '13722F', 'drug': 'adalimumab', 'brand': 'Abrilada', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled syringe', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months)', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '13722F', 'drug': 'adalimumab', 'brand': 'Hadlima', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled syringe', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months)', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '13722F', 'drug': 'adalimumab', 'brand': 'Idacio', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled syringe', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months)', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '13722F', 'drug': 'adalimumab', 'brand': 'Amgevita', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled syringe', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months)', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '13722F', 'drug': 'adalimumab', 'brand': 'Hyrimoz', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled syringe', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months)', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '13722F', 'drug': 'adalimumab', 'brand': 'Abrilada', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled syringe', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'Initial treatment - Initial 1 (new patient)', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '13722F', 'drug': 'adalimumab', 'brand': 'Hadlima', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled syringe', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'Initial treatment - Initial 1 (new patient)', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '13722F', 'drug': 'adalimumab', 'brand': 'Idacio', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled syringe', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'Initial treatment - Initial 1 (new patient)', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '13722F', 'drug': 'adalimumab', 'brand': 'Amgevita', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled syringe', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'Initial treatment - Initial 1 (new patient)', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '13722F', 'drug': 'adalimumab', 'brand': 'Hyrimoz', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled syringe', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'Initial treatment - Initial 1 (new patient)', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '10897M', 'drug': 'certolizumab pegol', 'brand': 'Cimzia', 'formulation': 'Injection 200 mg in 1 mL single use pre-filled syringe', 'indication': 'ankylosing spondylitis', 'treatment_phase': 'Initial treatment - Initial 1 (new patient), Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years) - balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '13214L', 'drug': 'adalimumab', 'brand': 'Yuflyma', 'formulation': 'Injection 40 mg in 0.4 mL pre-filled pen', 'indication': 'psoriatic arthritis', 'treatment_phase': 'Subsequent continuing treatment', 'streamlined_code': '11523', 'online_application': True, 'authority_method': 'STREAMLINED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '13214L', 'drug': 'adalimumab', 'brand': 'Adalicip', 'formulation': 'Injection 40 mg in 0.4 mL pre-filled pen', 'indication': 'psoriatic arthritis', 'treatment_phase': 'Subsequent continuing treatment', 'streamlined_code': '11523', 'online_application': True, 'authority_method': 'STREAMLINED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12444Y', 'drug': 'adalimumab', 'brand': 'Humira', 'formulation': 'Injection 40 mg in 0.4 mL pre-filled pen', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 12 months) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 12 months) - balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Public', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12444Y', 'drug': 'adalimumab', 'brand': 'Adalicip', 'formulation': 'Injection 40 mg in 0.4 mL pre-filled pen', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 12 months) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 12 months) - balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Public', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12444Y', 'drug': 'adalimumab', 'brand': 'Yuflyma', 'formulation': 'Injection 40 mg in 0.4 mL pre-filled pen', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 12 months) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 12 months) - balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Public', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12444Y', 'drug': 'adalimumab', 'brand': 'Humira', 'formulation': 'Injection 40 mg in 0.4 mL pre-filled pen', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 12 months)', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Public', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12444Y', 'drug': 'adalimumab', 'brand': 'Adalicip', 'formulation': 'Injection 40 mg in 0.4 mL pre-filled pen', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 12 months)', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Public', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12444Y', 'drug': 'adalimumab', 'brand': 'Yuflyma', 'formulation': 'Injection 40 mg in 0.4 mL pre-filled pen', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 12 months)', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Public', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12444Y', 'drug': 'adalimumab', 'brand': 'Humira', 'formulation': 'Injection 40 mg in 0.4 mL pre-filled pen', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial treatment - Initial 1 (new patient)', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Public', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12444Y', 'drug': 'adalimumab', 'brand': 'Adalicip', 'formulation': 'Injection 40 mg in 0.4 mL pre-filled pen', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial treatment - Initial 1 (new patient)', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Public', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12444Y', 'drug': 'adalimumab', 'brand': 'Yuflyma', 'formulation': 'Injection 40 mg in 0.4 mL pre-filled pen', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial treatment - Initial 1 (new patient)', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Public', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12444Y', 'drug': 'adalimumab', 'brand': 'Humira', 'formulation': 'Injection 40 mg in 0.4 mL pre-filled pen', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 12 months)', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Public', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12444Y', 'drug': 'adalimumab', 'brand': 'Adalicip', 'formulation': 'Injection 40 mg in 0.4 mL pre-filled pen', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 12 months)', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Public', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12444Y', 'drug': 'adalimumab', 'brand': 'Yuflyma', 'formulation': 'Injection 40 mg in 0.4 mL pre-filled pen', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 12 months)', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Public', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '11560K', 'drug': 'golimumab', 'brand': 'Simponi', 'formulation': 'Injection 50 mg in 0.5 mL single use pre-filled syringe', 'indication': 'non-radiographic axial spondyloarthritis', 'treatment_phase': 'Initial treatment - Initial 1 (New patient)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '11560K', 'drug': 'golimumab', 'brand': 'Simponi', 'formulation': 'Injection 50 mg in 0.5 mL single use pre-filled syringe', 'indication': 'non-radiographic axial spondyloarthritis', 'treatment_phase': 'Initial 1 (New patient), Initial 2 (Change or re-commencement of treatment after a break in biological medicine of less than 5 years) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years) - balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '11560K', 'drug': 'golimumab', 'brand': 'Simponi', 'formulation': 'Injection 50 mg in 0.5 mL single use pre-filled syringe', 'indication': 'non-radiographic axial spondyloarthritis', 'treatment_phase': 'Initial treatment - Initial 2 (Change or re-commencement of treatment after a break of less than 5 years)', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '11560K', 'drug': 'golimumab', 'brand': 'Simponi', 'formulation': 'Injection 50 mg in 0.5 mL single use pre-filled syringe', 'indication': 'non-radiographic axial spondyloarthritis', 'treatment_phase': 'Initial treatment - Initial 3 (Recommencement of treatment after a break in biological medicine of more than 5 years)', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12425Y', 'drug': 'adalimumab', 'brand': 'Humira', 'formulation': 'Injection 40 mg in 0.4 mL pre-filled pen', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Continuing treatment - balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12425Y', 'drug': 'adalimumab', 'brand': 'Yuflyma', 'formulation': 'Injection 40 mg in 0.4 mL pre-filled pen', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Continuing treatment - balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12425Y', 'drug': 'adalimumab', 'brand': 'Adalicip', 'formulation': 'Injection 40 mg in 0.4 mL pre-filled pen', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Continuing treatment - balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12425Y', 'drug': 'adalimumab', 'brand': 'Humira', 'formulation': 'Injection 40 mg in 0.4 mL pre-filled pen', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Subsequent continuing treatment', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12425Y', 'drug': 'adalimumab', 'brand': 'Yuflyma', 'formulation': 'Injection 40 mg in 0.4 mL pre-filled pen', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Subsequent continuing treatment', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12425Y', 'drug': 'adalimumab', 'brand': 'Adalicip', 'formulation': 'Injection 40 mg in 0.4 mL pre-filled pen', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Subsequent continuing treatment', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12425Y', 'drug': 'adalimumab', 'brand': 'Humira', 'formulation': 'Injection 40 mg in 0.4 mL pre-filled pen', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'First continuing treatment', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12425Y', 'drug': 'adalimumab', 'brand': 'Yuflyma', 'formulation': 'Injection 40 mg in 0.4 mL pre-filled pen', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'First continuing treatment', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12425Y', 'drug': 'adalimumab', 'brand': 'Adalicip', 'formulation': 'Injection 40 mg in 0.4 mL pre-filled pen', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'First continuing treatment', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '13725J', 'drug': 'abatacept', 'brand': 'Orencia', 'formulation': 'Powder for I.V. infusion 250 mg', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'Subsequent continuing treatment', 'streamlined_code': '14604', 'online_application': True, 'authority_method': 'STREAMLINED', 'hospital_type': 'Public', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12417M', 'drug': 'adalimumab', 'brand': 'Amgevita', 'formulation': 'Injection 20 mg in 0.4 mL pre-filled syringe', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Continuing treatment', 'streamlined_code': '14136', 'online_application': True, 'authority_method': 'STREAMLINED', 'hospital_type': 'Public', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '10890E', 'drug': 'secukinumab', 'brand': 'Cosentyx', 'formulation': 'Injection 150 mg in 1 mL pre-filled pen', 'indication': 'ankylosing spondylitis', 'treatment_phase': 'Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '10890E', 'drug': 'secukinumab', 'brand': 'Cosentyx', 'formulation': 'Injection 150 mg in 1 mL pre-filled pen', 'indication': 'ankylosing spondylitis', 'treatment_phase': 'Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '10890E', 'drug': 'secukinumab', 'brand': 'Cosentyx', 'formulation': 'Injection 150 mg in 1 mL pre-filled pen', 'indication': 'ankylosing spondylitis', 'treatment_phase': 'Initial treatment - Initial 1 (new patient)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '10892G', 'drug': 'certolizumab pegol', 'brand': 'Cimzia', 'formulation': 'Injection 200 mg in 1 mL single use pre-filled syringe', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 24 months) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months) - balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12328W', 'drug': 'adalimumab', 'brand': 'Amgevita', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled pen', 'indication': 'ankylosing spondylitis', 'treatment_phase': 'First continuing treatment', 'streamlined_code': '14683', 'online_application': True, 'authority_method': 'STREAMLINED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12328W', 'drug': 'adalimumab', 'brand': 'Hadlima', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled pen', 'indication': 'ankylosing spondylitis', 'treatment_phase': 'First continuing treatment', 'streamlined_code': '14683', 'online_application': True, 'authority_method': 'STREAMLINED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12328W', 'drug': 'adalimumab', 'brand': 'Abrilada', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled pen', 'indication': 'ankylosing spondylitis', 'treatment_phase': 'First continuing treatment', 'streamlined_code': '14683', 'online_application': True, 'authority_method': 'STREAMLINED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12328W', 'drug': 'adalimumab', 'brand': 'Hyrimoz', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled pen', 'indication': 'ankylosing spondylitis', 'treatment_phase': 'First continuing treatment', 'streamlined_code': '14683', 'online_application': True, 'authority_method': 'STREAMLINED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12328W', 'drug': 'adalimumab', 'brand': 'Idacio', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled pen', 'indication': 'ankylosing spondylitis', 'treatment_phase': 'First continuing treatment', 'streamlined_code': '14683', 'online_application': True, 'authority_method': 'STREAMLINED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12328W', 'drug': 'adalimumab', 'brand': 'Amgevita', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled pen', 'indication': 'ankylosing spondylitis', 'treatment_phase': 'Subsequent continuing treatment', 'streamlined_code': '14701', 'online_application': True, 'authority_method': 'STREAMLINED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12328W', 'drug': 'adalimumab', 'brand': 'Hadlima', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled pen', 'indication': 'ankylosing spondylitis', 'treatment_phase': 'Subsequent continuing treatment', 'streamlined_code': '14701', 'online_application': True, 'authority_method': 'STREAMLINED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12328W', 'drug': 'adalimumab', 'brand': 'Abrilada', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled pen', 'indication': 'ankylosing spondylitis', 'treatment_phase': 'Subsequent continuing treatment', 'streamlined_code': '14701', 'online_application': True, 'authority_method': 'STREAMLINED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12328W', 'drug': 'adalimumab', 'brand': 'Hyrimoz', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled pen', 'indication': 'ankylosing spondylitis', 'treatment_phase': 'Subsequent continuing treatment', 'streamlined_code': '14701', 'online_application': True, 'authority_method': 'STREAMLINED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12328W', 'drug': 'adalimumab', 'brand': 'Idacio', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled pen', 'indication': 'ankylosing spondylitis', 'treatment_phase': 'Subsequent continuing treatment', 'streamlined_code': '14701', 'online_application': True, 'authority_method': 'STREAMLINED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12415K', 'drug': 'adalimumab', 'brand': 'Hadlima', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled pen', 'indication': 'psoriatic arthritis', 'treatment_phase': 'Subsequent continuing treatment', 'streamlined_code': '11523', 'online_application': True, 'authority_method': 'STREAMLINED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12415K', 'drug': 'adalimumab', 'brand': 'Amgevita', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled pen', 'indication': 'psoriatic arthritis', 'treatment_phase': 'Subsequent continuing treatment', 'streamlined_code': '11523', 'online_application': True, 'authority_method': 'STREAMLINED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12415K', 'drug': 'adalimumab', 'brand': 'Hyrimoz', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled pen', 'indication': 'psoriatic arthritis', 'treatment_phase': 'Subsequent continuing treatment', 'streamlined_code': '11523', 'online_application': True, 'authority_method': 'STREAMLINED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12415K', 'drug': 'adalimumab', 'brand': 'Idacio', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled pen', 'indication': 'psoriatic arthritis', 'treatment_phase': 'Subsequent continuing treatment', 'streamlined_code': '11523', 'online_application': True, 'authority_method': 'STREAMLINED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12415K', 'drug': 'adalimumab', 'brand': 'Abrilada', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled pen', 'indication': 'psoriatic arthritis', 'treatment_phase': 'Subsequent continuing treatment', 'streamlined_code': '11523', 'online_application': True, 'authority_method': 'STREAMLINED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12576X', 'drug': 'infliximab', 'brand': 'Remsima SC', 'formulation': 'Solution for injection 120 mg in 1 mL pre-filled syringe', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'Initial treatment with the subcutaneous form where a concurrent PBS authority application for the intravenously (IV) administered formulation is being made', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '13216N', 'drug': 'adalimumab', 'brand': 'Yuflyma', 'formulation': 'Injection 40 mg in 0.4 mL pre-filled syringe', 'indication': 'psoriatic arthritis', 'treatment_phase': 'Subsequent continuing treatment', 'streamlined_code': '11523', 'online_application': True, 'authority_method': 'STREAMLINED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '13216N', 'drug': 'adalimumab', 'brand': 'Adalicip', 'formulation': 'Injection 40 mg in 0.4 mL pre-filled syringe', 'indication': 'psoriatic arthritis', 'treatment_phase': 'Subsequent continuing treatment', 'streamlined_code': '11523', 'online_application': True, 'authority_method': 'STREAMLINED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '11748H', 'drug': 'tocilizumab', 'brand': 'Actemra Subcutaneous Injection', 'formulation': 'Injection 162 mg in 0.9 mL single use pre-filled syringe', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial treatment - Initial 1 (new patient)', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '11748H', 'drug': 'tocilizumab', 'brand': 'Actemra Subcutaneous Injection', 'formulation': 'Injection 162 mg in 0.9 mL single use pre-filled syringe', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial treatment - Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 12 months) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 12 months) - balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '11748H', 'drug': 'tocilizumab', 'brand': 'Actemra Subcutaneous Injection', 'formulation': 'Injection 162 mg in 0.9 mL single use pre-filled syringe', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 12 months)', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '11748H', 'drug': 'tocilizumab', 'brand': 'Actemra Subcutaneous Injection', 'formulation': 'Injection 162 mg in 0.9 mL single use pre-filled syringe', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 12 months)', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12102Y', 'drug': 'tocilizumab', 'brand': 'Actemra Subcutaneous Injection', 'formulation': 'Injection 162 mg in 0.9 mL single use pre-filled syringe', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Balance of supply for Initial treatment - Initial 1 (new patient) or Initial 2 (retrial or recommencement of treatment after a break of less than 12 months) or Initial 3 (recommencement of treatment after a break of more than 12 months) - in a patient of any weight being administered a subcutaneous form of this biological medicine', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '13209F', 'drug': 'adalimumab', 'brand': 'Adalicip', 'formulation': 'Injection 40 mg in 0.4 mL pre-filled syringe', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Subsequent continuing treatment', 'streamlined_code': '11604', 'online_application': True, 'authority_method': 'STREAMLINED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '13209F', 'drug': 'adalimumab', 'brand': 'Yuflyma', 'formulation': 'Injection 40 mg in 0.4 mL pre-filled syringe', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Subsequent continuing treatment', 'streamlined_code': '11604', 'online_application': True, 'authority_method': 'STREAMLINED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '13770R', 'drug': 'tofacitinib', 'brand': 'Xeljanz', 'formulation': 'Oral solution 1 mg per mL, 240 mL', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial treatment - Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 12 months) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 12 months) - balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '13770R', 'drug': 'tofacitinib', 'brand': 'Xeljanz', 'formulation': 'Oral solution 1 mg per mL, 240 mL', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial treatment - Initial 1 (new patient)', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '13770R', 'drug': 'tofacitinib', 'brand': 'Xeljanz', 'formulation': 'Oral solution 1 mg per mL, 240 mL', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 12 months)', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '13770R', 'drug': 'tofacitinib', 'brand': 'Xeljanz', 'formulation': 'Oral solution 1 mg per mL, 240 mL', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 12 months)', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '11324B', 'drug': 'certolizumab pegol', 'brand': 'Cimzia', 'formulation': 'Solution for injection 200 mg in 1 mL pre-filled pen', 'indication': 'psoriatic arthritis', 'treatment_phase': 'Continuing treatment - balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '11324B', 'drug': 'certolizumab pegol', 'brand': 'Cimzia', 'formulation': 'Solution for injection 200 mg in 1 mL pre-filled pen', 'indication': 'psoriatic arthritis', 'treatment_phase': 'Continuing treatment', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '13696W', 'drug': 'tocilizumab', 'brand': 'Actemra', 'formulation': 'Concentrate for injection 80 mg in 4 mL', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'Subsequent continuing treatment', 'streamlined_code': '14485', 'online_application': True, 'authority_method': 'STREAMLINED', 'hospital_type': 'Private', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '10909E', 'drug': 'certolizumab pegol', 'brand': 'Cimzia', 'formulation': 'Injection 200 mg in 1 mL single use pre-filled syringe', 'indication': 'psoriatic arthritis', 'treatment_phase': 'Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '10909E', 'drug': 'certolizumab pegol', 'brand': 'Cimzia', 'formulation': 'Injection 200 mg in 1 mL single use pre-filled syringe', 'indication': 'psoriatic arthritis', 'treatment_phase': 'Initial treatment - Initial 1 (new patient)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '10909E', 'drug': 'certolizumab pegol', 'brand': 'Cimzia', 'formulation': 'Injection 200 mg in 1 mL single use pre-filled syringe', 'indication': 'psoriatic arthritis', 'treatment_phase': 'Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '13077G', 'drug': 'infliximab', 'brand': 'Remsima SC', 'formulation': 'Solution for injection 120 mg in 1 mL pre-filled pen', 'indication': 'psoriatic arthritis', 'treatment_phase': 'Initial treatment with the subcutaneous form where a concurrent PBS authority application for the intravenously (IV) administered formulation is being made', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12390D', 'drug': 'adalimumab', 'brand': 'Humira', 'formulation': 'Injection 40 mg in 0.4 mL pre-filled pen', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'First continuing treatment - balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12390D', 'drug': 'adalimumab', 'brand': 'Yuflyma', 'formulation': 'Injection 40 mg in 0.4 mL pre-filled pen', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'First continuing treatment - balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12390D', 'drug': 'adalimumab', 'brand': 'Adalicip', 'formulation': 'Injection 40 mg in 0.4 mL pre-filled pen', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'First continuing treatment - balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12390D', 'drug': 'adalimumab', 'brand': 'Humira', 'formulation': 'Injection 40 mg in 0.4 mL pre-filled pen', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'First continuing treatment', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12390D', 'drug': 'adalimumab', 'brand': 'Yuflyma', 'formulation': 'Injection 40 mg in 0.4 mL pre-filled pen', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'First continuing treatment', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12390D', 'drug': 'adalimumab', 'brand': 'Adalicip', 'formulation': 'Injection 40 mg in 0.4 mL pre-filled pen', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'First continuing treatment', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9458T', 'drug': 'etanercept', 'brand': 'Brenzys', 'formulation': 'Injection 50 mg in 1 mL single use auto-injector, 4', 'indication': 'psoriatic arthritis', 'treatment_phase': 'First continuing treatment', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9458T', 'drug': 'etanercept', 'brand': 'Enbrel', 'formulation': 'Injection 50 mg in 1 mL single use auto-injector, 4', 'indication': 'psoriatic arthritis', 'treatment_phase': 'First continuing treatment', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9458T', 'drug': 'etanercept', 'brand': 'Brenzys', 'formulation': 'Injection 50 mg in 1 mL single use auto-injector, 4', 'indication': 'psoriatic arthritis', 'treatment_phase': 'Continuing treatment - balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9458T', 'drug': 'etanercept', 'brand': 'Enbrel', 'formulation': 'Injection 50 mg in 1 mL single use auto-injector, 4', 'indication': 'psoriatic arthritis', 'treatment_phase': 'Continuing treatment - balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12577Y', 'drug': 'infliximab', 'brand': 'Remsima SC', 'formulation': 'Solution for injection 120 mg in 1 mL pre-filled pen', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'Initial treatment with the subcutaneous form where a concurrent PBS authority application for the intravenously (IV) administered formulation is being made', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '10900Q', 'drug': 'secukinumab', 'brand': 'Cosentyx', 'formulation': 'Injection 150 mg in 1 mL pre-filled pen', 'indication': 'psoriatic arthritis', 'treatment_phase': 'Initial treatment - Initial 1 (new patient)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '10900Q', 'drug': 'secukinumab', 'brand': 'Cosentyx', 'formulation': 'Injection 150 mg in 1 mL pre-filled pen', 'indication': 'psoriatic arthritis', 'treatment_phase': 'Initial treatment - Initial 2 (change or recommencement of treatment after a break in in biological medicine of less than 5 years)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '10900Q', 'drug': 'secukinumab', 'brand': 'Cosentyx', 'formulation': 'Injection 150 mg in 1 mL pre-filled pen', 'indication': 'psoriatic arthritis', 'treatment_phase': 'Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9104E', 'drug': 'adalimumab', 'brand': 'Hyrimoz', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled pen', 'indication': 'ankylosing spondylitis', 'treatment_phase': 'First continuing treatment', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9104E', 'drug': 'adalimumab', 'brand': 'Hadlima', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled pen', 'indication': 'ankylosing spondylitis', 'treatment_phase': 'First continuing treatment', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9104E', 'drug': 'adalimumab', 'brand': 'Abrilada', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled pen', 'indication': 'ankylosing spondylitis', 'treatment_phase': 'First continuing treatment', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9104E', 'drug': 'adalimumab', 'brand': 'Idacio', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled pen', 'indication': 'ankylosing spondylitis', 'treatment_phase': 'First continuing treatment', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9104E', 'drug': 'adalimumab', 'brand': 'Amgevita', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled pen', 'indication': 'ankylosing spondylitis', 'treatment_phase': 'First continuing treatment', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9104E', 'drug': 'adalimumab', 'brand': 'Hyrimoz', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled pen', 'indication': 'ankylosing spondylitis', 'treatment_phase': 'Subsequent continuing treatment', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9104E', 'drug': 'adalimumab', 'brand': 'Hadlima', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled pen', 'indication': 'ankylosing spondylitis', 'treatment_phase': 'Subsequent continuing treatment', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9104E', 'drug': 'adalimumab', 'brand': 'Abrilada', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled pen', 'indication': 'ankylosing spondylitis', 'treatment_phase': 'Subsequent continuing treatment', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9104E', 'drug': 'adalimumab', 'brand': 'Idacio', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled pen', 'indication': 'ankylosing spondylitis', 'treatment_phase': 'Subsequent continuing treatment', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9104E', 'drug': 'adalimumab', 'brand': 'Amgevita', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled pen', 'indication': 'ankylosing spondylitis', 'treatment_phase': 'Subsequent continuing treatment', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9104E', 'drug': 'adalimumab', 'brand': 'Hyrimoz', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled pen', 'indication': 'ankylosing spondylitis', 'treatment_phase': 'Continuing treatment - balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9104E', 'drug': 'adalimumab', 'brand': 'Hadlima', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled pen', 'indication': 'ankylosing spondylitis', 'treatment_phase': 'Continuing treatment - balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9104E', 'drug': 'adalimumab', 'brand': 'Abrilada', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled pen', 'indication': 'ankylosing spondylitis', 'treatment_phase': 'Continuing treatment - balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9104E', 'drug': 'adalimumab', 'brand': 'Idacio', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled pen', 'indication': 'ankylosing spondylitis', 'treatment_phase': 'Continuing treatment - balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9104E', 'drug': 'adalimumab', 'brand': 'Amgevita', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled pen', 'indication': 'ankylosing spondylitis', 'treatment_phase': 'Continuing treatment - balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '13293P', 'drug': 'adalimumab', 'brand': 'Humira', 'formulation': 'Injection 20 mg in 0.2 mL pre-filled syringe', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Continuing treatment', 'streamlined_code': '14136', 'online_application': True, 'authority_method': 'STREAMLINED', 'hospital_type': 'Public', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '11521J', 'drug': 'golimumab', 'brand': 'Simponi', 'formulation': 'Injection 50 mg in 0.5 mL single use pre-filled pen', 'indication': 'non-radiographic axial spondyloarthritis', 'treatment_phase': 'Continuing treatment', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '11521J', 'drug': 'golimumab', 'brand': 'Simponi', 'formulation': 'Injection 50 mg in 0.5 mL single use pre-filled pen', 'indication': 'non-radiographic axial spondyloarthritis', 'treatment_phase': 'Continuing treatment - balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '1423X', 'drug': 'tocilizumab', 'brand': 'Actemra', 'formulation': 'Concentrate for injection 200 mg in 10 mL', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial treatment - Initial 1 (new patient)', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Private', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '1423X', 'drug': 'tocilizumab', 'brand': 'Actemra', 'formulation': 'Concentrate for injection 200 mg in 10 mL', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial treatment - Initial 3 (recommencement of treatment after a break of more than 12 months)', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Private', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '1423X', 'drug': 'tocilizumab', 'brand': 'Actemra', 'formulation': 'Concentrate for injection 200 mg in 10 mL', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial treatment - Initial 2 (retrial or recommencement of treatment after a break of less than 12 months)', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Private', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '1423X', 'drug': 'tocilizumab', 'brand': 'Actemra', 'formulation': 'Concentrate for injection 200 mg in 10 mL', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Balance of supply for Initial treatment - Initial 1 (new patient) or Initial 2 (retrial or recommencement of treatment after a break of less than 12 months) or Initial 3 (recommencement of treatment after a break of more than 12 months)', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Private', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '11743C', 'drug': 'tocilizumab', 'brand': 'Actemra Subcutaneous Injection', 'formulation': 'Injection 162 mg in 0.9 mL single use pre-filled syringe', 'indication': 'giant cell arteritis', 'treatment_phase': 'Initial treatment', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12084B', 'drug': 'tocilizumab', 'brand': 'Actemra ACTPen', 'formulation': 'Injection 162 mg in 0.9 mL single use pre-filled pen', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Continuing treatment in a patient weighing at least 30 kg', 'streamlined_code': '14088', 'online_application': True, 'authority_method': 'STREAMLINED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '13345J', 'drug': 'tofacitinib', 'brand': 'Xeljanz', 'formulation': 'Tablet 5 mg', 'indication': 'ankylosing spondylitis', 'treatment_phase': 'Continuing treatment', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '13345J', 'drug': 'tofacitinib', 'brand': 'Xeljanz', 'formulation': 'Tablet 5 mg', 'indication': 'ankylosing spondylitis', 'treatment_phase': 'Continuing treatment - balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '13345J', 'drug': 'tofacitinib', 'brand': 'Xeljanz', 'formulation': 'Tablet 5 mg', 'indication': 'ankylosing spondylitis', 'treatment_phase': 'Transitioning from non-PBS to PBS-subsidised supply - Grandfather arrangements', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12795K', 'drug': 'tocilizumab', 'brand': 'Actemra', 'formulation': 'Concentrate for injection 200 mg in 10 mL', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial treatment - Initial 4 (Temporary listing - change of treatment from another biological medicine to tocilzumab after resolution of the critical shortage of tocilizumab)', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Private', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12795K', 'drug': 'tocilizumab', 'brand': 'Actemra', 'formulation': 'Concentrate for injection 200 mg in 10 mL', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial treatment - Initial 4 (Temporary listing - change of treatment from another biological medicine to tocilizumab after resolution of the critical shortage of tocilizumab)', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Private', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '13685G', 'drug': 'tocilizumab', 'brand': 'Actemra Subcutaneous Injection', 'formulation': 'Injection 162 mg in 0.9 mL single use pre-filled syringe', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'Subsequent continuing treatment', 'streamlined_code': '14499', 'online_application': True, 'authority_method': 'STREAMLINED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '13763J', 'drug': 'adalimumab', 'brand': 'Yuflyma', 'formulation': 'Injection 40 mg in 0.4 mL pre-filled syringe', 'indication': 'ankylosing spondylitis', 'treatment_phase': 'Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years)', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '13763J', 'drug': 'adalimumab', 'brand': 'Adalicip', 'formulation': 'Injection 40 mg in 0.4 mL pre-filled syringe', 'indication': 'ankylosing spondylitis', 'treatment_phase': 'Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years)', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '13763J', 'drug': 'adalimumab', 'brand': 'Yuflyma', 'formulation': 'Injection 40 mg in 0.4 mL pre-filled syringe', 'indication': 'ankylosing spondylitis', 'treatment_phase': 'Initial treatment - Initial 1 (new patient)', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '13763J', 'drug': 'adalimumab', 'brand': 'Adalicip', 'formulation': 'Injection 40 mg in 0.4 mL pre-filled syringe', 'indication': 'ankylosing spondylitis', 'treatment_phase': 'Initial treatment - Initial 1 (new patient)', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '13763J', 'drug': 'adalimumab', 'brand': 'Yuflyma', 'formulation': 'Injection 40 mg in 0.4 mL pre-filled syringe', 'indication': 'ankylosing spondylitis', 'treatment_phase': 'Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years)', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '13763J', 'drug': 'adalimumab', 'brand': 'Adalicip', 'formulation': 'Injection 40 mg in 0.4 mL pre-filled syringe', 'indication': 'ankylosing spondylitis', 'treatment_phase': 'Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years)', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12364R', 'drug': 'adalimumab', 'brand': 'Humira', 'formulation': 'Injection 40 mg in 0.4 mL pre-filled syringe', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12364R', 'drug': 'adalimumab', 'brand': 'Adalicip', 'formulation': 'Injection 40 mg in 0.4 mL pre-filled syringe', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12364R', 'drug': 'adalimumab', 'brand': 'Yuflyma', 'formulation': 'Injection 40 mg in 0.4 mL pre-filled syringe', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12364R', 'drug': 'adalimumab', 'brand': 'Humira', 'formulation': 'Injection 40 mg in 0.4 mL pre-filled syringe', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial treatment - Initial 2 (change or recommencement of treatment after break in biological medicine of less than 24 months)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12364R', 'drug': 'adalimumab', 'brand': 'Adalicip', 'formulation': 'Injection 40 mg in 0.4 mL pre-filled syringe', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial treatment - Initial 2 (change or recommencement of treatment after break in biological medicine of less than 24 months)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12364R', 'drug': 'adalimumab', 'brand': 'Yuflyma', 'formulation': 'Injection 40 mg in 0.4 mL pre-filled syringe', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial treatment - Initial 2 (change or recommencement of treatment after break in biological medicine of less than 24 months)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12364R', 'drug': 'adalimumab', 'brand': 'Humira', 'formulation': 'Injection 40 mg in 0.4 mL pre-filled syringe', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial treatment - Initial 1 (new patient)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12364R', 'drug': 'adalimumab', 'brand': 'Adalicip', 'formulation': 'Injection 40 mg in 0.4 mL pre-filled syringe', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial treatment - Initial 1 (new patient)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12364R', 'drug': 'adalimumab', 'brand': 'Yuflyma', 'formulation': 'Injection 40 mg in 0.4 mL pre-filled syringe', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial treatment - Initial 1 (new patient)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12364R', 'drug': 'adalimumab', 'brand': 'Humira', 'formulation': 'Injection 40 mg in 0.4 mL pre-filled syringe', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial treatment - Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after break of less than 24 months) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months) -  balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12364R', 'drug': 'adalimumab', 'brand': 'Adalicip', 'formulation': 'Injection 40 mg in 0.4 mL pre-filled syringe', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial treatment - Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after break of less than 24 months) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months) -  balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12364R', 'drug': 'adalimumab', 'brand': 'Yuflyma', 'formulation': 'Injection 40 mg in 0.4 mL pre-filled syringe', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial treatment - Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after break of less than 24 months) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months) -  balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '13332Q', 'drug': 'etanercept', 'brand': 'Enbrel', 'formulation': 'Injections 50 mg in 1 mL single use pre-filled syringes, 4', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Continuing treatment', 'streamlined_code': '14155', 'online_application': True, 'authority_method': 'STREAMLINED', 'hospital_type': 'Private', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12625L', 'drug': 'upadacitinib', 'brand': 'Rinvoq', 'formulation': 'Tablet 15 mg', 'indication': 'ankylosing spondylitis', 'treatment_phase': 'Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12625L', 'drug': 'upadacitinib', 'brand': 'Rinvoq', 'formulation': 'Tablet 15 mg', 'indication': 'ankylosing spondylitis', 'treatment_phase': 'Initial treatment - Initial 1 (new patient)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12625L', 'drug': 'upadacitinib', 'brand': 'Rinvoq', 'formulation': 'Tablet 15 mg', 'indication': 'ankylosing spondylitis', 'treatment_phase': 'Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12625L', 'drug': 'upadacitinib', 'brand': 'Rinvoq', 'formulation': 'Tablet 15 mg', 'indication': 'ankylosing spondylitis', 'treatment_phase': 'Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years) - balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9659J', 'drug': 'tocilizumab', 'brand': 'Actemra', 'formulation': 'Concentrate for injection 400 mg in 20 mL', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'First continuing treatment - balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Public', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9659J', 'drug': 'tocilizumab', 'brand': 'Actemra', 'formulation': 'Concentrate for injection 400 mg in 20 mL', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 24 months) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months) - balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Public', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9659J', 'drug': 'tocilizumab', 'brand': 'Actemra', 'formulation': 'Concentrate for injection 400 mg in 20 mL', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Public', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9659J', 'drug': 'tocilizumab', 'brand': 'Actemra', 'formulation': 'Concentrate for injection 400 mg in 20 mL', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 24 months)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Public', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9659J', 'drug': 'tocilizumab', 'brand': 'Actemra', 'formulation': 'Concentrate for injection 400 mg in 20 mL', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'First continuing treatment', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Public', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9659J', 'drug': 'tocilizumab', 'brand': 'Actemra', 'formulation': 'Concentrate for injection 400 mg in 20 mL', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'Initial treatment - Initial 1 (new patient)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Public', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '11481G', 'drug': 'infliximab', 'brand': 'Inflectra', 'formulation': 'Powder for I.V. infusion 100 mg', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'Subsequent continuing treatment', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Public', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '11481G', 'drug': 'infliximab', 'brand': 'Renflexis', 'formulation': 'Powder for I.V. infusion 100 mg', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'Subsequent continuing treatment', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Public', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '11481G', 'drug': 'infliximab', 'brand': 'Remicade', 'formulation': 'Powder for I.V. infusion 100 mg', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'Subsequent continuing treatment', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Public', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '1476Q', 'drug': 'tocilizumab', 'brand': 'Actemra', 'formulation': 'Concentrate for injection 80 mg in 4 mL', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial treatment - Initial 1 (new patient)', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Public', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '1476Q', 'drug': 'tocilizumab', 'brand': 'Actemra', 'formulation': 'Concentrate for injection 80 mg in 4 mL', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Balance of supply for Initial treatment - Initial 1 (new patient) or Initial 2 (retrial or recommencement of treatment after a break of less than 12 months) or Initial 3 (recommencement of treatment after a break of more than 12 months)', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Public', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '1476Q', 'drug': 'tocilizumab', 'brand': 'Actemra', 'formulation': 'Concentrate for injection 80 mg in 4 mL', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial treatment - Initial 2 (retrial or recommencement of treatment after a break of less than 12 months)', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Public', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '1476Q', 'drug': 'tocilizumab', 'brand': 'Actemra', 'formulation': 'Concentrate for injection 80 mg in 4 mL', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial treatment - Initial 3 (recommencement of treatment after a break of more than 12 months)', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Public', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '10895K', 'drug': 'secukinumab', 'brand': 'Cosentyx', 'formulation': 'Injection 150 mg in 1 mL pre-filled pen', 'indication': 'psoriatic arthritis', 'treatment_phase': 'Continuing treatment', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '10895K', 'drug': 'secukinumab', 'brand': 'Cosentyx', 'formulation': 'Injection 150 mg in 1 mL pre-filled pen', 'indication': 'psoriatic arthritis', 'treatment_phase': 'Continuing treatment - balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '6496X', 'drug': 'infliximab', 'brand': 'Inflectra', 'formulation': 'Powder for I.V. infusion 100 mg', 'indication': 'psoriatic arthritis', 'treatment_phase': 'First continuing treatment', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Private', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '6496X', 'drug': 'infliximab', 'brand': 'Remicade', 'formulation': 'Powder for I.V. infusion 100 mg', 'indication': 'psoriatic arthritis', 'treatment_phase': 'First continuing treatment', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Private', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '6496X', 'drug': 'infliximab', 'brand': 'Renflexis', 'formulation': 'Powder for I.V. infusion 100 mg', 'indication': 'psoriatic arthritis', 'treatment_phase': 'First continuing treatment', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Private', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '6496X', 'drug': 'infliximab', 'brand': 'Inflectra', 'formulation': 'Powder for I.V. infusion 100 mg', 'indication': 'psoriatic arthritis', 'treatment_phase': 'Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Private', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '6496X', 'drug': 'infliximab', 'brand': 'Remicade', 'formulation': 'Powder for I.V. infusion 100 mg', 'indication': 'psoriatic arthritis', 'treatment_phase': 'Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Private', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '6496X', 'drug': 'infliximab', 'brand': 'Renflexis', 'formulation': 'Powder for I.V. infusion 100 mg', 'indication': 'psoriatic arthritis', 'treatment_phase': 'Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Private', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '6496X', 'drug': 'infliximab', 'brand': 'Inflectra', 'formulation': 'Powder for I.V. infusion 100 mg', 'indication': 'psoriatic arthritis', 'treatment_phase': 'Initial treatment - Initial 1 (new patient)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Private', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '6496X', 'drug': 'infliximab', 'brand': 'Remicade', 'formulation': 'Powder for I.V. infusion 100 mg', 'indication': 'psoriatic arthritis', 'treatment_phase': 'Initial treatment - Initial 1 (new patient)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Private', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '6496X', 'drug': 'infliximab', 'brand': 'Renflexis', 'formulation': 'Powder for I.V. infusion 100 mg', 'indication': 'psoriatic arthritis', 'treatment_phase': 'Initial treatment - Initial 1 (new patient)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Private', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '6496X', 'drug': 'infliximab', 'brand': 'Inflectra', 'formulation': 'Powder for I.V. infusion 100 mg', 'indication': 'psoriatic arthritis', 'treatment_phase': 'Continuing treatment - balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Private', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '6496X', 'drug': 'infliximab', 'brand': 'Remicade', 'formulation': 'Powder for I.V. infusion 100 mg', 'indication': 'psoriatic arthritis', 'treatment_phase': 'Continuing treatment - balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Private', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '6496X', 'drug': 'infliximab', 'brand': 'Renflexis', 'formulation': 'Powder for I.V. infusion 100 mg', 'indication': 'psoriatic arthritis', 'treatment_phase': 'Continuing treatment - balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Private', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '6496X', 'drug': 'infliximab', 'brand': 'Inflectra', 'formulation': 'Powder for I.V. infusion 100 mg', 'indication': 'psoriatic arthritis', 'treatment_phase': 'Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Private', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '6496X', 'drug': 'infliximab', 'brand': 'Remicade', 'formulation': 'Powder for I.V. infusion 100 mg', 'indication': 'psoriatic arthritis', 'treatment_phase': 'Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Private', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '6496X', 'drug': 'infliximab', 'brand': 'Renflexis', 'formulation': 'Powder for I.V. infusion 100 mg', 'indication': 'psoriatic arthritis', 'treatment_phase': 'Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Private', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '6496X', 'drug': 'infliximab', 'brand': 'Inflectra', 'formulation': 'Powder for I.V. infusion 100 mg', 'indication': 'psoriatic arthritis', 'treatment_phase': 'Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years) - balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Private', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '6496X', 'drug': 'infliximab', 'brand': 'Remicade', 'formulation': 'Powder for I.V. infusion 100 mg', 'indication': 'psoriatic arthritis', 'treatment_phase': 'Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years) - balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Private', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '6496X', 'drug': 'infliximab', 'brand': 'Renflexis', 'formulation': 'Powder for I.V. infusion 100 mg', 'indication': 'psoriatic arthritis', 'treatment_phase': 'Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years) - balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Private', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '11320T', 'drug': 'certolizumab pegol', 'brand': 'Cimzia', 'formulation': 'Solution for injection 200 mg in 1 mL pre-filled pen', 'indication': 'ankylosing spondylitis', 'treatment_phase': 'Continuing treatment - balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '11320T', 'drug': 'certolizumab pegol', 'brand': 'Cimzia', 'formulation': 'Solution for injection 200 mg in 1 mL pre-filled pen', 'indication': 'ankylosing spondylitis', 'treatment_phase': 'Continuing treatment', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '11721X', 'drug': 'tocilizumab', 'brand': 'Actemra Subcutaneous Injection', 'formulation': 'Injection 162 mg in 0.9 mL single use pre-filled syringe', 'indication': 'giant cell arteritis', 'treatment_phase': 'Continuing treatment', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9615C', 'drug': 'etanercept', 'brand': 'Enbrel', 'formulation': 'Injections 50 mg in 1 mL single use pre-filled syringes, 4', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial treatment - Initial 1 (new patient)', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Private', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9615C', 'drug': 'etanercept', 'brand': 'Enbrel', 'formulation': 'Injections 50 mg in 1 mL single use pre-filled syringes, 4', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 12 months)', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Private', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9615C', 'drug': 'etanercept', 'brand': 'Enbrel', 'formulation': 'Injections 50 mg in 1 mL single use pre-filled syringes, 4', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 12 months)', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Private', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9615C', 'drug': 'etanercept', 'brand': 'Enbrel', 'formulation': 'Injections 50 mg in 1 mL single use pre-filled syringes, 4', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial treatment - Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 12 months) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 12 months) - balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Private', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9077R', 'drug': 'adalimumab', 'brand': 'Amgevita', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled syringe', 'indication': 'ankylosing spondylitis', 'treatment_phase': 'Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9077R', 'drug': 'adalimumab', 'brand': 'Hadlima', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled syringe', 'indication': 'ankylosing spondylitis', 'treatment_phase': 'Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9077R', 'drug': 'adalimumab', 'brand': 'Idacio', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled syringe', 'indication': 'ankylosing spondylitis', 'treatment_phase': 'Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9077R', 'drug': 'adalimumab', 'brand': 'Abrilada', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled syringe', 'indication': 'ankylosing spondylitis', 'treatment_phase': 'Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9077R', 'drug': 'adalimumab', 'brand': 'Hyrimoz', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled syringe', 'indication': 'ankylosing spondylitis', 'treatment_phase': 'Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9077R', 'drug': 'adalimumab', 'brand': 'Amgevita', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled syringe', 'indication': 'ankylosing spondylitis', 'treatment_phase': 'Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years) - balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9077R', 'drug': 'adalimumab', 'brand': 'Hadlima', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled syringe', 'indication': 'ankylosing spondylitis', 'treatment_phase': 'Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years) - balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9077R', 'drug': 'adalimumab', 'brand': 'Idacio', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled syringe', 'indication': 'ankylosing spondylitis', 'treatment_phase': 'Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years) - balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9077R', 'drug': 'adalimumab', 'brand': 'Abrilada', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled syringe', 'indication': 'ankylosing spondylitis', 'treatment_phase': 'Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years) - balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9077R', 'drug': 'adalimumab', 'brand': 'Hyrimoz', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled syringe', 'indication': 'ankylosing spondylitis', 'treatment_phase': 'Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years) - balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9077R', 'drug': 'adalimumab', 'brand': 'Amgevita', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled syringe', 'indication': 'ankylosing spondylitis', 'treatment_phase': 'Initial treatment - Initial 1 (new patient)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9077R', 'drug': 'adalimumab', 'brand': 'Hadlima', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled syringe', 'indication': 'ankylosing spondylitis', 'treatment_phase': 'Initial treatment - Initial 1 (new patient)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9077R', 'drug': 'adalimumab', 'brand': 'Idacio', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled syringe', 'indication': 'ankylosing spondylitis', 'treatment_phase': 'Initial treatment - Initial 1 (new patient)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9077R', 'drug': 'adalimumab', 'brand': 'Abrilada', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled syringe', 'indication': 'ankylosing spondylitis', 'treatment_phase': 'Initial treatment - Initial 1 (new patient)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9077R', 'drug': 'adalimumab', 'brand': 'Hyrimoz', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled syringe', 'indication': 'ankylosing spondylitis', 'treatment_phase': 'Initial treatment - Initial 1 (new patient)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9077R', 'drug': 'adalimumab', 'brand': 'Amgevita', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled syringe', 'indication': 'ankylosing spondylitis', 'treatment_phase': 'Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9077R', 'drug': 'adalimumab', 'brand': 'Hadlima', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled syringe', 'indication': 'ankylosing spondylitis', 'treatment_phase': 'Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9077R', 'drug': 'adalimumab', 'brand': 'Idacio', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled syringe', 'indication': 'ankylosing spondylitis', 'treatment_phase': 'Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9077R', 'drug': 'adalimumab', 'brand': 'Abrilada', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled syringe', 'indication': 'ankylosing spondylitis', 'treatment_phase': 'Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9077R', 'drug': 'adalimumab', 'brand': 'Hyrimoz', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled syringe', 'indication': 'ankylosing spondylitis', 'treatment_phase': 'Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '5284D', 'drug': 'adalimumab', 'brand': 'Idacio', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled pen', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Continuing treatment - balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '5284D', 'drug': 'adalimumab', 'brand': 'Hyrimoz', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled pen', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Continuing treatment - balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '5284D', 'drug': 'adalimumab', 'brand': 'Hadlima', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled pen', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Continuing treatment - balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '5284D', 'drug': 'adalimumab', 'brand': 'Abrilada', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled pen', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Continuing treatment - balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '5284D', 'drug': 'adalimumab', 'brand': 'Amgevita', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled pen', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Continuing treatment - balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '5284D', 'drug': 'adalimumab', 'brand': 'Idacio', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled pen', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Subsequent continuing treatment', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '5284D', 'drug': 'adalimumab', 'brand': 'Hyrimoz', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled pen', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Subsequent continuing treatment', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '5284D', 'drug': 'adalimumab', 'brand': 'Hadlima', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled pen', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Subsequent continuing treatment', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '5284D', 'drug': 'adalimumab', 'brand': 'Abrilada', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled pen', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Subsequent continuing treatment', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '5284D', 'drug': 'adalimumab', 'brand': 'Amgevita', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled pen', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Subsequent continuing treatment', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '5284D', 'drug': 'adalimumab', 'brand': 'Idacio', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled pen', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'First continuing treatment', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '5284D', 'drug': 'adalimumab', 'brand': 'Hyrimoz', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled pen', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'First continuing treatment', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '5284D', 'drug': 'adalimumab', 'brand': 'Hadlima', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled pen', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'First continuing treatment', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '5284D', 'drug': 'adalimumab', 'brand': 'Abrilada', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled pen', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'First continuing treatment', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '5284D', 'drug': 'adalimumab', 'brand': 'Amgevita', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled pen', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'First continuing treatment', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12321L', 'drug': 'secukinumab', 'brand': 'Cosentyx', 'formulation': 'Injection 150 mg in 1 mL pre-filled pen', 'indication': 'non-radiographic axial spondyloarthritis', 'treatment_phase': 'Initial treatment - Initial 1 (New patient)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12321L', 'drug': 'secukinumab', 'brand': 'Cosentyx', 'formulation': 'Injection 150 mg in 1 mL pre-filled pen', 'indication': 'non-radiographic axial spondyloarthritis', 'treatment_phase': 'Initial treatment - Initial 2 (Change or recommencement of treatment after a break in biological medicine of less than 5 years)', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12321L', 'drug': 'secukinumab', 'brand': 'Cosentyx', 'formulation': 'Injection 150 mg in 1 mL pre-filled pen', 'indication': 'non-radiographic axial spondyloarthritis', 'treatment_phase': 'Initial treatment - Initial 3 (Recommencement of treatment after a break in biological medicine of more than 5 years)', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12806B', 'drug': 'tocilizumab', 'brand': 'Actemra Subcutaneous Injection', 'formulation': 'Injection 162 mg in 0.9 mL single use pre-filled syringe', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'Initial treatment - Initial 4 (Temporary listing - change of treatment from another biological medicine to tocilizumab after resolution of the critical shortage of tocilizumab)', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9089J', 'drug': 'etanercept', 'brand': 'Brenzys', 'formulation': 'Injections 50 mg in 1 mL single use pre-filled syringes, 4', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'Initial treatment - Initial 1 (new patient)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9089J', 'drug': 'etanercept', 'brand': 'Enbrel', 'formulation': 'Injections 50 mg in 1 mL single use pre-filled syringes, 4', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'Initial treatment - Initial 1 (new patient)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9089J', 'drug': 'etanercept', 'brand': 'Brenzys', 'formulation': 'Injections 50 mg in 1 mL single use pre-filled syringes, 4', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 24 months)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9089J', 'drug': 'etanercept', 'brand': 'Enbrel', 'formulation': 'Injections 50 mg in 1 mL single use pre-filled syringes, 4', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 24 months)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9089J', 'drug': 'etanercept', 'brand': 'Brenzys', 'formulation': 'Injections 50 mg in 1 mL single use pre-filled syringes, 4', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9089J', 'drug': 'etanercept', 'brand': 'Enbrel', 'formulation': 'Injections 50 mg in 1 mL single use pre-filled syringes, 4', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9089J', 'drug': 'etanercept', 'brand': 'Brenzys', 'formulation': 'Injections 50 mg in 1 mL single use pre-filled syringes, 4', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 24 months) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months) - balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9089J', 'drug': 'etanercept', 'brand': 'Enbrel', 'formulation': 'Injections 50 mg in 1 mL single use pre-filled syringes, 4', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 24 months) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months) - balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '5282B', 'drug': 'adalimumab', 'brand': 'Idacio', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled pen', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial treatment - Initial 1 (new patient)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '5282B', 'drug': 'adalimumab', 'brand': 'Abrilada', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled pen', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial treatment - Initial 1 (new patient)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '5282B', 'drug': 'adalimumab', 'brand': 'Hadlima', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled pen', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial treatment - Initial 1 (new patient)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '5282B', 'drug': 'adalimumab', 'brand': 'Hyrimoz', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled pen', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial treatment - Initial 1 (new patient)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '5282B', 'drug': 'adalimumab', 'brand': 'Amgevita', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled pen', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial treatment - Initial 1 (new patient)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '5282B', 'drug': 'adalimumab', 'brand': 'Idacio', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled pen', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial treatment - Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after break of less than 24 months) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months) -  balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '5282B', 'drug': 'adalimumab', 'brand': 'Abrilada', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled pen', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial treatment - Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after break of less than 24 months) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months) -  balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '5282B', 'drug': 'adalimumab', 'brand': 'Hadlima', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled pen', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial treatment - Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after break of less than 24 months) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months) -  balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '5282B', 'drug': 'adalimumab', 'brand': 'Hyrimoz', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled pen', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial treatment - Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after break of less than 24 months) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months) -  balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '5282B', 'drug': 'adalimumab', 'brand': 'Amgevita', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled pen', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial treatment - Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after break of less than 24 months) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months) -  balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '5282B', 'drug': 'adalimumab', 'brand': 'Idacio', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled pen', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '5282B', 'drug': 'adalimumab', 'brand': 'Abrilada', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled pen', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '5282B', 'drug': 'adalimumab', 'brand': 'Hadlima', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled pen', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '5282B', 'drug': 'adalimumab', 'brand': 'Hyrimoz', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled pen', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '5282B', 'drug': 'adalimumab', 'brand': 'Amgevita', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled pen', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '5282B', 'drug': 'adalimumab', 'brand': 'Idacio', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled pen', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial treatment - Initial 2 (change or recommencement of treatment after break in biological medicine of less than 24 months)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '5282B', 'drug': 'adalimumab', 'brand': 'Abrilada', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled pen', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial treatment - Initial 2 (change or recommencement of treatment after break in biological medicine of less than 24 months)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '5282B', 'drug': 'adalimumab', 'brand': 'Hadlima', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled pen', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial treatment - Initial 2 (change or recommencement of treatment after break in biological medicine of less than 24 months)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '5282B', 'drug': 'adalimumab', 'brand': 'Hyrimoz', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled pen', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial treatment - Initial 2 (change or recommencement of treatment after break in biological medicine of less than 24 months)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '5282B', 'drug': 'adalimumab', 'brand': 'Amgevita', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled pen', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial treatment - Initial 2 (change or recommencement of treatment after break in biological medicine of less than 24 months)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '11979L', 'drug': 'upadacitinib', 'brand': 'Rinvoq', 'formulation': 'Tablet 15 mg', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'First Continuing treatment', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '11979L', 'drug': 'upadacitinib', 'brand': 'Rinvoq', 'formulation': 'Tablet 15 mg', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'First Continuing treatment - balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9090K', 'drug': 'etanercept', 'brand': 'Brenzys', 'formulation': 'Injections 50 mg in 1 mL single use pre-filled syringes, 4', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'First continuing treatment', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9090K', 'drug': 'etanercept', 'brand': 'Enbrel', 'formulation': 'Injections 50 mg in 1 mL single use pre-filled syringes, 4', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'First continuing treatment', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9090K', 'drug': 'etanercept', 'brand': 'Brenzys', 'formulation': 'Injections 50 mg in 1 mL single use pre-filled syringes, 4', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'First continuing treatment - balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9090K', 'drug': 'etanercept', 'brand': 'Enbrel', 'formulation': 'Injections 50 mg in 1 mL single use pre-filled syringes, 4', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'First continuing treatment - balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12810F', 'drug': 'tocilizumab', 'brand': 'Actemra', 'formulation': 'Concentrate for injection 400 mg in 20 mL', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial treatment - Initial 4 (Temporary listing - change of treatment from another biological medicine to tocilzumab after resolution of the critical shortage of tocilizumab)', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Private', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12810F', 'drug': 'tocilizumab', 'brand': 'Actemra', 'formulation': 'Concentrate for injection 400 mg in 20 mL', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial treatment - Initial 4 (Temporary listing - change of treatment from another biological medicine to tocilizumab after resolution of the critical shortage of tocilizumab)', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Private', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12568L', 'drug': 'guselkumab', 'brand': 'Tremfya', 'formulation': 'Injection 100 mg in 1 mL single use pre-filled pen', 'indication': 'psoriatic arthritis', 'treatment_phase': 'Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years) - balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12568L', 'drug': 'guselkumab', 'brand': 'Tremfya', 'formulation': 'Injection 100 mg in 1 mL single use pre-filled pen', 'indication': 'psoriatic arthritis', 'treatment_phase': 'Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12568L', 'drug': 'guselkumab', 'brand': 'Tremfya', 'formulation': 'Injection 100 mg in 1 mL single use pre-filled pen', 'indication': 'psoriatic arthritis', 'treatment_phase': 'Continuing treatment - balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12568L', 'drug': 'guselkumab', 'brand': 'Tremfya', 'formulation': 'Injection 100 mg in 1 mL single use pre-filled pen', 'indication': 'psoriatic arthritis', 'treatment_phase': 'Initial treatment - Initial 1 (new patient)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12568L', 'drug': 'guselkumab', 'brand': 'Tremfya', 'formulation': 'Injection 100 mg in 1 mL single use pre-filled pen', 'indication': 'psoriatic arthritis', 'treatment_phase': 'Continuing treatment', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12568L', 'drug': 'guselkumab', 'brand': 'Tremfya', 'formulation': 'Injection 100 mg in 1 mL single use pre-filled pen', 'indication': 'psoriatic arthritis', 'treatment_phase': 'Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '13706J', 'drug': 'golimumab', 'brand': 'Simponi', 'formulation': 'Injection 50 mg in 0.5 mL single use pre-filled pen', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'Subsequent continuing treatment', 'streamlined_code': '14604', 'online_application': True, 'authority_method': 'STREAMLINED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12761P', 'drug': 'tocilizumab', 'brand': 'Actemra ACTPen', 'formulation': 'Injection 162 mg in 0.9 mL single use pre-filled pen', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial treatment - Initial 4 (Temporary listing - change of treatment from another biological medicine to tocilizumab after resolution of the critical shortage of tocilizumab)', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12396K', 'drug': 'adalimumab', 'brand': 'Humira', 'formulation': 'Injection 40 mg in 0.4 mL pre-filled syringe', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 12 months)', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Private', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12396K', 'drug': 'adalimumab', 'brand': 'Yuflyma', 'formulation': 'Injection 40 mg in 0.4 mL pre-filled syringe', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 12 months)', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Private', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12396K', 'drug': 'adalimumab', 'brand': 'Adalicip', 'formulation': 'Injection 40 mg in 0.4 mL pre-filled syringe', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 12 months)', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Private', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12396K', 'drug': 'adalimumab', 'brand': 'Humira', 'formulation': 'Injection 40 mg in 0.4 mL pre-filled syringe', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial treatment - Initial 1 (new patient)', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Private', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12396K', 'drug': 'adalimumab', 'brand': 'Yuflyma', 'formulation': 'Injection 40 mg in 0.4 mL pre-filled syringe', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial treatment - Initial 1 (new patient)', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Private', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12396K', 'drug': 'adalimumab', 'brand': 'Adalicip', 'formulation': 'Injection 40 mg in 0.4 mL pre-filled syringe', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial treatment - Initial 1 (new patient)', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Private', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12396K', 'drug': 'adalimumab', 'brand': 'Humira', 'formulation': 'Injection 40 mg in 0.4 mL pre-filled syringe', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 12 months)', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Private', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12396K', 'drug': 'adalimumab', 'brand': 'Yuflyma', 'formulation': 'Injection 40 mg in 0.4 mL pre-filled syringe', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 12 months)', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Private', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12396K', 'drug': 'adalimumab', 'brand': 'Adalicip', 'formulation': 'Injection 40 mg in 0.4 mL pre-filled syringe', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 12 months)', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Private', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12396K', 'drug': 'adalimumab', 'brand': 'Humira', 'formulation': 'Injection 40 mg in 0.4 mL pre-filled syringe', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 12 months) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 12 months) - balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Private', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12396K', 'drug': 'adalimumab', 'brand': 'Yuflyma', 'formulation': 'Injection 40 mg in 0.4 mL pre-filled syringe', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 12 months) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 12 months) - balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Private', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12396K', 'drug': 'adalimumab', 'brand': 'Adalicip', 'formulation': 'Injection 40 mg in 0.4 mL pre-filled syringe', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 12 months) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 12 months) - balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Private', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9460X', 'drug': 'etanercept', 'brand': 'Brenzys', 'formulation': 'Injection 50 mg in 1 mL single use auto-injector, 4', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'First continuing treatment - balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9460X', 'drug': 'etanercept', 'brand': 'Enbrel', 'formulation': 'Injection 50 mg in 1 mL single use auto-injector, 4', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'First continuing treatment - balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9460X', 'drug': 'etanercept', 'brand': 'Brenzys', 'formulation': 'Injection 50 mg in 1 mL single use auto-injector, 4', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'First continuing treatment', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9460X', 'drug': 'etanercept', 'brand': 'Enbrel', 'formulation': 'Injection 50 mg in 1 mL single use auto-injector, 4', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'First continuing treatment', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '1482B', 'drug': 'tocilizumab', 'brand': 'Actemra', 'formulation': 'Concentrate for injection 400 mg in 20 mL', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Balance of supply for Initial treatment - Initial 1 (new patient) or Initial 2 (retrial or recommencement of treatment after a break of less than 12 months) or Initial 3 (recommencement of treatment after a break of more than 12 months)', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Public', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '1482B', 'drug': 'tocilizumab', 'brand': 'Actemra', 'formulation': 'Concentrate for injection 400 mg in 20 mL', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial treatment - Initial 3 (recommencement of treatment after a break of more than 12 months)', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Public', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '1482B', 'drug': 'tocilizumab', 'brand': 'Actemra', 'formulation': 'Concentrate for injection 400 mg in 20 mL', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial treatment - Initial 2 (retrial or recommencement of treatment after a break of less than 12 months)', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Public', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '1482B', 'drug': 'tocilizumab', 'brand': 'Actemra', 'formulation': 'Concentrate for injection 400 mg in 20 mL', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial treatment - Initial 1 (new patient)', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Public', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '10898N', 'drug': 'secukinumab', 'brand': 'Cosentyx', 'formulation': 'Injection 150 mg in 1 mL pre-filled pen', 'indication': 'psoriatic arthritis', 'treatment_phase': 'Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years) - balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9658H', 'drug': 'tocilizumab', 'brand': 'Actemra', 'formulation': 'Concentrate for injection 200 mg in 10 mL', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 24 months)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Public', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9658H', 'drug': 'tocilizumab', 'brand': 'Actemra', 'formulation': 'Concentrate for injection 200 mg in 10 mL', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Public', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9658H', 'drug': 'tocilizumab', 'brand': 'Actemra', 'formulation': 'Concentrate for injection 200 mg in 10 mL', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'First continuing treatment', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Public', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9658H', 'drug': 'tocilizumab', 'brand': 'Actemra', 'formulation': 'Concentrate for injection 200 mg in 10 mL', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'First continuing treatment - balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Public', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9658H', 'drug': 'tocilizumab', 'brand': 'Actemra', 'formulation': 'Concentrate for injection 200 mg in 10 mL', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 24 months) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months) - balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Public', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9658H', 'drug': 'tocilizumab', 'brand': 'Actemra', 'formulation': 'Concentrate for injection 200 mg in 10 mL', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'Initial treatment - Initial 1 (new patient)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Public', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '1419Q', 'drug': 'tocilizumab', 'brand': 'Actemra', 'formulation': 'Concentrate for injection 80 mg in 4 mL', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Balance of supply for Initial treatment - Initial 1 (new patient) or Initial 2 (retrial or recommencement of treatment after a break of less than 12 months) or Initial 3 (recommencement of treatment after a break of more than 12 months)', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Private', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '1419Q', 'drug': 'tocilizumab', 'brand': 'Actemra', 'formulation': 'Concentrate for injection 80 mg in 4 mL', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial treatment - Initial 1 (new patient)', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Private', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '1419Q', 'drug': 'tocilizumab', 'brand': 'Actemra', 'formulation': 'Concentrate for injection 80 mg in 4 mL', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial treatment - Initial 3 (recommencement of treatment after a break of more than 12 months)', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Private', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '1419Q', 'drug': 'tocilizumab', 'brand': 'Actemra', 'formulation': 'Concentrate for injection 80 mg in 4 mL', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial treatment - Initial 2 (retrial or recommencement of treatment after a break of less than 12 months)', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Private', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '14195D', 'drug': 'anifrolumab', 'brand': 'Saphnelo', 'formulation': 'Solution concentrate for I.V. infusion 300 mg in 2 mL', 'indication': 'systemic lupus erythematosus', 'treatment_phase': 'Initial treatment', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Public', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '14195D', 'drug': 'anifrolumab', 'brand': 'Saphnelo', 'formulation': 'Solution concentrate for I.V. infusion 300 mg in 2 mL', 'indication': 'systemic lupus erythematosus', 'treatment_phase': 'Transitioning from non-PBS to PBS-subsidised supply - Grandfather arrangements', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Public', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '14195D', 'drug': 'anifrolumab', 'brand': 'Saphnelo', 'formulation': 'Solution concentrate for I.V. infusion 300 mg in 2 mL', 'indication': 'systemic lupus erythematosus', 'treatment_phase': 'Continuing or recommencement of treatment (within 12 months of a treatment break)', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Public', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '10517M', 'drug': 'tofacitinib', 'brand': 'Xeljanz', 'formulation': 'Tablet 5 mg', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '10517M', 'drug': 'tofacitinib', 'brand': 'Xeljanz', 'formulation': 'Tablet 5 mg', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'Initial treatment - Initial 1 (new patient)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '10517M', 'drug': 'tofacitinib', 'brand': 'Xeljanz', 'formulation': 'Tablet 5 mg', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 24 months)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '10517M', 'drug': 'tofacitinib', 'brand': 'Xeljanz', 'formulation': 'Tablet 5 mg', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 24 months) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months) - balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '13737B', 'drug': 'tofacitinib', 'brand': 'Xeljanz', 'formulation': 'Tablet 5 mg', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Continuing treatment', 'streamlined_code': '14697', 'online_application': True, 'authority_method': 'STREAMLINED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '13304F', 'drug': 'tocilizumab', 'brand': 'Actemra', 'formulation': 'Concentrate for injection 80 mg in 4 mL', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Continuing treatment', 'streamlined_code': '14093', 'online_application': True, 'authority_method': 'STREAMLINED', 'hospital_type': 'Public', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '11323Y', 'drug': 'certolizumab pegol', 'brand': 'Cimzia', 'formulation': 'Solution for injection 200 mg in 1 mL pre-filled pen', 'indication': 'psoriatic arthritis', 'treatment_phase': 'Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '11323Y', 'drug': 'certolizumab pegol', 'brand': 'Cimzia', 'formulation': 'Solution for injection 200 mg in 1 mL pre-filled pen', 'indication': 'psoriatic arthritis', 'treatment_phase': 'Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '11323Y', 'drug': 'certolizumab pegol', 'brand': 'Cimzia', 'formulation': 'Solution for injection 200 mg in 1 mL pre-filled pen', 'indication': 'psoriatic arthritis', 'treatment_phase': 'Initial treatment - Initial 1 (new patient)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '8779C', 'drug': 'etanercept', 'brand': 'Enbrel', 'formulation': 'Injection set containing 4 vials powder for injection 25 mg and 4 pre-filled syringes solvent 1 mL', 'indication': 'ankylosing spondylitis', 'treatment_phase': 'First continuing treatment', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '8779C', 'drug': 'etanercept', 'brand': 'Enbrel', 'formulation': 'Injection set containing 4 vials powder for injection 25 mg and 4 pre-filled syringes solvent 1 mL', 'indication': 'ankylosing spondylitis', 'treatment_phase': 'Continuing treatment - balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '5283C', 'drug': 'adalimumab', 'brand': 'Amgevita', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled syringe', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'First continuing treatment', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '5283C', 'drug': 'adalimumab', 'brand': 'Hadlima', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled syringe', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'First continuing treatment', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '5283C', 'drug': 'adalimumab', 'brand': 'Idacio', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled syringe', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'First continuing treatment', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '5283C', 'drug': 'adalimumab', 'brand': 'Hyrimoz', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled syringe', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'First continuing treatment', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '5283C', 'drug': 'adalimumab', 'brand': 'Abrilada', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled syringe', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'First continuing treatment', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '5283C', 'drug': 'adalimumab', 'brand': 'Amgevita', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled syringe', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Continuing treatment - balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '5283C', 'drug': 'adalimumab', 'brand': 'Hadlima', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled syringe', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Continuing treatment - balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '5283C', 'drug': 'adalimumab', 'brand': 'Idacio', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled syringe', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Continuing treatment - balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '5283C', 'drug': 'adalimumab', 'brand': 'Hyrimoz', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled syringe', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Continuing treatment - balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '5283C', 'drug': 'adalimumab', 'brand': 'Abrilada', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled syringe', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Continuing treatment - balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '5283C', 'drug': 'adalimumab', 'brand': 'Amgevita', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled syringe', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Subsequent continuing treatment', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '5283C', 'drug': 'adalimumab', 'brand': 'Hadlima', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled syringe', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Subsequent continuing treatment', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '5283C', 'drug': 'adalimumab', 'brand': 'Idacio', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled syringe', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Subsequent continuing treatment', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '5283C', 'drug': 'adalimumab', 'brand': 'Hyrimoz', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled syringe', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Subsequent continuing treatment', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '5283C', 'drug': 'adalimumab', 'brand': 'Abrilada', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled syringe', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Subsequent continuing treatment', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9101B', 'drug': 'adalimumab', 'brand': 'Hadlima', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled pen', 'indication': 'psoriatic arthritis', 'treatment_phase': 'Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9101B', 'drug': 'adalimumab', 'brand': 'Abrilada', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled pen', 'indication': 'psoriatic arthritis', 'treatment_phase': 'Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9101B', 'drug': 'adalimumab', 'brand': 'Hyrimoz', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled pen', 'indication': 'psoriatic arthritis', 'treatment_phase': 'Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9101B', 'drug': 'adalimumab', 'brand': 'Amgevita', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled pen', 'indication': 'psoriatic arthritis', 'treatment_phase': 'Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9101B', 'drug': 'adalimumab', 'brand': 'Idacio', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled pen', 'indication': 'psoriatic arthritis', 'treatment_phase': 'Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9101B', 'drug': 'adalimumab', 'brand': 'Hadlima', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled pen', 'indication': 'psoriatic arthritis', 'treatment_phase': 'Initial treatment - Initial 1 (new patient)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9101B', 'drug': 'adalimumab', 'brand': 'Abrilada', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled pen', 'indication': 'psoriatic arthritis', 'treatment_phase': 'Initial treatment - Initial 1 (new patient)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9101B', 'drug': 'adalimumab', 'brand': 'Hyrimoz', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled pen', 'indication': 'psoriatic arthritis', 'treatment_phase': 'Initial treatment - Initial 1 (new patient)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9101B', 'drug': 'adalimumab', 'brand': 'Amgevita', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled pen', 'indication': 'psoriatic arthritis', 'treatment_phase': 'Initial treatment - Initial 1 (new patient)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9101B', 'drug': 'adalimumab', 'brand': 'Idacio', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled pen', 'indication': 'psoriatic arthritis', 'treatment_phase': 'Initial treatment - Initial 1 (new patient)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9101B', 'drug': 'adalimumab', 'brand': 'Hadlima', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled pen', 'indication': 'psoriatic arthritis', 'treatment_phase': 'Initial treatment - Initial 2 (change or recommencement of treatment after a break in in biological medicine of less than 5 years)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9101B', 'drug': 'adalimumab', 'brand': 'Abrilada', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled pen', 'indication': 'psoriatic arthritis', 'treatment_phase': 'Initial treatment - Initial 2 (change or recommencement of treatment after a break in in biological medicine of less than 5 years)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9101B', 'drug': 'adalimumab', 'brand': 'Hyrimoz', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled pen', 'indication': 'psoriatic arthritis', 'treatment_phase': 'Initial treatment - Initial 2 (change or recommencement of treatment after a break in in biological medicine of less than 5 years)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9101B', 'drug': 'adalimumab', 'brand': 'Amgevita', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled pen', 'indication': 'psoriatic arthritis', 'treatment_phase': 'Initial treatment - Initial 2 (change or recommencement of treatment after a break in in biological medicine of less than 5 years)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9101B', 'drug': 'adalimumab', 'brand': 'Idacio', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled pen', 'indication': 'psoriatic arthritis', 'treatment_phase': 'Initial treatment - Initial 2 (change or recommencement of treatment after a break in in biological medicine of less than 5 years)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9101B', 'drug': 'adalimumab', 'brand': 'Hadlima', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled pen', 'indication': 'psoriatic arthritis', 'treatment_phase': 'Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years) - balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9101B', 'drug': 'adalimumab', 'brand': 'Abrilada', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled pen', 'indication': 'psoriatic arthritis', 'treatment_phase': 'Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years) - balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9101B', 'drug': 'adalimumab', 'brand': 'Hyrimoz', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled pen', 'indication': 'psoriatic arthritis', 'treatment_phase': 'Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years) - balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9101B', 'drug': 'adalimumab', 'brand': 'Amgevita', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled pen', 'indication': 'psoriatic arthritis', 'treatment_phase': 'Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years) - balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9101B', 'drug': 'adalimumab', 'brand': 'Idacio', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled pen', 'indication': 'psoriatic arthritis', 'treatment_phase': 'Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years) - balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12811G', 'drug': 'tocilizumab', 'brand': 'Actemra', 'formulation': 'Concentrate for injection 80 mg in 4 mL', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial treatment - Initial 4 (Temporary listing - change of treatment from another biological medicine to tocilzumab after resolution of the critical shortage of tocilizumab)', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Private', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12811G', 'drug': 'tocilizumab', 'brand': 'Actemra', 'formulation': 'Concentrate for injection 80 mg in 4 mL', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial treatment - Initial 4 (Temporary listing - change of treatment from another biological medicine to tocilizumab after resolution of the critical shortage of tocilizumab)', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Private', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '13054C', 'drug': 'infliximab', 'brand': 'Remsima SC', 'formulation': 'Solution for injection 120 mg in 1 mL pre-filled pen', 'indication': 'psoriatic arthritis', 'treatment_phase': 'Continuing treatment with subcutaneous form or switching from intravenous form to subcutaneous form', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12429E', 'drug': 'adalimumab', 'brand': 'Humira', 'formulation': 'Injection 40 mg in 0.4 mL pre-filled pen', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'Initial treatment - Initial 1 (new patient)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12429E', 'drug': 'adalimumab', 'brand': 'Yuflyma', 'formulation': 'Injection 40 mg in 0.4 mL pre-filled pen', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'Initial treatment - Initial 1 (new patient)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12429E', 'drug': 'adalimumab', 'brand': 'Adalicip', 'formulation': 'Injection 40 mg in 0.4 mL pre-filled pen', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'Initial treatment - Initial 1 (new patient)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12429E', 'drug': 'adalimumab', 'brand': 'Humira', 'formulation': 'Injection 40 mg in 0.4 mL pre-filled pen', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 24 months)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12429E', 'drug': 'adalimumab', 'brand': 'Yuflyma', 'formulation': 'Injection 40 mg in 0.4 mL pre-filled pen', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 24 months)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12429E', 'drug': 'adalimumab', 'brand': 'Adalicip', 'formulation': 'Injection 40 mg in 0.4 mL pre-filled pen', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 24 months)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12429E', 'drug': 'adalimumab', 'brand': 'Humira', 'formulation': 'Injection 40 mg in 0.4 mL pre-filled pen', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12429E', 'drug': 'adalimumab', 'brand': 'Yuflyma', 'formulation': 'Injection 40 mg in 0.4 mL pre-filled pen', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12429E', 'drug': 'adalimumab', 'brand': 'Adalicip', 'formulation': 'Injection 40 mg in 0.4 mL pre-filled pen', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12429E', 'drug': 'adalimumab', 'brand': 'Humira', 'formulation': 'Injection 40 mg in 0.4 mL pre-filled pen', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 24 months) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months) - balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12429E', 'drug': 'adalimumab', 'brand': 'Yuflyma', 'formulation': 'Injection 40 mg in 0.4 mL pre-filled pen', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 24 months) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months) - balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12429E', 'drug': 'adalimumab', 'brand': 'Adalicip', 'formulation': 'Injection 40 mg in 0.4 mL pre-filled pen', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 24 months) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months) - balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '11376R', 'drug': 'golimumab', 'brand': 'Simponi', 'formulation': 'Injection 50 mg in 0.5 mL single use pre-filled pen', 'indication': 'ankylosing spondylitis', 'treatment_phase': 'Continuing treatment - balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '11376R', 'drug': 'golimumab', 'brand': 'Simponi', 'formulation': 'Injection 50 mg in 0.5 mL single use pre-filled pen', 'indication': 'ankylosing spondylitis', 'treatment_phase': 'Continuing treatment', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12554R', 'drug': 'infliximab', 'brand': 'Remsima SC', 'formulation': 'Solution for injection 120 mg in 1 mL pre-filled pen', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'Continuing treatment with subcutaneous form or switching from intravenous form to subcutaneous form', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '11208X', 'drug': 'etanercept', 'brand': 'Brenzys', 'formulation': 'Injections 50 mg in 1 mL single use pre-filled syringes, 4', 'indication': 'psoriatic arthritis', 'treatment_phase': 'Continuing treatment - balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '11208X', 'drug': 'etanercept', 'brand': 'Enbrel', 'formulation': 'Injections 50 mg in 1 mL single use pre-filled syringes, 4', 'indication': 'psoriatic arthritis', 'treatment_phase': 'Continuing treatment - balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '11208X', 'drug': 'etanercept', 'brand': 'Brenzys', 'formulation': 'Injections 50 mg in 1 mL single use pre-filled syringes, 4', 'indication': 'psoriatic arthritis', 'treatment_phase': 'Subsequent continuing treatment', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '11208X', 'drug': 'etanercept', 'brand': 'Enbrel', 'formulation': 'Injections 50 mg in 1 mL single use pre-filled syringes, 4', 'indication': 'psoriatic arthritis', 'treatment_phase': 'Subsequent continuing treatment', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12363Q', 'drug': 'adalimumab', 'brand': 'Yuflyma', 'formulation': 'Injection 40 mg in 0.4 mL pre-filled pen', 'indication': 'ankylosing spondylitis', 'treatment_phase': 'Continuing treatment - balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12363Q', 'drug': 'adalimumab', 'brand': 'Adalicip', 'formulation': 'Injection 40 mg in 0.4 mL pre-filled pen', 'indication': 'ankylosing spondylitis', 'treatment_phase': 'Continuing treatment - balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12363Q', 'drug': 'adalimumab', 'brand': 'Humira', 'formulation': 'Injection 40 mg in 0.4 mL pre-filled pen', 'indication': 'ankylosing spondylitis', 'treatment_phase': 'Continuing treatment - balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12363Q', 'drug': 'adalimumab', 'brand': 'Yuflyma', 'formulation': 'Injection 40 mg in 0.4 mL pre-filled pen', 'indication': 'ankylosing spondylitis', 'treatment_phase': 'Subsequent continuing treatment', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12363Q', 'drug': 'adalimumab', 'brand': 'Adalicip', 'formulation': 'Injection 40 mg in 0.4 mL pre-filled pen', 'indication': 'ankylosing spondylitis', 'treatment_phase': 'Subsequent continuing treatment', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12363Q', 'drug': 'adalimumab', 'brand': 'Humira', 'formulation': 'Injection 40 mg in 0.4 mL pre-filled pen', 'indication': 'ankylosing spondylitis', 'treatment_phase': 'Subsequent continuing treatment', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12363Q', 'drug': 'adalimumab', 'brand': 'Yuflyma', 'formulation': 'Injection 40 mg in 0.4 mL pre-filled pen', 'indication': 'ankylosing spondylitis', 'treatment_phase': 'First continuing treatment', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12363Q', 'drug': 'adalimumab', 'brand': 'Adalicip', 'formulation': 'Injection 40 mg in 0.4 mL pre-filled pen', 'indication': 'ankylosing spondylitis', 'treatment_phase': 'First continuing treatment', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12363Q', 'drug': 'adalimumab', 'brand': 'Humira', 'formulation': 'Injection 40 mg in 0.4 mL pre-filled pen', 'indication': 'ankylosing spondylitis', 'treatment_phase': 'First continuing treatment', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '13774Y', 'drug': 'etanercept', 'brand': 'Brenzys', 'formulation': 'Injection 50 mg in 1 mL single use auto-injector, 4', 'indication': 'ankylosing spondylitis', 'treatment_phase': 'Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years)', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '13774Y', 'drug': 'etanercept', 'brand': 'Brenzys', 'formulation': 'Injection 50 mg in 1 mL single use auto-injector, 4', 'indication': 'ankylosing spondylitis', 'treatment_phase': 'Initial treatment - Initial 1 (new patient)', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '13774Y', 'drug': 'etanercept', 'brand': 'Brenzys', 'formulation': 'Injection 50 mg in 1 mL single use auto-injector, 4', 'indication': 'ankylosing spondylitis', 'treatment_phase': 'Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years)', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9663N', 'drug': 'adalimumab', 'brand': 'Abrilada', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled pen', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial treatment - Initial 1 (new patient)', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Public', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9663N', 'drug': 'adalimumab', 'brand': 'Hadlima', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled pen', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial treatment - Initial 1 (new patient)', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Public', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9663N', 'drug': 'adalimumab', 'brand': 'Hyrimoz', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled pen', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial treatment - Initial 1 (new patient)', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Public', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9663N', 'drug': 'adalimumab', 'brand': 'Amgevita', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled pen', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial treatment - Initial 1 (new patient)', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Public', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9663N', 'drug': 'adalimumab', 'brand': 'Idacio', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled pen', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial treatment - Initial 1 (new patient)', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Public', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9663N', 'drug': 'adalimumab', 'brand': 'Abrilada', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled pen', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 12 months)', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Public', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9663N', 'drug': 'adalimumab', 'brand': 'Hadlima', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled pen', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 12 months)', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Public', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9663N', 'drug': 'adalimumab', 'brand': 'Hyrimoz', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled pen', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 12 months)', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Public', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9663N', 'drug': 'adalimumab', 'brand': 'Amgevita', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled pen', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 12 months)', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Public', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9663N', 'drug': 'adalimumab', 'brand': 'Idacio', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled pen', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 12 months)', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Public', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9663N', 'drug': 'adalimumab', 'brand': 'Abrilada', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled pen', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 12 months) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 12 months) - balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Public', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9663N', 'drug': 'adalimumab', 'brand': 'Hadlima', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled pen', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 12 months) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 12 months) - balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Public', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9663N', 'drug': 'adalimumab', 'brand': 'Hyrimoz', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled pen', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 12 months) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 12 months) - balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Public', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9663N', 'drug': 'adalimumab', 'brand': 'Amgevita', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled pen', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 12 months) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 12 months) - balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Public', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9663N', 'drug': 'adalimumab', 'brand': 'Idacio', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled pen', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 12 months) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 12 months) - balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Public', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9663N', 'drug': 'adalimumab', 'brand': 'Abrilada', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled pen', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 12 months)', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Public', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9663N', 'drug': 'adalimumab', 'brand': 'Hadlima', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled pen', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 12 months)', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Public', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9663N', 'drug': 'adalimumab', 'brand': 'Hyrimoz', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled pen', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 12 months)', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Public', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9663N', 'drug': 'adalimumab', 'brand': 'Amgevita', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled pen', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 12 months)', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Public', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9663N', 'drug': 'adalimumab', 'brand': 'Idacio', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled pen', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 12 months)', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Public', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12040Q', 'drug': 'certolizumab pegol', 'brand': 'Cimzia', 'formulation': 'Injection 200 mg in 1 mL single use pre-filled syringe', 'indication': 'non-radiographic axial spondyloarthritis', 'treatment_phase': 'Continuing treatment - balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12040Q', 'drug': 'certolizumab pegol', 'brand': 'Cimzia', 'formulation': 'Injection 200 mg in 1 mL single use pre-filled syringe', 'indication': 'non-radiographic axial spondyloarthritis', 'treatment_phase': 'Initial 1 (New patient), Initial 2 (Change or re-commencement of treatment after a break in biological medicine of less than 5 years) or Initial 3 (Recommencement of treatment after a break in biological medicine of more than 5 years) - balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '13323F', 'drug': 'tocilizumab', 'brand': 'Actemra', 'formulation': 'Concentrate for injection 400 mg in 20 mL', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Continuing treatment', 'streamlined_code': '14179', 'online_application': True, 'authority_method': 'STREAMLINED', 'hospital_type': 'Private', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '10077J', 'drug': 'tocilizumab', 'brand': 'Actemra', 'formulation': 'Concentrate for injection 80 mg in 4 mL', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial treatment - Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 12 months) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 12 months) - balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Public', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '10077J', 'drug': 'tocilizumab', 'brand': 'Actemra', 'formulation': 'Concentrate for injection 80 mg in 4 mL', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 12 months)', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Public', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '10077J', 'drug': 'tocilizumab', 'brand': 'Actemra', 'formulation': 'Concentrate for injection 80 mg in 4 mL', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial treatment - Initial 1 (new patient)', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Public', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '10077J', 'drug': 'tocilizumab', 'brand': 'Actemra', 'formulation': 'Concentrate for injection 80 mg in 4 mL', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 12 months)', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Public', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '11211C', 'drug': 'etanercept', 'brand': 'Brenzys', 'formulation': 'Injections 50 mg in 1 mL single use pre-filled syringes, 4', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'Subsequent continuing treatment', 'streamlined_code': '14499', 'online_application': True, 'authority_method': 'STREAMLINED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '11211C', 'drug': 'etanercept', 'brand': 'Enbrel', 'formulation': 'Injections 50 mg in 1 mL single use pre-filled syringes, 4', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'Subsequent continuing treatment', 'streamlined_code': '14499', 'online_application': True, 'authority_method': 'STREAMLINED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12590P', 'drug': 'guselkumab', 'brand': 'Tremfya', 'formulation': 'Injection 100 mg in 1 mL single use pre-filled syringe', 'indication': 'psoriatic arthritis', 'treatment_phase': 'Continuing treatment - balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12590P', 'drug': 'guselkumab', 'brand': 'Tremfya', 'formulation': 'Injection 100 mg in 1 mL single use pre-filled syringe', 'indication': 'psoriatic arthritis', 'treatment_phase': 'Initial treatment - Initial 1 (new patient)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12590P', 'drug': 'guselkumab', 'brand': 'Tremfya', 'formulation': 'Injection 100 mg in 1 mL single use pre-filled syringe', 'indication': 'psoriatic arthritis', 'treatment_phase': 'Continuing treatment', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12590P', 'drug': 'guselkumab', 'brand': 'Tremfya', 'formulation': 'Injection 100 mg in 1 mL single use pre-filled syringe', 'indication': 'psoriatic arthritis', 'treatment_phase': 'Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12590P', 'drug': 'guselkumab', 'brand': 'Tremfya', 'formulation': 'Injection 100 mg in 1 mL single use pre-filled syringe', 'indication': 'psoriatic arthritis', 'treatment_phase': 'Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12590P', 'drug': 'guselkumab', 'brand': 'Tremfya', 'formulation': 'Injection 100 mg in 1 mL single use pre-filled syringe', 'indication': 'psoriatic arthritis', 'treatment_phase': 'Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years) - balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12099T', 'drug': 'tocilizumab', 'brand': 'Actemra Subcutaneous Injection', 'formulation': 'Injection 162 mg in 0.9 mL single use pre-filled syringe', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Continuing treatment in a patient weighing at least 30 kg', 'streamlined_code': '14088', 'online_application': True, 'authority_method': 'STREAMLINED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '11204Q', 'drug': 'etanercept', 'brand': 'Enbrel', 'formulation': 'Injection set containing 4 vials powder for injection 25 mg and 4 pre-filled syringes solvent 1 mL', 'indication': 'ankylosing spondylitis', 'treatment_phase': 'Subsequent continuing treatment', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12435L', 'drug': 'adalimumab', 'brand': 'Amgevita', 'formulation': 'Injection 20 mg in 0.4 mL pre-filled syringe', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 12 months)', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Public', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12435L', 'drug': 'adalimumab', 'brand': 'Amgevita', 'formulation': 'Injection 20 mg in 0.4 mL pre-filled syringe', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 12 months)', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Public', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12435L', 'drug': 'adalimumab', 'brand': 'Amgevita', 'formulation': 'Injection 20 mg in 0.4 mL pre-filled syringe', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial treatment - Initial 1 (new patient)', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Public', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12435L', 'drug': 'adalimumab', 'brand': 'Amgevita', 'formulation': 'Injection 20 mg in 0.4 mL pre-filled syringe', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 12 months) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 12 months) - balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Public', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9455P', 'drug': 'etanercept', 'brand': 'Brenzys', 'formulation': 'Injection 50 mg in 1 mL single use auto-injector, 4', 'indication': 'ankylosing spondylitis', 'treatment_phase': 'Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years) - balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9455P', 'drug': 'etanercept', 'brand': 'Enbrel', 'formulation': 'Injection 50 mg in 1 mL single use auto-injector, 4', 'indication': 'ankylosing spondylitis', 'treatment_phase': 'Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years) - balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9455P', 'drug': 'etanercept', 'brand': 'Brenzys', 'formulation': 'Injection 50 mg in 1 mL single use auto-injector, 4', 'indication': 'ankylosing spondylitis', 'treatment_phase': 'Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9455P', 'drug': 'etanercept', 'brand': 'Enbrel', 'formulation': 'Injection 50 mg in 1 mL single use auto-injector, 4', 'indication': 'ankylosing spondylitis', 'treatment_phase': 'Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9455P', 'drug': 'etanercept', 'brand': 'Brenzys', 'formulation': 'Injection 50 mg in 1 mL single use auto-injector, 4', 'indication': 'ankylosing spondylitis', 'treatment_phase': 'Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9455P', 'drug': 'etanercept', 'brand': 'Enbrel', 'formulation': 'Injection 50 mg in 1 mL single use auto-injector, 4', 'indication': 'ankylosing spondylitis', 'treatment_phase': 'Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9455P', 'drug': 'etanercept', 'brand': 'Brenzys', 'formulation': 'Injection 50 mg in 1 mL single use auto-injector, 4', 'indication': 'ankylosing spondylitis', 'treatment_phase': 'Initial treatment - Initial 1 (new patient)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9455P', 'drug': 'etanercept', 'brand': 'Enbrel', 'formulation': 'Injection 50 mg in 1 mL single use auto-injector, 4', 'indication': 'ankylosing spondylitis', 'treatment_phase': 'Initial treatment - Initial 1 (new patient)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12648Q', 'drug': 'upadacitinib', 'brand': 'Rinvoq', 'formulation': 'Tablet 15 mg', 'indication': 'psoriatic arthritis', 'treatment_phase': 'Continuing treatment', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12648Q', 'drug': 'upadacitinib', 'brand': 'Rinvoq', 'formulation': 'Tablet 15 mg', 'indication': 'psoriatic arthritis', 'treatment_phase': 'Continuing treatment - balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '10238W', 'drug': 'certolizumab pegol', 'brand': 'Cimzia', 'formulation': 'Injection 200 mg in 1 mL single use pre-filled syringe', 'indication': 'psoriatic arthritis', 'treatment_phase': 'Continuing treatment - balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '10238W', 'drug': 'certolizumab pegol', 'brand': 'Cimzia', 'formulation': 'Injection 200 mg in 1 mL single use pre-filled syringe', 'indication': 'psoriatic arthritis', 'treatment_phase': 'Continuing treatment', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '13698Y', 'drug': 'etanercept', 'brand': 'Brenzys', 'formulation': 'Injections 50 mg in 1 mL single use pre-filled syringes, 4', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 24 months)', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '13698Y', 'drug': 'etanercept', 'brand': 'Brenzys', 'formulation': 'Injections 50 mg in 1 mL single use pre-filled syringes, 4', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 24 months) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months) - balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '13698Y', 'drug': 'etanercept', 'brand': 'Brenzys', 'formulation': 'Injections 50 mg in 1 mL single use pre-filled syringes, 4', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'Initial treatment - Initial 1 (new patient)', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '13698Y', 'drug': 'etanercept', 'brand': 'Brenzys', 'formulation': 'Injections 50 mg in 1 mL single use pre-filled syringes, 4', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months)', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '13738C', 'drug': 'tofacitinib', 'brand': 'Xeljanz', 'formulation': 'Oral solution 1 mg per mL, 240 mL', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Continuing treatment', 'streamlined_code': '14697', 'online_application': True, 'authority_method': 'STREAMLINED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '13684F', 'drug': 'tocilizumab', 'brand': 'Actemra', 'formulation': 'Concentrate for injection 200 mg in 10 mL', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'Subsequent continuing treatment', 'streamlined_code': '14621', 'online_application': True, 'authority_method': 'STREAMLINED', 'hospital_type': 'Public', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '13226D', 'drug': 'adalimumab', 'brand': 'Adalicip', 'formulation': 'Injection 40 mg in 0.4 mL pre-filled pen', 'indication': 'ankylosing spondylitis', 'treatment_phase': 'First continuing treatment', 'streamlined_code': '14683', 'online_application': True, 'authority_method': 'STREAMLINED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '13226D', 'drug': 'adalimumab', 'brand': 'Yuflyma', 'formulation': 'Injection 40 mg in 0.4 mL pre-filled pen', 'indication': 'ankylosing spondylitis', 'treatment_phase': 'First continuing treatment', 'streamlined_code': '14683', 'online_application': True, 'authority_method': 'STREAMLINED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '13226D', 'drug': 'adalimumab', 'brand': 'Adalicip', 'formulation': 'Injection 40 mg in 0.4 mL pre-filled pen', 'indication': 'ankylosing spondylitis', 'treatment_phase': 'Subsequent continuing treatment', 'streamlined_code': '14701', 'online_application': True, 'authority_method': 'STREAMLINED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '13226D', 'drug': 'adalimumab', 'brand': 'Yuflyma', 'formulation': 'Injection 40 mg in 0.4 mL pre-filled pen', 'indication': 'ankylosing spondylitis', 'treatment_phase': 'Subsequent continuing treatment', 'streamlined_code': '14701', 'online_application': True, 'authority_method': 'STREAMLINED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12335F', 'drug': 'adalimumab', 'brand': 'Yuflyma', 'formulation': 'Injection 40 mg in 0.4 mL pre-filled pen', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 12 months)', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Private', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12335F', 'drug': 'adalimumab', 'brand': 'Adalicip', 'formulation': 'Injection 40 mg in 0.4 mL pre-filled pen', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 12 months)', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Private', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12335F', 'drug': 'adalimumab', 'brand': 'Humira', 'formulation': 'Injection 40 mg in 0.4 mL pre-filled pen', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 12 months)', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Private', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12335F', 'drug': 'adalimumab', 'brand': 'Yuflyma', 'formulation': 'Injection 40 mg in 0.4 mL pre-filled pen', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 12 months)', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Private', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12335F', 'drug': 'adalimumab', 'brand': 'Adalicip', 'formulation': 'Injection 40 mg in 0.4 mL pre-filled pen', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 12 months)', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Private', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12335F', 'drug': 'adalimumab', 'brand': 'Humira', 'formulation': 'Injection 40 mg in 0.4 mL pre-filled pen', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 12 months)', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Private', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12335F', 'drug': 'adalimumab', 'brand': 'Yuflyma', 'formulation': 'Injection 40 mg in 0.4 mL pre-filled pen', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial treatment - Initial 1 (new patient)', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Private', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12335F', 'drug': 'adalimumab', 'brand': 'Adalicip', 'formulation': 'Injection 40 mg in 0.4 mL pre-filled pen', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial treatment - Initial 1 (new patient)', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Private', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12335F', 'drug': 'adalimumab', 'brand': 'Humira', 'formulation': 'Injection 40 mg in 0.4 mL pre-filled pen', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial treatment - Initial 1 (new patient)', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Private', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12335F', 'drug': 'adalimumab', 'brand': 'Yuflyma', 'formulation': 'Injection 40 mg in 0.4 mL pre-filled pen', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 12 months) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 12 months) - balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Private', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12335F', 'drug': 'adalimumab', 'brand': 'Adalicip', 'formulation': 'Injection 40 mg in 0.4 mL pre-filled pen', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 12 months) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 12 months) - balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Private', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12335F', 'drug': 'adalimumab', 'brand': 'Humira', 'formulation': 'Injection 40 mg in 0.4 mL pre-filled pen', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 12 months) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 12 months) - balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Private', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '5733R', 'drug': 'etanercept', 'brand': 'Enbrel', 'formulation': 'Injections 50 mg in 1 mL single use pre-filled syringes, 4', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 12 months)', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Public', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '5733R', 'drug': 'etanercept', 'brand': 'Enbrel', 'formulation': 'Injections 50 mg in 1 mL single use pre-filled syringes, 4', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 12 months)', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Public', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '5733R', 'drug': 'etanercept', 'brand': 'Enbrel', 'formulation': 'Injections 50 mg in 1 mL single use pre-filled syringes, 4', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial treatment - Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 12 months) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 12 months) - balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Public', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '5733R', 'drug': 'etanercept', 'brand': 'Enbrel', 'formulation': 'Injections 50 mg in 1 mL single use pre-filled syringes, 4', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial treatment - Initial 1 (new patient)', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Public', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '1481Y', 'drug': 'tocilizumab', 'brand': 'Actemra', 'formulation': 'Concentrate for injection 200 mg in 10 mL', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Balance of supply for Initial treatment - Initial 1 (new patient) or Initial 2 (retrial or recommencement of treatment after a break of less than 12 months) or Initial 3 (recommencement of treatment after a break of more than 12 months)', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Public', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '1481Y', 'drug': 'tocilizumab', 'brand': 'Actemra', 'formulation': 'Concentrate for injection 200 mg in 10 mL', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial treatment - Initial 1 (new patient)', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Public', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '1481Y', 'drug': 'tocilizumab', 'brand': 'Actemra', 'formulation': 'Concentrate for injection 200 mg in 10 mL', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial treatment - Initial 2 (retrial or recommencement of treatment after a break of less than 12 months)', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Public', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '1481Y', 'drug': 'tocilizumab', 'brand': 'Actemra', 'formulation': 'Concentrate for injection 200 mg in 10 mL', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial treatment - Initial 3 (recommencement of treatment after a break of more than 12 months)', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Public', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12624K', 'drug': 'upadacitinib', 'brand': 'Rinvoq', 'formulation': 'Tablet 15 mg', 'indication': 'psoriatic arthritis', 'treatment_phase': 'Initial treatment - Initial 2 (change or recommencement of treatment after a break in in biological medicine of less than 5 years)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12624K', 'drug': 'upadacitinib', 'brand': 'Rinvoq', 'formulation': 'Tablet 15 mg', 'indication': 'psoriatic arthritis', 'treatment_phase': 'Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12624K', 'drug': 'upadacitinib', 'brand': 'Rinvoq', 'formulation': 'Tablet 15 mg', 'indication': 'psoriatic arthritis', 'treatment_phase': 'Initial treatment - Initial 1 (new patient)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12624K', 'drug': 'upadacitinib', 'brand': 'Rinvoq', 'formulation': 'Tablet 15 mg', 'indication': 'psoriatic arthritis', 'treatment_phase': 'Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years) - balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '11437Y', 'drug': 'baricitinib', 'brand': 'Olumiant', 'formulation': 'Tablet 2 mg', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'Initial treatment - Initial 1 (new patient)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '11437Y', 'drug': 'baricitinib', 'brand': 'Olumiant', 'formulation': 'Tablet 2 mg', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 24 months)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '11437Y', 'drug': 'baricitinib', 'brand': 'Olumiant', 'formulation': 'Tablet 2 mg', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '11437Y', 'drug': 'baricitinib', 'brand': 'Olumiant', 'formulation': 'Tablet 2 mg', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 24 months) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months) - balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '11565Q', 'drug': 'tocilizumab', 'brand': 'Actemra ACTPen', 'formulation': 'Injection 162 mg in 0.9 mL single use pre-filled pen', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'Initial treatment - Initial 1 (new patient)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '11565Q', 'drug': 'tocilizumab', 'brand': 'Actemra ACTPen', 'formulation': 'Injection 162 mg in 0.9 mL single use pre-filled pen', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 24 months)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '11565Q', 'drug': 'tocilizumab', 'brand': 'Actemra ACTPen', 'formulation': 'Injection 162 mg in 0.9 mL single use pre-filled pen', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '11565Q', 'drug': 'tocilizumab', 'brand': 'Actemra ACTPen', 'formulation': 'Injection 162 mg in 0.9 mL single use pre-filled pen', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 24 months) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months) - balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '4284L', 'drug': 'infliximab', 'brand': 'Remicade', 'formulation': 'Powder for I.V. infusion 100 mg', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'Initial treatment', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '4284L', 'drug': 'infliximab', 'brand': 'Remicade', 'formulation': 'Powder for I.V. infusion 100 mg', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'Continuing treatment', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12105D', 'drug': 'tocilizumab', 'brand': 'Actemra Subcutaneous Injection', 'formulation': 'Injection 162 mg in 0.9 mL single use pre-filled syringe', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial treatment - Initial 3 (recommencement of a new treatment cycle after a break of more than 12 months in a patient weighing less than 30 kg)', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12105D', 'drug': 'tocilizumab', 'brand': 'Actemra Subcutaneous Injection', 'formulation': 'Injection 162 mg in 0.9 mL single use pre-filled syringe', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial treatment - Initial 1 (new patient weighing less than 30 kg)', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12105D', 'drug': 'tocilizumab', 'brand': 'Actemra Subcutaneous Injection', 'formulation': 'Injection 162 mg in 0.9 mL single use pre-filled syringe', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial treatment - Initial 2 (retrial or recommencement of treatment after a break of less than 12 months in a patient weighing less than 30 kg)', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12384T', 'drug': 'adalimumab', 'brand': 'Idacio', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled syringe', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Continuing treatment', 'streamlined_code': '14107', 'online_application': True, 'authority_method': 'STREAMLINED', 'hospital_type': 'Private', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12384T', 'drug': 'adalimumab', 'brand': 'Amgevita', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled syringe', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Continuing treatment', 'streamlined_code': '14107', 'online_application': True, 'authority_method': 'STREAMLINED', 'hospital_type': 'Private', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12384T', 'drug': 'adalimumab', 'brand': 'Hyrimoz', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled syringe', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Continuing treatment', 'streamlined_code': '14107', 'online_application': True, 'authority_method': 'STREAMLINED', 'hospital_type': 'Private', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12384T', 'drug': 'adalimumab', 'brand': 'Hadlima', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled syringe', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Continuing treatment', 'streamlined_code': '14107', 'online_application': True, 'authority_method': 'STREAMLINED', 'hospital_type': 'Private', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12384T', 'drug': 'adalimumab', 'brand': 'Abrilada', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled syringe', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Continuing treatment', 'streamlined_code': '14107', 'online_application': True, 'authority_method': 'STREAMLINED', 'hospital_type': 'Private', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '3446J', 'drug': 'etanercept', 'brand': 'Enbrel', 'formulation': 'Injections 50 mg in 1 mL single use pre-filled syringes, 4', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial treatment - Initial 1 (new patient)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '3446J', 'drug': 'etanercept', 'brand': 'Enbrel', 'formulation': 'Injections 50 mg in 1 mL single use pre-filled syringes, 4', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 24 months)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '3446J', 'drug': 'etanercept', 'brand': 'Enbrel', 'formulation': 'Injections 50 mg in 1 mL single use pre-filled syringes, 4', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial treatment - Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after break of less than 24 months) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months) -  balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '3446J', 'drug': 'etanercept', 'brand': 'Enbrel', 'formulation': 'Injections 50 mg in 1 mL single use pre-filled syringes, 4', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '11744D', 'drug': 'tocilizumab', 'brand': 'Actemra ACTPen', 'formulation': 'Injection 162 mg in 0.9 mL single use pre-filled pen', 'indication': 'giant cell arteritis', 'treatment_phase': 'Initial treatment', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '11486M', 'drug': 'infliximab', 'brand': 'Inflectra', 'formulation': 'Powder for I.V. infusion 100 mg', 'indication': 'ankylosing spondylitis', 'treatment_phase': 'First continuing treatment', 'streamlined_code': '14683', 'online_application': True, 'authority_method': 'STREAMLINED', 'hospital_type': 'Public', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '11486M', 'drug': 'infliximab', 'brand': 'Renflexis', 'formulation': 'Powder for I.V. infusion 100 mg', 'indication': 'ankylosing spondylitis', 'treatment_phase': 'First continuing treatment', 'streamlined_code': '14683', 'online_application': True, 'authority_method': 'STREAMLINED', 'hospital_type': 'Public', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '11486M', 'drug': 'infliximab', 'brand': 'Inflectra', 'formulation': 'Powder for I.V. infusion 100 mg', 'indication': 'ankylosing spondylitis', 'treatment_phase': 'Subsequent continuing treatment', 'streamlined_code': '14701', 'online_application': True, 'authority_method': 'STREAMLINED', 'hospital_type': 'Public', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '11486M', 'drug': 'infliximab', 'brand': 'Renflexis', 'formulation': 'Powder for I.V. infusion 100 mg', 'indication': 'ankylosing spondylitis', 'treatment_phase': 'Subsequent continuing treatment', 'streamlined_code': '14701', 'online_application': True, 'authority_method': 'STREAMLINED', 'hospital_type': 'Public', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '11734N', 'drug': 'tocilizumab', 'brand': 'Actemra ACTPen', 'formulation': 'Injection 162 mg in 0.9 mL single use pre-filled pen', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 12 months)', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '11734N', 'drug': 'tocilizumab', 'brand': 'Actemra ACTPen', 'formulation': 'Injection 162 mg in 0.9 mL single use pre-filled pen', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 12 months)', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '11734N', 'drug': 'tocilizumab', 'brand': 'Actemra ACTPen', 'formulation': 'Injection 162 mg in 0.9 mL single use pre-filled pen', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial treatment - Initial 1 (new patient)', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '11734N', 'drug': 'tocilizumab', 'brand': 'Actemra ACTPen', 'formulation': 'Injection 162 mg in 0.9 mL single use pre-filled pen', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial treatment - Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 12 months) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 12 months) - balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12297F', 'drug': 'secukinumab', 'brand': 'Cosentyx', 'formulation': 'Injection 150 mg in 1 mL pre-filled pen', 'indication': 'non-radiographic axial spondyloarthritis', 'treatment_phase': 'Initial 1 (New patient), Initial 2 (Change or recommencement of treatment after a break in biological medicine of less than 5 years) or Initial 3 (Recommencement of treatment after a break in biological medicine of more than 5 years) - balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12297F', 'drug': 'secukinumab', 'brand': 'Cosentyx', 'formulation': 'Injection 150 mg in 1 mL pre-filled pen', 'indication': 'non-radiographic axial spondyloarthritis', 'treatment_phase': 'Continuing treatment - balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '14125K', 'drug': 'upadacitinib', 'brand': 'Rinvoq', 'formulation': 'Tablet 15 mg', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'Subsequent continuing treatment', 'streamlined_code': '14499', 'online_application': True, 'authority_method': 'STREAMLINED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9100Y', 'drug': 'adalimumab', 'brand': 'Hadlima', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled pen', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'First continuing treatment', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9100Y', 'drug': 'adalimumab', 'brand': 'Hyrimoz', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled pen', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'First continuing treatment', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9100Y', 'drug': 'adalimumab', 'brand': 'Idacio', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled pen', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'First continuing treatment', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9100Y', 'drug': 'adalimumab', 'brand': 'Abrilada', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled pen', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'First continuing treatment', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9100Y', 'drug': 'adalimumab', 'brand': 'Amgevita', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled pen', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'First continuing treatment', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9100Y', 'drug': 'adalimumab', 'brand': 'Hadlima', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled pen', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'First continuing treatment - balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9100Y', 'drug': 'adalimumab', 'brand': 'Hyrimoz', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled pen', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'First continuing treatment - balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9100Y', 'drug': 'adalimumab', 'brand': 'Idacio', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled pen', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'First continuing treatment - balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9100Y', 'drug': 'adalimumab', 'brand': 'Abrilada', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled pen', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'First continuing treatment - balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9100Y', 'drug': 'adalimumab', 'brand': 'Amgevita', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled pen', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'First continuing treatment - balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '10904X', 'drug': 'certolizumab pegol', 'brand': 'Cimzia', 'formulation': 'Injection 200 mg in 1 mL single use pre-filled syringe', 'indication': 'ankylosing spondylitis', 'treatment_phase': 'Initial treatment - Initial 1 (new patient)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '10904X', 'drug': 'certolizumab pegol', 'brand': 'Cimzia', 'formulation': 'Injection 200 mg in 1 mL single use pre-filled syringe', 'indication': 'ankylosing spondylitis', 'treatment_phase': 'Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '10904X', 'drug': 'certolizumab pegol', 'brand': 'Cimzia', 'formulation': 'Injection 200 mg in 1 mL single use pre-filled syringe', 'indication': 'ankylosing spondylitis', 'treatment_phase': 'Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9680L', 'drug': 'adalimumab', 'brand': 'Amgevita', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled pen', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 12 months)', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Private', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9680L', 'drug': 'adalimumab', 'brand': 'Abrilada', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled pen', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 12 months)', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Private', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9680L', 'drug': 'adalimumab', 'brand': 'Hadlima', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled pen', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 12 months)', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Private', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9680L', 'drug': 'adalimumab', 'brand': 'Hyrimoz', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled pen', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 12 months)', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Private', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9680L', 'drug': 'adalimumab', 'brand': 'Idacio', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled pen', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 12 months)', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Private', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9680L', 'drug': 'adalimumab', 'brand': 'Amgevita', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled pen', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 12 months) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 12 months) - balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Private', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9680L', 'drug': 'adalimumab', 'brand': 'Abrilada', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled pen', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 12 months) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 12 months) - balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Private', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9680L', 'drug': 'adalimumab', 'brand': 'Hadlima', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled pen', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 12 months) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 12 months) - balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Private', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9680L', 'drug': 'adalimumab', 'brand': 'Hyrimoz', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled pen', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 12 months) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 12 months) - balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Private', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9680L', 'drug': 'adalimumab', 'brand': 'Idacio', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled pen', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 12 months) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 12 months) - balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Private', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9680L', 'drug': 'adalimumab', 'brand': 'Amgevita', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled pen', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 12 months)', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Private', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9680L', 'drug': 'adalimumab', 'brand': 'Abrilada', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled pen', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 12 months)', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Private', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9680L', 'drug': 'adalimumab', 'brand': 'Hadlima', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled pen', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 12 months)', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Private', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9680L', 'drug': 'adalimumab', 'brand': 'Hyrimoz', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled pen', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 12 months)', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Private', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9680L', 'drug': 'adalimumab', 'brand': 'Idacio', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled pen', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 12 months)', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Private', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9680L', 'drug': 'adalimumab', 'brand': 'Amgevita', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled pen', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial treatment - Initial 1 (new patient)', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Private', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9680L', 'drug': 'adalimumab', 'brand': 'Abrilada', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled pen', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial treatment - Initial 1 (new patient)', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Private', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9680L', 'drug': 'adalimumab', 'brand': 'Hadlima', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled pen', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial treatment - Initial 1 (new patient)', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Private', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9680L', 'drug': 'adalimumab', 'brand': 'Hyrimoz', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled pen', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial treatment - Initial 1 (new patient)', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Private', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9680L', 'drug': 'adalimumab', 'brand': 'Idacio', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled pen', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial treatment - Initial 1 (new patient)', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Private', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '13716X', 'drug': 'tocilizumab', 'brand': 'Actemra', 'formulation': 'Concentrate for injection 200 mg in 10 mL', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'Subsequent continuing treatment', 'streamlined_code': '14485', 'online_application': True, 'authority_method': 'STREAMLINED', 'hospital_type': 'Private', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12327T', 'drug': 'adalimumab', 'brand': 'Idacio', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled syringe', 'indication': 'ankylosing spondylitis', 'treatment_phase': 'First continuing treatment', 'streamlined_code': '14683', 'online_application': True, 'authority_method': 'STREAMLINED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12327T', 'drug': 'adalimumab', 'brand': 'Hadlima', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled syringe', 'indication': 'ankylosing spondylitis', 'treatment_phase': 'First continuing treatment', 'streamlined_code': '14683', 'online_application': True, 'authority_method': 'STREAMLINED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12327T', 'drug': 'adalimumab', 'brand': 'Abrilada', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled syringe', 'indication': 'ankylosing spondylitis', 'treatment_phase': 'First continuing treatment', 'streamlined_code': '14683', 'online_application': True, 'authority_method': 'STREAMLINED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12327T', 'drug': 'adalimumab', 'brand': 'Amgevita', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled syringe', 'indication': 'ankylosing spondylitis', 'treatment_phase': 'First continuing treatment', 'streamlined_code': '14683', 'online_application': True, 'authority_method': 'STREAMLINED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12327T', 'drug': 'adalimumab', 'brand': 'Hyrimoz', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled syringe', 'indication': 'ankylosing spondylitis', 'treatment_phase': 'First continuing treatment', 'streamlined_code': '14683', 'online_application': True, 'authority_method': 'STREAMLINED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12327T', 'drug': 'adalimumab', 'brand': 'Idacio', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled syringe', 'indication': 'ankylosing spondylitis', 'treatment_phase': 'Subsequent continuing treatment', 'streamlined_code': '14701', 'online_application': True, 'authority_method': 'STREAMLINED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12327T', 'drug': 'adalimumab', 'brand': 'Hadlima', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled syringe', 'indication': 'ankylosing spondylitis', 'treatment_phase': 'Subsequent continuing treatment', 'streamlined_code': '14701', 'online_application': True, 'authority_method': 'STREAMLINED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12327T', 'drug': 'adalimumab', 'brand': 'Abrilada', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled syringe', 'indication': 'ankylosing spondylitis', 'treatment_phase': 'Subsequent continuing treatment', 'streamlined_code': '14701', 'online_application': True, 'authority_method': 'STREAMLINED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12327T', 'drug': 'adalimumab', 'brand': 'Amgevita', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled syringe', 'indication': 'ankylosing spondylitis', 'treatment_phase': 'Subsequent continuing treatment', 'streamlined_code': '14701', 'online_application': True, 'authority_method': 'STREAMLINED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12327T', 'drug': 'adalimumab', 'brand': 'Hyrimoz', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled syringe', 'indication': 'ankylosing spondylitis', 'treatment_phase': 'Subsequent continuing treatment', 'streamlined_code': '14701', 'online_application': True, 'authority_method': 'STREAMLINED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '11196G', 'drug': 'etanercept', 'brand': 'Enbrel', 'formulation': 'Injections 50 mg in 1 mL single use pre-filled syringes, 4', 'indication': 'ankylosing spondylitis', 'treatment_phase': 'Subsequent continuing treatment', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '11196G', 'drug': 'etanercept', 'brand': 'Brenzys', 'formulation': 'Injections 50 mg in 1 mL single use pre-filled syringes, 4', 'indication': 'ankylosing spondylitis', 'treatment_phase': 'Subsequent continuing treatment', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '10951J', 'drug': 'tocilizumab', 'brand': 'Actemra Subcutaneous Injection', 'formulation': 'Injection 162 mg in 0.9 mL single use pre-filled syringe', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 24 months)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '10951J', 'drug': 'tocilizumab', 'brand': 'Actemra Subcutaneous Injection', 'formulation': 'Injection 162 mg in 0.9 mL single use pre-filled syringe', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '10951J', 'drug': 'tocilizumab', 'brand': 'Actemra Subcutaneous Injection', 'formulation': 'Injection 162 mg in 0.9 mL single use pre-filled syringe', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 24 months) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months) - balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '10951J', 'drug': 'tocilizumab', 'brand': 'Actemra Subcutaneous Injection', 'formulation': 'Injection 162 mg in 0.9 mL single use pre-filled syringe', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'Initial treatment - Initial 1 (new patient)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9087G', 'drug': 'etanercept', 'brand': 'Brenzys', 'formulation': 'Injections 50 mg in 1 mL single use pre-filled syringes, 4', 'indication': 'psoriatic arthritis', 'treatment_phase': 'Initial treatment - Initial 1 (new patient)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9087G', 'drug': 'etanercept', 'brand': 'Enbrel', 'formulation': 'Injections 50 mg in 1 mL single use pre-filled syringes, 4', 'indication': 'psoriatic arthritis', 'treatment_phase': 'Initial treatment - Initial 1 (new patient)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9087G', 'drug': 'etanercept', 'brand': 'Brenzys', 'formulation': 'Injections 50 mg in 1 mL single use pre-filled syringes, 4', 'indication': 'psoriatic arthritis', 'treatment_phase': 'Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years) - balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9087G', 'drug': 'etanercept', 'brand': 'Enbrel', 'formulation': 'Injections 50 mg in 1 mL single use pre-filled syringes, 4', 'indication': 'psoriatic arthritis', 'treatment_phase': 'Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years) - balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9087G', 'drug': 'etanercept', 'brand': 'Brenzys', 'formulation': 'Injections 50 mg in 1 mL single use pre-filled syringes, 4', 'indication': 'psoriatic arthritis', 'treatment_phase': 'Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9087G', 'drug': 'etanercept', 'brand': 'Enbrel', 'formulation': 'Injections 50 mg in 1 mL single use pre-filled syringes, 4', 'indication': 'psoriatic arthritis', 'treatment_phase': 'Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9087G', 'drug': 'etanercept', 'brand': 'Brenzys', 'formulation': 'Injections 50 mg in 1 mL single use pre-filled syringes, 4', 'indication': 'psoriatic arthritis', 'treatment_phase': 'Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9087G', 'drug': 'etanercept', 'brand': 'Enbrel', 'formulation': 'Injections 50 mg in 1 mL single use pre-filled syringes, 4', 'indication': 'psoriatic arthritis', 'treatment_phase': 'Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '13734W', 'drug': 'infliximab', 'brand': 'Inflectra', 'formulation': 'Powder for I.V. infusion 100 mg', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'First continuing treatment', 'streamlined_code': '14638', 'online_application': True, 'authority_method': 'STREAMLINED', 'hospital_type': 'Public', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '13734W', 'drug': 'infliximab', 'brand': 'Renflexis', 'formulation': 'Powder for I.V. infusion 100 mg', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'First continuing treatment', 'streamlined_code': '14638', 'online_application': True, 'authority_method': 'STREAMLINED', 'hospital_type': 'Public', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9088H', 'drug': 'etanercept', 'brand': 'Enbrel', 'formulation': 'Injections 50 mg in 1 mL single use pre-filled syringes, 4', 'indication': 'psoriatic arthritis', 'treatment_phase': 'Continuing treatment - balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9088H', 'drug': 'etanercept', 'brand': 'Brenzys', 'formulation': 'Injections 50 mg in 1 mL single use pre-filled syringes, 4', 'indication': 'psoriatic arthritis', 'treatment_phase': 'Continuing treatment - balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9088H', 'drug': 'etanercept', 'brand': 'Enbrel', 'formulation': 'Injections 50 mg in 1 mL single use pre-filled syringes, 4', 'indication': 'psoriatic arthritis', 'treatment_phase': 'First continuing treatment', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9088H', 'drug': 'etanercept', 'brand': 'Brenzys', 'formulation': 'Injections 50 mg in 1 mL single use pre-filled syringes, 4', 'indication': 'psoriatic arthritis', 'treatment_phase': 'First continuing treatment', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '13212J', 'drug': 'adalimumab', 'brand': 'Humira', 'formulation': 'Injection 40 mg in 0.4 mL pre-filled pen', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Continuing treatment', 'streamlined_code': '14136', 'online_application': True, 'authority_method': 'STREAMLINED', 'hospital_type': 'Public', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '13212J', 'drug': 'adalimumab', 'brand': 'Yuflyma', 'formulation': 'Injection 40 mg in 0.4 mL pre-filled pen', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Continuing treatment', 'streamlined_code': '14136', 'online_application': True, 'authority_method': 'STREAMLINED', 'hospital_type': 'Public', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '13212J', 'drug': 'adalimumab', 'brand': 'Adalicip', 'formulation': 'Injection 40 mg in 0.4 mL pre-filled pen', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Continuing treatment', 'streamlined_code': '14136', 'online_application': True, 'authority_method': 'STREAMLINED', 'hospital_type': 'Public', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12368Y', 'drug': 'adalimumab', 'brand': 'Amgevita', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled pen', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Continuing treatment', 'streamlined_code': '14107', 'online_application': True, 'authority_method': 'STREAMLINED', 'hospital_type': 'Private', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12368Y', 'drug': 'adalimumab', 'brand': 'Hadlima', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled pen', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Continuing treatment', 'streamlined_code': '14107', 'online_application': True, 'authority_method': 'STREAMLINED', 'hospital_type': 'Private', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12368Y', 'drug': 'adalimumab', 'brand': 'Hyrimoz', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled pen', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Continuing treatment', 'streamlined_code': '14107', 'online_application': True, 'authority_method': 'STREAMLINED', 'hospital_type': 'Private', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12368Y', 'drug': 'adalimumab', 'brand': 'Abrilada', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled pen', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Continuing treatment', 'streamlined_code': '14107', 'online_application': True, 'authority_method': 'STREAMLINED', 'hospital_type': 'Private', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12368Y', 'drug': 'adalimumab', 'brand': 'Idacio', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled pen', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Continuing treatment', 'streamlined_code': '14107', 'online_application': True, 'authority_method': 'STREAMLINED', 'hospital_type': 'Private', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '13692P', 'drug': 'adalimumab', 'brand': 'Hadlima', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled pen', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'Initial treatment - Initial 1 (new patient)', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '13692P', 'drug': 'adalimumab', 'brand': 'Idacio', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled pen', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'Initial treatment - Initial 1 (new patient)', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '13692P', 'drug': 'adalimumab', 'brand': 'Hyrimoz', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled pen', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'Initial treatment - Initial 1 (new patient)', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '13692P', 'drug': 'adalimumab', 'brand': 'Amgevita', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled pen', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'Initial treatment - Initial 1 (new patient)', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '13692P', 'drug': 'adalimumab', 'brand': 'Abrilada', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled pen', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'Initial treatment - Initial 1 (new patient)', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '13692P', 'drug': 'adalimumab', 'brand': 'Hadlima', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled pen', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 24 months)', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '13692P', 'drug': 'adalimumab', 'brand': 'Idacio', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled pen', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 24 months)', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '13692P', 'drug': 'adalimumab', 'brand': 'Hyrimoz', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled pen', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 24 months)', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '13692P', 'drug': 'adalimumab', 'brand': 'Amgevita', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled pen', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 24 months)', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '13692P', 'drug': 'adalimumab', 'brand': 'Abrilada', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled pen', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 24 months)', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '13692P', 'drug': 'adalimumab', 'brand': 'Hadlima', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled pen', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months)', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '13692P', 'drug': 'adalimumab', 'brand': 'Idacio', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled pen', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months)', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '13692P', 'drug': 'adalimumab', 'brand': 'Hyrimoz', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled pen', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months)', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '13692P', 'drug': 'adalimumab', 'brand': 'Amgevita', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled pen', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months)', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '13692P', 'drug': 'adalimumab', 'brand': 'Abrilada', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled pen', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months)', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '11720W', 'drug': 'tocilizumab', 'brand': 'Actemra Subcutaneous Injection', 'formulation': 'Injection 162 mg in 0.9 mL single use pre-filled syringe', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Continuing treatment', 'streamlined_code': '14150', 'online_application': True, 'authority_method': 'STREAMLINED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '13311N', 'drug': 'tocilizumab', 'brand': 'Actemra', 'formulation': 'Concentrate for injection 80 mg in 4 mL', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Continuing treatment', 'streamlined_code': '14082', 'online_application': True, 'authority_method': 'STREAMLINED', 'hospital_type': 'Private', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12401Q', 'drug': 'adalimumab', 'brand': 'Hadlima', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled pen', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Subsequent continuing treatment', 'streamlined_code': '11604', 'online_application': True, 'authority_method': 'STREAMLINED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12401Q', 'drug': 'adalimumab', 'brand': 'Amgevita', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled pen', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Subsequent continuing treatment', 'streamlined_code': '11604', 'online_application': True, 'authority_method': 'STREAMLINED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12401Q', 'drug': 'adalimumab', 'brand': 'Hyrimoz', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled pen', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Subsequent continuing treatment', 'streamlined_code': '11604', 'online_application': True, 'authority_method': 'STREAMLINED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12401Q', 'drug': 'adalimumab', 'brand': 'Idacio', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled pen', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Subsequent continuing treatment', 'streamlined_code': '11604', 'online_application': True, 'authority_method': 'STREAMLINED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12401Q', 'drug': 'adalimumab', 'brand': 'Abrilada', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled pen', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Subsequent continuing treatment', 'streamlined_code': '11604', 'online_application': True, 'authority_method': 'STREAMLINED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '11361Y', 'drug': 'golimumab', 'brand': 'Simponi', 'formulation': 'Injection 50 mg in 0.5 mL single use pre-filled pen', 'indication': 'ankylosing spondylitis', 'treatment_phase': 'Initial treatment - Initial 1 (new patient)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '11361Y', 'drug': 'golimumab', 'brand': 'Simponi', 'formulation': 'Injection 50 mg in 0.5 mL single use pre-filled pen', 'indication': 'ankylosing spondylitis', 'treatment_phase': 'Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '11361Y', 'drug': 'golimumab', 'brand': 'Simponi', 'formulation': 'Injection 50 mg in 0.5 mL single use pre-filled pen', 'indication': 'ankylosing spondylitis', 'treatment_phase': 'Initial treatment - Initial 1 (new patient), Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years) - balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '11361Y', 'drug': 'golimumab', 'brand': 'Simponi', 'formulation': 'Injection 50 mg in 0.5 mL single use pre-filled pen', 'indication': 'ankylosing spondylitis', 'treatment_phase': 'Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '8638P', 'drug': 'etanercept', 'brand': 'Enbrel', 'formulation': 'Injection set containing 4 vials powder for injection 25 mg and 4 pre-filled syringes solvent 1 mL', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'First continuing treatment', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '8638P', 'drug': 'etanercept', 'brand': 'Enbrel', 'formulation': 'Injection set containing 4 vials powder for injection 25 mg and 4 pre-filled syringes solvent 1 mL', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'First continuing treatment - balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12442W', 'drug': 'adalimumab', 'brand': 'Humira', 'formulation': 'Injection 40 mg in 0.4 mL pre-filled syringe', 'indication': 'ankylosing spondylitis', 'treatment_phase': 'Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12442W', 'drug': 'adalimumab', 'brand': 'Adalicip', 'formulation': 'Injection 40 mg in 0.4 mL pre-filled syringe', 'indication': 'ankylosing spondylitis', 'treatment_phase': 'Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12442W', 'drug': 'adalimumab', 'brand': 'Yuflyma', 'formulation': 'Injection 40 mg in 0.4 mL pre-filled syringe', 'indication': 'ankylosing spondylitis', 'treatment_phase': 'Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12442W', 'drug': 'adalimumab', 'brand': 'Humira', 'formulation': 'Injection 40 mg in 0.4 mL pre-filled syringe', 'indication': 'ankylosing spondylitis', 'treatment_phase': 'Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years) - balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12442W', 'drug': 'adalimumab', 'brand': 'Adalicip', 'formulation': 'Injection 40 mg in 0.4 mL pre-filled syringe', 'indication': 'ankylosing spondylitis', 'treatment_phase': 'Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years) - balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12442W', 'drug': 'adalimumab', 'brand': 'Yuflyma', 'formulation': 'Injection 40 mg in 0.4 mL pre-filled syringe', 'indication': 'ankylosing spondylitis', 'treatment_phase': 'Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years) - balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12442W', 'drug': 'adalimumab', 'brand': 'Humira', 'formulation': 'Injection 40 mg in 0.4 mL pre-filled syringe', 'indication': 'ankylosing spondylitis', 'treatment_phase': 'Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12442W', 'drug': 'adalimumab', 'brand': 'Adalicip', 'formulation': 'Injection 40 mg in 0.4 mL pre-filled syringe', 'indication': 'ankylosing spondylitis', 'treatment_phase': 'Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12442W', 'drug': 'adalimumab', 'brand': 'Yuflyma', 'formulation': 'Injection 40 mg in 0.4 mL pre-filled syringe', 'indication': 'ankylosing spondylitis', 'treatment_phase': 'Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12442W', 'drug': 'adalimumab', 'brand': 'Humira', 'formulation': 'Injection 40 mg in 0.4 mL pre-filled syringe', 'indication': 'ankylosing spondylitis', 'treatment_phase': 'Initial treatment - Initial 1 (new patient)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12442W', 'drug': 'adalimumab', 'brand': 'Adalicip', 'formulation': 'Injection 40 mg in 0.4 mL pre-filled syringe', 'indication': 'ankylosing spondylitis', 'treatment_phase': 'Initial treatment - Initial 1 (new patient)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12442W', 'drug': 'adalimumab', 'brand': 'Yuflyma', 'formulation': 'Injection 40 mg in 0.4 mL pre-filled syringe', 'indication': 'ankylosing spondylitis', 'treatment_phase': 'Initial treatment - Initial 1 (new patient)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12767Y', 'drug': 'tocilizumab', 'brand': 'Actemra ACTPen', 'formulation': 'Injection 162 mg in 0.9 mL single use pre-filled pen', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial treatment - Initial 4 (Temporary listing - change of treatment from another biological medicine to tocilizumab after resolution of the critical shortage of tocilizumab)', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '11216H', 'drug': 'etanercept', 'brand': 'Brenzys', 'formulation': 'Injections 50 mg in 1 mL single use pre-filled syringes, 4', 'indication': 'psoriatic arthritis', 'treatment_phase': 'Subsequent continuing treatment', 'streamlined_code': '9156', 'online_application': True, 'authority_method': 'STREAMLINED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '13715W', 'drug': 'tocilizumab', 'brand': 'Actemra', 'formulation': 'Concentrate for injection 400 mg in 20 mL', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'Subsequent continuing treatment', 'streamlined_code': '14621', 'online_application': True, 'authority_method': 'STREAMLINED', 'hospital_type': 'Public', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '13066Q', 'drug': 'infliximab', 'brand': 'Remsima SC', 'formulation': 'Solution for injection 120 mg in 1 mL pre-filled syringe', 'indication': 'psoriatic arthritis', 'treatment_phase': 'Initial treatment with the subcutaneous form where a concurrent PBS authority application for the intravenously (IV) administered formulation is being made', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '11322X', 'drug': 'certolizumab pegol', 'brand': 'Cimzia', 'formulation': 'Solution for injection 200 mg in 1 mL pre-filled pen', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'Initial treatment - Initial 1 (new patient)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '11322X', 'drug': 'certolizumab pegol', 'brand': 'Cimzia', 'formulation': 'Solution for injection 200 mg in 1 mL pre-filled pen', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '11322X', 'drug': 'certolizumab pegol', 'brand': 'Cimzia', 'formulation': 'Solution for injection 200 mg in 1 mL pre-filled pen', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 24 months)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '13075E', 'drug': 'infliximab', 'brand': 'Remsima SC', 'formulation': 'Solution for injection 120 mg in 1 mL pre-filled pen', 'indication': 'ankylosing spondylitis', 'treatment_phase': 'Balance of supply (including switching formulation) where the full duration of treatment available under a particular treatment phase was not requested in the preceding prescription', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12326R', 'drug': 'adalimumab', 'brand': 'Hadlima', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled syringe', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'Subsequent continuing treatment', 'streamlined_code': '14499', 'online_application': True, 'authority_method': 'STREAMLINED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12326R', 'drug': 'adalimumab', 'brand': 'Abrilada', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled syringe', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'Subsequent continuing treatment', 'streamlined_code': '14499', 'online_application': True, 'authority_method': 'STREAMLINED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12326R', 'drug': 'adalimumab', 'brand': 'Idacio', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled syringe', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'Subsequent continuing treatment', 'streamlined_code': '14499', 'online_application': True, 'authority_method': 'STREAMLINED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12326R', 'drug': 'adalimumab', 'brand': 'Amgevita', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled syringe', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'Subsequent continuing treatment', 'streamlined_code': '14499', 'online_application': True, 'authority_method': 'STREAMLINED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12326R', 'drug': 'adalimumab', 'brand': 'Hyrimoz', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled syringe', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'Subsequent continuing treatment', 'streamlined_code': '14499', 'online_application': True, 'authority_method': 'STREAMLINED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '11750K', 'drug': 'tocilizumab', 'brand': 'Actemra ACTPen', 'formulation': 'Injection 162 mg in 0.9 mL single use pre-filled pen', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Continuing treatment', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '11750K', 'drug': 'tocilizumab', 'brand': 'Actemra ACTPen', 'formulation': 'Injection 162 mg in 0.9 mL single use pre-filled pen', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Continuing Treatment - balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '10073E', 'drug': 'tocilizumab', 'brand': 'Actemra', 'formulation': 'Concentrate for injection 80 mg in 4 mL', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Continuing Treatment - balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Private', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '10073E', 'drug': 'tocilizumab', 'brand': 'Actemra', 'formulation': 'Concentrate for injection 80 mg in 4 mL', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 24 months)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Private', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '10073E', 'drug': 'tocilizumab', 'brand': 'Actemra', 'formulation': 'Concentrate for injection 80 mg in 4 mL', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial treatment - Initial 1 (new patient)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Private', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '10073E', 'drug': 'tocilizumab', 'brand': 'Actemra', 'formulation': 'Concentrate for injection 80 mg in 4 mL', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Private', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '10073E', 'drug': 'tocilizumab', 'brand': 'Actemra', 'formulation': 'Concentrate for injection 80 mg in 4 mL', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial treatment - Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after break of less than 24 months) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months) -  balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Private', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '10073E', 'drug': 'tocilizumab', 'brand': 'Actemra', 'formulation': 'Concentrate for injection 80 mg in 4 mL', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Continuing treatment', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Private', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12428D', 'drug': 'adalimumab', 'brand': 'Yuflyma', 'formulation': 'Injection 40 mg in 0.4 mL pre-filled pen', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial treatment - Initial 2 (change or recommencement of treatment after break in biological medicine of less than 24 months)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12428D', 'drug': 'adalimumab', 'brand': 'Adalicip', 'formulation': 'Injection 40 mg in 0.4 mL pre-filled pen', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial treatment - Initial 2 (change or recommencement of treatment after break in biological medicine of less than 24 months)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12428D', 'drug': 'adalimumab', 'brand': 'Humira', 'formulation': 'Injection 40 mg in 0.4 mL pre-filled pen', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial treatment - Initial 2 (change or recommencement of treatment after break in biological medicine of less than 24 months)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12428D', 'drug': 'adalimumab', 'brand': 'Yuflyma', 'formulation': 'Injection 40 mg in 0.4 mL pre-filled pen', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial treatment - Initial 1 (new patient)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12428D', 'drug': 'adalimumab', 'brand': 'Adalicip', 'formulation': 'Injection 40 mg in 0.4 mL pre-filled pen', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial treatment - Initial 1 (new patient)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12428D', 'drug': 'adalimumab', 'brand': 'Humira', 'formulation': 'Injection 40 mg in 0.4 mL pre-filled pen', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial treatment - Initial 1 (new patient)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12428D', 'drug': 'adalimumab', 'brand': 'Yuflyma', 'formulation': 'Injection 40 mg in 0.4 mL pre-filled pen', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial treatment - Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after break of less than 24 months) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months) -  balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12428D', 'drug': 'adalimumab', 'brand': 'Adalicip', 'formulation': 'Injection 40 mg in 0.4 mL pre-filled pen', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial treatment - Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after break of less than 24 months) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months) -  balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12428D', 'drug': 'adalimumab', 'brand': 'Humira', 'formulation': 'Injection 40 mg in 0.4 mL pre-filled pen', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial treatment - Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after break of less than 24 months) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months) -  balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12428D', 'drug': 'adalimumab', 'brand': 'Yuflyma', 'formulation': 'Injection 40 mg in 0.4 mL pre-filled pen', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12428D', 'drug': 'adalimumab', 'brand': 'Adalicip', 'formulation': 'Injection 40 mg in 0.4 mL pre-filled pen', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12428D', 'drug': 'adalimumab', 'brand': 'Humira', 'formulation': 'Injection 40 mg in 0.4 mL pre-filled pen', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '3434R', 'drug': 'golimumab', 'brand': 'Simponi', 'formulation': 'Injection 50 mg in 0.5 mL single use pre-filled syringe', 'indication': 'ankylosing spondylitis', 'treatment_phase': 'Initial treatment - Initial 1 (new patient)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '3434R', 'drug': 'golimumab', 'brand': 'Simponi', 'formulation': 'Injection 50 mg in 0.5 mL single use pre-filled syringe', 'indication': 'ankylosing spondylitis', 'treatment_phase': 'Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '3434R', 'drug': 'golimumab', 'brand': 'Simponi', 'formulation': 'Injection 50 mg in 0.5 mL single use pre-filled syringe', 'indication': 'ankylosing spondylitis', 'treatment_phase': 'Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '3434R', 'drug': 'golimumab', 'brand': 'Simponi', 'formulation': 'Injection 50 mg in 0.5 mL single use pre-filled syringe', 'indication': 'ankylosing spondylitis', 'treatment_phase': 'Initial treatment - Initial 1 (new patient), Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years) - balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '11321W', 'drug': 'certolizumab pegol', 'brand': 'Cimzia', 'formulation': 'Solution for injection 200 mg in 1 mL pre-filled pen', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 24 months) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months) - balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '13324G', 'drug': 'tocilizumab', 'brand': 'Actemra', 'formulation': 'Concentrate for injection 80 mg in 4 mL', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Continuing treatment', 'streamlined_code': '14164', 'online_application': True, 'authority_method': 'STREAMLINED', 'hospital_type': 'Public', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '5605B', 'drug': 'abatacept', 'brand': 'Orencia', 'formulation': 'Powder for I.V. infusion 250 mg', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Public', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '5605B', 'drug': 'abatacept', 'brand': 'Orencia', 'formulation': 'Powder for I.V. infusion 250 mg', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'First continuing treatment', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Public', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '5605B', 'drug': 'abatacept', 'brand': 'Orencia', 'formulation': 'Powder for I.V. infusion 250 mg', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'Initial treatment - Initial 1 (new patient)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Public', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '5605B', 'drug': 'abatacept', 'brand': 'Orencia', 'formulation': 'Powder for I.V. infusion 250 mg', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'First continuing treatment - balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Public', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '5605B', 'drug': 'abatacept', 'brand': 'Orencia', 'formulation': 'Powder for I.V. infusion 250 mg', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 24 months)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Public', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '5605B', 'drug': 'abatacept', 'brand': 'Orencia', 'formulation': 'Powder for I.V. infusion 250 mg', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 24 months) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months) - balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Public', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '11514B', 'drug': 'infliximab', 'brand': 'Inflectra', 'formulation': 'Powder for I.V. infusion 100 mg', 'indication': 'psoriatic arthritis', 'treatment_phase': 'Subsequent continuing treatment', 'streamlined_code': '9188', 'online_application': True, 'authority_method': 'STREAMLINED', 'hospital_type': 'Public', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '11514B', 'drug': 'infliximab', 'brand': 'Renflexis', 'formulation': 'Powder for I.V. infusion 100 mg', 'indication': 'psoriatic arthritis', 'treatment_phase': 'Subsequent continuing treatment', 'streamlined_code': '9188', 'online_application': True, 'authority_method': 'STREAMLINED', 'hospital_type': 'Public', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '13350P', 'drug': 'upadacitinib', 'brand': 'Rinvoq', 'formulation': 'Tablet 15 mg', 'indication': 'non-radiographic axial spondyloarthritis', 'treatment_phase': 'Initial treatment - Initial 1 (New patient)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '13350P', 'drug': 'upadacitinib', 'brand': 'Rinvoq', 'formulation': 'Tablet 15 mg', 'indication': 'non-radiographic axial spondyloarthritis', 'treatment_phase': 'Initial treatment - Initial 2 (Change or recommencement of treatment after a break in biological medicine of less than 5 years)', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '13350P', 'drug': 'upadacitinib', 'brand': 'Rinvoq', 'formulation': 'Tablet 15 mg', 'indication': 'non-radiographic axial spondyloarthritis', 'treatment_phase': 'Initial treatment - Initial 3 (Recommencement of treatment after a break in biological medicine of more than 5 years)', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '13350P', 'drug': 'upadacitinib', 'brand': 'Rinvoq', 'formulation': 'Tablet 15 mg', 'indication': 'non-radiographic axial spondyloarthritis', 'treatment_phase': 'Initial 1 (New patient), Initial 2 (Change or recommencement of treatment after a break in biological medicine of less than 5 years) or Initial 3 (Recommencement of treatment after a break in biological medicine of more than 5 years) - balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '13343G', 'drug': 'upadacitinib', 'brand': 'Rinvoq', 'formulation': 'Tablet 15 mg', 'indication': 'non-radiographic axial spondyloarthritis', 'treatment_phase': 'Transitioning from non-PBS to PBS-subsidised supply - Grandfather arrangements', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '13343G', 'drug': 'upadacitinib', 'brand': 'Rinvoq', 'formulation': 'Tablet 15 mg', 'indication': 'non-radiographic axial spondyloarthritis', 'treatment_phase': 'Continuing treatment - balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '13343G', 'drug': 'upadacitinib', 'brand': 'Rinvoq', 'formulation': 'Tablet 15 mg', 'indication': 'non-radiographic axial spondyloarthritis', 'treatment_phase': 'Continuing treatment', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '11447L', 'drug': 'baricitinib', 'brand': 'Olumiant', 'formulation': 'Tablet 4 mg', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'Initial treatment - Initial 1 (new patient)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '11447L', 'drug': 'baricitinib', 'brand': 'Olumiant', 'formulation': 'Tablet 4 mg', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '11447L', 'drug': 'baricitinib', 'brand': 'Olumiant', 'formulation': 'Tablet 4 mg', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 24 months) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months) - balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '11447L', 'drug': 'baricitinib', 'brand': 'Olumiant', 'formulation': 'Tablet 4 mg', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 24 months)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9641K', 'drug': 'etanercept', 'brand': 'Enbrel', 'formulation': 'Injection 50 mg in 1 mL single use auto-injector, 4', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial treatment - Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 12 months) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 12 months) - balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Private', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9641K', 'drug': 'etanercept', 'brand': 'Enbrel', 'formulation': 'Injection 50 mg in 1 mL single use auto-injector, 4', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 12 months)', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Private', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9641K', 'drug': 'etanercept', 'brand': 'Enbrel', 'formulation': 'Injection 50 mg in 1 mL single use auto-injector, 4', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial treatment - Initial 1 (new patient)', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Private', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9641K', 'drug': 'etanercept', 'brand': 'Enbrel', 'formulation': 'Injection 50 mg in 1 mL single use auto-injector, 4', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 12 months)', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Private', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '13776C', 'drug': 'tofacitinib', 'brand': 'Xeljanz', 'formulation': 'Oral solution 1 mg per mL, 240 mL', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Transitioning from non-PBS to PBS-subsidised supply - Grandfather arrangements', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '13778E', 'drug': 'infliximab', 'brand': 'Inflectra', 'formulation': 'Powder for I.V. infusion 100 mg', 'indication': 'ankylosing spondylitis', 'treatment_phase': 'Initial treatment - Initial 1 (new patient)', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Private', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '13778E', 'drug': 'infliximab', 'brand': 'Renflexis', 'formulation': 'Powder for I.V. infusion 100 mg', 'indication': 'ankylosing spondylitis', 'treatment_phase': 'Initial treatment - Initial 1 (new patient)', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Private', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '13778E', 'drug': 'infliximab', 'brand': 'Inflectra', 'formulation': 'Powder for I.V. infusion 100 mg', 'indication': 'ankylosing spondylitis', 'treatment_phase': 'Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years)', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Private', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '13778E', 'drug': 'infliximab', 'brand': 'Renflexis', 'formulation': 'Powder for I.V. infusion 100 mg', 'indication': 'ankylosing spondylitis', 'treatment_phase': 'Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years)', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Private', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '13778E', 'drug': 'infliximab', 'brand': 'Inflectra', 'formulation': 'Powder for I.V. infusion 100 mg', 'indication': 'ankylosing spondylitis', 'treatment_phase': 'Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years)', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Private', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '13778E', 'drug': 'infliximab', 'brand': 'Renflexis', 'formulation': 'Powder for I.V. infusion 100 mg', 'indication': 'ankylosing spondylitis', 'treatment_phase': 'Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years)', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Private', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '13726K', 'drug': 'abatacept', 'brand': 'Orencia', 'formulation': 'Injection 125 mg in 1 mL single dose pre-filled syringe', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'Subsequent continuing treatment', 'streamlined_code': '14604', 'online_application': True, 'authority_method': 'STREAMLINED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '11201M', 'drug': 'etanercept', 'brand': 'Brenzys', 'formulation': 'Injection 50 mg in 1 mL single use auto-injector, 4', 'indication': 'ankylosing spondylitis', 'treatment_phase': 'Subsequent continuing treatment', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '11201M', 'drug': 'etanercept', 'brand': 'Enbrel', 'formulation': 'Injection 50 mg in 1 mL single use auto-injector, 4', 'indication': 'ankylosing spondylitis', 'treatment_phase': 'Subsequent continuing treatment', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '1220F', 'drug': 'abatacept', 'brand': 'Orencia', 'formulation': 'Injection 125 mg in 1 mL single dose pre-filled syringe', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 24 months)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '1220F', 'drug': 'abatacept', 'brand': 'Orencia', 'formulation': 'Injection 125 mg in 1 mL single dose pre-filled syringe', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '1220F', 'drug': 'abatacept', 'brand': 'Orencia', 'formulation': 'Injection 125 mg in 1 mL single dose pre-filled syringe', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'Initial treatment - Initial 1 (new patient)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '1220F', 'drug': 'abatacept', 'brand': 'Orencia', 'formulation': 'Injection 125 mg in 1 mL single dose pre-filled syringe', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 24 months) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months) - balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '13732R', 'drug': 'adalimumab', 'brand': 'Yuflyma', 'formulation': 'Injection 40 mg in 0.4 mL pre-filled syringe', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'First continuing treatment', 'streamlined_code': '14567', 'online_application': True, 'authority_method': 'STREAMLINED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '13732R', 'drug': 'adalimumab', 'brand': 'Adalicip', 'formulation': 'Injection 40 mg in 0.4 mL pre-filled syringe', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'First continuing treatment', 'streamlined_code': '14567', 'online_application': True, 'authority_method': 'STREAMLINED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '13222X', 'drug': 'adalimumab', 'brand': 'Humira', 'formulation': 'Injection 40 mg in 0.4 mL pre-filled syringe', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'Subsequent continuing treatment', 'streamlined_code': '14499', 'online_application': True, 'authority_method': 'STREAMLINED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '13222X', 'drug': 'adalimumab', 'brand': 'Yuflyma', 'formulation': 'Injection 40 mg in 0.4 mL pre-filled syringe', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'Subsequent continuing treatment', 'streamlined_code': '14499', 'online_application': True, 'authority_method': 'STREAMLINED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '13222X', 'drug': 'adalimumab', 'brand': 'Adalicip', 'formulation': 'Injection 40 mg in 0.4 mL pre-filled syringe', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'Subsequent continuing treatment', 'streamlined_code': '14499', 'online_application': True, 'authority_method': 'STREAMLINED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '13751R', 'drug': 'etanercept', 'brand': 'Brenzys', 'formulation': 'Injections 50 mg in 1 mL single use pre-filled syringes, 4', 'indication': 'ankylosing spondylitis', 'treatment_phase': 'Initial treatment - Initial 1 (new patient)', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '13751R', 'drug': 'etanercept', 'brand': 'Brenzys', 'formulation': 'Injections 50 mg in 1 mL single use pre-filled syringes, 4', 'indication': 'ankylosing spondylitis', 'treatment_phase': 'Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years)', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '13751R', 'drug': 'etanercept', 'brand': 'Brenzys', 'formulation': 'Injections 50 mg in 1 mL single use pre-filled syringes, 4', 'indication': 'ankylosing spondylitis', 'treatment_phase': 'Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years)', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12762Q', 'drug': 'tocilizumab', 'brand': 'Actemra Subcutaneous Injection', 'formulation': 'Injection 162 mg in 0.9 mL single use pre-filled syringe', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial treatment - Initial 4 (Temporary listing - change of treatment from another biological medicine to tocilizumab after resolution of the critical shortage of tocilizumab)', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '11538G', 'drug': 'golimumab', 'brand': 'Simponi', 'formulation': 'Injection 50 mg in 0.5 mL single use pre-filled pen', 'indication': 'non-radiographic axial spondyloarthritis', 'treatment_phase': 'Initial 1 (New patient), Initial 2 (Change or re-commencement of treatment after a break in biological medicine of less than 5 years) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years) - balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '11538G', 'drug': 'golimumab', 'brand': 'Simponi', 'formulation': 'Injection 50 mg in 0.5 mL single use pre-filled pen', 'indication': 'non-radiographic axial spondyloarthritis', 'treatment_phase': 'Initial treatment - Initial 3 (Recommencement of treatment after a break in biological medicine of more than 5 years)', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '11538G', 'drug': 'golimumab', 'brand': 'Simponi', 'formulation': 'Injection 50 mg in 0.5 mL single use pre-filled pen', 'indication': 'non-radiographic axial spondyloarthritis', 'treatment_phase': 'Initial treatment - Initial 1 (New patient)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '11538G', 'drug': 'golimumab', 'brand': 'Simponi', 'formulation': 'Injection 50 mg in 0.5 mL single use pre-filled pen', 'indication': 'non-radiographic axial spondyloarthritis', 'treatment_phase': 'Initial treatment - Initial 2 (Change or re-commencement of treatment after a break of less than 5 years)', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '11490R', 'drug': 'infliximab', 'brand': 'Inflectra', 'formulation': 'Powder for I.V. infusion 100 mg', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'Subsequent continuing treatment', 'streamlined_code': '14504', 'online_application': True, 'authority_method': 'STREAMLINED', 'hospital_type': 'Public', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '11490R', 'drug': 'infliximab', 'brand': 'Remicade', 'formulation': 'Powder for I.V. infusion 100 mg', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'Subsequent continuing treatment', 'streamlined_code': '14504', 'online_application': True, 'authority_method': 'STREAMLINED', 'hospital_type': 'Public', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '11490R', 'drug': 'infliximab', 'brand': 'Renflexis', 'formulation': 'Powder for I.V. infusion 100 mg', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'Subsequent continuing treatment', 'streamlined_code': '14504', 'online_application': True, 'authority_method': 'STREAMLINED', 'hospital_type': 'Public', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12791F', 'drug': 'tocilizumab', 'brand': 'Actemra', 'formulation': 'Concentrate for injection 200 mg in 10 mL', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'Initial treatment - Initial 4 (Temporary listing - change of treatment from another biological medicine to tocilizumab after resolution of the critical shortage of tocilizumab)', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Public', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '13312P', 'drug': 'tocilizumab', 'brand': 'Actemra', 'formulation': 'Concentrate for injection 200 mg in 10 mL', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Continuing treatment', 'streamlined_code': '14082', 'online_application': True, 'authority_method': 'STREAMLINED', 'hospital_type': 'Private', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '3447K', 'drug': 'etanercept', 'brand': 'Enbrel', 'formulation': 'Injection 50 mg in 1 mL single use auto-injector, 4', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial treatment - Initial 1 (new patient)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '3447K', 'drug': 'etanercept', 'brand': 'Enbrel', 'formulation': 'Injection 50 mg in 1 mL single use auto-injector, 4', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial treatment - Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after break of less than 24 months) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months) -  balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '3447K', 'drug': 'etanercept', 'brand': 'Enbrel', 'formulation': 'Injection 50 mg in 1 mL single use auto-injector, 4', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 24 months)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '3447K', 'drug': 'etanercept', 'brand': 'Enbrel', 'formulation': 'Injection 50 mg in 1 mL single use auto-injector, 4', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '11684Y', 'drug': 'abatacept', 'brand': 'Orencia ClickJect', 'formulation': 'Injection 125 mg in 1 mL single dose autoinjector', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'First continuing treatment', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '11684Y', 'drug': 'abatacept', 'brand': 'Orencia ClickJect', 'formulation': 'Injection 125 mg in 1 mL single dose autoinjector', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'First continuing treatment - balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12361N', 'drug': 'adalimumab', 'brand': 'Humira', 'formulation': 'Injection 40 mg in 0.4 mL pre-filled syringe', 'indication': 'ankylosing spondylitis', 'treatment_phase': 'Subsequent continuing treatment', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12361N', 'drug': 'adalimumab', 'brand': 'Yuflyma', 'formulation': 'Injection 40 mg in 0.4 mL pre-filled syringe', 'indication': 'ankylosing spondylitis', 'treatment_phase': 'Subsequent continuing treatment', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12361N', 'drug': 'adalimumab', 'brand': 'Adalicip', 'formulation': 'Injection 40 mg in 0.4 mL pre-filled syringe', 'indication': 'ankylosing spondylitis', 'treatment_phase': 'Subsequent continuing treatment', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12361N', 'drug': 'adalimumab', 'brand': 'Humira', 'formulation': 'Injection 40 mg in 0.4 mL pre-filled syringe', 'indication': 'ankylosing spondylitis', 'treatment_phase': 'First continuing treatment', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12361N', 'drug': 'adalimumab', 'brand': 'Yuflyma', 'formulation': 'Injection 40 mg in 0.4 mL pre-filled syringe', 'indication': 'ankylosing spondylitis', 'treatment_phase': 'First continuing treatment', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12361N', 'drug': 'adalimumab', 'brand': 'Adalicip', 'formulation': 'Injection 40 mg in 0.4 mL pre-filled syringe', 'indication': 'ankylosing spondylitis', 'treatment_phase': 'First continuing treatment', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12361N', 'drug': 'adalimumab', 'brand': 'Humira', 'formulation': 'Injection 40 mg in 0.4 mL pre-filled syringe', 'indication': 'ankylosing spondylitis', 'treatment_phase': 'Continuing treatment - balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12361N', 'drug': 'adalimumab', 'brand': 'Yuflyma', 'formulation': 'Injection 40 mg in 0.4 mL pre-filled syringe', 'indication': 'ankylosing spondylitis', 'treatment_phase': 'Continuing treatment - balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12361N', 'drug': 'adalimumab', 'brand': 'Adalicip', 'formulation': 'Injection 40 mg in 0.4 mL pre-filled syringe', 'indication': 'ankylosing spondylitis', 'treatment_phase': 'Continuing treatment - balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '11722Y', 'drug': 'tocilizumab', 'brand': 'Actemra ACTPen', 'formulation': 'Injection 162 mg in 0.9 mL single use pre-filled pen', 'indication': 'giant cell arteritis', 'treatment_phase': 'Continuing treatment', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12787B', 'drug': 'tocilizumab', 'brand': 'Actemra', 'formulation': 'Concentrate for injection 80 mg in 4 mL', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'Initial treatment - Initial 4 (Temporary listing - change of treatment from another biological medicine to tocilizumab after resolution of the critical shortage of tocilizumab)', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Private', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9102C', 'drug': 'adalimumab', 'brand': 'Amgevita', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled pen', 'indication': 'psoriatic arthritis', 'treatment_phase': 'Subsequent continuing treatment', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9102C', 'drug': 'adalimumab', 'brand': 'Abrilada', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled pen', 'indication': 'psoriatic arthritis', 'treatment_phase': 'Subsequent continuing treatment', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9102C', 'drug': 'adalimumab', 'brand': 'Idacio', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled pen', 'indication': 'psoriatic arthritis', 'treatment_phase': 'Subsequent continuing treatment', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9102C', 'drug': 'adalimumab', 'brand': 'Hyrimoz', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled pen', 'indication': 'psoriatic arthritis', 'treatment_phase': 'Subsequent continuing treatment', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9102C', 'drug': 'adalimumab', 'brand': 'Hadlima', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled pen', 'indication': 'psoriatic arthritis', 'treatment_phase': 'Subsequent continuing treatment', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9102C', 'drug': 'adalimumab', 'brand': 'Amgevita', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled pen', 'indication': 'psoriatic arthritis', 'treatment_phase': 'First continuing treatment', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9102C', 'drug': 'adalimumab', 'brand': 'Abrilada', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled pen', 'indication': 'psoriatic arthritis', 'treatment_phase': 'First continuing treatment', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9102C', 'drug': 'adalimumab', 'brand': 'Idacio', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled pen', 'indication': 'psoriatic arthritis', 'treatment_phase': 'First continuing treatment', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9102C', 'drug': 'adalimumab', 'brand': 'Hyrimoz', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled pen', 'indication': 'psoriatic arthritis', 'treatment_phase': 'First continuing treatment', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9102C', 'drug': 'adalimumab', 'brand': 'Hadlima', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled pen', 'indication': 'psoriatic arthritis', 'treatment_phase': 'First continuing treatment', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9102C', 'drug': 'adalimumab', 'brand': 'Amgevita', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled pen', 'indication': 'psoriatic arthritis', 'treatment_phase': 'Continuing treatment - balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9102C', 'drug': 'adalimumab', 'brand': 'Abrilada', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled pen', 'indication': 'psoriatic arthritis', 'treatment_phase': 'Continuing treatment - balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9102C', 'drug': 'adalimumab', 'brand': 'Idacio', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled pen', 'indication': 'psoriatic arthritis', 'treatment_phase': 'Continuing treatment - balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9102C', 'drug': 'adalimumab', 'brand': 'Hyrimoz', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled pen', 'indication': 'psoriatic arthritis', 'treatment_phase': 'Continuing treatment - balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9102C', 'drug': 'adalimumab', 'brand': 'Hadlima', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled pen', 'indication': 'psoriatic arthritis', 'treatment_phase': 'Continuing treatment - balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '13292N', 'drug': 'adalimumab', 'brand': 'Humira', 'formulation': 'Injection 20 mg in 0.2 mL pre-filled syringe', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Continuing treatment', 'streamlined_code': '14107', 'online_application': True, 'authority_method': 'STREAMLINED', 'hospital_type': 'Private', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '13754X', 'drug': 'adalimumab', 'brand': 'Idacio', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled pen', 'indication': 'ankylosing spondylitis', 'treatment_phase': 'Initial treatment - Initial 1 (new patient)', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '13754X', 'drug': 'adalimumab', 'brand': 'Hyrimoz', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled pen', 'indication': 'ankylosing spondylitis', 'treatment_phase': 'Initial treatment - Initial 1 (new patient)', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '13754X', 'drug': 'adalimumab', 'brand': 'Abrilada', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled pen', 'indication': 'ankylosing spondylitis', 'treatment_phase': 'Initial treatment - Initial 1 (new patient)', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '13754X', 'drug': 'adalimumab', 'brand': 'Hadlima', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled pen', 'indication': 'ankylosing spondylitis', 'treatment_phase': 'Initial treatment - Initial 1 (new patient)', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '13754X', 'drug': 'adalimumab', 'brand': 'Amgevita', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled pen', 'indication': 'ankylosing spondylitis', 'treatment_phase': 'Initial treatment - Initial 1 (new patient)', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '13754X', 'drug': 'adalimumab', 'brand': 'Idacio', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled pen', 'indication': 'ankylosing spondylitis', 'treatment_phase': 'Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years)', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '13754X', 'drug': 'adalimumab', 'brand': 'Hyrimoz', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled pen', 'indication': 'ankylosing spondylitis', 'treatment_phase': 'Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years)', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '13754X', 'drug': 'adalimumab', 'brand': 'Abrilada', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled pen', 'indication': 'ankylosing spondylitis', 'treatment_phase': 'Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years)', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '13754X', 'drug': 'adalimumab', 'brand': 'Hadlima', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled pen', 'indication': 'ankylosing spondylitis', 'treatment_phase': 'Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years)', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '13754X', 'drug': 'adalimumab', 'brand': 'Amgevita', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled pen', 'indication': 'ankylosing spondylitis', 'treatment_phase': 'Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years)', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '13754X', 'drug': 'adalimumab', 'brand': 'Idacio', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled pen', 'indication': 'ankylosing spondylitis', 'treatment_phase': 'Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years)', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '13754X', 'drug': 'adalimumab', 'brand': 'Hyrimoz', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled pen', 'indication': 'ankylosing spondylitis', 'treatment_phase': 'Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years)', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '13754X', 'drug': 'adalimumab', 'brand': 'Abrilada', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled pen', 'indication': 'ankylosing spondylitis', 'treatment_phase': 'Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years)', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '13754X', 'drug': 'adalimumab', 'brand': 'Hadlima', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled pen', 'indication': 'ankylosing spondylitis', 'treatment_phase': 'Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years)', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '13754X', 'drug': 'adalimumab', 'brand': 'Amgevita', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled pen', 'indication': 'ankylosing spondylitis', 'treatment_phase': 'Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years)', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9033K', 'drug': 'adalimumab', 'brand': 'Idacio', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled syringe', 'indication': 'psoriatic arthritis', 'treatment_phase': 'Initial treatment - Initial 2 (change or recommencement of treatment after a break in in biological medicine of less than 5 years)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9033K', 'drug': 'adalimumab', 'brand': 'Amgevita', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled syringe', 'indication': 'psoriatic arthritis', 'treatment_phase': 'Initial treatment - Initial 2 (change or recommencement of treatment after a break in in biological medicine of less than 5 years)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9033K', 'drug': 'adalimumab', 'brand': 'Hadlima', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled syringe', 'indication': 'psoriatic arthritis', 'treatment_phase': 'Initial treatment - Initial 2 (change or recommencement of treatment after a break in in biological medicine of less than 5 years)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9033K', 'drug': 'adalimumab', 'brand': 'Hyrimoz', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled syringe', 'indication': 'psoriatic arthritis', 'treatment_phase': 'Initial treatment - Initial 2 (change or recommencement of treatment after a break in in biological medicine of less than 5 years)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9033K', 'drug': 'adalimumab', 'brand': 'Idacio', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled syringe', 'indication': 'psoriatic arthritis', 'treatment_phase': 'Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years) - balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9033K', 'drug': 'adalimumab', 'brand': 'Amgevita', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled syringe', 'indication': 'psoriatic arthritis', 'treatment_phase': 'Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years) - balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9033K', 'drug': 'adalimumab', 'brand': 'Hadlima', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled syringe', 'indication': 'psoriatic arthritis', 'treatment_phase': 'Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years) - balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9033K', 'drug': 'adalimumab', 'brand': 'Hyrimoz', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled syringe', 'indication': 'psoriatic arthritis', 'treatment_phase': 'Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years) - balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9033K', 'drug': 'adalimumab', 'brand': 'Idacio', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled syringe', 'indication': 'psoriatic arthritis', 'treatment_phase': 'Initial treatment - Initial 1 (new patient)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9033K', 'drug': 'adalimumab', 'brand': 'Amgevita', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled syringe', 'indication': 'psoriatic arthritis', 'treatment_phase': 'Initial treatment - Initial 1 (new patient)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9033K', 'drug': 'adalimumab', 'brand': 'Hadlima', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled syringe', 'indication': 'psoriatic arthritis', 'treatment_phase': 'Initial treatment - Initial 1 (new patient)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9033K', 'drug': 'adalimumab', 'brand': 'Hyrimoz', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled syringe', 'indication': 'psoriatic arthritis', 'treatment_phase': 'Initial treatment - Initial 1 (new patient)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9033K', 'drug': 'adalimumab', 'brand': 'Idacio', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled syringe', 'indication': 'psoriatic arthritis', 'treatment_phase': 'Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9033K', 'drug': 'adalimumab', 'brand': 'Amgevita', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled syringe', 'indication': 'psoriatic arthritis', 'treatment_phase': 'Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9033K', 'drug': 'adalimumab', 'brand': 'Hadlima', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled syringe', 'indication': 'psoriatic arthritis', 'treatment_phase': 'Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9033K', 'drug': 'adalimumab', 'brand': 'Hyrimoz', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled syringe', 'indication': 'psoriatic arthritis', 'treatment_phase': 'Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12406Y', 'drug': 'adalimumab', 'brand': 'Humira', 'formulation': 'Injection 20 mg in 0.2 mL pre-filled syringe', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 12 months)', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Public', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12406Y', 'drug': 'adalimumab', 'brand': 'Humira', 'formulation': 'Injection 20 mg in 0.2 mL pre-filled syringe', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 12 months)', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Public', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12406Y', 'drug': 'adalimumab', 'brand': 'Humira', 'formulation': 'Injection 20 mg in 0.2 mL pre-filled syringe', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 12 months) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 12 months) - balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Public', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12406Y', 'drug': 'adalimumab', 'brand': 'Humira', 'formulation': 'Injection 20 mg in 0.2 mL pre-filled syringe', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial treatment - Initial 1 (new patient)', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Public', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '11220M', 'drug': 'etanercept', 'brand': 'Enbrel', 'formulation': 'Injection 50 mg in 1 mL single use auto-injector, 4', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'Continuing treatment - balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '11220M', 'drug': 'etanercept', 'brand': 'Brenzys', 'formulation': 'Injection 50 mg in 1 mL single use auto-injector, 4', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'Continuing treatment - balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '11220M', 'drug': 'etanercept', 'brand': 'Enbrel', 'formulation': 'Injection 50 mg in 1 mL single use auto-injector, 4', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'Subsequent continuing treatment', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '11220M', 'drug': 'etanercept', 'brand': 'Brenzys', 'formulation': 'Injection 50 mg in 1 mL single use auto-injector, 4', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'Subsequent continuing treatment', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12307R', 'drug': 'secukinumab', 'brand': 'Cosentyx', 'formulation': 'Injection 150 mg in 1 mL pre-filled pen', 'indication': 'non-radiographic axial spondyloarthritis', 'treatment_phase': 'Continuing treatment', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '13701D', 'drug': 'certolizumab pegol', 'brand': 'Cimzia', 'formulation': 'Solution for injection 200 mg in 1 mL pre-filled pen', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'Subsequent continuing treatment', 'streamlined_code': '14499', 'online_application': True, 'authority_method': 'STREAMLINED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '11326D', 'drug': 'certolizumab pegol', 'brand': 'Cimzia', 'formulation': 'Solution for injection 200 mg in 1 mL pre-filled pen', 'indication': 'psoriatic arthritis', 'treatment_phase': 'Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years) - balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '13056E', 'drug': 'infliximab', 'brand': 'Remsima SC', 'formulation': 'Solution for injection 120 mg in 1 mL pre-filled pen', 'indication': 'psoriatic arthritis', 'treatment_phase': 'Balance of supply (including switching formulation) where the full duration of treatment available under a particular treatment phase was not requested in the preceding prescription', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '13703F', 'drug': 'adalimumab', 'brand': 'Yuflyma', 'formulation': 'Injection 40 mg in 0.4 mL pre-filled pen', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'First continuing treatment', 'streamlined_code': '14567', 'online_application': True, 'authority_method': 'STREAMLINED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '13703F', 'drug': 'adalimumab', 'brand': 'Adalicip', 'formulation': 'Injection 40 mg in 0.4 mL pre-filled pen', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'First continuing treatment', 'streamlined_code': '14567', 'online_application': True, 'authority_method': 'STREAMLINED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '11198J', 'drug': 'etanercept', 'brand': 'Brenzys', 'formulation': 'Injection 50 mg in 1 mL single use auto-injector, 4', 'indication': 'psoriatic arthritis', 'treatment_phase': 'Subsequent continuing treatment', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '11198J', 'drug': 'etanercept', 'brand': 'Enbrel', 'formulation': 'Injection 50 mg in 1 mL single use auto-injector, 4', 'indication': 'psoriatic arthritis', 'treatment_phase': 'Subsequent continuing treatment', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '11198J', 'drug': 'etanercept', 'brand': 'Brenzys', 'formulation': 'Injection 50 mg in 1 mL single use auto-injector, 4', 'indication': 'psoriatic arthritis', 'treatment_phase': 'Continuing treatment - balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '11198J', 'drug': 'etanercept', 'brand': 'Enbrel', 'formulation': 'Injection 50 mg in 1 mL single use auto-injector, 4', 'indication': 'psoriatic arthritis', 'treatment_phase': 'Continuing treatment - balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '11365E', 'drug': 'golimumab', 'brand': 'Simponi', 'formulation': 'Injection 50 mg in 0.5 mL single use pre-filled pen', 'indication': 'psoriatic arthritis', 'treatment_phase': 'Initial treatment - Initial 2 (change or recommencement of treatment after a break in in biological medicine of less than 5 years)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '11365E', 'drug': 'golimumab', 'brand': 'Simponi', 'formulation': 'Injection 50 mg in 0.5 mL single use pre-filled pen', 'indication': 'psoriatic arthritis', 'treatment_phase': 'Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years) - balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '11365E', 'drug': 'golimumab', 'brand': 'Simponi', 'formulation': 'Injection 50 mg in 0.5 mL single use pre-filled pen', 'indication': 'psoriatic arthritis', 'treatment_phase': 'Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '11365E', 'drug': 'golimumab', 'brand': 'Simponi', 'formulation': 'Injection 50 mg in 0.5 mL single use pre-filled pen', 'indication': 'psoriatic arthritis', 'treatment_phase': 'Initial treatment - Initial 1 (new patient)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '13227E', 'drug': 'adalimumab', 'brand': 'Humira', 'formulation': 'Injection 40 mg in 0.4 mL pre-filled pen', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'Subsequent continuing treatment', 'streamlined_code': '14499', 'online_application': True, 'authority_method': 'STREAMLINED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '13227E', 'drug': 'adalimumab', 'brand': 'Yuflyma', 'formulation': 'Injection 40 mg in 0.4 mL pre-filled pen', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'Subsequent continuing treatment', 'streamlined_code': '14499', 'online_application': True, 'authority_method': 'STREAMLINED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '13227E', 'drug': 'adalimumab', 'brand': 'Adalicip', 'formulation': 'Injection 40 mg in 0.4 mL pre-filled pen', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'Subsequent continuing treatment', 'streamlined_code': '14499', 'online_application': True, 'authority_method': 'STREAMLINED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '5281Y', 'drug': 'adalimumab', 'brand': 'Hyrimoz', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled syringe', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial treatment - Initial 2 (change or recommencement of treatment after break in biological medicine of less than 24 months)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '5281Y', 'drug': 'adalimumab', 'brand': 'Idacio', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled syringe', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial treatment - Initial 2 (change or recommencement of treatment after break in biological medicine of less than 24 months)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '5281Y', 'drug': 'adalimumab', 'brand': 'Abrilada', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled syringe', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial treatment - Initial 2 (change or recommencement of treatment after break in biological medicine of less than 24 months)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '5281Y', 'drug': 'adalimumab', 'brand': 'Hadlima', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled syringe', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial treatment - Initial 2 (change or recommencement of treatment after break in biological medicine of less than 24 months)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '5281Y', 'drug': 'adalimumab', 'brand': 'Amgevita', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled syringe', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial treatment - Initial 2 (change or recommencement of treatment after break in biological medicine of less than 24 months)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '5281Y', 'drug': 'adalimumab', 'brand': 'Hyrimoz', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled syringe', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial treatment - Initial 1 (new patient)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '5281Y', 'drug': 'adalimumab', 'brand': 'Idacio', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled syringe', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial treatment - Initial 1 (new patient)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '5281Y', 'drug': 'adalimumab', 'brand': 'Abrilada', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled syringe', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial treatment - Initial 1 (new patient)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '5281Y', 'drug': 'adalimumab', 'brand': 'Hadlima', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled syringe', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial treatment - Initial 1 (new patient)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '5281Y', 'drug': 'adalimumab', 'brand': 'Amgevita', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled syringe', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial treatment - Initial 1 (new patient)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '5281Y', 'drug': 'adalimumab', 'brand': 'Hyrimoz', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled syringe', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial treatment - Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after break of less than 24 months) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months) -  balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '5281Y', 'drug': 'adalimumab', 'brand': 'Idacio', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled syringe', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial treatment - Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after break of less than 24 months) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months) -  balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '5281Y', 'drug': 'adalimumab', 'brand': 'Abrilada', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled syringe', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial treatment - Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after break of less than 24 months) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months) -  balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '5281Y', 'drug': 'adalimumab', 'brand': 'Hadlima', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled syringe', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial treatment - Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after break of less than 24 months) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months) -  balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '5281Y', 'drug': 'adalimumab', 'brand': 'Amgevita', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled syringe', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial treatment - Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after break of less than 24 months) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months) -  balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '5281Y', 'drug': 'adalimumab', 'brand': 'Hyrimoz', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled syringe', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '5281Y', 'drug': 'adalimumab', 'brand': 'Idacio', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled syringe', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '5281Y', 'drug': 'adalimumab', 'brand': 'Abrilada', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled syringe', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '5281Y', 'drug': 'adalimumab', 'brand': 'Hadlima', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled syringe', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '5281Y', 'drug': 'adalimumab', 'brand': 'Amgevita', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled syringe', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12027B', 'drug': 'certolizumab pegol', 'brand': 'Cimzia', 'formulation': 'Solution for injection 200 mg in 1 mL pre-filled pen', 'indication': 'non-radiographic axial spondyloarthritis', 'treatment_phase': 'Initial treatment - Initial 3 (Recommencement of treatment after a break in biological medicine of more than 5 years)', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12027B', 'drug': 'certolizumab pegol', 'brand': 'Cimzia', 'formulation': 'Solution for injection 200 mg in 1 mL pre-filled pen', 'indication': 'non-radiographic axial spondyloarthritis', 'treatment_phase': 'Initial treatment - Initial 1 (New patient)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12027B', 'drug': 'certolizumab pegol', 'brand': 'Cimzia', 'formulation': 'Solution for injection 200 mg in 1 mL pre-filled pen', 'indication': 'non-radiographic axial spondyloarthritis', 'treatment_phase': 'Initial treatment - Initial 2 (Change or re-commencement of treatment after a break in biological medicine of less than 5 years)', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '14276J', 'drug': 'adalimumab', 'brand': 'Abrilada', 'formulation': 'Injection 20 mg in 0.4 mL pre-filled syringe', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 12 months)', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Private', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '14276J', 'drug': 'adalimumab', 'brand': 'Abrilada', 'formulation': 'Injection 20 mg in 0.4 mL pre-filled syringe', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 12 months)', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Private', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '14276J', 'drug': 'adalimumab', 'brand': 'Abrilada', 'formulation': 'Injection 20 mg in 0.4 mL pre-filled syringe', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 12 months) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 12 months) - balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Private', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '14276J', 'drug': 'adalimumab', 'brand': 'Abrilada', 'formulation': 'Injection 20 mg in 0.4 mL pre-filled syringe', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial treatment - Initial 1 (new patient)', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Private', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '10078K', 'drug': 'tocilizumab', 'brand': 'Actemra', 'formulation': 'Concentrate for injection 400 mg in 20 mL', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial treatment - Initial 1 (new patient)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Private', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '10078K', 'drug': 'tocilizumab', 'brand': 'Actemra', 'formulation': 'Concentrate for injection 400 mg in 20 mL', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Private', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '10078K', 'drug': 'tocilizumab', 'brand': 'Actemra', 'formulation': 'Concentrate for injection 400 mg in 20 mL', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial treatment - Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after break of less than 24 months) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months) -  balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Private', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '10078K', 'drug': 'tocilizumab', 'brand': 'Actemra', 'formulation': 'Concentrate for injection 400 mg in 20 mL', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 24 months)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Private', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '10078K', 'drug': 'tocilizumab', 'brand': 'Actemra', 'formulation': 'Concentrate for injection 400 mg in 20 mL', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Continuing Treatment - balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Private', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '10078K', 'drug': 'tocilizumab', 'brand': 'Actemra', 'formulation': 'Concentrate for injection 400 mg in 20 mL', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Continuing treatment', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Private', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '13755Y', 'drug': 'tofacitinib', 'brand': 'Xeljanz', 'formulation': 'Tablet 5 mg', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial treatment - Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 12 months) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 12 months) - balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '13755Y', 'drug': 'tofacitinib', 'brand': 'Xeljanz', 'formulation': 'Tablet 5 mg', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial treatment - Initial 1 (new patient)', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '13755Y', 'drug': 'tofacitinib', 'brand': 'Xeljanz', 'formulation': 'Tablet 5 mg', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 12 months)', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '13755Y', 'drug': 'tofacitinib', 'brand': 'Xeljanz', 'formulation': 'Tablet 5 mg', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 12 months)', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '1221G', 'drug': 'abatacept', 'brand': 'Orencia', 'formulation': 'Injection 125 mg in 1 mL single dose pre-filled syringe', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'First continuing treatment', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '1221G', 'drug': 'abatacept', 'brand': 'Orencia', 'formulation': 'Injection 125 mg in 1 mL single dose pre-filled syringe', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'First continuing treatment - balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '11693K', 'drug': 'abatacept', 'brand': 'Orencia ClickJect', 'formulation': 'Injection 125 mg in 1 mL single dose autoinjector', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 24 months)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '11693K', 'drug': 'abatacept', 'brand': 'Orencia ClickJect', 'formulation': 'Injection 125 mg in 1 mL single dose autoinjector', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '11693K', 'drug': 'abatacept', 'brand': 'Orencia ClickJect', 'formulation': 'Injection 125 mg in 1 mL single dose autoinjector', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'Initial treatment - Initial 1 (new patient)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '11693K', 'drug': 'abatacept', 'brand': 'Orencia ClickJect', 'formulation': 'Injection 125 mg in 1 mL single dose autoinjector', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 24 months) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months) - balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '11567T', 'drug': 'tocilizumab', 'brand': 'Actemra ACTPen', 'formulation': 'Injection 162 mg in 0.9 mL single use pre-filled pen', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'First continuing treatment', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '11567T', 'drug': 'tocilizumab', 'brand': 'Actemra ACTPen', 'formulation': 'Injection 162 mg in 0.9 mL single use pre-filled pen', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'First continuing treatment - balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '13048R', 'drug': 'infliximab', 'brand': 'Remsima SC', 'formulation': 'Solution for injection 120 mg in 1 mL pre-filled pen', 'indication': 'ankylosing spondylitis', 'treatment_phase': 'Continuing treatment with subcutaneous form or switching from intravenous form to subcutaneous form', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '8737W', 'drug': 'adalimumab', 'brand': 'Hadlima', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled syringe', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'Initial treatment - Initial 1 (new patient)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '8737W', 'drug': 'adalimumab', 'brand': 'Idacio', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled syringe', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'Initial treatment - Initial 1 (new patient)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '8737W', 'drug': 'adalimumab', 'brand': 'Amgevita', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled syringe', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'Initial treatment - Initial 1 (new patient)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '8737W', 'drug': 'adalimumab', 'brand': 'Hyrimoz', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled syringe', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'Initial treatment - Initial 1 (new patient)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '8737W', 'drug': 'adalimumab', 'brand': 'Abrilada', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled syringe', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'Initial treatment - Initial 1 (new patient)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '8737W', 'drug': 'adalimumab', 'brand': 'Hadlima', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled syringe', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 24 months)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '8737W', 'drug': 'adalimumab', 'brand': 'Idacio', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled syringe', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 24 months)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '8737W', 'drug': 'adalimumab', 'brand': 'Amgevita', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled syringe', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 24 months)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '8737W', 'drug': 'adalimumab', 'brand': 'Hyrimoz', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled syringe', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 24 months)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '8737W', 'drug': 'adalimumab', 'brand': 'Abrilada', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled syringe', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 24 months)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '8737W', 'drug': 'adalimumab', 'brand': 'Hadlima', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled syringe', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '8737W', 'drug': 'adalimumab', 'brand': 'Idacio', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled syringe', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '8737W', 'drug': 'adalimumab', 'brand': 'Amgevita', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled syringe', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '8737W', 'drug': 'adalimumab', 'brand': 'Hyrimoz', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled syringe', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '8737W', 'drug': 'adalimumab', 'brand': 'Abrilada', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled syringe', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '8737W', 'drug': 'adalimumab', 'brand': 'Hadlima', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled syringe', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 24 months) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months) - balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '8737W', 'drug': 'adalimumab', 'brand': 'Idacio', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled syringe', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 24 months) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months) - balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '8737W', 'drug': 'adalimumab', 'brand': 'Amgevita', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled syringe', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 24 months) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months) - balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '8737W', 'drug': 'adalimumab', 'brand': 'Hyrimoz', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled syringe', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 24 months) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months) - balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '8737W', 'drug': 'adalimumab', 'brand': 'Abrilada', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled syringe', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 24 months) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months) - balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '3445H', 'drug': 'etanercept', 'brand': 'Enbrel', 'formulation': 'Injection set containing 4 vials powder for injection 25 mg and 4 pre-filled syringes solvent 1 mL', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 24 months)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '3445H', 'drug': 'etanercept', 'brand': 'Enbrel', 'formulation': 'Injection set containing 4 vials powder for injection 25 mg and 4 pre-filled syringes solvent 1 mL', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial treatment - Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after break of less than 24 months) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months) -  balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '3445H', 'drug': 'etanercept', 'brand': 'Enbrel', 'formulation': 'Injection set containing 4 vials powder for injection 25 mg and 4 pre-filled syringes solvent 1 mL', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '3445H', 'drug': 'etanercept', 'brand': 'Enbrel', 'formulation': 'Injection set containing 4 vials powder for injection 25 mg and 4 pre-filled syringes solvent 1 mL', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial treatment - Initial 1 (new patient)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '11623R', 'drug': 'ixekizumab', 'brand': 'Taltz', 'formulation': 'Injection 80 mg in 1 mL single dose pre-filled pen', 'indication': 'psoriatic arthritis', 'treatment_phase': 'Continuing treatment - balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '11623R', 'drug': 'ixekizumab', 'brand': 'Taltz', 'formulation': 'Injection 80 mg in 1 mL single dose pre-filled pen', 'indication': 'psoriatic arthritis', 'treatment_phase': 'Continuing treatment', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '11623R', 'drug': 'ixekizumab', 'brand': 'Taltz', 'formulation': 'Injection 80 mg in 1 mL single dose pre-filled pen', 'indication': 'psoriatic arthritis', 'treatment_phase': 'Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '11623R', 'drug': 'ixekizumab', 'brand': 'Taltz', 'formulation': 'Injection 80 mg in 1 mL single dose pre-filled pen', 'indication': 'psoriatic arthritis', 'treatment_phase': 'Initial treatment - Initial 1 (new patient)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '11623R', 'drug': 'ixekizumab', 'brand': 'Taltz', 'formulation': 'Injection 80 mg in 1 mL single dose pre-filled pen', 'indication': 'psoriatic arthritis', 'treatment_phase': 'Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '11623R', 'drug': 'ixekizumab', 'brand': 'Taltz', 'formulation': 'Injection 80 mg in 1 mL single dose pre-filled pen', 'indication': 'psoriatic arthritis', 'treatment_phase': 'Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years) - balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '11725D', 'drug': 'tocilizumab', 'brand': 'Actemra ACTPen', 'formulation': 'Injection 162 mg in 0.9 mL single use pre-filled pen', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial treatment - Initial 1 (new patient)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '11725D', 'drug': 'tocilizumab', 'brand': 'Actemra ACTPen', 'formulation': 'Injection 162 mg in 0.9 mL single use pre-filled pen', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '11725D', 'drug': 'tocilizumab', 'brand': 'Actemra ACTPen', 'formulation': 'Injection 162 mg in 0.9 mL single use pre-filled pen', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 24 months)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '11725D', 'drug': 'tocilizumab', 'brand': 'Actemra ACTPen', 'formulation': 'Injection 162 mg in 0.9 mL single use pre-filled pen', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial treatment - Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after break of less than 24 months) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months) -  balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '13724H', 'drug': 'infliximab', 'brand': 'Inflectra', 'formulation': 'Powder for I.V. infusion 100 mg', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months)', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Private', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '13724H', 'drug': 'infliximab', 'brand': 'Renflexis', 'formulation': 'Powder for I.V. infusion 100 mg', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months)', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Private', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '13724H', 'drug': 'infliximab', 'brand': 'Inflectra', 'formulation': 'Powder for I.V. infusion 100 mg', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 24 months) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months) - balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Private', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '13724H', 'drug': 'infliximab', 'brand': 'Renflexis', 'formulation': 'Powder for I.V. infusion 100 mg', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 24 months) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months) - balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Private', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '13724H', 'drug': 'infliximab', 'brand': 'Inflectra', 'formulation': 'Powder for I.V. infusion 100 mg', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 24 months)', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Private', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '13724H', 'drug': 'infliximab', 'brand': 'Renflexis', 'formulation': 'Powder for I.V. infusion 100 mg', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 24 months)', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Private', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '13724H', 'drug': 'infliximab', 'brand': 'Inflectra', 'formulation': 'Powder for I.V. infusion 100 mg', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'Initial treatment - Initial 1 (new patient)', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Private', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '13724H', 'drug': 'infliximab', 'brand': 'Renflexis', 'formulation': 'Powder for I.V. infusion 100 mg', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'Initial treatment - Initial 1 (new patient)', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Private', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12438P', 'drug': 'adalimumab', 'brand': 'Hadlima', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled syringe', 'indication': 'psoriatic arthritis', 'treatment_phase': 'Subsequent continuing treatment', 'streamlined_code': '11523', 'online_application': True, 'authority_method': 'STREAMLINED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12438P', 'drug': 'adalimumab', 'brand': 'Idacio', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled syringe', 'indication': 'psoriatic arthritis', 'treatment_phase': 'Subsequent continuing treatment', 'streamlined_code': '11523', 'online_application': True, 'authority_method': 'STREAMLINED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12438P', 'drug': 'adalimumab', 'brand': 'Hyrimoz', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled syringe', 'indication': 'psoriatic arthritis', 'treatment_phase': 'Subsequent continuing treatment', 'streamlined_code': '11523', 'online_application': True, 'authority_method': 'STREAMLINED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12438P', 'drug': 'adalimumab', 'brand': 'Abrilada', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled syringe', 'indication': 'psoriatic arthritis', 'treatment_phase': 'Subsequent continuing treatment', 'streamlined_code': '11523', 'online_application': True, 'authority_method': 'STREAMLINED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12438P', 'drug': 'adalimumab', 'brand': 'Amgevita', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled syringe', 'indication': 'psoriatic arthritis', 'treatment_phase': 'Subsequent continuing treatment', 'streamlined_code': '11523', 'online_application': True, 'authority_method': 'STREAMLINED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '10060L', 'drug': 'tocilizumab', 'brand': 'Actemra', 'formulation': 'Concentrate for injection 400 mg in 20 mL', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 12 months)', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Private', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '10060L', 'drug': 'tocilizumab', 'brand': 'Actemra', 'formulation': 'Concentrate for injection 400 mg in 20 mL', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 12 months)', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Private', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '10060L', 'drug': 'tocilizumab', 'brand': 'Actemra', 'formulation': 'Concentrate for injection 400 mg in 20 mL', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial treatment - Initial 1 (new patient)', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Private', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '10060L', 'drug': 'tocilizumab', 'brand': 'Actemra', 'formulation': 'Concentrate for injection 400 mg in 20 mL', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial treatment - Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 12 months) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 12 months) - balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Private', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '11741Y', 'drug': 'tocilizumab', 'brand': 'Actemra Subcutaneous Injection', 'formulation': 'Injection 162 mg in 0.9 mL single use pre-filled syringe', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 24 months)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '11741Y', 'drug': 'tocilizumab', 'brand': 'Actemra Subcutaneous Injection', 'formulation': 'Injection 162 mg in 0.9 mL single use pre-filled syringe', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '11741Y', 'drug': 'tocilizumab', 'brand': 'Actemra Subcutaneous Injection', 'formulation': 'Injection 162 mg in 0.9 mL single use pre-filled syringe', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial treatment - Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after break of less than 24 months) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months) -  balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '11741Y', 'drug': 'tocilizumab', 'brand': 'Actemra Subcutaneous Injection', 'formulation': 'Injection 162 mg in 0.9 mL single use pre-filled syringe', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial treatment - Initial 1 (new patient)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12362P', 'drug': 'adalimumab', 'brand': 'Yuflyma', 'formulation': 'Injection 40 mg in 0.4 mL pre-filled pen', 'indication': 'psoriatic arthritis', 'treatment_phase': 'Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12362P', 'drug': 'adalimumab', 'brand': 'Humira', 'formulation': 'Injection 40 mg in 0.4 mL pre-filled pen', 'indication': 'psoriatic arthritis', 'treatment_phase': 'Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12362P', 'drug': 'adalimumab', 'brand': 'Adalicip', 'formulation': 'Injection 40 mg in 0.4 mL pre-filled pen', 'indication': 'psoriatic arthritis', 'treatment_phase': 'Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12362P', 'drug': 'adalimumab', 'brand': 'Yuflyma', 'formulation': 'Injection 40 mg in 0.4 mL pre-filled pen', 'indication': 'psoriatic arthritis', 'treatment_phase': 'Initial treatment - Initial 1 (new patient)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12362P', 'drug': 'adalimumab', 'brand': 'Humira', 'formulation': 'Injection 40 mg in 0.4 mL pre-filled pen', 'indication': 'psoriatic arthritis', 'treatment_phase': 'Initial treatment - Initial 1 (new patient)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12362P', 'drug': 'adalimumab', 'brand': 'Adalicip', 'formulation': 'Injection 40 mg in 0.4 mL pre-filled pen', 'indication': 'psoriatic arthritis', 'treatment_phase': 'Initial treatment - Initial 1 (new patient)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12362P', 'drug': 'adalimumab', 'brand': 'Yuflyma', 'formulation': 'Injection 40 mg in 0.4 mL pre-filled pen', 'indication': 'psoriatic arthritis', 'treatment_phase': 'Initial treatment - Initial 2 (change or recommencement of treatment after a break in in biological medicine of less than 5 years)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12362P', 'drug': 'adalimumab', 'brand': 'Humira', 'formulation': 'Injection 40 mg in 0.4 mL pre-filled pen', 'indication': 'psoriatic arthritis', 'treatment_phase': 'Initial treatment - Initial 2 (change or recommencement of treatment after a break in in biological medicine of less than 5 years)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12362P', 'drug': 'adalimumab', 'brand': 'Adalicip', 'formulation': 'Injection 40 mg in 0.4 mL pre-filled pen', 'indication': 'psoriatic arthritis', 'treatment_phase': 'Initial treatment - Initial 2 (change or recommencement of treatment after a break in in biological medicine of less than 5 years)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12362P', 'drug': 'adalimumab', 'brand': 'Yuflyma', 'formulation': 'Injection 40 mg in 0.4 mL pre-filled pen', 'indication': 'psoriatic arthritis', 'treatment_phase': 'Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years) - balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12362P', 'drug': 'adalimumab', 'brand': 'Humira', 'formulation': 'Injection 40 mg in 0.4 mL pre-filled pen', 'indication': 'psoriatic arthritis', 'treatment_phase': 'Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years) - balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12362P', 'drug': 'adalimumab', 'brand': 'Adalicip', 'formulation': 'Injection 40 mg in 0.4 mL pre-filled pen', 'indication': 'psoriatic arthritis', 'treatment_phase': 'Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years) - balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '13708L', 'drug': 'etanercept', 'brand': 'Brenzys', 'formulation': 'Injection 50 mg in 1 mL single use auto-injector, 4', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'First continuing treatment', 'streamlined_code': '14629', 'online_application': True, 'authority_method': 'STREAMLINED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '11318Q', 'drug': 'certolizumab pegol', 'brand': 'Cimzia', 'formulation': 'Solution for injection 200 mg in 1 mL pre-filled pen', 'indication': 'ankylosing spondylitis', 'treatment_phase': 'Initial treatment - Initial 1 (new patient), Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years) - balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '13330N', 'drug': 'tocilizumab', 'brand': 'Actemra', 'formulation': 'Concentrate for injection 200 mg in 10 mL', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Continuing treatment', 'streamlined_code': '14093', 'online_application': True, 'authority_method': 'STREAMLINED', 'hospital_type': 'Public', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12805Y', 'drug': 'tocilizumab', 'brand': 'Actemra', 'formulation': 'Concentrate for injection 400 mg in 20 mL', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'Initial treatment - Initial 4 (Temporary listing - change of treatment from another biological medicine to tocilizumab after resolution of the critical shortage of tocilizumab)', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Private', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '13301C', 'drug': 'tocilizumab', 'brand': 'Actemra Subcutaneous Injection', 'formulation': 'Injection 162 mg in 0.9 mL single use pre-filled syringe', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Continuing treatment', 'streamlined_code': '14104', 'online_application': True, 'authority_method': 'STREAMLINED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9671B', 'drug': 'tocilizumab', 'brand': 'Actemra', 'formulation': 'Concentrate for injection 80 mg in 4 mL', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 24 months) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months) - balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Private', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9671B', 'drug': 'tocilizumab', 'brand': 'Actemra', 'formulation': 'Concentrate for injection 80 mg in 4 mL', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Private', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9671B', 'drug': 'tocilizumab', 'brand': 'Actemra', 'formulation': 'Concentrate for injection 80 mg in 4 mL', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 24 months)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Private', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9671B', 'drug': 'tocilizumab', 'brand': 'Actemra', 'formulation': 'Concentrate for injection 80 mg in 4 mL', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'First continuing treatment', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Private', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9671B', 'drug': 'tocilizumab', 'brand': 'Actemra', 'formulation': 'Concentrate for injection 80 mg in 4 mL', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'First continuing treatment - balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Private', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9671B', 'drug': 'tocilizumab', 'brand': 'Actemra', 'formulation': 'Concentrate for injection 80 mg in 4 mL', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'Initial treatment - Initial 1 (new patient)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Private', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '3450N', 'drug': 'etanercept', 'brand': 'Enbrel', 'formulation': 'Injection 50 mg in 1 mL single use auto-injector, 4', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Continuing Treatment - balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '3450N', 'drug': 'etanercept', 'brand': 'Enbrel', 'formulation': 'Injection 50 mg in 1 mL single use auto-injector, 4', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Continuing treatment', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '11487N', 'drug': 'infliximab', 'brand': 'Inflectra', 'formulation': 'Powder for I.V. infusion 100 mg', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'Subsequent continuing treatment', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Private', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '11487N', 'drug': 'infliximab', 'brand': 'Remicade', 'formulation': 'Powder for I.V. infusion 100 mg', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'Subsequent continuing treatment', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Private', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '11487N', 'drug': 'infliximab', 'brand': 'Renflexis', 'formulation': 'Powder for I.V. infusion 100 mg', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'Subsequent continuing treatment', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Private', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9456Q', 'drug': 'etanercept', 'brand': 'Brenzys', 'formulation': 'Injection 50 mg in 1 mL single use auto-injector, 4', 'indication': 'ankylosing spondylitis', 'treatment_phase': 'First continuing treatment', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9456Q', 'drug': 'etanercept', 'brand': 'Enbrel', 'formulation': 'Injection 50 mg in 1 mL single use auto-injector, 4', 'indication': 'ankylosing spondylitis', 'treatment_phase': 'First continuing treatment', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9456Q', 'drug': 'etanercept', 'brand': 'Brenzys', 'formulation': 'Injection 50 mg in 1 mL single use auto-injector, 4', 'indication': 'ankylosing spondylitis', 'treatment_phase': 'Continuing treatment - balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9456Q', 'drug': 'etanercept', 'brand': 'Enbrel', 'formulation': 'Injection 50 mg in 1 mL single use auto-injector, 4', 'indication': 'ankylosing spondylitis', 'treatment_phase': 'Continuing treatment - balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12398M', 'drug': 'adalimumab', 'brand': 'Adalicip', 'formulation': 'Injection 40 mg in 0.4 mL pre-filled syringe', 'indication': 'psoriatic arthritis', 'treatment_phase': 'First continuing treatment', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12398M', 'drug': 'adalimumab', 'brand': 'Humira', 'formulation': 'Injection 40 mg in 0.4 mL pre-filled syringe', 'indication': 'psoriatic arthritis', 'treatment_phase': 'First continuing treatment', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12398M', 'drug': 'adalimumab', 'brand': 'Yuflyma', 'formulation': 'Injection 40 mg in 0.4 mL pre-filled syringe', 'indication': 'psoriatic arthritis', 'treatment_phase': 'First continuing treatment', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12398M', 'drug': 'adalimumab', 'brand': 'Adalicip', 'formulation': 'Injection 40 mg in 0.4 mL pre-filled syringe', 'indication': 'psoriatic arthritis', 'treatment_phase': 'Subsequent continuing treatment', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12398M', 'drug': 'adalimumab', 'brand': 'Humira', 'formulation': 'Injection 40 mg in 0.4 mL pre-filled syringe', 'indication': 'psoriatic arthritis', 'treatment_phase': 'Subsequent continuing treatment', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12398M', 'drug': 'adalimumab', 'brand': 'Yuflyma', 'formulation': 'Injection 40 mg in 0.4 mL pre-filled syringe', 'indication': 'psoriatic arthritis', 'treatment_phase': 'Subsequent continuing treatment', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12398M', 'drug': 'adalimumab', 'brand': 'Adalicip', 'formulation': 'Injection 40 mg in 0.4 mL pre-filled syringe', 'indication': 'psoriatic arthritis', 'treatment_phase': 'Continuing treatment - balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12398M', 'drug': 'adalimumab', 'brand': 'Humira', 'formulation': 'Injection 40 mg in 0.4 mL pre-filled syringe', 'indication': 'psoriatic arthritis', 'treatment_phase': 'Continuing treatment - balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12398M', 'drug': 'adalimumab', 'brand': 'Yuflyma', 'formulation': 'Injection 40 mg in 0.4 mL pre-filled syringe', 'indication': 'psoriatic arthritis', 'treatment_phase': 'Continuing treatment - balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '3425G', 'drug': 'certolizumab pegol', 'brand': 'Cimzia', 'formulation': 'Injection 200 mg in 1 mL single use pre-filled syringe', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'First continuing treatment', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '3425G', 'drug': 'certolizumab pegol', 'brand': 'Cimzia', 'formulation': 'Injection 200 mg in 1 mL single use pre-filled syringe', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'First continuing treatment - balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9621J', 'drug': 'abatacept', 'brand': 'Orencia', 'formulation': 'Powder for I.V. infusion 250 mg', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'First continuing treatment', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Private', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9621J', 'drug': 'abatacept', 'brand': 'Orencia', 'formulation': 'Powder for I.V. infusion 250 mg', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'Initial treatment - Initial 1 (new patient)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Private', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9621J', 'drug': 'abatacept', 'brand': 'Orencia', 'formulation': 'Powder for I.V. infusion 250 mg', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Private', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9621J', 'drug': 'abatacept', 'brand': 'Orencia', 'formulation': 'Powder for I.V. infusion 250 mg', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 24 months) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months) - balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Private', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9621J', 'drug': 'abatacept', 'brand': 'Orencia', 'formulation': 'Powder for I.V. infusion 250 mg', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 24 months)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Private', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9621J', 'drug': 'abatacept', 'brand': 'Orencia', 'formulation': 'Powder for I.V. infusion 250 mg', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'First continuing treatment - balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Private', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '13306H', 'drug': 'tocilizumab', 'brand': 'Actemra ACTPen', 'formulation': 'Injection 162 mg in 0.9 mL single use pre-filled pen', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Continuing treatment', 'streamlined_code': '14104', 'online_application': True, 'authority_method': 'STREAMLINED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12063X', 'drug': 'certolizumab pegol', 'brand': 'Cimzia', 'formulation': 'Injection 200 mg in 1 mL single use pre-filled syringe', 'indication': 'non-radiographic axial spondyloarthritis', 'treatment_phase': 'Initial treatment - Initial 2 (Change or re-commencement of treatment after a break in biological medicine of less than 5 years)', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12063X', 'drug': 'certolizumab pegol', 'brand': 'Cimzia', 'formulation': 'Injection 200 mg in 1 mL single use pre-filled syringe', 'indication': 'non-radiographic axial spondyloarthritis', 'treatment_phase': 'Initial treatment - Initial 1 (New patient)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12063X', 'drug': 'certolizumab pegol', 'brand': 'Cimzia', 'formulation': 'Injection 200 mg in 1 mL single use pre-filled syringe', 'indication': 'non-radiographic axial spondyloarthritis', 'treatment_phase': 'Initial treatment - Initial 3 (Recommencement of treatment after a break in biological medicine of more than 5 years)', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '13700C', 'drug': 'infliximab', 'brand': 'Inflectra', 'formulation': 'Powder for I.V. infusion 100 mg', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'First continuing treatment', 'streamlined_code': '14585', 'online_application': True, 'authority_method': 'STREAMLINED', 'hospital_type': 'Private', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '13700C', 'drug': 'infliximab', 'brand': 'Renflexis', 'formulation': 'Powder for I.V. infusion 100 mg', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'First continuing treatment', 'streamlined_code': '14585', 'online_application': True, 'authority_method': 'STREAMLINED', 'hospital_type': 'Private', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9457R', 'drug': 'etanercept', 'brand': 'Brenzys', 'formulation': 'Injection 50 mg in 1 mL single use auto-injector, 4', 'indication': 'psoriatic arthritis', 'treatment_phase': 'Initial treatment - Initial 1 (new patient)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9457R', 'drug': 'etanercept', 'brand': 'Enbrel', 'formulation': 'Injection 50 mg in 1 mL single use auto-injector, 4', 'indication': 'psoriatic arthritis', 'treatment_phase': 'Initial treatment - Initial 1 (new patient)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9457R', 'drug': 'etanercept', 'brand': 'Brenzys', 'formulation': 'Injection 50 mg in 1 mL single use auto-injector, 4', 'indication': 'psoriatic arthritis', 'treatment_phase': 'Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9457R', 'drug': 'etanercept', 'brand': 'Enbrel', 'formulation': 'Injection 50 mg in 1 mL single use auto-injector, 4', 'indication': 'psoriatic arthritis', 'treatment_phase': 'Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9457R', 'drug': 'etanercept', 'brand': 'Brenzys', 'formulation': 'Injection 50 mg in 1 mL single use auto-injector, 4', 'indication': 'psoriatic arthritis', 'treatment_phase': 'Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9457R', 'drug': 'etanercept', 'brand': 'Enbrel', 'formulation': 'Injection 50 mg in 1 mL single use auto-injector, 4', 'indication': 'psoriatic arthritis', 'treatment_phase': 'Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9457R', 'drug': 'etanercept', 'brand': 'Brenzys', 'formulation': 'Injection 50 mg in 1 mL single use auto-injector, 4', 'indication': 'psoriatic arthritis', 'treatment_phase': 'Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years) - balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9457R', 'drug': 'etanercept', 'brand': 'Enbrel', 'formulation': 'Injection 50 mg in 1 mL single use auto-injector, 4', 'indication': 'psoriatic arthritis', 'treatment_phase': 'Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years) - balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '11215G', 'drug': 'etanercept', 'brand': 'Brenzys', 'formulation': 'Injection 50 mg in 1 mL single use auto-injector, 4', 'indication': 'ankylosing spondylitis', 'treatment_phase': 'First continuing treatment', 'streamlined_code': '14683', 'online_application': True, 'authority_method': 'STREAMLINED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '11215G', 'drug': 'etanercept', 'brand': 'Brenzys', 'formulation': 'Injection 50 mg in 1 mL single use auto-injector, 4', 'indication': 'ankylosing spondylitis', 'treatment_phase': 'Subsequent continuing treatment', 'streamlined_code': '14701', 'online_application': True, 'authority_method': 'STREAMLINED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '10899P', 'drug': 'secukinumab', 'brand': 'Cosentyx', 'formulation': 'Injection 150 mg in 1 mL pre-filled pen', 'indication': 'psoriatic arthritis', 'treatment_phase': 'Continuing treatment', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '10899P', 'drug': 'secukinumab', 'brand': 'Cosentyx', 'formulation': 'Injection 150 mg in 1 mL pre-filled pen', 'indication': 'psoriatic arthritis', 'treatment_phase': 'Continuing treatment - balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '14286X', 'drug': 'adalimumab', 'brand': 'Abrilada', 'formulation': 'Injection 20 mg in 0.4 mL pre-filled syringe', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Continuing treatment', 'streamlined_code': '14136', 'online_application': True, 'authority_method': 'STREAMLINED', 'hospital_type': 'Public', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12028C', 'drug': 'certolizumab pegol', 'brand': 'Cimzia', 'formulation': 'Solution for injection 200 mg in 1 mL pre-filled pen', 'indication': 'non-radiographic axial spondyloarthritis', 'treatment_phase': 'Continuing treatment', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '11319R', 'drug': 'certolizumab pegol', 'brand': 'Cimzia', 'formulation': 'Solution for injection 200 mg in 1 mL pre-filled pen', 'indication': 'ankylosing spondylitis', 'treatment_phase': 'Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '11319R', 'drug': 'certolizumab pegol', 'brand': 'Cimzia', 'formulation': 'Solution for injection 200 mg in 1 mL pre-filled pen', 'indication': 'ankylosing spondylitis', 'treatment_phase': 'Initial treatment - Initial 1 (new patient)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '11319R', 'drug': 'certolizumab pegol', 'brand': 'Cimzia', 'formulation': 'Solution for injection 200 mg in 1 mL pre-filled pen', 'indication': 'ankylosing spondylitis', 'treatment_phase': 'Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12768B', 'drug': 'tocilizumab', 'brand': 'Actemra Subcutaneous Injection', 'formulation': 'Injection 162 mg in 0.9 mL single use pre-filled syringe', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial treatment - Initial 4 (Temporary listing - change of treatment from another biological medicine to tocilizumab after resolution of the critical shortage of tocilizumab)', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '13329M', 'drug': 'tocilizumab', 'brand': 'Actemra', 'formulation': 'Concentrate for injection 200 mg in 10 mL', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Continuing treatment', 'streamlined_code': '14179', 'online_application': True, 'authority_method': 'STREAMLINED', 'hospital_type': 'Private', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '11372M', 'drug': 'golimumab', 'brand': 'Simponi', 'formulation': 'Injection 50 mg in 0.5 mL single use pre-filled pen', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'Initial treatment - Initial 1 (new patient)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '11372M', 'drug': 'golimumab', 'brand': 'Simponi', 'formulation': 'Injection 50 mg in 0.5 mL single use pre-filled pen', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '11372M', 'drug': 'golimumab', 'brand': 'Simponi', 'formulation': 'Injection 50 mg in 0.5 mL single use pre-filled pen', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 24 months)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '11372M', 'drug': 'golimumab', 'brand': 'Simponi', 'formulation': 'Injection 50 mg in 0.5 mL single use pre-filled pen', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 24 months) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months) - balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12766X', 'drug': 'tocilizumab', 'brand': 'Actemra', 'formulation': 'Concentrate for injection 200 mg in 10 mL', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'Initial treatment - Initial 4 (Temporary listing - change of treatment from another biological medicine to tocilizumab after resolution of the critical shortage of tocilizumab)', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Private', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12083Y', 'drug': 'tocilizumab', 'brand': 'Actemra ACTPen', 'formulation': 'Injection 162 mg in 0.9 mL single use pre-filled pen', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial treatment - Initial 2 (retrial or recommencement of treatment after a break of less than 12 months in a patient weighing at least 30 kg)', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12083Y', 'drug': 'tocilizumab', 'brand': 'Actemra ACTPen', 'formulation': 'Injection 162 mg in 0.9 mL single use pre-filled pen', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial treatment - Initial 1 (new patient weighing at least 30 kg)', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12083Y', 'drug': 'tocilizumab', 'brand': 'Actemra ACTPen', 'formulation': 'Injection 162 mg in 0.9 mL single use pre-filled pen', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial treatment - Initial 3 (recommencement of treatment after a break of more than 12 months in a patient weighing at least 30 kg)', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '13049T', 'drug': 'infliximab', 'brand': 'Remsima SC', 'formulation': 'Solution for injection 120 mg in 1 mL pre-filled pen', 'indication': 'ankylosing spondylitis', 'treatment_phase': 'Initial treatment with the subcutaneous form where a concurrent PBS authority application for the intravenously (IV) administered formulation is being made', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '11373N', 'drug': 'golimumab', 'brand': 'Simponi', 'formulation': 'Injection 50 mg in 0.5 mL single use pre-filled pen', 'indication': 'psoriatic arthritis', 'treatment_phase': 'Continuing treatment', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '11373N', 'drug': 'golimumab', 'brand': 'Simponi', 'formulation': 'Injection 50 mg in 0.5 mL single use pre-filled pen', 'indication': 'psoriatic arthritis', 'treatment_phase': 'Continuing treatment - balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '13730P', 'drug': 'tofacitinib', 'brand': 'Xeljanz', 'formulation': 'Tablet 5 mg', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'Subsequent continuing treatment', 'streamlined_code': '14499', 'online_application': True, 'authority_method': 'STREAMLINED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '3432P', 'drug': 'golimumab', 'brand': 'Simponi', 'formulation': 'Injection 50 mg in 0.5 mL single use pre-filled syringe', 'indication': 'psoriatic arthritis', 'treatment_phase': 'Continuing treatment - balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '3432P', 'drug': 'golimumab', 'brand': 'Simponi', 'formulation': 'Injection 50 mg in 0.5 mL single use pre-filled syringe', 'indication': 'psoriatic arthritis', 'treatment_phase': 'Continuing treatment', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12431G', 'drug': 'adalimumab', 'brand': 'Yuflyma', 'formulation': 'Injection 40 mg in 0.4 mL pre-filled syringe', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial treatment - Initial 1 (new patient)', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Public', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12431G', 'drug': 'adalimumab', 'brand': 'Humira', 'formulation': 'Injection 40 mg in 0.4 mL pre-filled syringe', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial treatment - Initial 1 (new patient)', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Public', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12431G', 'drug': 'adalimumab', 'brand': 'Adalicip', 'formulation': 'Injection 40 mg in 0.4 mL pre-filled syringe', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial treatment - Initial 1 (new patient)', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Public', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12431G', 'drug': 'adalimumab', 'brand': 'Yuflyma', 'formulation': 'Injection 40 mg in 0.4 mL pre-filled syringe', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 12 months)', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Public', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12431G', 'drug': 'adalimumab', 'brand': 'Humira', 'formulation': 'Injection 40 mg in 0.4 mL pre-filled syringe', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 12 months)', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Public', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12431G', 'drug': 'adalimumab', 'brand': 'Adalicip', 'formulation': 'Injection 40 mg in 0.4 mL pre-filled syringe', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 12 months)', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Public', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12431G', 'drug': 'adalimumab', 'brand': 'Yuflyma', 'formulation': 'Injection 40 mg in 0.4 mL pre-filled syringe', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 12 months) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 12 months) - balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Public', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12431G', 'drug': 'adalimumab', 'brand': 'Humira', 'formulation': 'Injection 40 mg in 0.4 mL pre-filled syringe', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 12 months) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 12 months) - balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Public', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12431G', 'drug': 'adalimumab', 'brand': 'Adalicip', 'formulation': 'Injection 40 mg in 0.4 mL pre-filled syringe', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 12 months) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 12 months) - balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Public', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12431G', 'drug': 'adalimumab', 'brand': 'Yuflyma', 'formulation': 'Injection 40 mg in 0.4 mL pre-filled syringe', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 12 months)', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Public', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12431G', 'drug': 'adalimumab', 'brand': 'Humira', 'formulation': 'Injection 40 mg in 0.4 mL pre-filled syringe', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 12 months)', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Public', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12431G', 'drug': 'adalimumab', 'brand': 'Adalicip', 'formulation': 'Injection 40 mg in 0.4 mL pre-filled syringe', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 12 months)', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Public', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '3436W', 'drug': 'golimumab', 'brand': 'Simponi', 'formulation': 'Injection 50 mg in 0.5 mL single use pre-filled syringe', 'indication': 'ankylosing spondylitis', 'treatment_phase': 'Continuing treatment - balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '3436W', 'drug': 'golimumab', 'brand': 'Simponi', 'formulation': 'Injection 50 mg in 0.5 mL single use pre-filled syringe', 'indication': 'ankylosing spondylitis', 'treatment_phase': 'Continuing treatment', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '14189T', 'drug': 'anifrolumab', 'brand': 'Saphnelo', 'formulation': 'Solution concentrate for I.V. infusion 300 mg in 2 mL', 'indication': 'systemic lupus erythematosus', 'treatment_phase': 'Continuing or recommencement of treatment (within 12 months of a treatment break)', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Private', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '14189T', 'drug': 'anifrolumab', 'brand': 'Saphnelo', 'formulation': 'Solution concentrate for I.V. infusion 300 mg in 2 mL', 'indication': 'systemic lupus erythematosus', 'treatment_phase': 'Initial treatment', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Private', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '14189T', 'drug': 'anifrolumab', 'brand': 'Saphnelo', 'formulation': 'Solution concentrate for I.V. infusion 300 mg in 2 mL', 'indication': 'systemic lupus erythematosus', 'treatment_phase': 'Transitioning from non-PBS to PBS-subsidised supply - Grandfather arrangements', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Private', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '13764K', 'drug': 'adalimumab', 'brand': 'Yuflyma', 'formulation': 'Injection 40 mg in 0.4 mL pre-filled pen', 'indication': 'ankylosing spondylitis', 'treatment_phase': 'Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years)', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '13764K', 'drug': 'adalimumab', 'brand': 'Adalicip', 'formulation': 'Injection 40 mg in 0.4 mL pre-filled pen', 'indication': 'ankylosing spondylitis', 'treatment_phase': 'Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years)', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '13764K', 'drug': 'adalimumab', 'brand': 'Yuflyma', 'formulation': 'Injection 40 mg in 0.4 mL pre-filled pen', 'indication': 'ankylosing spondylitis', 'treatment_phase': 'Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years)', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '13764K', 'drug': 'adalimumab', 'brand': 'Adalicip', 'formulation': 'Injection 40 mg in 0.4 mL pre-filled pen', 'indication': 'ankylosing spondylitis', 'treatment_phase': 'Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years)', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '13764K', 'drug': 'adalimumab', 'brand': 'Yuflyma', 'formulation': 'Injection 40 mg in 0.4 mL pre-filled pen', 'indication': 'ankylosing spondylitis', 'treatment_phase': 'Initial treatment - Initial 1 (new patient)', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '13764K', 'drug': 'adalimumab', 'brand': 'Adalicip', 'formulation': 'Injection 40 mg in 0.4 mL pre-filled pen', 'indication': 'ankylosing spondylitis', 'treatment_phase': 'Initial treatment - Initial 1 (new patient)', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '10905Y', 'drug': 'certolizumab pegol', 'brand': 'Cimzia', 'formulation': 'Injection 200 mg in 1 mL single use pre-filled syringe', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 24 months)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '10905Y', 'drug': 'certolizumab pegol', 'brand': 'Cimzia', 'formulation': 'Injection 200 mg in 1 mL single use pre-filled syringe', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'Initial treatment - Initial 1 (new patient)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '10905Y', 'drug': 'certolizumab pegol', 'brand': 'Cimzia', 'formulation': 'Injection 200 mg in 1 mL single use pre-filled syringe', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '13319B', 'drug': 'etanercept', 'brand': 'Enbrel', 'formulation': 'Injection 50 mg in 1 mL single use auto-injector, 4', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Continuing treatment', 'streamlined_code': '14154', 'online_application': True, 'authority_method': 'STREAMLINED', 'hospital_type': 'Public', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '10954M', 'drug': 'tocilizumab', 'brand': 'Actemra Subcutaneous Injection', 'formulation': 'Injection 162 mg in 0.9 mL single use pre-filled syringe', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'First continuing treatment - balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '10954M', 'drug': 'tocilizumab', 'brand': 'Actemra Subcutaneous Injection', 'formulation': 'Injection 162 mg in 0.9 mL single use pre-filled syringe', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'First continuing treatment', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '13078H', 'drug': 'infliximab', 'brand': 'Remsima SC', 'formulation': 'Solution for injection 120 mg in 1 mL pre-filled syringe', 'indication': 'psoriatic arthritis', 'treatment_phase': 'Balance of supply (including switching formulation) where the full duration of treatment available under a particular treatment phase was not requested in the preceding prescription', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '13690M', 'drug': 'tocilizumab', 'brand': 'Actemra', 'formulation': 'Concentrate for injection 80 mg in 4 mL', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'Subsequent continuing treatment', 'streamlined_code': '14621', 'online_application': True, 'authority_method': 'STREAMLINED', 'hospital_type': 'Public', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '13721E', 'drug': 'adalimumab', 'brand': 'Abrilada', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled syringe', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'First continuing treatment', 'streamlined_code': '14567', 'online_application': True, 'authority_method': 'STREAMLINED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '13721E', 'drug': 'adalimumab', 'brand': 'Hadlima', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled syringe', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'First continuing treatment', 'streamlined_code': '14567', 'online_application': True, 'authority_method': 'STREAMLINED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '13721E', 'drug': 'adalimumab', 'brand': 'Idacio', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled syringe', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'First continuing treatment', 'streamlined_code': '14567', 'online_application': True, 'authority_method': 'STREAMLINED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '13721E', 'drug': 'adalimumab', 'brand': 'Amgevita', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled syringe', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'First continuing treatment', 'streamlined_code': '14567', 'online_application': True, 'authority_method': 'STREAMLINED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '13721E', 'drug': 'adalimumab', 'brand': 'Hyrimoz', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled syringe', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'First continuing treatment', 'streamlined_code': '14567', 'online_application': True, 'authority_method': 'STREAMLINED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12555T', 'drug': 'infliximab', 'brand': 'Remsima SC', 'formulation': 'Solution for injection 120 mg in 1 mL pre-filled syringe', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'Balance of supply for Initial treatment, Continuing treatment - subcutaneous form', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12439Q', 'drug': 'adalimumab', 'brand': 'Amgevita', 'formulation': 'Injection 20 mg in 0.4 mL pre-filled syringe', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 12 months)', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Private', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12439Q', 'drug': 'adalimumab', 'brand': 'Amgevita', 'formulation': 'Injection 20 mg in 0.4 mL pre-filled syringe', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial treatment - Initial 1 (new patient)', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Private', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12439Q', 'drug': 'adalimumab', 'brand': 'Amgevita', 'formulation': 'Injection 20 mg in 0.4 mL pre-filled syringe', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 12 months) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 12 months) - balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Private', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12439Q', 'drug': 'adalimumab', 'brand': 'Amgevita', 'formulation': 'Injection 20 mg in 0.4 mL pre-filled syringe', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 12 months)', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Private', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '10071C', 'drug': 'tocilizumab', 'brand': 'Actemra', 'formulation': 'Concentrate for injection 200 mg in 10 mL', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Continuing Treatment - balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Private', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '10071C', 'drug': 'tocilizumab', 'brand': 'Actemra', 'formulation': 'Concentrate for injection 200 mg in 10 mL', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Private', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '10071C', 'drug': 'tocilizumab', 'brand': 'Actemra', 'formulation': 'Concentrate for injection 200 mg in 10 mL', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 24 months)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Private', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '10071C', 'drug': 'tocilizumab', 'brand': 'Actemra', 'formulation': 'Concentrate for injection 200 mg in 10 mL', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Continuing treatment', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Private', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '10071C', 'drug': 'tocilizumab', 'brand': 'Actemra', 'formulation': 'Concentrate for injection 200 mg in 10 mL', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial treatment - Initial 1 (new patient)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Private', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '10071C', 'drug': 'tocilizumab', 'brand': 'Actemra', 'formulation': 'Concentrate for injection 200 mg in 10 mL', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial treatment - Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after break of less than 24 months) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months) -  balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Private', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '13326J', 'drug': 'etanercept', 'brand': 'Enbrel', 'formulation': 'Injection 50 mg in 1 mL single use auto-injector, 4', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Continuing treatment', 'streamlined_code': '14155', 'online_application': True, 'authority_method': 'STREAMLINED', 'hospital_type': 'Private', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12095N', 'drug': 'tocilizumab', 'brand': 'Actemra Subcutaneous Injection', 'formulation': 'Injection 162 mg in 0.9 mL single use pre-filled syringe', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial treatment - Initial 1 (new patient weighing at least 30 kg)', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12095N', 'drug': 'tocilizumab', 'brand': 'Actemra Subcutaneous Injection', 'formulation': 'Injection 162 mg in 0.9 mL single use pre-filled syringe', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial treatment - Initial 3 (recommencement of treatment after a break of more than 12 months in a patient weighing at least 30 kg)', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12095N', 'drug': 'tocilizumab', 'brand': 'Actemra Subcutaneous Injection', 'formulation': 'Injection 162 mg in 0.9 mL single use pre-filled syringe', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial treatment - Initial 2 (retrial or recommencement of treatment after a break of less than 12 months in a patient weighing at least 30 kg)', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '13229G', 'drug': 'adalimumab', 'brand': 'Humira', 'formulation': 'Injection 40 mg in 0.4 mL pre-filled pen', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Continuing treatment', 'streamlined_code': '14107', 'online_application': True, 'authority_method': 'STREAMLINED', 'hospital_type': 'Private', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '13229G', 'drug': 'adalimumab', 'brand': 'Yuflyma', 'formulation': 'Injection 40 mg in 0.4 mL pre-filled pen', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Continuing treatment', 'streamlined_code': '14107', 'online_application': True, 'authority_method': 'STREAMLINED', 'hospital_type': 'Private', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '13229G', 'drug': 'adalimumab', 'brand': 'Adalicip', 'formulation': 'Injection 40 mg in 0.4 mL pre-filled pen', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Continuing treatment', 'streamlined_code': '14107', 'online_application': True, 'authority_method': 'STREAMLINED', 'hospital_type': 'Private', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '10081N', 'drug': 'tocilizumab', 'brand': 'Actemra', 'formulation': 'Concentrate for injection 80 mg in 4 mL', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Continuing Treatment - balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Public', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '10081N', 'drug': 'tocilizumab', 'brand': 'Actemra', 'formulation': 'Concentrate for injection 80 mg in 4 mL', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial treatment - Initial 1 (new patient)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Public', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '10081N', 'drug': 'tocilizumab', 'brand': 'Actemra', 'formulation': 'Concentrate for injection 80 mg in 4 mL', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Public', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '10081N', 'drug': 'tocilizumab', 'brand': 'Actemra', 'formulation': 'Concentrate for injection 80 mg in 4 mL', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Continuing treatment', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Public', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '10081N', 'drug': 'tocilizumab', 'brand': 'Actemra', 'formulation': 'Concentrate for injection 80 mg in 4 mL', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 24 months)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Public', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '10081N', 'drug': 'tocilizumab', 'brand': 'Actemra', 'formulation': 'Concentrate for injection 80 mg in 4 mL', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial treatment - Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after break of less than 24 months) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months) -  balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Public', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12005W', 'drug': 'certolizumab pegol', 'brand': 'Cimzia', 'formulation': 'Injection 200 mg in 1 mL single use pre-filled syringe', 'indication': 'non-radiographic axial spondyloarthritis', 'treatment_phase': 'Continuing treatment', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '10906B', 'drug': 'secukinumab', 'brand': 'Cosentyx', 'formulation': 'Injection 150 mg in 1 mL pre-filled pen', 'indication': 'ankylosing spondylitis', 'treatment_phase': 'Continuing treatment - balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '10906B', 'drug': 'secukinumab', 'brand': 'Cosentyx', 'formulation': 'Injection 150 mg in 1 mL pre-filled pen', 'indication': 'ankylosing spondylitis', 'treatment_phase': 'Continuing treatment', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '11219L', 'drug': 'etanercept', 'brand': 'Enbrel', 'formulation': 'Injections 50 mg in 1 mL single use pre-filled syringes, 4', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'Subsequent continuing treatment', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '11219L', 'drug': 'etanercept', 'brand': 'Brenzys', 'formulation': 'Injections 50 mg in 1 mL single use pre-filled syringes, 4', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'Subsequent continuing treatment', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '11219L', 'drug': 'etanercept', 'brand': 'Enbrel', 'formulation': 'Injections 50 mg in 1 mL single use pre-filled syringes, 4', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'Continuing treatment - balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '11219L', 'drug': 'etanercept', 'brand': 'Brenzys', 'formulation': 'Injections 50 mg in 1 mL single use pre-filled syringes, 4', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'Continuing treatment - balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '1464C', 'drug': 'tocilizumab', 'brand': 'Actemra', 'formulation': 'Concentrate for injection 400 mg in 20 mL', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Balance of supply for Initial treatment - Initial 1 (new patient) or Initial 2 (retrial or recommencement of treatment after a break of less than 12 months) or Initial 3 (recommencement of treatment after a break of more than 12 months)', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Private', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '1464C', 'drug': 'tocilizumab', 'brand': 'Actemra', 'formulation': 'Concentrate for injection 400 mg in 20 mL', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial treatment - Initial 3 (recommencement of treatment after a break of more than 12 months)', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Private', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '1464C', 'drug': 'tocilizumab', 'brand': 'Actemra', 'formulation': 'Concentrate for injection 400 mg in 20 mL', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial treatment - Initial 2 (retrial or recommencement of treatment after a break of less than 12 months)', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Private', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '1464C', 'drug': 'tocilizumab', 'brand': 'Actemra', 'formulation': 'Concentrate for injection 400 mg in 20 mL', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial treatment - Initial 1 (new patient)', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Private', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12375H', 'drug': 'adalimumab', 'brand': 'Humira', 'formulation': 'Injection 40 mg in 0.4 mL pre-filled pen', 'indication': 'psoriatic arthritis', 'treatment_phase': 'Continuing treatment - balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12375H', 'drug': 'adalimumab', 'brand': 'Yuflyma', 'formulation': 'Injection 40 mg in 0.4 mL pre-filled pen', 'indication': 'psoriatic arthritis', 'treatment_phase': 'Continuing treatment - balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12375H', 'drug': 'adalimumab', 'brand': 'Adalicip', 'formulation': 'Injection 40 mg in 0.4 mL pre-filled pen', 'indication': 'psoriatic arthritis', 'treatment_phase': 'Continuing treatment - balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12375H', 'drug': 'adalimumab', 'brand': 'Humira', 'formulation': 'Injection 40 mg in 0.4 mL pre-filled pen', 'indication': 'psoriatic arthritis', 'treatment_phase': 'Subsequent continuing treatment', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12375H', 'drug': 'adalimumab', 'brand': 'Yuflyma', 'formulation': 'Injection 40 mg in 0.4 mL pre-filled pen', 'indication': 'psoriatic arthritis', 'treatment_phase': 'Subsequent continuing treatment', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12375H', 'drug': 'adalimumab', 'brand': 'Adalicip', 'formulation': 'Injection 40 mg in 0.4 mL pre-filled pen', 'indication': 'psoriatic arthritis', 'treatment_phase': 'Subsequent continuing treatment', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12375H', 'drug': 'adalimumab', 'brand': 'Humira', 'formulation': 'Injection 40 mg in 0.4 mL pre-filled pen', 'indication': 'psoriatic arthritis', 'treatment_phase': 'First continuing treatment', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12375H', 'drug': 'adalimumab', 'brand': 'Yuflyma', 'formulation': 'Injection 40 mg in 0.4 mL pre-filled pen', 'indication': 'psoriatic arthritis', 'treatment_phase': 'First continuing treatment', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12375H', 'drug': 'adalimumab', 'brand': 'Adalicip', 'formulation': 'Injection 40 mg in 0.4 mL pre-filled pen', 'indication': 'psoriatic arthritis', 'treatment_phase': 'First continuing treatment', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9679K', 'drug': 'adalimumab', 'brand': 'Idacio', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled syringe', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 12 months)', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Private', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9679K', 'drug': 'adalimumab', 'brand': 'Hyrimoz', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled syringe', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 12 months)', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Private', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9679K', 'drug': 'adalimumab', 'brand': 'Hadlima', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled syringe', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 12 months)', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Private', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9679K', 'drug': 'adalimumab', 'brand': 'Amgevita', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled syringe', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 12 months)', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Private', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9679K', 'drug': 'adalimumab', 'brand': 'Abrilada', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled syringe', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 12 months)', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Private', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9679K', 'drug': 'adalimumab', 'brand': 'Idacio', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled syringe', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 12 months) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 12 months) - balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Private', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9679K', 'drug': 'adalimumab', 'brand': 'Hyrimoz', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled syringe', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 12 months) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 12 months) - balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Private', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9679K', 'drug': 'adalimumab', 'brand': 'Hadlima', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled syringe', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 12 months) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 12 months) - balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Private', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9679K', 'drug': 'adalimumab', 'brand': 'Amgevita', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled syringe', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 12 months) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 12 months) - balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Private', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9679K', 'drug': 'adalimumab', 'brand': 'Abrilada', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled syringe', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 12 months) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 12 months) - balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Private', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9679K', 'drug': 'adalimumab', 'brand': 'Idacio', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled syringe', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial treatment - Initial 1 (new patient)', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Private', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9679K', 'drug': 'adalimumab', 'brand': 'Hyrimoz', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled syringe', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial treatment - Initial 1 (new patient)', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Private', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9679K', 'drug': 'adalimumab', 'brand': 'Hadlima', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled syringe', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial treatment - Initial 1 (new patient)', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Private', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9679K', 'drug': 'adalimumab', 'brand': 'Amgevita', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled syringe', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial treatment - Initial 1 (new patient)', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Private', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9679K', 'drug': 'adalimumab', 'brand': 'Abrilada', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled syringe', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial treatment - Initial 1 (new patient)', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Private', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9679K', 'drug': 'adalimumab', 'brand': 'Idacio', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled syringe', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 12 months)', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Private', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9679K', 'drug': 'adalimumab', 'brand': 'Hyrimoz', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled syringe', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 12 months)', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Private', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9679K', 'drug': 'adalimumab', 'brand': 'Hadlima', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled syringe', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 12 months)', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Private', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9679K', 'drug': 'adalimumab', 'brand': 'Amgevita', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled syringe', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 12 months)', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Private', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9679K', 'drug': 'adalimumab', 'brand': 'Abrilada', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled syringe', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 12 months)', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Private', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '10056G', 'drug': 'tocilizumab', 'brand': 'Actemra', 'formulation': 'Concentrate for injection 200 mg in 10 mL', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial treatment - Initial 1 (new patient)', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Public', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '10056G', 'drug': 'tocilizumab', 'brand': 'Actemra', 'formulation': 'Concentrate for injection 200 mg in 10 mL', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 12 months)', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Public', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '10056G', 'drug': 'tocilizumab', 'brand': 'Actemra', 'formulation': 'Concentrate for injection 200 mg in 10 mL', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 12 months)', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Public', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '10056G', 'drug': 'tocilizumab', 'brand': 'Actemra', 'formulation': 'Concentrate for injection 200 mg in 10 mL', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial treatment - Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 12 months) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 12 months) - balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Public', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12802T', 'drug': 'tocilizumab', 'brand': 'Actemra', 'formulation': 'Concentrate for injection 400 mg in 20 mL', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial treatment - Initial 4 (Temporary listing - change of treatment from another biological medicine to tocilizumab after resolution of the critical shortage of tocilizumab)', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Public', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12802T', 'drug': 'tocilizumab', 'brand': 'Actemra', 'formulation': 'Concentrate for injection 400 mg in 20 mL', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial treatment - Initial 4 (Temporary listing - change of treatment from another biological medicine to tocilzumab after resolution of the critical shortage of tocilizumab)', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Public', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '10894J', 'drug': 'secukinumab', 'brand': 'Cosentyx', 'formulation': 'Injection 150 mg in 1 mL pre-filled pen', 'indication': 'psoriatic arthritis', 'treatment_phase': 'Initial treatment - Initial 1 (new patient)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '10894J', 'drug': 'secukinumab', 'brand': 'Cosentyx', 'formulation': 'Injection 150 mg in 1 mL pre-filled pen', 'indication': 'psoriatic arthritis', 'treatment_phase': 'Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '10894J', 'drug': 'secukinumab', 'brand': 'Cosentyx', 'formulation': 'Injection 150 mg in 1 mL pre-filled pen', 'indication': 'psoriatic arthritis', 'treatment_phase': 'Initial treatment - Initial 2 (change or recommencement of treatment after a break in in biological medicine of less than 5 years)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '13069W', 'drug': 'infliximab', 'brand': 'Remsima SC', 'formulation': 'Solution for injection 120 mg in 1 mL pre-filled syringe', 'indication': 'ankylosing spondylitis', 'treatment_phase': 'Continuing treatment with subcutaneous form or switching from intravenous form to subcutaneous form', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12430F', 'drug': 'adalimumab', 'brand': 'Humira', 'formulation': 'Injection 40 mg in 0.4 mL pre-filled syringe', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'First continuing treatment', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12430F', 'drug': 'adalimumab', 'brand': 'Yuflyma', 'formulation': 'Injection 40 mg in 0.4 mL pre-filled syringe', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'First continuing treatment', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12430F', 'drug': 'adalimumab', 'brand': 'Adalicip', 'formulation': 'Injection 40 mg in 0.4 mL pre-filled syringe', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'First continuing treatment', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12430F', 'drug': 'adalimumab', 'brand': 'Humira', 'formulation': 'Injection 40 mg in 0.4 mL pre-filled syringe', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'First continuing treatment - balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12430F', 'drug': 'adalimumab', 'brand': 'Yuflyma', 'formulation': 'Injection 40 mg in 0.4 mL pre-filled syringe', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'First continuing treatment - balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12430F', 'drug': 'adalimumab', 'brand': 'Adalicip', 'formulation': 'Injection 40 mg in 0.4 mL pre-filled syringe', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'First continuing treatment - balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '10511F', 'drug': 'tofacitinib', 'brand': 'Xeljanz', 'formulation': 'Tablet 5 mg', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'First continuing treatment', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '10511F', 'drug': 'tofacitinib', 'brand': 'Xeljanz', 'formulation': 'Tablet 5 mg', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'First continuing treatment - balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '11482H', 'drug': 'infliximab', 'brand': 'Inflectra', 'formulation': 'Powder for I.V. infusion 100 mg', 'indication': 'ankylosing spondylitis', 'treatment_phase': 'Subsequent continuing treatment', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Public', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '11482H', 'drug': 'infliximab', 'brand': 'Renflexis', 'formulation': 'Powder for I.V. infusion 100 mg', 'indication': 'ankylosing spondylitis', 'treatment_phase': 'Subsequent continuing treatment', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Public', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '11482H', 'drug': 'infliximab', 'brand': 'Remicade', 'formulation': 'Powder for I.V. infusion 100 mg', 'indication': 'ankylosing spondylitis', 'treatment_phase': 'Subsequent continuing treatment', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Public', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '8741C', 'drug': 'adalimumab', 'brand': 'Idacio', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled syringe', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'First continuing treatment', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '8741C', 'drug': 'adalimumab', 'brand': 'Hadlima', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled syringe', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'First continuing treatment', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '8741C', 'drug': 'adalimumab', 'brand': 'Abrilada', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled syringe', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'First continuing treatment', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '8741C', 'drug': 'adalimumab', 'brand': 'Amgevita', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled syringe', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'First continuing treatment', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '8741C', 'drug': 'adalimumab', 'brand': 'Hyrimoz', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled syringe', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'First continuing treatment', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '8741C', 'drug': 'adalimumab', 'brand': 'Idacio', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled syringe', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'First continuing treatment - balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '8741C', 'drug': 'adalimumab', 'brand': 'Hadlima', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled syringe', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'First continuing treatment - balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '8741C', 'drug': 'adalimumab', 'brand': 'Abrilada', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled syringe', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'First continuing treatment - balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '8741C', 'drug': 'adalimumab', 'brand': 'Amgevita', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled syringe', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'First continuing treatment - balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '8741C', 'drug': 'adalimumab', 'brand': 'Hyrimoz', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled syringe', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'First continuing treatment - balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9672C', 'drug': 'tocilizumab', 'brand': 'Actemra', 'formulation': 'Concentrate for injection 200 mg in 10 mL', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 24 months)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Private', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9672C', 'drug': 'tocilizumab', 'brand': 'Actemra', 'formulation': 'Concentrate for injection 200 mg in 10 mL', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 24 months) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months) - balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Private', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9672C', 'drug': 'tocilizumab', 'brand': 'Actemra', 'formulation': 'Concentrate for injection 200 mg in 10 mL', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'First continuing treatment', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Private', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9672C', 'drug': 'tocilizumab', 'brand': 'Actemra', 'formulation': 'Concentrate for injection 200 mg in 10 mL', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'Initial treatment - Initial 1 (new patient)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Private', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9672C', 'drug': 'tocilizumab', 'brand': 'Actemra', 'formulation': 'Concentrate for injection 200 mg in 10 mL', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'First continuing treatment - balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Private', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9672C', 'drug': 'tocilizumab', 'brand': 'Actemra', 'formulation': 'Concentrate for injection 200 mg in 10 mL', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Private', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9099X', 'drug': 'adalimumab', 'brand': 'Abrilada', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled pen', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'Initial treatment - Initial 1 (new patient)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9099X', 'drug': 'adalimumab', 'brand': 'Hadlima', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled pen', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'Initial treatment - Initial 1 (new patient)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9099X', 'drug': 'adalimumab', 'brand': 'Hyrimoz', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled pen', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'Initial treatment - Initial 1 (new patient)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9099X', 'drug': 'adalimumab', 'brand': 'Idacio', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled pen', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'Initial treatment - Initial 1 (new patient)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9099X', 'drug': 'adalimumab', 'brand': 'Amgevita', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled pen', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'Initial treatment - Initial 1 (new patient)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9099X', 'drug': 'adalimumab', 'brand': 'Abrilada', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled pen', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 24 months)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9099X', 'drug': 'adalimumab', 'brand': 'Hadlima', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled pen', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 24 months)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9099X', 'drug': 'adalimumab', 'brand': 'Hyrimoz', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled pen', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 24 months)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9099X', 'drug': 'adalimumab', 'brand': 'Idacio', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled pen', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 24 months)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9099X', 'drug': 'adalimumab', 'brand': 'Amgevita', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled pen', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 24 months)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9099X', 'drug': 'adalimumab', 'brand': 'Abrilada', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled pen', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9099X', 'drug': 'adalimumab', 'brand': 'Hadlima', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled pen', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9099X', 'drug': 'adalimumab', 'brand': 'Hyrimoz', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled pen', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9099X', 'drug': 'adalimumab', 'brand': 'Idacio', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled pen', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9099X', 'drug': 'adalimumab', 'brand': 'Amgevita', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled pen', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9099X', 'drug': 'adalimumab', 'brand': 'Abrilada', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled pen', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 24 months) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months) - balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9099X', 'drug': 'adalimumab', 'brand': 'Hadlima', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled pen', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 24 months) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months) - balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9099X', 'drug': 'adalimumab', 'brand': 'Hyrimoz', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled pen', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 24 months) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months) - balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9099X', 'drug': 'adalimumab', 'brand': 'Idacio', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled pen', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 24 months) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months) - balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9099X', 'drug': 'adalimumab', 'brand': 'Amgevita', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled pen', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 24 months) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months) - balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '13727L', 'drug': 'abatacept', 'brand': 'Orencia ClickJect', 'formulation': 'Injection 125 mg in 1 mL single dose autoinjector', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'Subsequent continuing treatment', 'streamlined_code': '14604', 'online_application': True, 'authority_method': 'STREAMLINED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9459W', 'drug': 'etanercept', 'brand': 'Brenzys', 'formulation': 'Injection 50 mg in 1 mL single use auto-injector, 4', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 24 months) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months) - balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9459W', 'drug': 'etanercept', 'brand': 'Enbrel', 'formulation': 'Injection 50 mg in 1 mL single use auto-injector, 4', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 24 months) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months) - balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9459W', 'drug': 'etanercept', 'brand': 'Brenzys', 'formulation': 'Injection 50 mg in 1 mL single use auto-injector, 4', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9459W', 'drug': 'etanercept', 'brand': 'Enbrel', 'formulation': 'Injection 50 mg in 1 mL single use auto-injector, 4', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9459W', 'drug': 'etanercept', 'brand': 'Brenzys', 'formulation': 'Injection 50 mg in 1 mL single use auto-injector, 4', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'Initial treatment - Initial 1 (new patient)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9459W', 'drug': 'etanercept', 'brand': 'Enbrel', 'formulation': 'Injection 50 mg in 1 mL single use auto-injector, 4', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'Initial treatment - Initial 1 (new patient)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9459W', 'drug': 'etanercept', 'brand': 'Brenzys', 'formulation': 'Injection 50 mg in 1 mL single use auto-injector, 4', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 24 months)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9459W', 'drug': 'etanercept', 'brand': 'Enbrel', 'formulation': 'Injection 50 mg in 1 mL single use auto-injector, 4', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 24 months)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '10774C', 'drug': 'ustekinumab', 'brand': 'Stelara', 'formulation': 'Injection 45 mg in 0.5 mL', 'indication': 'psoriatic arthritis', 'treatment_phase': 'Initial treatment - Initial 1 (new patient), Initial 2 (change or recommencement of treatment after a break in medicine of less than 5 years) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years) - balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '10774C', 'drug': 'ustekinumab', 'brand': 'Stelara', 'formulation': 'Injection 45 mg in 0.5 mL', 'indication': 'psoriatic arthritis', 'treatment_phase': 'Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '10774C', 'drug': 'ustekinumab', 'brand': 'Stelara', 'formulation': 'Injection 45 mg in 0.5 mL', 'indication': 'psoriatic arthritis', 'treatment_phase': 'Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '10774C', 'drug': 'ustekinumab', 'brand': 'Stelara', 'formulation': 'Injection 45 mg in 0.5 mL', 'indication': 'psoriatic arthritis', 'treatment_phase': 'Initial treatment - Initial 1 (new patient)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12085C', 'drug': 'tocilizumab', 'brand': 'Actemra ACTPen', 'formulation': 'Injection 162 mg in 0.9 mL single use pre-filled pen', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial treatment - Initial 3 (recommencement of a new treatment cycle after a break of more than 12 months in a patient weighing less than 30 kg)', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12085C', 'drug': 'tocilizumab', 'brand': 'Actemra ACTPen', 'formulation': 'Injection 162 mg in 0.9 mL single use pre-filled pen', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial treatment - Initial 1 (new patient weighing less than 30 kg)', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12085C', 'drug': 'tocilizumab', 'brand': 'Actemra ACTPen', 'formulation': 'Injection 162 mg in 0.9 mL single use pre-filled pen', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial treatment - Initial 2 (retrial or recommencement of treatment after a break of less than 12 months in a patient weighing less than 30 kg)', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9086F', 'drug': 'etanercept', 'brand': 'Brenzys', 'formulation': 'Injections 50 mg in 1 mL single use pre-filled syringes, 4', 'indication': 'ankylosing spondylitis', 'treatment_phase': 'First continuing treatment', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9086F', 'drug': 'etanercept', 'brand': 'Enbrel', 'formulation': 'Injections 50 mg in 1 mL single use pre-filled syringes, 4', 'indication': 'ankylosing spondylitis', 'treatment_phase': 'First continuing treatment', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9086F', 'drug': 'etanercept', 'brand': 'Brenzys', 'formulation': 'Injections 50 mg in 1 mL single use pre-filled syringes, 4', 'indication': 'ankylosing spondylitis', 'treatment_phase': 'Continuing treatment - balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9086F', 'drug': 'etanercept', 'brand': 'Enbrel', 'formulation': 'Injections 50 mg in 1 mL single use pre-filled syringes, 4', 'indication': 'ankylosing spondylitis', 'treatment_phase': 'Continuing treatment - balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '8637N', 'drug': 'etanercept', 'brand': 'Enbrel', 'formulation': 'Injection set containing 4 vials powder for injection 25 mg and 4 pre-filled syringes solvent 1 mL', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '8637N', 'drug': 'etanercept', 'brand': 'Enbrel', 'formulation': 'Injection set containing 4 vials powder for injection 25 mg and 4 pre-filled syringes solvent 1 mL', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 24 months) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months) - balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '8637N', 'drug': 'etanercept', 'brand': 'Enbrel', 'formulation': 'Injection set containing 4 vials powder for injection 25 mg and 4 pre-filled syringes solvent 1 mL', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'Initial treatment - Initial 1 (new patient)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '8637N', 'drug': 'etanercept', 'brand': 'Enbrel', 'formulation': 'Injection set containing 4 vials powder for injection 25 mg and 4 pre-filled syringes solvent 1 mL', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 24 months)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '11218K', 'drug': 'etanercept', 'brand': 'Brenzys', 'formulation': 'Injection 50 mg in 1 mL single use auto-injector, 4', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'Subsequent continuing treatment', 'streamlined_code': '14499', 'online_application': True, 'authority_method': 'STREAMLINED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '11218K', 'drug': 'etanercept', 'brand': 'Enbrel', 'formulation': 'Injection 50 mg in 1 mL single use auto-injector, 4', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'Subsequent continuing treatment', 'streamlined_code': '14499', 'online_application': True, 'authority_method': 'STREAMLINED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '10901R', 'drug': 'secukinumab', 'brand': 'Cosentyx', 'formulation': 'Injection 150 mg in 1 mL pre-filled pen', 'indication': 'psoriatic arthritis', 'treatment_phase': 'Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years) - balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '13208E', 'drug': 'adalimumab', 'brand': 'Yuflyma', 'formulation': 'Injection 40 mg in 0.4 mL pre-filled syringe', 'indication': 'ankylosing spondylitis', 'treatment_phase': 'Subsequent continuing treatment', 'streamlined_code': '14701', 'online_application': True, 'authority_method': 'STREAMLINED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '13208E', 'drug': 'adalimumab', 'brand': 'Adalicip', 'formulation': 'Injection 40 mg in 0.4 mL pre-filled syringe', 'indication': 'ankylosing spondylitis', 'treatment_phase': 'Subsequent continuing treatment', 'streamlined_code': '14701', 'online_application': True, 'authority_method': 'STREAMLINED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '13208E', 'drug': 'adalimumab', 'brand': 'Yuflyma', 'formulation': 'Injection 40 mg in 0.4 mL pre-filled syringe', 'indication': 'ankylosing spondylitis', 'treatment_phase': 'First continuing treatment', 'streamlined_code': '14683', 'online_application': True, 'authority_method': 'STREAMLINED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '13208E', 'drug': 'adalimumab', 'brand': 'Adalicip', 'formulation': 'Injection 40 mg in 0.4 mL pre-filled syringe', 'indication': 'ankylosing spondylitis', 'treatment_phase': 'First continuing treatment', 'streamlined_code': '14683', 'online_application': True, 'authority_method': 'STREAMLINED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '13294Q', 'drug': 'etanercept', 'brand': 'Enbrel', 'formulation': 'Injection set containing 4 vials powder for injection 25 mg and 4 pre-filled syringes solvent 1 mL', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Continuing treatment', 'streamlined_code': '14154', 'online_application': True, 'authority_method': 'STREAMLINED', 'hospital_type': 'Public', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '10068X', 'drug': 'tocilizumab', 'brand': 'Actemra', 'formulation': 'Concentrate for injection 80 mg in 4 mL', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial treatment - Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 12 months) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 12 months) - balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Private', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '10068X', 'drug': 'tocilizumab', 'brand': 'Actemra', 'formulation': 'Concentrate for injection 80 mg in 4 mL', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial treatment - Initial 1 (new patient)', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Private', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '10068X', 'drug': 'tocilizumab', 'brand': 'Actemra', 'formulation': 'Concentrate for injection 80 mg in 4 mL', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 12 months)', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Private', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '10068X', 'drug': 'tocilizumab', 'brand': 'Actemra', 'formulation': 'Concentrate for injection 80 mg in 4 mL', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 12 months)', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Private', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '11325C', 'drug': 'certolizumab pegol', 'brand': 'Cimzia', 'formulation': 'Solution for injection 200 mg in 1 mL pre-filled pen', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'First continuing treatment - balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '11325C', 'drug': 'certolizumab pegol', 'brand': 'Cimzia', 'formulation': 'Solution for injection 200 mg in 1 mL pre-filled pen', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'First continuing treatment', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '13210G', 'drug': 'adalimumab', 'brand': 'Humira', 'formulation': 'Injection 40 mg in 0.4 mL pre-filled syringe', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Continuing treatment', 'streamlined_code': '14107', 'online_application': True, 'authority_method': 'STREAMLINED', 'hospital_type': 'Private', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '13210G', 'drug': 'adalimumab', 'brand': 'Yuflyma', 'formulation': 'Injection 40 mg in 0.4 mL pre-filled syringe', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Continuing treatment', 'streamlined_code': '14107', 'online_application': True, 'authority_method': 'STREAMLINED', 'hospital_type': 'Private', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '13210G', 'drug': 'adalimumab', 'brand': 'Adalicip', 'formulation': 'Injection 40 mg in 0.4 mL pre-filled syringe', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Continuing treatment', 'streamlined_code': '14107', 'online_application': True, 'authority_method': 'STREAMLINED', 'hospital_type': 'Private', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '11730J', 'drug': 'tocilizumab', 'brand': 'Actemra Subcutaneous Injection', 'formulation': 'Injection 162 mg in 0.9 mL single use pre-filled syringe', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Continuing treatment', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '11730J', 'drug': 'tocilizumab', 'brand': 'Actemra Subcutaneous Injection', 'formulation': 'Injection 162 mg in 0.9 mL single use pre-filled syringe', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Continuing Treatment - balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9662M', 'drug': 'adalimumab', 'brand': 'Abrilada', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled syringe', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 12 months)', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Public', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9662M', 'drug': 'adalimumab', 'brand': 'Hadlima', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled syringe', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 12 months)', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Public', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9662M', 'drug': 'adalimumab', 'brand': 'Idacio', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled syringe', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 12 months)', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Public', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9662M', 'drug': 'adalimumab', 'brand': 'Amgevita', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled syringe', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 12 months)', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Public', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9662M', 'drug': 'adalimumab', 'brand': 'Hyrimoz', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled syringe', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 12 months)', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Public', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9662M', 'drug': 'adalimumab', 'brand': 'Abrilada', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled syringe', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 12 months) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 12 months) - balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Public', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9662M', 'drug': 'adalimumab', 'brand': 'Hadlima', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled syringe', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 12 months) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 12 months) - balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Public', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9662M', 'drug': 'adalimumab', 'brand': 'Idacio', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled syringe', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 12 months) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 12 months) - balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Public', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9662M', 'drug': 'adalimumab', 'brand': 'Amgevita', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled syringe', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 12 months) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 12 months) - balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Public', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9662M', 'drug': 'adalimumab', 'brand': 'Hyrimoz', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled syringe', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 12 months) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 12 months) - balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Public', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9662M', 'drug': 'adalimumab', 'brand': 'Abrilada', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled syringe', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 12 months)', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Public', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9662M', 'drug': 'adalimumab', 'brand': 'Hadlima', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled syringe', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 12 months)', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Public', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9662M', 'drug': 'adalimumab', 'brand': 'Idacio', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled syringe', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 12 months)', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Public', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9662M', 'drug': 'adalimumab', 'brand': 'Amgevita', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled syringe', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 12 months)', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Public', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9662M', 'drug': 'adalimumab', 'brand': 'Hyrimoz', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled syringe', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 12 months)', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Public', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9662M', 'drug': 'adalimumab', 'brand': 'Abrilada', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled syringe', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial treatment - Initial 1 (new patient)', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Public', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9662M', 'drug': 'adalimumab', 'brand': 'Hadlima', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled syringe', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial treatment - Initial 1 (new patient)', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Public', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9662M', 'drug': 'adalimumab', 'brand': 'Idacio', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled syringe', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial treatment - Initial 1 (new patient)', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Public', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9662M', 'drug': 'adalimumab', 'brand': 'Amgevita', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled syringe', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial treatment - Initial 1 (new patient)', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Public', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9662M', 'drug': 'adalimumab', 'brand': 'Hyrimoz', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled syringe', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial treatment - Initial 1 (new patient)', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Public', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '13765L', 'drug': 'infliximab', 'brand': 'Inflectra', 'formulation': 'Powder for I.V. infusion 100 mg', 'indication': 'ankylosing spondylitis', 'treatment_phase': 'Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years)', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Public', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '13765L', 'drug': 'infliximab', 'brand': 'Renflexis', 'formulation': 'Powder for I.V. infusion 100 mg', 'indication': 'ankylosing spondylitis', 'treatment_phase': 'Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years)', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Public', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '13765L', 'drug': 'infliximab', 'brand': 'Inflectra', 'formulation': 'Powder for I.V. infusion 100 mg', 'indication': 'ankylosing spondylitis', 'treatment_phase': 'Initial treatment - Initial 1 (new patient)', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Public', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '13765L', 'drug': 'infliximab', 'brand': 'Renflexis', 'formulation': 'Powder for I.V. infusion 100 mg', 'indication': 'ankylosing spondylitis', 'treatment_phase': 'Initial treatment - Initial 1 (new patient)', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Public', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '13765L', 'drug': 'infliximab', 'brand': 'Inflectra', 'formulation': 'Powder for I.V. infusion 100 mg', 'indication': 'ankylosing spondylitis', 'treatment_phase': 'Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years)', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Public', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '13765L', 'drug': 'infliximab', 'brand': 'Renflexis', 'formulation': 'Powder for I.V. infusion 100 mg', 'indication': 'ankylosing spondylitis', 'treatment_phase': 'Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years)', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Public', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '13702E', 'drug': 'baricitinib', 'brand': 'Olumiant', 'formulation': 'Tablet 4 mg', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'Subsequent continuing treatment', 'streamlined_code': '14499', 'online_application': True, 'authority_method': 'STREAMLINED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '10896L', 'drug': 'certolizumab pegol', 'brand': 'Cimzia', 'formulation': 'Injection 200 mg in 1 mL single use pre-filled syringe', 'indication': 'psoriatic arthritis', 'treatment_phase': 'Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years) - balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '11488P', 'drug': 'infliximab', 'brand': 'Inflectra', 'formulation': 'Powder for I.V. infusion 100 mg', 'indication': 'ankylosing spondylitis', 'treatment_phase': 'First continuing treatment', 'streamlined_code': '14689', 'online_application': True, 'authority_method': 'STREAMLINED', 'hospital_type': 'Private', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '11488P', 'drug': 'infliximab', 'brand': 'Renflexis', 'formulation': 'Powder for I.V. infusion 100 mg', 'indication': 'ankylosing spondylitis', 'treatment_phase': 'First continuing treatment', 'streamlined_code': '14689', 'online_application': True, 'authority_method': 'STREAMLINED', 'hospital_type': 'Private', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '11488P', 'drug': 'infliximab', 'brand': 'Inflectra', 'formulation': 'Powder for I.V. infusion 100 mg', 'indication': 'ankylosing spondylitis', 'treatment_phase': 'Subsequent continuing treatment', 'streamlined_code': '14723', 'online_application': True, 'authority_method': 'STREAMLINED', 'hospital_type': 'Private', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '11488P', 'drug': 'infliximab', 'brand': 'Renflexis', 'formulation': 'Powder for I.V. infusion 100 mg', 'indication': 'ankylosing spondylitis', 'treatment_phase': 'Subsequent continuing treatment', 'streamlined_code': '14723', 'online_application': True, 'authority_method': 'STREAMLINED', 'hospital_type': 'Private', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '5734T', 'drug': 'etanercept', 'brand': 'Enbrel', 'formulation': 'Injection set containing 4 vials powder for injection 25 mg and 4 pre-filled syringes solvent 1 mL', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 12 months)', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Public', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '5734T', 'drug': 'etanercept', 'brand': 'Enbrel', 'formulation': 'Injection set containing 4 vials powder for injection 25 mg and 4 pre-filled syringes solvent 1 mL', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial treatment - Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 12 months) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 12 months) - balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Public', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '5734T', 'drug': 'etanercept', 'brand': 'Enbrel', 'formulation': 'Injection set containing 4 vials powder for injection 25 mg and 4 pre-filled syringes solvent 1 mL', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial treatment - Initial 1 (new patient)', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Public', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '5734T', 'drug': 'etanercept', 'brand': 'Enbrel', 'formulation': 'Injection set containing 4 vials powder for injection 25 mg and 4 pre-filled syringes solvent 1 mL', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 12 months)', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Public', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '11442F', 'drug': 'baricitinib', 'brand': 'Olumiant', 'formulation': 'Tablet 2 mg', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'First continuing treatment - balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '11442F', 'drug': 'baricitinib', 'brand': 'Olumiant', 'formulation': 'Tablet 2 mg', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'First continuing treatment', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '5756Y', 'drug': 'infliximab', 'brand': 'Inflectra', 'formulation': 'Powder for I.V. infusion 100 mg', 'indication': 'psoriatic arthritis', 'treatment_phase': 'Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Public', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '5756Y', 'drug': 'infliximab', 'brand': 'Remicade', 'formulation': 'Powder for I.V. infusion 100 mg', 'indication': 'psoriatic arthritis', 'treatment_phase': 'Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Public', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '5756Y', 'drug': 'infliximab', 'brand': 'Renflexis', 'formulation': 'Powder for I.V. infusion 100 mg', 'indication': 'psoriatic arthritis', 'treatment_phase': 'Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Public', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '5756Y', 'drug': 'infliximab', 'brand': 'Inflectra', 'formulation': 'Powder for I.V. infusion 100 mg', 'indication': 'psoriatic arthritis', 'treatment_phase': 'First continuing treatment', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Public', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '5756Y', 'drug': 'infliximab', 'brand': 'Remicade', 'formulation': 'Powder for I.V. infusion 100 mg', 'indication': 'psoriatic arthritis', 'treatment_phase': 'First continuing treatment', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Public', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '5756Y', 'drug': 'infliximab', 'brand': 'Renflexis', 'formulation': 'Powder for I.V. infusion 100 mg', 'indication': 'psoriatic arthritis', 'treatment_phase': 'First continuing treatment', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Public', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '5756Y', 'drug': 'infliximab', 'brand': 'Inflectra', 'formulation': 'Powder for I.V. infusion 100 mg', 'indication': 'psoriatic arthritis', 'treatment_phase': 'Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Public', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '5756Y', 'drug': 'infliximab', 'brand': 'Remicade', 'formulation': 'Powder for I.V. infusion 100 mg', 'indication': 'psoriatic arthritis', 'treatment_phase': 'Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Public', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '5756Y', 'drug': 'infliximab', 'brand': 'Renflexis', 'formulation': 'Powder for I.V. infusion 100 mg', 'indication': 'psoriatic arthritis', 'treatment_phase': 'Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Public', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '5756Y', 'drug': 'infliximab', 'brand': 'Inflectra', 'formulation': 'Powder for I.V. infusion 100 mg', 'indication': 'psoriatic arthritis', 'treatment_phase': 'Continuing treatment - balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Public', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '5756Y', 'drug': 'infliximab', 'brand': 'Remicade', 'formulation': 'Powder for I.V. infusion 100 mg', 'indication': 'psoriatic arthritis', 'treatment_phase': 'Continuing treatment - balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Public', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '5756Y', 'drug': 'infliximab', 'brand': 'Renflexis', 'formulation': 'Powder for I.V. infusion 100 mg', 'indication': 'psoriatic arthritis', 'treatment_phase': 'Continuing treatment - balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Public', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '5756Y', 'drug': 'infliximab', 'brand': 'Inflectra', 'formulation': 'Powder for I.V. infusion 100 mg', 'indication': 'psoriatic arthritis', 'treatment_phase': 'Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years) - balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Public', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '5756Y', 'drug': 'infliximab', 'brand': 'Remicade', 'formulation': 'Powder for I.V. infusion 100 mg', 'indication': 'psoriatic arthritis', 'treatment_phase': 'Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years) - balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Public', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '5756Y', 'drug': 'infliximab', 'brand': 'Renflexis', 'formulation': 'Powder for I.V. infusion 100 mg', 'indication': 'psoriatic arthritis', 'treatment_phase': 'Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years) - balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Public', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '5756Y', 'drug': 'infliximab', 'brand': 'Inflectra', 'formulation': 'Powder for I.V. infusion 100 mg', 'indication': 'psoriatic arthritis', 'treatment_phase': 'Initial treatment - Initial 1 (new patient)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Public', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '5756Y', 'drug': 'infliximab', 'brand': 'Remicade', 'formulation': 'Powder for I.V. infusion 100 mg', 'indication': 'psoriatic arthritis', 'treatment_phase': 'Initial treatment - Initial 1 (new patient)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Public', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '5756Y', 'drug': 'infliximab', 'brand': 'Renflexis', 'formulation': 'Powder for I.V. infusion 100 mg', 'indication': 'psoriatic arthritis', 'treatment_phase': 'Initial treatment - Initial 1 (new patient)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Public', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '11515C', 'drug': 'infliximab', 'brand': 'Inflectra', 'formulation': 'Powder for I.V. infusion 100 mg', 'indication': 'psoriatic arthritis', 'treatment_phase': 'Subsequent continuing treatment', 'streamlined_code': '9472', 'online_application': True, 'authority_method': 'STREAMLINED', 'hospital_type': 'Private', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '11515C', 'drug': 'infliximab', 'brand': 'Renflexis', 'formulation': 'Powder for I.V. infusion 100 mg', 'indication': 'psoriatic arthritis', 'treatment_phase': 'Subsequent continuing treatment', 'streamlined_code': '9472', 'online_application': True, 'authority_method': 'STREAMLINED', 'hospital_type': 'Private', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '11217J', 'drug': 'etanercept', 'brand': 'Brenzys', 'formulation': 'Injections 50 mg in 1 mL single use pre-filled syringes, 4', 'indication': 'ankylosing spondylitis', 'treatment_phase': 'Subsequent continuing treatment', 'streamlined_code': '14701', 'online_application': True, 'authority_method': 'STREAMLINED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '11217J', 'drug': 'etanercept', 'brand': 'Brenzys', 'formulation': 'Injections 50 mg in 1 mL single use pre-filled syringes, 4', 'indication': 'ankylosing spondylitis', 'treatment_phase': 'First continuing treatment', 'streamlined_code': '14683', 'online_application': True, 'authority_method': 'STREAMLINED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '10072D', 'drug': 'tocilizumab', 'brand': 'Actemra', 'formulation': 'Concentrate for injection 400 mg in 20 mL', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial treatment - Initial 1 (new patient)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Public', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '10072D', 'drug': 'tocilizumab', 'brand': 'Actemra', 'formulation': 'Concentrate for injection 400 mg in 20 mL', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Public', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '10072D', 'drug': 'tocilizumab', 'brand': 'Actemra', 'formulation': 'Concentrate for injection 400 mg in 20 mL', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 24 months)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Public', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '10072D', 'drug': 'tocilizumab', 'brand': 'Actemra', 'formulation': 'Concentrate for injection 400 mg in 20 mL', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial treatment - Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after break of less than 24 months) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months) -  balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Public', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '10072D', 'drug': 'tocilizumab', 'brand': 'Actemra', 'formulation': 'Concentrate for injection 400 mg in 20 mL', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Continuing treatment', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Public', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '10072D', 'drug': 'tocilizumab', 'brand': 'Actemra', 'formulation': 'Concentrate for injection 400 mg in 20 mL', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Continuing Treatment - balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Public', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9657G', 'drug': 'tocilizumab', 'brand': 'Actemra', 'formulation': 'Concentrate for injection 80 mg in 4 mL', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'First continuing treatment', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Public', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9657G', 'drug': 'tocilizumab', 'brand': 'Actemra', 'formulation': 'Concentrate for injection 80 mg in 4 mL', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'First continuing treatment - balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Public', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9657G', 'drug': 'tocilizumab', 'brand': 'Actemra', 'formulation': 'Concentrate for injection 80 mg in 4 mL', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Public', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9657G', 'drug': 'tocilizumab', 'brand': 'Actemra', 'formulation': 'Concentrate for injection 80 mg in 4 mL', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 24 months)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Public', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9657G', 'drug': 'tocilizumab', 'brand': 'Actemra', 'formulation': 'Concentrate for injection 80 mg in 4 mL', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 24 months) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months) - balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Public', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9657G', 'drug': 'tocilizumab', 'brand': 'Actemra', 'formulation': 'Concentrate for injection 80 mg in 4 mL', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'Initial treatment - Initial 1 (new patient)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Public', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12794J', 'drug': 'tocilizumab', 'brand': 'Actemra', 'formulation': 'Concentrate for injection 80 mg in 4 mL', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial treatment - Initial 4 (Temporary listing - change of treatment from another biological medicine to tocilizumab after resolution of the critical shortage of tocilizumab)', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Public', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12794J', 'drug': 'tocilizumab', 'brand': 'Actemra', 'formulation': 'Concentrate for injection 80 mg in 4 mL', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial treatment - Initial 4 (Temporary listing - change of treatment from another biological medicine to tocilzumab after resolution of the critical shortage of tocilizumab)', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Public', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '11207W', 'drug': 'etanercept', 'brand': 'Enbrel', 'formulation': 'Injection set containing 4 vials powder for injection 25 mg and 4 pre-filled syringes solvent 1 mL', 'indication': 'psoriatic arthritis', 'treatment_phase': 'Continuing treatment - balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '11207W', 'drug': 'etanercept', 'brand': 'Enbrel', 'formulation': 'Injection set containing 4 vials powder for injection 25 mg and 4 pre-filled syringes solvent 1 mL', 'indication': 'psoriatic arthritis', 'treatment_phase': 'Subsequent continuing treatment', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '3426H', 'drug': 'golimumab', 'brand': 'Simponi', 'formulation': 'Injection 50 mg in 0.5 mL single use pre-filled syringe', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 24 months)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '3426H', 'drug': 'golimumab', 'brand': 'Simponi', 'formulation': 'Injection 50 mg in 0.5 mL single use pre-filled syringe', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '3426H', 'drug': 'golimumab', 'brand': 'Simponi', 'formulation': 'Injection 50 mg in 0.5 mL single use pre-filled syringe', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 24 months) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months) - balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '3426H', 'drug': 'golimumab', 'brand': 'Simponi', 'formulation': 'Injection 50 mg in 0.5 mL single use pre-filled syringe', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'Initial treatment - Initial 1 (new patient)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12376J', 'drug': 'adalimumab', 'brand': 'Yuflyma', 'formulation': 'Injection 40 mg in 0.4 mL pre-filled pen', 'indication': 'ankylosing spondylitis', 'treatment_phase': 'Initial treatment - Initial 1 (new patient)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12376J', 'drug': 'adalimumab', 'brand': 'Adalicip', 'formulation': 'Injection 40 mg in 0.4 mL pre-filled pen', 'indication': 'ankylosing spondylitis', 'treatment_phase': 'Initial treatment - Initial 1 (new patient)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12376J', 'drug': 'adalimumab', 'brand': 'Humira', 'formulation': 'Injection 40 mg in 0.4 mL pre-filled pen', 'indication': 'ankylosing spondylitis', 'treatment_phase': 'Initial treatment - Initial 1 (new patient)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12376J', 'drug': 'adalimumab', 'brand': 'Yuflyma', 'formulation': 'Injection 40 mg in 0.4 mL pre-filled pen', 'indication': 'ankylosing spondylitis', 'treatment_phase': 'Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12376J', 'drug': 'adalimumab', 'brand': 'Adalicip', 'formulation': 'Injection 40 mg in 0.4 mL pre-filled pen', 'indication': 'ankylosing spondylitis', 'treatment_phase': 'Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12376J', 'drug': 'adalimumab', 'brand': 'Humira', 'formulation': 'Injection 40 mg in 0.4 mL pre-filled pen', 'indication': 'ankylosing spondylitis', 'treatment_phase': 'Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12376J', 'drug': 'adalimumab', 'brand': 'Yuflyma', 'formulation': 'Injection 40 mg in 0.4 mL pre-filled pen', 'indication': 'ankylosing spondylitis', 'treatment_phase': 'Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years) - balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12376J', 'drug': 'adalimumab', 'brand': 'Adalicip', 'formulation': 'Injection 40 mg in 0.4 mL pre-filled pen', 'indication': 'ankylosing spondylitis', 'treatment_phase': 'Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years) - balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12376J', 'drug': 'adalimumab', 'brand': 'Humira', 'formulation': 'Injection 40 mg in 0.4 mL pre-filled pen', 'indication': 'ankylosing spondylitis', 'treatment_phase': 'Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years) - balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12376J', 'drug': 'adalimumab', 'brand': 'Yuflyma', 'formulation': 'Injection 40 mg in 0.4 mL pre-filled pen', 'indication': 'ankylosing spondylitis', 'treatment_phase': 'Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12376J', 'drug': 'adalimumab', 'brand': 'Adalicip', 'formulation': 'Injection 40 mg in 0.4 mL pre-filled pen', 'indication': 'ankylosing spondylitis', 'treatment_phase': 'Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12376J', 'drug': 'adalimumab', 'brand': 'Humira', 'formulation': 'Injection 40 mg in 0.4 mL pre-filled pen', 'indication': 'ankylosing spondylitis', 'treatment_phase': 'Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '13691N', 'drug': 'adalimumab', 'brand': 'Adalicip', 'formulation': 'Injection 40 mg in 0.4 mL pre-filled pen', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'Initial treatment - Initial 1 (new patient)', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '13691N', 'drug': 'adalimumab', 'brand': 'Yuflyma', 'formulation': 'Injection 40 mg in 0.4 mL pre-filled pen', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'Initial treatment - Initial 1 (new patient)', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '13691N', 'drug': 'adalimumab', 'brand': 'Adalicip', 'formulation': 'Injection 40 mg in 0.4 mL pre-filled pen', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months)', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '13691N', 'drug': 'adalimumab', 'brand': 'Yuflyma', 'formulation': 'Injection 40 mg in 0.4 mL pre-filled pen', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months)', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '13691N', 'drug': 'adalimumab', 'brand': 'Adalicip', 'formulation': 'Injection 40 mg in 0.4 mL pre-filled pen', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 24 months)', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '13691N', 'drug': 'adalimumab', 'brand': 'Yuflyma', 'formulation': 'Injection 40 mg in 0.4 mL pre-filled pen', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 24 months)', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12086D', 'drug': 'tocilizumab', 'brand': 'Actemra Subcutaneous Injection', 'formulation': 'Injection 162 mg in 0.9 mL single use pre-filled syringe', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Continuing treatment in a patient weighing less than 30 kg', 'streamlined_code': '14084', 'online_application': True, 'authority_method': 'STREAMLINED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12348X', 'drug': 'adalimumab', 'brand': 'Idacio', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled syringe', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Continuing treatment', 'streamlined_code': '14136', 'online_application': True, 'authority_method': 'STREAMLINED', 'hospital_type': 'Public', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12348X', 'drug': 'adalimumab', 'brand': 'Hadlima', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled syringe', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Continuing treatment', 'streamlined_code': '14136', 'online_application': True, 'authority_method': 'STREAMLINED', 'hospital_type': 'Public', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12348X', 'drug': 'adalimumab', 'brand': 'Amgevita', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled syringe', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Continuing treatment', 'streamlined_code': '14136', 'online_application': True, 'authority_method': 'STREAMLINED', 'hospital_type': 'Public', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12348X', 'drug': 'adalimumab', 'brand': 'Hyrimoz', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled syringe', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Continuing treatment', 'streamlined_code': '14136', 'online_application': True, 'authority_method': 'STREAMLINED', 'hospital_type': 'Public', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12348X', 'drug': 'adalimumab', 'brand': 'Abrilada', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled syringe', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Continuing treatment', 'streamlined_code': '14136', 'online_application': True, 'authority_method': 'STREAMLINED', 'hospital_type': 'Public', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '13689L', 'drug': 'baricitinib', 'brand': 'Olumiant', 'formulation': 'Tablet 2 mg', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'Subsequent continuing treatment', 'streamlined_code': '14499', 'online_application': True, 'authority_method': 'STREAMLINED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '13731Q', 'drug': 'tocilizumab', 'brand': 'Actemra', 'formulation': 'Concentrate for injection 400 mg in 20 mL', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'Subsequent continuing treatment', 'streamlined_code': '14485', 'online_application': True, 'authority_method': 'STREAMLINED', 'hospital_type': 'Private', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '11742B', 'drug': 'tocilizumab', 'brand': 'Actemra ACTPen', 'formulation': 'Injection 162 mg in 0.9 mL single use pre-filled pen', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Continuing treatment', 'streamlined_code': '14150', 'online_application': True, 'authority_method': 'STREAMLINED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12621G', 'drug': 'upadacitinib', 'brand': 'Rinvoq', 'formulation': 'Tablet 15 mg', 'indication': 'ankylosing spondylitis', 'treatment_phase': 'Continuing treatment - balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12621G', 'drug': 'upadacitinib', 'brand': 'Rinvoq', 'formulation': 'Tablet 15 mg', 'indication': 'ankylosing spondylitis', 'treatment_phase': 'Continuing treatment', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12400P', 'drug': 'adalimumab', 'brand': 'Humira', 'formulation': 'Injection 40 mg in 0.4 mL pre-filled syringe', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12400P', 'drug': 'adalimumab', 'brand': 'Yuflyma', 'formulation': 'Injection 40 mg in 0.4 mL pre-filled syringe', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12400P', 'drug': 'adalimumab', 'brand': 'Adalicip', 'formulation': 'Injection 40 mg in 0.4 mL pre-filled syringe', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12400P', 'drug': 'adalimumab', 'brand': 'Humira', 'formulation': 'Injection 40 mg in 0.4 mL pre-filled syringe', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 24 months)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12400P', 'drug': 'adalimumab', 'brand': 'Yuflyma', 'formulation': 'Injection 40 mg in 0.4 mL pre-filled syringe', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 24 months)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12400P', 'drug': 'adalimumab', 'brand': 'Adalicip', 'formulation': 'Injection 40 mg in 0.4 mL pre-filled syringe', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 24 months)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12400P', 'drug': 'adalimumab', 'brand': 'Humira', 'formulation': 'Injection 40 mg in 0.4 mL pre-filled syringe', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'Initial treatment - Initial 1 (new patient)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12400P', 'drug': 'adalimumab', 'brand': 'Yuflyma', 'formulation': 'Injection 40 mg in 0.4 mL pre-filled syringe', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'Initial treatment - Initial 1 (new patient)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12400P', 'drug': 'adalimumab', 'brand': 'Adalicip', 'formulation': 'Injection 40 mg in 0.4 mL pre-filled syringe', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'Initial treatment - Initial 1 (new patient)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12400P', 'drug': 'adalimumab', 'brand': 'Humira', 'formulation': 'Injection 40 mg in 0.4 mL pre-filled syringe', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 24 months) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months) - balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12400P', 'drug': 'adalimumab', 'brand': 'Yuflyma', 'formulation': 'Injection 40 mg in 0.4 mL pre-filled syringe', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 24 months) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months) - balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12400P', 'drug': 'adalimumab', 'brand': 'Adalicip', 'formulation': 'Injection 40 mg in 0.4 mL pre-filled syringe', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 24 months) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months) - balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12209N', 'drug': 'ixekizumab', 'brand': 'Taltz', 'formulation': 'Injection 80 mg in 1 mL single dose pre-filled pen', 'indication': 'ankylosing spondylitis', 'treatment_phase': 'Continuing treatment', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12209N', 'drug': 'ixekizumab', 'brand': 'Taltz', 'formulation': 'Injection 80 mg in 1 mL single dose pre-filled pen', 'indication': 'ankylosing spondylitis', 'treatment_phase': 'Continuing treatment - balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12365T', 'drug': 'adalimumab', 'brand': 'Amgevita', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled syringe', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Subsequent continuing treatment', 'streamlined_code': '11604', 'online_application': True, 'authority_method': 'STREAMLINED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12365T', 'drug': 'adalimumab', 'brand': 'Abrilada', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled syringe', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Subsequent continuing treatment', 'streamlined_code': '11604', 'online_application': True, 'authority_method': 'STREAMLINED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12365T', 'drug': 'adalimumab', 'brand': 'Hadlima', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled syringe', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Subsequent continuing treatment', 'streamlined_code': '11604', 'online_application': True, 'authority_method': 'STREAMLINED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12365T', 'drug': 'adalimumab', 'brand': 'Idacio', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled syringe', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Subsequent continuing treatment', 'streamlined_code': '11604', 'online_application': True, 'authority_method': 'STREAMLINED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12365T', 'drug': 'adalimumab', 'brand': 'Hyrimoz', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled syringe', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Subsequent continuing treatment', 'streamlined_code': '11604', 'online_application': True, 'authority_method': 'STREAMLINED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '13057F', 'drug': 'infliximab', 'brand': 'Remsima SC', 'formulation': 'Solution for injection 120 mg in 1 mL pre-filled syringe', 'indication': 'ankylosing spondylitis', 'treatment_phase': 'Initial treatment with the subcutaneous form where a concurrent PBS authority application for the intravenously (IV) administered formulation is being made', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12399N', 'drug': 'adalimumab', 'brand': 'Yuflyma', 'formulation': 'Injection 40 mg in 0.4 mL pre-filled syringe', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'First continuing treatment', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12399N', 'drug': 'adalimumab', 'brand': 'Adalicip', 'formulation': 'Injection 40 mg in 0.4 mL pre-filled syringe', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'First continuing treatment', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12399N', 'drug': 'adalimumab', 'brand': 'Humira', 'formulation': 'Injection 40 mg in 0.4 mL pre-filled syringe', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'First continuing treatment', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12399N', 'drug': 'adalimumab', 'brand': 'Yuflyma', 'formulation': 'Injection 40 mg in 0.4 mL pre-filled syringe', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Subsequent continuing treatment', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12399N', 'drug': 'adalimumab', 'brand': 'Adalicip', 'formulation': 'Injection 40 mg in 0.4 mL pre-filled syringe', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Subsequent continuing treatment', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12399N', 'drug': 'adalimumab', 'brand': 'Humira', 'formulation': 'Injection 40 mg in 0.4 mL pre-filled syringe', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Subsequent continuing treatment', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12399N', 'drug': 'adalimumab', 'brand': 'Yuflyma', 'formulation': 'Injection 40 mg in 0.4 mL pre-filled syringe', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Continuing treatment - balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12399N', 'drug': 'adalimumab', 'brand': 'Adalicip', 'formulation': 'Injection 40 mg in 0.4 mL pre-filled syringe', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Continuing treatment - balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12399N', 'drug': 'adalimumab', 'brand': 'Humira', 'formulation': 'Injection 40 mg in 0.4 mL pre-filled syringe', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Continuing treatment - balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12378L', 'drug': 'adalimumab', 'brand': 'Humira', 'formulation': 'Injection 40 mg in 0.4 mL pre-filled syringe', 'indication': 'psoriatic arthritis', 'treatment_phase': 'Initial treatment - Initial 1 (new patient)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12378L', 'drug': 'adalimumab', 'brand': 'Yuflyma', 'formulation': 'Injection 40 mg in 0.4 mL pre-filled syringe', 'indication': 'psoriatic arthritis', 'treatment_phase': 'Initial treatment - Initial 1 (new patient)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12378L', 'drug': 'adalimumab', 'brand': 'Adalicip', 'formulation': 'Injection 40 mg in 0.4 mL pre-filled syringe', 'indication': 'psoriatic arthritis', 'treatment_phase': 'Initial treatment - Initial 1 (new patient)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12378L', 'drug': 'adalimumab', 'brand': 'Humira', 'formulation': 'Injection 40 mg in 0.4 mL pre-filled syringe', 'indication': 'psoriatic arthritis', 'treatment_phase': 'Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12378L', 'drug': 'adalimumab', 'brand': 'Yuflyma', 'formulation': 'Injection 40 mg in 0.4 mL pre-filled syringe', 'indication': 'psoriatic arthritis', 'treatment_phase': 'Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12378L', 'drug': 'adalimumab', 'brand': 'Adalicip', 'formulation': 'Injection 40 mg in 0.4 mL pre-filled syringe', 'indication': 'psoriatic arthritis', 'treatment_phase': 'Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12378L', 'drug': 'adalimumab', 'brand': 'Humira', 'formulation': 'Injection 40 mg in 0.4 mL pre-filled syringe', 'indication': 'psoriatic arthritis', 'treatment_phase': 'Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years) - balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12378L', 'drug': 'adalimumab', 'brand': 'Yuflyma', 'formulation': 'Injection 40 mg in 0.4 mL pre-filled syringe', 'indication': 'psoriatic arthritis', 'treatment_phase': 'Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years) - balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12378L', 'drug': 'adalimumab', 'brand': 'Adalicip', 'formulation': 'Injection 40 mg in 0.4 mL pre-filled syringe', 'indication': 'psoriatic arthritis', 'treatment_phase': 'Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years) - balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12378L', 'drug': 'adalimumab', 'brand': 'Humira', 'formulation': 'Injection 40 mg in 0.4 mL pre-filled syringe', 'indication': 'psoriatic arthritis', 'treatment_phase': 'Initial treatment - Initial 2 (change or recommencement of treatment after a break in in biological medicine of less than 5 years)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12378L', 'drug': 'adalimumab', 'brand': 'Yuflyma', 'formulation': 'Injection 40 mg in 0.4 mL pre-filled syringe', 'indication': 'psoriatic arthritis', 'treatment_phase': 'Initial treatment - Initial 2 (change or recommencement of treatment after a break in in biological medicine of less than 5 years)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12378L', 'drug': 'adalimumab', 'brand': 'Adalicip', 'formulation': 'Injection 40 mg in 0.4 mL pre-filled syringe', 'indication': 'psoriatic arthritis', 'treatment_phase': 'Initial treatment - Initial 2 (change or recommencement of treatment after a break in in biological medicine of less than 5 years)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12013G', 'drug': 'certolizumab pegol', 'brand': 'Cimzia', 'formulation': 'Solution for injection 200 mg in 1 mL pre-filled pen', 'indication': 'non-radiographic axial spondyloarthritis', 'treatment_phase': 'Continuing treatment - balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12013G', 'drug': 'certolizumab pegol', 'brand': 'Cimzia', 'formulation': 'Solution for injection 200 mg in 1 mL pre-filled pen', 'indication': 'non-radiographic axial spondyloarthritis', 'treatment_phase': 'Initial 1 (New patient), Initial 2 (Change or re-commencement of treatment after a break in biological medicine of less than 5 years) or Initial 3 (Recommencement of treatment after a break in biological medicine of more than 5 years) - balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12443X', 'drug': 'adalimumab', 'brand': 'Humira', 'formulation': 'Injection 20 mg in 0.2 mL pre-filled syringe', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 12 months) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 12 months) - balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Private', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12443X', 'drug': 'adalimumab', 'brand': 'Humira', 'formulation': 'Injection 20 mg in 0.2 mL pre-filled syringe', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 12 months)', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Private', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12443X', 'drug': 'adalimumab', 'brand': 'Humira', 'formulation': 'Injection 20 mg in 0.2 mL pre-filled syringe', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial treatment - Initial 1 (new patient)', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Private', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12443X', 'drug': 'adalimumab', 'brand': 'Humira', 'formulation': 'Injection 20 mg in 0.2 mL pre-filled syringe', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 12 months)', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Private', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '13349N', 'drug': 'tofacitinib', 'brand': 'Xeljanz', 'formulation': 'Tablet 5 mg', 'indication': 'ankylosing spondylitis', 'treatment_phase': 'Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '13349N', 'drug': 'tofacitinib', 'brand': 'Xeljanz', 'formulation': 'Tablet 5 mg', 'indication': 'ankylosing spondylitis', 'treatment_phase': 'Initial treatment - Initial 1 (new patient)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '13349N', 'drug': 'tofacitinib', 'brand': 'Xeljanz', 'formulation': 'Tablet 5 mg', 'indication': 'ankylosing spondylitis', 'treatment_phase': 'Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years) - balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '13349N', 'drug': 'tofacitinib', 'brand': 'Xeljanz', 'formulation': 'Tablet 5 mg', 'indication': 'ankylosing spondylitis', 'treatment_phase': 'Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9036N', 'drug': 'etanercept', 'brand': 'Enbrel', 'formulation': 'Injection set containing 4 vials powder for injection 25 mg and 4 pre-filled syringes solvent 1 mL', 'indication': 'psoriatic arthritis', 'treatment_phase': 'First continuing treatment', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9036N', 'drug': 'etanercept', 'brand': 'Enbrel', 'formulation': 'Injection set containing 4 vials powder for injection 25 mg and 4 pre-filled syringes solvent 1 mL', 'indication': 'psoriatic arthritis', 'treatment_phase': 'Continuing treatment - balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '10893H', 'drug': 'secukinumab', 'brand': 'Cosentyx', 'formulation': 'Injection 150 mg in 1 mL pre-filled pen', 'indication': 'ankylosing spondylitis', 'treatment_phase': 'Initial treatment - Initial 1 (new patient), Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years) - balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '13707K', 'drug': 'etanercept', 'brand': 'Brenzys', 'formulation': 'Injections 50 mg in 1 mL single use pre-filled syringes, 4', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'First continuing treatment', 'streamlined_code': '14629', 'online_application': True, 'authority_method': 'STREAMLINED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9035M', 'drug': 'etanercept', 'brand': 'Enbrel', 'formulation': 'Injection set containing 4 vials powder for injection 25 mg and 4 pre-filled syringes solvent 1 mL', 'indication': 'psoriatic arthritis', 'treatment_phase': 'Initial treatment - Initial 1 (new patient)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9035M', 'drug': 'etanercept', 'brand': 'Enbrel', 'formulation': 'Injection set containing 4 vials powder for injection 25 mg and 4 pre-filled syringes solvent 1 mL', 'indication': 'psoriatic arthritis', 'treatment_phase': 'Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years) - balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9035M', 'drug': 'etanercept', 'brand': 'Enbrel', 'formulation': 'Injection set containing 4 vials powder for injection 25 mg and 4 pre-filled syringes solvent 1 mL', 'indication': 'psoriatic arthritis', 'treatment_phase': 'Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9035M', 'drug': 'etanercept', 'brand': 'Enbrel', 'formulation': 'Injection set containing 4 vials powder for injection 25 mg and 4 pre-filled syringes solvent 1 mL', 'indication': 'psoriatic arthritis', 'treatment_phase': 'Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '13705H', 'drug': 'abatacept', 'brand': 'Orencia', 'formulation': 'Powder for I.V. infusion 250 mg', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'Subsequent continuing treatment', 'streamlined_code': '14555', 'online_application': True, 'authority_method': 'STREAMLINED', 'hospital_type': 'Private', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '13744J', 'drug': 'adalimumab', 'brand': 'Hadlima', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled syringe', 'indication': 'ankylosing spondylitis', 'treatment_phase': 'Initial treatment - Initial 1 (new patient)', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '13744J', 'drug': 'adalimumab', 'brand': 'Idacio', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled syringe', 'indication': 'ankylosing spondylitis', 'treatment_phase': 'Initial treatment - Initial 1 (new patient)', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '13744J', 'drug': 'adalimumab', 'brand': 'Abrilada', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled syringe', 'indication': 'ankylosing spondylitis', 'treatment_phase': 'Initial treatment - Initial 1 (new patient)', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '13744J', 'drug': 'adalimumab', 'brand': 'Hyrimoz', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled syringe', 'indication': 'ankylosing spondylitis', 'treatment_phase': 'Initial treatment - Initial 1 (new patient)', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '13744J', 'drug': 'adalimumab', 'brand': 'Amgevita', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled syringe', 'indication': 'ankylosing spondylitis', 'treatment_phase': 'Initial treatment - Initial 1 (new patient)', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '13744J', 'drug': 'adalimumab', 'brand': 'Hadlima', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled syringe', 'indication': 'ankylosing spondylitis', 'treatment_phase': 'Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years)', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '13744J', 'drug': 'adalimumab', 'brand': 'Idacio', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled syringe', 'indication': 'ankylosing spondylitis', 'treatment_phase': 'Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years)', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '13744J', 'drug': 'adalimumab', 'brand': 'Abrilada', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled syringe', 'indication': 'ankylosing spondylitis', 'treatment_phase': 'Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years)', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '13744J', 'drug': 'adalimumab', 'brand': 'Hyrimoz', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled syringe', 'indication': 'ankylosing spondylitis', 'treatment_phase': 'Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years)', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '13744J', 'drug': 'adalimumab', 'brand': 'Amgevita', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled syringe', 'indication': 'ankylosing spondylitis', 'treatment_phase': 'Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years)', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '13744J', 'drug': 'adalimumab', 'brand': 'Hadlima', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled syringe', 'indication': 'ankylosing spondylitis', 'treatment_phase': 'Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years)', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '13744J', 'drug': 'adalimumab', 'brand': 'Idacio', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled syringe', 'indication': 'ankylosing spondylitis', 'treatment_phase': 'Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years)', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '13744J', 'drug': 'adalimumab', 'brand': 'Abrilada', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled syringe', 'indication': 'ankylosing spondylitis', 'treatment_phase': 'Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years)', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '13744J', 'drug': 'adalimumab', 'brand': 'Hyrimoz', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled syringe', 'indication': 'ankylosing spondylitis', 'treatment_phase': 'Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years)', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '13744J', 'drug': 'adalimumab', 'brand': 'Amgevita', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled syringe', 'indication': 'ankylosing spondylitis', 'treatment_phase': 'Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years)', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9078T', 'drug': 'adalimumab', 'brand': 'Hadlima', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled syringe', 'indication': 'ankylosing spondylitis', 'treatment_phase': 'First continuing treatment', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9078T', 'drug': 'adalimumab', 'brand': 'Idacio', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled syringe', 'indication': 'ankylosing spondylitis', 'treatment_phase': 'First continuing treatment', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9078T', 'drug': 'adalimumab', 'brand': 'Amgevita', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled syringe', 'indication': 'ankylosing spondylitis', 'treatment_phase': 'First continuing treatment', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9078T', 'drug': 'adalimumab', 'brand': 'Hyrimoz', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled syringe', 'indication': 'ankylosing spondylitis', 'treatment_phase': 'First continuing treatment', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9078T', 'drug': 'adalimumab', 'brand': 'Abrilada', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled syringe', 'indication': 'ankylosing spondylitis', 'treatment_phase': 'First continuing treatment', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9078T', 'drug': 'adalimumab', 'brand': 'Hadlima', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled syringe', 'indication': 'ankylosing spondylitis', 'treatment_phase': 'Continuing treatment - balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9078T', 'drug': 'adalimumab', 'brand': 'Idacio', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled syringe', 'indication': 'ankylosing spondylitis', 'treatment_phase': 'Continuing treatment - balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9078T', 'drug': 'adalimumab', 'brand': 'Amgevita', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled syringe', 'indication': 'ankylosing spondylitis', 'treatment_phase': 'Continuing treatment - balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9078T', 'drug': 'adalimumab', 'brand': 'Hyrimoz', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled syringe', 'indication': 'ankylosing spondylitis', 'treatment_phase': 'Continuing treatment - balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9078T', 'drug': 'adalimumab', 'brand': 'Abrilada', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled syringe', 'indication': 'ankylosing spondylitis', 'treatment_phase': 'Continuing treatment - balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9078T', 'drug': 'adalimumab', 'brand': 'Hadlima', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled syringe', 'indication': 'ankylosing spondylitis', 'treatment_phase': 'Subsequent continuing treatment', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9078T', 'drug': 'adalimumab', 'brand': 'Idacio', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled syringe', 'indication': 'ankylosing spondylitis', 'treatment_phase': 'Subsequent continuing treatment', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9078T', 'drug': 'adalimumab', 'brand': 'Amgevita', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled syringe', 'indication': 'ankylosing spondylitis', 'treatment_phase': 'Subsequent continuing treatment', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9078T', 'drug': 'adalimumab', 'brand': 'Hyrimoz', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled syringe', 'indication': 'ankylosing spondylitis', 'treatment_phase': 'Subsequent continuing treatment', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9078T', 'drug': 'adalimumab', 'brand': 'Abrilada', 'formulation': 'Injection 40 mg in 0.8 mL pre-filled syringe', 'indication': 'ankylosing spondylitis', 'treatment_phase': 'Subsequent continuing treatment', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '11989B', 'drug': 'upadacitinib', 'brand': 'Rinvoq', 'formulation': 'Tablet 15 mg', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 24 months) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months) - balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '11989B', 'drug': 'upadacitinib', 'brand': 'Rinvoq', 'formulation': 'Tablet 15 mg', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'Initial treatment - Initial 1 (new patient)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '11989B', 'drug': 'upadacitinib', 'brand': 'Rinvoq', 'formulation': 'Tablet 15 mg', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 24 months)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '11989B', 'drug': 'upadacitinib', 'brand': 'Rinvoq', 'formulation': 'Tablet 15 mg', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '5753T', 'drug': 'infliximab', 'brand': 'Inflectra', 'formulation': 'Powder for I.V. infusion 100 mg', 'indication': 'ankylosing spondylitis', 'treatment_phase': 'Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Public', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '5753T', 'drug': 'infliximab', 'brand': 'Remicade', 'formulation': 'Powder for I.V. infusion 100 mg', 'indication': 'ankylosing spondylitis', 'treatment_phase': 'Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Public', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '5753T', 'drug': 'infliximab', 'brand': 'Renflexis', 'formulation': 'Powder for I.V. infusion 100 mg', 'indication': 'ankylosing spondylitis', 'treatment_phase': 'Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Public', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '5753T', 'drug': 'infliximab', 'brand': 'Inflectra', 'formulation': 'Powder for I.V. infusion 100 mg', 'indication': 'ankylosing spondylitis', 'treatment_phase': 'Initial treatment - Initial 1 (new patient)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Public', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '5753T', 'drug': 'infliximab', 'brand': 'Remicade', 'formulation': 'Powder for I.V. infusion 100 mg', 'indication': 'ankylosing spondylitis', 'treatment_phase': 'Initial treatment - Initial 1 (new patient)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Public', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '5753T', 'drug': 'infliximab', 'brand': 'Renflexis', 'formulation': 'Powder for I.V. infusion 100 mg', 'indication': 'ankylosing spondylitis', 'treatment_phase': 'Initial treatment - Initial 1 (new patient)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Public', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '5753T', 'drug': 'infliximab', 'brand': 'Inflectra', 'formulation': 'Powder for I.V. infusion 100 mg', 'indication': 'ankylosing spondylitis', 'treatment_phase': 'Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Public', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '5753T', 'drug': 'infliximab', 'brand': 'Remicade', 'formulation': 'Powder for I.V. infusion 100 mg', 'indication': 'ankylosing spondylitis', 'treatment_phase': 'Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Public', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '5753T', 'drug': 'infliximab', 'brand': 'Renflexis', 'formulation': 'Powder for I.V. infusion 100 mg', 'indication': 'ankylosing spondylitis', 'treatment_phase': 'Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Public', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '5753T', 'drug': 'infliximab', 'brand': 'Inflectra', 'formulation': 'Powder for I.V. infusion 100 mg', 'indication': 'ankylosing spondylitis', 'treatment_phase': 'Continuing treatment - balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Public', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '5753T', 'drug': 'infliximab', 'brand': 'Remicade', 'formulation': 'Powder for I.V. infusion 100 mg', 'indication': 'ankylosing spondylitis', 'treatment_phase': 'Continuing treatment - balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Public', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '5753T', 'drug': 'infliximab', 'brand': 'Renflexis', 'formulation': 'Powder for I.V. infusion 100 mg', 'indication': 'ankylosing spondylitis', 'treatment_phase': 'Continuing treatment - balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Public', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '5753T', 'drug': 'infliximab', 'brand': 'Inflectra', 'formulation': 'Powder for I.V. infusion 100 mg', 'indication': 'ankylosing spondylitis', 'treatment_phase': 'First continuing treatment', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Public', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '5753T', 'drug': 'infliximab', 'brand': 'Remicade', 'formulation': 'Powder for I.V. infusion 100 mg', 'indication': 'ankylosing spondylitis', 'treatment_phase': 'First continuing treatment', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Public', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '5753T', 'drug': 'infliximab', 'brand': 'Renflexis', 'formulation': 'Powder for I.V. infusion 100 mg', 'indication': 'ankylosing spondylitis', 'treatment_phase': 'First continuing treatment', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Public', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '5753T', 'drug': 'infliximab', 'brand': 'Inflectra', 'formulation': 'Powder for I.V. infusion 100 mg', 'indication': 'ankylosing spondylitis', 'treatment_phase': 'Initial treatment - Initial 1 (new patient), Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years) - balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Public', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '5753T', 'drug': 'infliximab', 'brand': 'Remicade', 'formulation': 'Powder for I.V. infusion 100 mg', 'indication': 'ankylosing spondylitis', 'treatment_phase': 'Initial treatment - Initial 1 (new patient), Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years) - balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Public', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '5753T', 'drug': 'infliximab', 'brand': 'Renflexis', 'formulation': 'Powder for I.V. infusion 100 mg', 'indication': 'ankylosing spondylitis', 'treatment_phase': 'Initial treatment - Initial 1 (new patient), Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years) - balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Public', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9673D', 'drug': 'tocilizumab', 'brand': 'Actemra', 'formulation': 'Concentrate for injection 400 mg in 20 mL', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 24 months) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months) - balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Private', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9673D', 'drug': 'tocilizumab', 'brand': 'Actemra', 'formulation': 'Concentrate for injection 400 mg in 20 mL', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'First continuing treatment - balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Private', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9673D', 'drug': 'tocilizumab', 'brand': 'Actemra', 'formulation': 'Concentrate for injection 400 mg in 20 mL', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'Initial treatment - Initial 1 (new patient)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Private', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9673D', 'drug': 'tocilizumab', 'brand': 'Actemra', 'formulation': 'Concentrate for injection 400 mg in 20 mL', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 24 months)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Private', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9673D', 'drug': 'tocilizumab', 'brand': 'Actemra', 'formulation': 'Concentrate for injection 400 mg in 20 mL', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'First continuing treatment', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Private', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9673D', 'drug': 'tocilizumab', 'brand': 'Actemra', 'formulation': 'Concentrate for injection 400 mg in 20 mL', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Private', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '10064Q', 'drug': 'tocilizumab', 'brand': 'Actemra', 'formulation': 'Concentrate for injection 400 mg in 20 mL', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 12 months)', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Public', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '10064Q', 'drug': 'tocilizumab', 'brand': 'Actemra', 'formulation': 'Concentrate for injection 400 mg in 20 mL', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial treatment - Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 12 months) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 12 months) - balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Public', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '10064Q', 'drug': 'tocilizumab', 'brand': 'Actemra', 'formulation': 'Concentrate for injection 400 mg in 20 mL', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 12 months)', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Public', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '10064Q', 'drug': 'tocilizumab', 'brand': 'Actemra', 'formulation': 'Concentrate for injection 400 mg in 20 mL', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial treatment - Initial 1 (new patient)', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Public', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '12553Q', 'drug': 'infliximab', 'brand': 'Remsima SC', 'formulation': 'Solution for injection 120 mg in 1 mL pre-filled syringe', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'Continuing treatment with subcutaneous form or switching from intravenous form to subcutaneous form', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '11443G', 'drug': 'baricitinib', 'brand': 'Olumiant', 'formulation': 'Tablet 4 mg', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'First continuing treatment', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '11443G', 'drug': 'baricitinib', 'brand': 'Olumiant', 'formulation': 'Tablet 4 mg', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'First continuing treatment - balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9085E', 'drug': 'etanercept', 'brand': 'Brenzys', 'formulation': 'Injections 50 mg in 1 mL single use pre-filled syringes, 4', 'indication': 'ankylosing spondylitis', 'treatment_phase': 'Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9085E', 'drug': 'etanercept', 'brand': 'Enbrel', 'formulation': 'Injections 50 mg in 1 mL single use pre-filled syringes, 4', 'indication': 'ankylosing spondylitis', 'treatment_phase': 'Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9085E', 'drug': 'etanercept', 'brand': 'Brenzys', 'formulation': 'Injections 50 mg in 1 mL single use pre-filled syringes, 4', 'indication': 'ankylosing spondylitis', 'treatment_phase': 'Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9085E', 'drug': 'etanercept', 'brand': 'Enbrel', 'formulation': 'Injections 50 mg in 1 mL single use pre-filled syringes, 4', 'indication': 'ankylosing spondylitis', 'treatment_phase': 'Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9085E', 'drug': 'etanercept', 'brand': 'Brenzys', 'formulation': 'Injections 50 mg in 1 mL single use pre-filled syringes, 4', 'indication': 'ankylosing spondylitis', 'treatment_phase': 'Initial treatment - Initial 1 (new patient)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9085E', 'drug': 'etanercept', 'brand': 'Enbrel', 'formulation': 'Injections 50 mg in 1 mL single use pre-filled syringes, 4', 'indication': 'ankylosing spondylitis', 'treatment_phase': 'Initial treatment - Initial 1 (new patient)', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9085E', 'drug': 'etanercept', 'brand': 'Brenzys', 'formulation': 'Injections 50 mg in 1 mL single use pre-filled syringes, 4', 'indication': 'ankylosing spondylitis', 'treatment_phase': 'Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years) - balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '9085E', 'drug': 'etanercept', 'brand': 'Enbrel', 'formulation': 'Injections 50 mg in 1 mL single use pre-filled syringes, 4', 'indication': 'ankylosing spondylitis', 'treatment_phase': 'Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years) - balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Any', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '5735W', 'drug': 'etanercept', 'brand': 'Enbrel', 'formulation': 'Injection 50 mg in 1 mL single use auto-injector, 4', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial treatment - Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 12 months) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 12 months) - balance of supply', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Public', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '5735W', 'drug': 'etanercept', 'brand': 'Enbrel', 'formulation': 'Injection 50 mg in 1 mL single use auto-injector, 4', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 12 months)', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Public', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '5735W', 'drug': 'etanercept', 'brand': 'Enbrel', 'formulation': 'Injection 50 mg in 1 mL single use auto-injector, 4', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 12 months)', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Public', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '5735W', 'drug': 'etanercept', 'brand': 'Enbrel', 'formulation': 'Injection 50 mg in 1 mL single use auto-injector, 4', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Initial treatment - Initial 1 (new patient)', 'streamlined_code': None, 'online_application': True, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Public', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '11497D', 'drug': 'infliximab', 'brand': 'Inflectra', 'formulation': 'Powder for I.V. infusion 100 mg', 'indication': 'psoriatic arthritis', 'treatment_phase': 'Subsequent continuing treatment', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Public', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '11497D', 'drug': 'infliximab', 'brand': 'Renflexis', 'formulation': 'Powder for I.V. infusion 100 mg', 'indication': 'psoriatic arthritis', 'treatment_phase': 'Subsequent continuing treatment', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Public', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '11497D', 'drug': 'infliximab', 'brand': 'Remicade', 'formulation': 'Powder for I.V. infusion 100 mg', 'indication': 'psoriatic arthritis', 'treatment_phase': 'Subsequent continuing treatment', 'streamlined_code': None, 'online_application': False, 'authority_method': 'AUTHORITY_REQUIRED', 'hospital_type': 'Public', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '11483J', 'drug': 'infliximab', 'brand': 'Inflectra', 'formulation': 'Powder for I.V. infusion 100 mg', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'Subsequent continuing treatment', 'streamlined_code': '14505', 'online_application': True, 'authority_method': 'STREAMLINED', 'hospital_type': 'Private', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '11483J', 'drug': 'infliximab', 'brand': 'Remicade', 'formulation': 'Powder for I.V. infusion 100 mg', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'Subsequent continuing treatment', 'streamlined_code': '14505', 'online_application': True, 'authority_method': 'STREAMLINED', 'hospital_type': 'Private', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '11483J', 'drug': 'infliximab', 'brand': 'Renflexis', 'formulation': 'Powder for I.V. infusion 100 mg', 'indication': 'rheumatoid arthritis', 'treatment_phase': 'Subsequent continuing treatment', 'streamlined_code': '14505', 'online_application': True, 'authority_method': 'STREAMLINED', 'hospital_type': 'Private', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}","{'pbs_code': '13338B', 'drug': 'tocilizumab', 'brand': 'Actemra', 'formulation': 'Concentrate for injection 400 mg in 20 mL', 'indication': 'juvenile idiopathic arthritis', 'treatment_phase': 'Continuing treatment', 'streamlined_code': '14082', 'online_application': True, 'authority_method': 'STREAMLINED', 'hospital_type': 'Private', 'schedule_code': 4030, 'schedule_year': 2024, 'schedule_month': 'AUGUST'}"
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
-pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
 pbs_code,drug,brand,formulation,indication,treatment_phase,streamlined_code,online_application,authority_method,hospital_type,schedule_code,schedule_year,schedule_month
+13308K,etanercept,Enbrel,"Injections 50 mg in 1 mL single use pre-filled syringes, 4",juvenile idiopathic arthritis,Continuing treatment,14154,True,STREAMLINED,Public,4030,2024,AUGUST
+13757C,tofacitinib,Xeljanz,Tablet 5 mg,juvenile idiopathic arthritis,Transitioning from non-PBS to PBS-subsidised supply - Grandfather arrangements,,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+9034L,adalimumab,Abrilada,Injection 40 mg in 0.8 mL pre-filled syringe,psoriatic arthritis,Continuing treatment - balance of supply,,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+9034L,adalimumab,Idacio,Injection 40 mg in 0.8 mL pre-filled syringe,psoriatic arthritis,Continuing treatment - balance of supply,,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+9034L,adalimumab,Hadlima,Injection 40 mg in 0.8 mL pre-filled syringe,psoriatic arthritis,Continuing treatment - balance of supply,,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+9034L,adalimumab,Hyrimoz,Injection 40 mg in 0.8 mL pre-filled syringe,psoriatic arthritis,Continuing treatment - balance of supply,,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+9034L,adalimumab,Amgevita,Injection 40 mg in 0.8 mL pre-filled syringe,psoriatic arthritis,Continuing treatment - balance of supply,,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+9034L,adalimumab,Abrilada,Injection 40 mg in 0.8 mL pre-filled syringe,psoriatic arthritis,First continuing treatment,,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+9034L,adalimumab,Idacio,Injection 40 mg in 0.8 mL pre-filled syringe,psoriatic arthritis,First continuing treatment,,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+9034L,adalimumab,Hadlima,Injection 40 mg in 0.8 mL pre-filled syringe,psoriatic arthritis,First continuing treatment,,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+9034L,adalimumab,Hyrimoz,Injection 40 mg in 0.8 mL pre-filled syringe,psoriatic arthritis,First continuing treatment,,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+9034L,adalimumab,Amgevita,Injection 40 mg in 0.8 mL pre-filled syringe,psoriatic arthritis,First continuing treatment,,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+9034L,adalimumab,Abrilada,Injection 40 mg in 0.8 mL pre-filled syringe,psoriatic arthritis,Subsequent continuing treatment,,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+9034L,adalimumab,Idacio,Injection 40 mg in 0.8 mL pre-filled syringe,psoriatic arthritis,Subsequent continuing treatment,,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+9034L,adalimumab,Hadlima,Injection 40 mg in 0.8 mL pre-filled syringe,psoriatic arthritis,Subsequent continuing treatment,,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+9034L,adalimumab,Hyrimoz,Injection 40 mg in 0.8 mL pre-filled syringe,psoriatic arthritis,Subsequent continuing treatment,,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+9034L,adalimumab,Amgevita,Injection 40 mg in 0.8 mL pre-filled syringe,psoriatic arthritis,Subsequent continuing treatment,,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+11516D,golimumab,Simponi,Injection 50 mg in 0.5 mL single use pre-filled syringe,non-radiographic axial spondyloarthritis,Continuing treatment - balance of supply,,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+11516D,golimumab,Simponi,Injection 50 mg in 0.5 mL single use pre-filled syringe,non-radiographic axial spondyloarthritis,Continuing treatment,,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+10767Q,ustekinumab,Stelara,Injection 45 mg in 0.5 mL,psoriatic arthritis,Continuing treatment - balance of supply,,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+10767Q,ustekinumab,Stelara,Injection 45 mg in 0.5 mL,psoriatic arthritis,Continuing treatment,,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+13720D,tocilizumab,Actemra ACTPen,Injection 162 mg in 0.9 mL single use pre-filled pen,rheumatoid arthritis,Subsequent continuing treatment,14499,True,STREAMLINED,Any,4030,2024,AUGUST
+13065P,infliximab,Remsima SC,Solution for injection 120 mg in 1 mL pre-filled syringe,ankylosing spondylitis,Balance of supply (including switching formulation) where the full duration of treatment available under a particular treatment phase was not requested in the preceding prescription,,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+12217B,ixekizumab,Taltz,Injection 80 mg in 1 mL single dose pre-filled pen,ankylosing spondylitis,Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years),,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+12217B,ixekizumab,Taltz,Injection 80 mg in 1 mL single dose pre-filled pen,ankylosing spondylitis,Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years),,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+12217B,ixekizumab,Taltz,Injection 80 mg in 1 mL single dose pre-filled pen,ankylosing spondylitis,"Initial treatment - Initial 1 (new patient), Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years) - balance of supply",,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+12217B,ixekizumab,Taltz,Injection 80 mg in 1 mL single dose pre-filled pen,ankylosing spondylitis,Initial treatment - Initial 1 (new patient),,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+3428K,golimumab,Simponi,Injection 50 mg in 0.5 mL single use pre-filled syringe,rheumatoid arthritis,First continuing treatment,,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+3428K,golimumab,Simponi,Injection 50 mg in 0.5 mL single use pre-filled syringe,rheumatoid arthritis,First continuing treatment - balance of supply,,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+11375Q,golimumab,Simponi,Injection 50 mg in 0.5 mL single use pre-filled pen,rheumatoid arthritis,First continuing treatment - balance of supply,,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+11375Q,golimumab,Simponi,Injection 50 mg in 0.5 mL single use pre-filled pen,rheumatoid arthritis,First continuing treatment,,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+3449M,etanercept,Enbrel,"Injections 50 mg in 1 mL single use pre-filled syringes, 4",juvenile idiopathic arthritis,Continuing Treatment - balance of supply,,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+3449M,etanercept,Enbrel,"Injections 50 mg in 1 mL single use pre-filled syringes, 4",juvenile idiopathic arthritis,Continuing treatment,,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+13223Y,adalimumab,Yuflyma,Injection 40 mg in 0.4 mL pre-filled pen,juvenile idiopathic arthritis,Subsequent continuing treatment,11604,True,STREAMLINED,Any,4030,2024,AUGUST
+13223Y,adalimumab,Adalicip,Injection 40 mg in 0.4 mL pre-filled pen,juvenile idiopathic arthritis,Subsequent continuing treatment,11604,True,STREAMLINED,Any,4030,2024,AUGUST
+11498E,infliximab,Inflectra,Powder for I.V. infusion 100 mg,psoriatic arthritis,Subsequent continuing treatment,,False,AUTHORITY_REQUIRED,Private,4030,2024,AUGUST
+11498E,infliximab,Renflexis,Powder for I.V. infusion 100 mg,psoriatic arthritis,Subsequent continuing treatment,,False,AUTHORITY_REQUIRED,Private,4030,2024,AUGUST
+11498E,infliximab,Remicade,Powder for I.V. infusion 100 mg,psoriatic arthritis,Subsequent continuing treatment,,False,AUTHORITY_REQUIRED,Private,4030,2024,AUGUST
+11197H,etanercept,Enbrel,Injection set containing 4 vials powder for injection 25 mg and 4 pre-filled syringes solvent 1 mL,rheumatoid arthritis,Subsequent continuing treatment,14499,True,STREAMLINED,Any,4030,2024,AUGUST
+6448J,infliximab,Remicade,Powder for I.V. infusion 100 mg,ankylosing spondylitis,"Initial treatment - Initial 1 (new patient), Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years) - balance of supply",,True,AUTHORITY_REQUIRED,Private,4030,2024,AUGUST
+6448J,infliximab,Inflectra,Powder for I.V. infusion 100 mg,ankylosing spondylitis,"Initial treatment - Initial 1 (new patient), Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years) - balance of supply",,True,AUTHORITY_REQUIRED,Private,4030,2024,AUGUST
+6448J,infliximab,Renflexis,Powder for I.V. infusion 100 mg,ankylosing spondylitis,"Initial treatment - Initial 1 (new patient), Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years) - balance of supply",,True,AUTHORITY_REQUIRED,Private,4030,2024,AUGUST
+6448J,infliximab,Remicade,Powder for I.V. infusion 100 mg,ankylosing spondylitis,Initial treatment - Initial 1 (new patient),,False,AUTHORITY_REQUIRED,Private,4030,2024,AUGUST
+6448J,infliximab,Inflectra,Powder for I.V. infusion 100 mg,ankylosing spondylitis,Initial treatment - Initial 1 (new patient),,False,AUTHORITY_REQUIRED,Private,4030,2024,AUGUST
+6448J,infliximab,Renflexis,Powder for I.V. infusion 100 mg,ankylosing spondylitis,Initial treatment - Initial 1 (new patient),,False,AUTHORITY_REQUIRED,Private,4030,2024,AUGUST
+6448J,infliximab,Remicade,Powder for I.V. infusion 100 mg,ankylosing spondylitis,Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years),,False,AUTHORITY_REQUIRED,Private,4030,2024,AUGUST
+6448J,infliximab,Inflectra,Powder for I.V. infusion 100 mg,ankylosing spondylitis,Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years),,False,AUTHORITY_REQUIRED,Private,4030,2024,AUGUST
+6448J,infliximab,Renflexis,Powder for I.V. infusion 100 mg,ankylosing spondylitis,Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years),,False,AUTHORITY_REQUIRED,Private,4030,2024,AUGUST
+6448J,infliximab,Remicade,Powder for I.V. infusion 100 mg,ankylosing spondylitis,Continuing treatment - balance of supply,,True,AUTHORITY_REQUIRED,Private,4030,2024,AUGUST
+6448J,infliximab,Inflectra,Powder for I.V. infusion 100 mg,ankylosing spondylitis,Continuing treatment - balance of supply,,True,AUTHORITY_REQUIRED,Private,4030,2024,AUGUST
+6448J,infliximab,Renflexis,Powder for I.V. infusion 100 mg,ankylosing spondylitis,Continuing treatment - balance of supply,,True,AUTHORITY_REQUIRED,Private,4030,2024,AUGUST
+6448J,infliximab,Remicade,Powder for I.V. infusion 100 mg,ankylosing spondylitis,Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years),,False,AUTHORITY_REQUIRED,Private,4030,2024,AUGUST
+6448J,infliximab,Inflectra,Powder for I.V. infusion 100 mg,ankylosing spondylitis,Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years),,False,AUTHORITY_REQUIRED,Private,4030,2024,AUGUST
+6448J,infliximab,Renflexis,Powder for I.V. infusion 100 mg,ankylosing spondylitis,Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years),,False,AUTHORITY_REQUIRED,Private,4030,2024,AUGUST
+6448J,infliximab,Remicade,Powder for I.V. infusion 100 mg,ankylosing spondylitis,First continuing treatment,,False,AUTHORITY_REQUIRED,Private,4030,2024,AUGUST
+6448J,infliximab,Inflectra,Powder for I.V. infusion 100 mg,ankylosing spondylitis,First continuing treatment,,False,AUTHORITY_REQUIRED,Private,4030,2024,AUGUST
+6448J,infliximab,Renflexis,Powder for I.V. infusion 100 mg,ankylosing spondylitis,First continuing treatment,,False,AUTHORITY_REQUIRED,Private,4030,2024,AUGUST
+13228F,adalimumab,Humira,Injection 40 mg in 0.4 mL pre-filled syringe,juvenile idiopathic arthritis,Continuing treatment,14136,True,STREAMLINED,Public,4030,2024,AUGUST
+13228F,adalimumab,Yuflyma,Injection 40 mg in 0.4 mL pre-filled syringe,juvenile idiopathic arthritis,Continuing treatment,14136,True,STREAMLINED,Public,4030,2024,AUGUST
+13228F,adalimumab,Adalicip,Injection 40 mg in 0.4 mL pre-filled syringe,juvenile idiopathic arthritis,Continuing treatment,14136,True,STREAMLINED,Public,4030,2024,AUGUST
+13315T,tocilizumab,Actemra,Concentrate for injection 80 mg in 4 mL,juvenile idiopathic arthritis,Continuing treatment,14179,True,STREAMLINED,Private,4030,2024,AUGUST
+13047Q,infliximab,Remsima SC,Solution for injection 120 mg in 1 mL pre-filled syringe,psoriatic arthritis,Continuing treatment with subcutaneous form or switching from intravenous form to subcutaneous form,,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+6397Q,infliximab,Remicade,Powder for I.V. infusion 100 mg,rheumatoid arthritis,Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months),,False,AUTHORITY_REQUIRED,Private,4030,2024,AUGUST
+6397Q,infliximab,Renflexis,Powder for I.V. infusion 100 mg,rheumatoid arthritis,Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months),,False,AUTHORITY_REQUIRED,Private,4030,2024,AUGUST
+6397Q,infliximab,Inflectra,Powder for I.V. infusion 100 mg,rheumatoid arthritis,Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months),,False,AUTHORITY_REQUIRED,Private,4030,2024,AUGUST
+6397Q,infliximab,Remicade,Powder for I.V. infusion 100 mg,rheumatoid arthritis,Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 24 months) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months) - balance of supply,,True,AUTHORITY_REQUIRED,Private,4030,2024,AUGUST
+6397Q,infliximab,Renflexis,Powder for I.V. infusion 100 mg,rheumatoid arthritis,Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 24 months) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months) - balance of supply,,True,AUTHORITY_REQUIRED,Private,4030,2024,AUGUST
+6397Q,infliximab,Inflectra,Powder for I.V. infusion 100 mg,rheumatoid arthritis,Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 24 months) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months) - balance of supply,,True,AUTHORITY_REQUIRED,Private,4030,2024,AUGUST
+6397Q,infliximab,Remicade,Powder for I.V. infusion 100 mg,rheumatoid arthritis,First continuing treatment,,False,AUTHORITY_REQUIRED,Private,4030,2024,AUGUST
+6397Q,infliximab,Renflexis,Powder for I.V. infusion 100 mg,rheumatoid arthritis,First continuing treatment,,False,AUTHORITY_REQUIRED,Private,4030,2024,AUGUST
+6397Q,infliximab,Inflectra,Powder for I.V. infusion 100 mg,rheumatoid arthritis,First continuing treatment,,False,AUTHORITY_REQUIRED,Private,4030,2024,AUGUST
+6397Q,infliximab,Remicade,Powder for I.V. infusion 100 mg,rheumatoid arthritis,Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 24 months),,False,AUTHORITY_REQUIRED,Private,4030,2024,AUGUST
+6397Q,infliximab,Renflexis,Powder for I.V. infusion 100 mg,rheumatoid arthritis,Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 24 months),,False,AUTHORITY_REQUIRED,Private,4030,2024,AUGUST
+6397Q,infliximab,Inflectra,Powder for I.V. infusion 100 mg,rheumatoid arthritis,Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 24 months),,False,AUTHORITY_REQUIRED,Private,4030,2024,AUGUST
+6397Q,infliximab,Remicade,Powder for I.V. infusion 100 mg,rheumatoid arthritis,First continuing treatment - balance of supply,,True,AUTHORITY_REQUIRED,Private,4030,2024,AUGUST
+6397Q,infliximab,Renflexis,Powder for I.V. infusion 100 mg,rheumatoid arthritis,First continuing treatment - balance of supply,,True,AUTHORITY_REQUIRED,Private,4030,2024,AUGUST
+6397Q,infliximab,Inflectra,Powder for I.V. infusion 100 mg,rheumatoid arthritis,First continuing treatment - balance of supply,,True,AUTHORITY_REQUIRED,Private,4030,2024,AUGUST
+6397Q,infliximab,Remicade,Powder for I.V. infusion 100 mg,rheumatoid arthritis,Initial treatment - Initial 1 (new patient),,False,AUTHORITY_REQUIRED,Private,4030,2024,AUGUST
+6397Q,infliximab,Renflexis,Powder for I.V. infusion 100 mg,rheumatoid arthritis,Initial treatment - Initial 1 (new patient),,False,AUTHORITY_REQUIRED,Private,4030,2024,AUGUST
+6397Q,infliximab,Inflectra,Powder for I.V. infusion 100 mg,rheumatoid arthritis,Initial treatment - Initial 1 (new patient),,False,AUTHORITY_REQUIRED,Private,4030,2024,AUGUST
+11675L,tofacitinib,Xeljanz,Tablet 5 mg,psoriatic arthritis,Continuing treatment,,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+11675L,tofacitinib,Xeljanz,Tablet 5 mg,psoriatic arthritis,Continuing treatment - balance of supply,,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+12094M,tocilizumab,Actemra ACTPen,Injection 162 mg in 0.9 mL single use pre-filled pen,juvenile idiopathic arthritis,Balance of supply for Initial treatment - Initial 1 (new patient) or Initial 2 (retrial or recommencement of treatment after a break of less than 12 months) or Initial 3 (recommencement of treatment after a break of more than 12 months) - in a patient of any weight being administered a subcutaneous form of this biological medicine,,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+12355G,adalimumab,Abrilada,Injection 40 mg in 0.8 mL pre-filled pen,juvenile idiopathic arthritis,Continuing treatment,14136,True,STREAMLINED,Public,4030,2024,AUGUST
+12355G,adalimumab,Amgevita,Injection 40 mg in 0.8 mL pre-filled pen,juvenile idiopathic arthritis,Continuing treatment,14136,True,STREAMLINED,Public,4030,2024,AUGUST
+12355G,adalimumab,Hyrimoz,Injection 40 mg in 0.8 mL pre-filled pen,juvenile idiopathic arthritis,Continuing treatment,14136,True,STREAMLINED,Public,4030,2024,AUGUST
+12355G,adalimumab,Hadlima,Injection 40 mg in 0.8 mL pre-filled pen,juvenile idiopathic arthritis,Continuing treatment,14136,True,STREAMLINED,Public,4030,2024,AUGUST
+12355G,adalimumab,Idacio,Injection 40 mg in 0.8 mL pre-filled pen,juvenile idiopathic arthritis,Continuing treatment,14136,True,STREAMLINED,Public,4030,2024,AUGUST
+13723G,infliximab,Inflectra,Powder for I.V. infusion 100 mg,rheumatoid arthritis,Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months),,True,AUTHORITY_REQUIRED,Public,4030,2024,AUGUST
+13723G,infliximab,Renflexis,Powder for I.V. infusion 100 mg,rheumatoid arthritis,Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months),,True,AUTHORITY_REQUIRED,Public,4030,2024,AUGUST
+13723G,infliximab,Inflectra,Powder for I.V. infusion 100 mg,rheumatoid arthritis,Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 24 months) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months) - balance of supply,,True,AUTHORITY_REQUIRED,Public,4030,2024,AUGUST
+13723G,infliximab,Renflexis,Powder for I.V. infusion 100 mg,rheumatoid arthritis,Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 24 months) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months) - balance of supply,,True,AUTHORITY_REQUIRED,Public,4030,2024,AUGUST
+13723G,infliximab,Inflectra,Powder for I.V. infusion 100 mg,rheumatoid arthritis,Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 24 months),,True,AUTHORITY_REQUIRED,Public,4030,2024,AUGUST
+13723G,infliximab,Renflexis,Powder for I.V. infusion 100 mg,rheumatoid arthritis,Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 24 months),,True,AUTHORITY_REQUIRED,Public,4030,2024,AUGUST
+13723G,infliximab,Inflectra,Powder for I.V. infusion 100 mg,rheumatoid arthritis,Initial treatment - Initial 1 (new patient),,True,AUTHORITY_REQUIRED,Public,4030,2024,AUGUST
+13723G,infliximab,Renflexis,Powder for I.V. infusion 100 mg,rheumatoid arthritis,Initial treatment - Initial 1 (new patient),,True,AUTHORITY_REQUIRED,Public,4030,2024,AUGUST
+13305G,tocilizumab,Actemra,Concentrate for injection 200 mg in 10 mL,juvenile idiopathic arthritis,Continuing treatment,14164,True,STREAMLINED,Public,4030,2024,AUGUST
+13735X,certolizumab pegol,Cimzia,Injection 200 mg in 1 mL single use pre-filled syringe,rheumatoid arthritis,Subsequent continuing treatment,14499,True,STREAMLINED,Any,4030,2024,AUGUST
+12775J,tocilizumab,Actemra,Concentrate for injection 80 mg in 4 mL,rheumatoid arthritis,Initial treatment - Initial 4 (Temporary listing - change of treatment from another biological medicine to tocilizumab after resolution of the critical shortage of tocilizumab),,True,AUTHORITY_REQUIRED,Public,4030,2024,AUGUST
+13704G,adalimumab,Adalicip,Injection 40 mg in 0.4 mL pre-filled syringe,rheumatoid arthritis,Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 24 months),,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+13704G,adalimumab,Yuflyma,Injection 40 mg in 0.4 mL pre-filled syringe,rheumatoid arthritis,Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 24 months),,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+13704G,adalimumab,Adalicip,Injection 40 mg in 0.4 mL pre-filled syringe,rheumatoid arthritis,Initial treatment - Initial 1 (new patient),,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+13704G,adalimumab,Yuflyma,Injection 40 mg in 0.4 mL pre-filled syringe,rheumatoid arthritis,Initial treatment - Initial 1 (new patient),,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+13704G,adalimumab,Adalicip,Injection 40 mg in 0.4 mL pre-filled syringe,rheumatoid arthritis,Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months),,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+13704G,adalimumab,Yuflyma,Injection 40 mg in 0.4 mL pre-filled syringe,rheumatoid arthritis,Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months),,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+10137M,certolizumab pegol,Cimzia,Injection 200 mg in 1 mL single use pre-filled syringe,ankylosing spondylitis,Continuing treatment,,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+10137M,certolizumab pegol,Cimzia,Injection 200 mg in 1 mL single use pre-filled syringe,ankylosing spondylitis,Continuing treatment - balance of supply,,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+5757B,infliximab,Inflectra,Powder for I.V. infusion 100 mg,rheumatoid arthritis,Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 24 months),,False,AUTHORITY_REQUIRED,Public,4030,2024,AUGUST
+5757B,infliximab,Renflexis,Powder for I.V. infusion 100 mg,rheumatoid arthritis,Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 24 months),,False,AUTHORITY_REQUIRED,Public,4030,2024,AUGUST
+5757B,infliximab,Remicade,Powder for I.V. infusion 100 mg,rheumatoid arthritis,Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 24 months),,False,AUTHORITY_REQUIRED,Public,4030,2024,AUGUST
+5757B,infliximab,Inflectra,Powder for I.V. infusion 100 mg,rheumatoid arthritis,Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 24 months) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months) - balance of supply,,True,AUTHORITY_REQUIRED,Public,4030,2024,AUGUST
+5757B,infliximab,Renflexis,Powder for I.V. infusion 100 mg,rheumatoid arthritis,Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 24 months) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months) - balance of supply,,True,AUTHORITY_REQUIRED,Public,4030,2024,AUGUST
+5757B,infliximab,Remicade,Powder for I.V. infusion 100 mg,rheumatoid arthritis,Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 24 months) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months) - balance of supply,,True,AUTHORITY_REQUIRED,Public,4030,2024,AUGUST
+5757B,infliximab,Inflectra,Powder for I.V. infusion 100 mg,rheumatoid arthritis,Initial treatment - Initial 1 (new patient),,False,AUTHORITY_REQUIRED,Public,4030,2024,AUGUST
+5757B,infliximab,Renflexis,Powder for I.V. infusion 100 mg,rheumatoid arthritis,Initial treatment - Initial 1 (new patient),,False,AUTHORITY_REQUIRED,Public,4030,2024,AUGUST
+5757B,infliximab,Remicade,Powder for I.V. infusion 100 mg,rheumatoid arthritis,Initial treatment - Initial 1 (new patient),,False,AUTHORITY_REQUIRED,Public,4030,2024,AUGUST
+5757B,infliximab,Inflectra,Powder for I.V. infusion 100 mg,rheumatoid arthritis,First continuing treatment - balance of supply,,True,AUTHORITY_REQUIRED,Public,4030,2024,AUGUST
+5757B,infliximab,Renflexis,Powder for I.V. infusion 100 mg,rheumatoid arthritis,First continuing treatment - balance of supply,,True,AUTHORITY_REQUIRED,Public,4030,2024,AUGUST
+5757B,infliximab,Remicade,Powder for I.V. infusion 100 mg,rheumatoid arthritis,First continuing treatment - balance of supply,,True,AUTHORITY_REQUIRED,Public,4030,2024,AUGUST
+5757B,infliximab,Inflectra,Powder for I.V. infusion 100 mg,rheumatoid arthritis,Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months),,False,AUTHORITY_REQUIRED,Public,4030,2024,AUGUST
+5757B,infliximab,Renflexis,Powder for I.V. infusion 100 mg,rheumatoid arthritis,Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months),,False,AUTHORITY_REQUIRED,Public,4030,2024,AUGUST
+5757B,infliximab,Remicade,Powder for I.V. infusion 100 mg,rheumatoid arthritis,Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months),,False,AUTHORITY_REQUIRED,Public,4030,2024,AUGUST
+5757B,infliximab,Inflectra,Powder for I.V. infusion 100 mg,rheumatoid arthritis,First continuing treatment,,False,AUTHORITY_REQUIRED,Public,4030,2024,AUGUST
+5757B,infliximab,Renflexis,Powder for I.V. infusion 100 mg,rheumatoid arthritis,First continuing treatment,,False,AUTHORITY_REQUIRED,Public,4030,2024,AUGUST
+5757B,infliximab,Remicade,Powder for I.V. infusion 100 mg,rheumatoid arthritis,First continuing treatment,,False,AUTHORITY_REQUIRED,Public,4030,2024,AUGUST
+9103D,adalimumab,Hyrimoz,Injection 40 mg in 0.8 mL pre-filled pen,ankylosing spondylitis,Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years) - balance of supply,,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+9103D,adalimumab,Hadlima,Injection 40 mg in 0.8 mL pre-filled pen,ankylosing spondylitis,Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years) - balance of supply,,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+9103D,adalimumab,Amgevita,Injection 40 mg in 0.8 mL pre-filled pen,ankylosing spondylitis,Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years) - balance of supply,,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+9103D,adalimumab,Idacio,Injection 40 mg in 0.8 mL pre-filled pen,ankylosing spondylitis,Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years) - balance of supply,,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+9103D,adalimumab,Abrilada,Injection 40 mg in 0.8 mL pre-filled pen,ankylosing spondylitis,Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years) - balance of supply,,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+9103D,adalimumab,Hyrimoz,Injection 40 mg in 0.8 mL pre-filled pen,ankylosing spondylitis,Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years),,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+9103D,adalimumab,Hadlima,Injection 40 mg in 0.8 mL pre-filled pen,ankylosing spondylitis,Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years),,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+9103D,adalimumab,Amgevita,Injection 40 mg in 0.8 mL pre-filled pen,ankylosing spondylitis,Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years),,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+9103D,adalimumab,Idacio,Injection 40 mg in 0.8 mL pre-filled pen,ankylosing spondylitis,Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years),,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+9103D,adalimumab,Abrilada,Injection 40 mg in 0.8 mL pre-filled pen,ankylosing spondylitis,Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years),,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+9103D,adalimumab,Hyrimoz,Injection 40 mg in 0.8 mL pre-filled pen,ankylosing spondylitis,Initial treatment - Initial 1 (new patient),,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+9103D,adalimumab,Hadlima,Injection 40 mg in 0.8 mL pre-filled pen,ankylosing spondylitis,Initial treatment - Initial 1 (new patient),,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+9103D,adalimumab,Amgevita,Injection 40 mg in 0.8 mL pre-filled pen,ankylosing spondylitis,Initial treatment - Initial 1 (new patient),,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+9103D,adalimumab,Idacio,Injection 40 mg in 0.8 mL pre-filled pen,ankylosing spondylitis,Initial treatment - Initial 1 (new patient),,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+9103D,adalimumab,Abrilada,Injection 40 mg in 0.8 mL pre-filled pen,ankylosing spondylitis,Initial treatment - Initial 1 (new patient),,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+9103D,adalimumab,Hyrimoz,Injection 40 mg in 0.8 mL pre-filled pen,ankylosing spondylitis,Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years),,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+9103D,adalimumab,Hadlima,Injection 40 mg in 0.8 mL pre-filled pen,ankylosing spondylitis,Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years),,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+9103D,adalimumab,Amgevita,Injection 40 mg in 0.8 mL pre-filled pen,ankylosing spondylitis,Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years),,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+9103D,adalimumab,Idacio,Injection 40 mg in 0.8 mL pre-filled pen,ankylosing spondylitis,Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years),,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+9103D,adalimumab,Abrilada,Injection 40 mg in 0.8 mL pre-filled pen,ankylosing spondylitis,Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years),,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+3448L,etanercept,Enbrel,Injection set containing 4 vials powder for injection 25 mg and 4 pre-filled syringes solvent 1 mL,juvenile idiopathic arthritis,Continuing Treatment - balance of supply,,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+3448L,etanercept,Enbrel,Injection set containing 4 vials powder for injection 25 mg and 4 pre-filled syringes solvent 1 mL,juvenile idiopathic arthritis,Continuing treatment,,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+11690G,tofacitinib,Xeljanz,Tablet 5 mg,psoriatic arthritis,Initial treatment - Initial 1 (new patient),,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+11690G,tofacitinib,Xeljanz,Tablet 5 mg,psoriatic arthritis,Initial treatment - Initial 2 (change or recommencement of treatment after a break in in biological medicine of less than 5 years),,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+11690G,tofacitinib,Xeljanz,Tablet 5 mg,psoriatic arthritis,Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years) - balance of supply,,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+11690G,tofacitinib,Xeljanz,Tablet 5 mg,psoriatic arthritis,Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years),,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+12329X,adalimumab,Hadlima,Injection 40 mg in 0.8 mL pre-filled pen,rheumatoid arthritis,Subsequent continuing treatment,14499,True,STREAMLINED,Any,4030,2024,AUGUST
+12329X,adalimumab,Hyrimoz,Injection 40 mg in 0.8 mL pre-filled pen,rheumatoid arthritis,Subsequent continuing treatment,14499,True,STREAMLINED,Any,4030,2024,AUGUST
+12329X,adalimumab,Amgevita,Injection 40 mg in 0.8 mL pre-filled pen,rheumatoid arthritis,Subsequent continuing treatment,14499,True,STREAMLINED,Any,4030,2024,AUGUST
+12329X,adalimumab,Abrilada,Injection 40 mg in 0.8 mL pre-filled pen,rheumatoid arthritis,Subsequent continuing treatment,14499,True,STREAMLINED,Any,4030,2024,AUGUST
+12329X,adalimumab,Idacio,Injection 40 mg in 0.8 mL pre-filled pen,rheumatoid arthritis,Subsequent continuing treatment,14499,True,STREAMLINED,Any,4030,2024,AUGUST
+12763R,tocilizumab,Actemra,Concentrate for injection 400 mg in 20 mL,rheumatoid arthritis,Initial treatment - Initial 4 (Temporary listing - change of treatment from another biological medicine to tocilizumab after resolution of the critical shortage of tocilizumab),,True,AUTHORITY_REQUIRED,Public,4030,2024,AUGUST
+14285W,adalimumab,Abrilada,Injection 20 mg in 0.4 mL pre-filled syringe,juvenile idiopathic arthritis,Continuing treatment,14107,True,STREAMLINED,Private,4030,2024,AUGUST
+13686H,adalimumab,Amgevita,Injection 40 mg in 0.8 mL pre-filled pen,rheumatoid arthritis,First continuing treatment,14567,True,STREAMLINED,Any,4030,2024,AUGUST
+13686H,adalimumab,Abrilada,Injection 40 mg in 0.8 mL pre-filled pen,rheumatoid arthritis,First continuing treatment,14567,True,STREAMLINED,Any,4030,2024,AUGUST
+13686H,adalimumab,Hadlima,Injection 40 mg in 0.8 mL pre-filled pen,rheumatoid arthritis,First continuing treatment,14567,True,STREAMLINED,Any,4030,2024,AUGUST
+13686H,adalimumab,Idacio,Injection 40 mg in 0.8 mL pre-filled pen,rheumatoid arthritis,First continuing treatment,14567,True,STREAMLINED,Any,4030,2024,AUGUST
+13686H,adalimumab,Hyrimoz,Injection 40 mg in 0.8 mL pre-filled pen,rheumatoid arthritis,First continuing treatment,14567,True,STREAMLINED,Any,4030,2024,AUGUST
+13299Y,tocilizumab,Actemra,Concentrate for injection 400 mg in 20 mL,juvenile idiopathic arthritis,Continuing treatment,14093,True,STREAMLINED,Public,4030,2024,AUGUST
+6367D,etanercept,Enbrel,Injection set containing 4 vials powder for injection 25 mg and 4 pre-filled syringes solvent 1 mL,juvenile idiopathic arthritis,Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 12 months),,True,AUTHORITY_REQUIRED,Private,4030,2024,AUGUST
+6367D,etanercept,Enbrel,Injection set containing 4 vials powder for injection 25 mg and 4 pre-filled syringes solvent 1 mL,juvenile idiopathic arthritis,Initial treatment - Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 12 months) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 12 months) - balance of supply,,True,AUTHORITY_REQUIRED,Private,4030,2024,AUGUST
+6367D,etanercept,Enbrel,Injection set containing 4 vials powder for injection 25 mg and 4 pre-filled syringes solvent 1 mL,juvenile idiopathic arthritis,Initial treatment - Initial 1 (new patient),,True,AUTHORITY_REQUIRED,Private,4030,2024,AUGUST
+6367D,etanercept,Enbrel,Injection set containing 4 vials powder for injection 25 mg and 4 pre-filled syringes solvent 1 mL,juvenile idiopathic arthritis,Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 12 months),,True,AUTHORITY_REQUIRED,Private,4030,2024,AUGUST
+13687J,etanercept,Brenzys,"Injection 50 mg in 1 mL single use auto-injector, 4",rheumatoid arthritis,Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 24 months),,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+13687J,etanercept,Brenzys,"Injection 50 mg in 1 mL single use auto-injector, 4",rheumatoid arthritis,Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 24 months) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months) - balance of supply,,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+13687J,etanercept,Brenzys,"Injection 50 mg in 1 mL single use auto-injector, 4",rheumatoid arthritis,Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months),,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+13687J,etanercept,Brenzys,"Injection 50 mg in 1 mL single use auto-injector, 4",rheumatoid arthritis,Initial treatment - Initial 1 (new patient),,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+10058J,tocilizumab,Actemra,Concentrate for injection 200 mg in 10 mL,juvenile idiopathic arthritis,Continuing treatment,,False,AUTHORITY_REQUIRED,Public,4030,2024,AUGUST
+10058J,tocilizumab,Actemra,Concentrate for injection 200 mg in 10 mL,juvenile idiopathic arthritis,Initial treatment - Initial 1 (new patient),,False,AUTHORITY_REQUIRED,Public,4030,2024,AUGUST
+10058J,tocilizumab,Actemra,Concentrate for injection 200 mg in 10 mL,juvenile idiopathic arthritis,Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months),,False,AUTHORITY_REQUIRED,Public,4030,2024,AUGUST
+10058J,tocilizumab,Actemra,Concentrate for injection 200 mg in 10 mL,juvenile idiopathic arthritis,Continuing Treatment - balance of supply,,True,AUTHORITY_REQUIRED,Public,4030,2024,AUGUST
+10058J,tocilizumab,Actemra,Concentrate for injection 200 mg in 10 mL,juvenile idiopathic arthritis,Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 24 months),,False,AUTHORITY_REQUIRED,Public,4030,2024,AUGUST
+10058J,tocilizumab,Actemra,Concentrate for injection 200 mg in 10 mL,juvenile idiopathic arthritis,Initial treatment - Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after break of less than 24 months) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months) -  balance of supply,,True,AUTHORITY_REQUIRED,Public,4030,2024,AUGUST
+12090H,tocilizumab,Actemra ACTPen,Injection 162 mg in 0.9 mL single use pre-filled pen,juvenile idiopathic arthritis,Continuing treatment in a patient weighing less than 30 kg,14084,True,STREAMLINED,Any,4030,2024,AUGUST
+14235F,adalimumab,Abrilada,Injection 20 mg in 0.4 mL pre-filled syringe,juvenile idiopathic arthritis,Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 12 months) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 12 months) - balance of supply,,True,AUTHORITY_REQUIRED,Public,4030,2024,AUGUST
+14235F,adalimumab,Abrilada,Injection 20 mg in 0.4 mL pre-filled syringe,juvenile idiopathic arthritis,Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 12 months),,True,AUTHORITY_REQUIRED,Public,4030,2024,AUGUST
+14235F,adalimumab,Abrilada,Injection 20 mg in 0.4 mL pre-filled syringe,juvenile idiopathic arthritis,Initial treatment - Initial 1 (new patient),,True,AUTHORITY_REQUIRED,Public,4030,2024,AUGUST
+14235F,adalimumab,Abrilada,Injection 20 mg in 0.4 mL pre-filled syringe,juvenile idiopathic arthritis,Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 12 months),,True,AUTHORITY_REQUIRED,Public,4030,2024,AUGUST
+10079L,tocilizumab,Actemra,Concentrate for injection 200 mg in 10 mL,juvenile idiopathic arthritis,Initial treatment - Initial 1 (new patient),,True,AUTHORITY_REQUIRED,Private,4030,2024,AUGUST
+10079L,tocilizumab,Actemra,Concentrate for injection 200 mg in 10 mL,juvenile idiopathic arthritis,Initial treatment - Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 12 months) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 12 months) - balance of supply,,True,AUTHORITY_REQUIRED,Private,4030,2024,AUGUST
+10079L,tocilizumab,Actemra,Concentrate for injection 200 mg in 10 mL,juvenile idiopathic arthritis,Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 12 months),,True,AUTHORITY_REQUIRED,Private,4030,2024,AUGUST
+10079L,tocilizumab,Actemra,Concentrate for injection 200 mg in 10 mL,juvenile idiopathic arthritis,Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 12 months),,True,AUTHORITY_REQUIRED,Private,4030,2024,AUGUST
+11202N,etanercept,Brenzys,"Injection 50 mg in 1 mL single use auto-injector, 4",psoriatic arthritis,Subsequent continuing treatment,9156,True,STREAMLINED,Any,4030,2024,AUGUST
+12566J,infliximab,Remsima SC,Solution for injection 120 mg in 1 mL pre-filled pen,rheumatoid arthritis,"Balance of supply for Initial treatment, Continuing treatment - subcutaneous form",,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+3430M,golimumab,Simponi,Injection 50 mg in 0.5 mL single use pre-filled syringe,psoriatic arthritis,Initial treatment - Initial 1 (new patient),,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+3430M,golimumab,Simponi,Injection 50 mg in 0.5 mL single use pre-filled syringe,psoriatic arthritis,Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years),,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+3430M,golimumab,Simponi,Injection 50 mg in 0.5 mL single use pre-filled syringe,psoriatic arthritis,Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years) - balance of supply,,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+3430M,golimumab,Simponi,Injection 50 mg in 0.5 mL single use pre-filled syringe,psoriatic arthritis,Initial treatment - Initial 2 (change or recommencement of treatment after a break in in biological medicine of less than 5 years),,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+8778B,etanercept,Enbrel,Injection set containing 4 vials powder for injection 25 mg and 4 pre-filled syringes solvent 1 mL,ankylosing spondylitis,Initial treatment - Initial 1 (new patient),,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+8778B,etanercept,Enbrel,Injection set containing 4 vials powder for injection 25 mg and 4 pre-filled syringes solvent 1 mL,ankylosing spondylitis,Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years),,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+8778B,etanercept,Enbrel,Injection set containing 4 vials powder for injection 25 mg and 4 pre-filled syringes solvent 1 mL,ankylosing spondylitis,Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years),,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+8778B,etanercept,Enbrel,Injection set containing 4 vials powder for injection 25 mg and 4 pre-filled syringes solvent 1 mL,ankylosing spondylitis,Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years) - balance of supply,,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+12349Y,adalimumab,Amgevita,Injection 20 mg in 0.4 mL pre-filled syringe,juvenile idiopathic arthritis,Continuing treatment,14107,True,STREAMLINED,Private,4030,2024,AUGUST
+12792G,tocilizumab,Actemra ACTPen,Injection 162 mg in 0.9 mL single use pre-filled pen,rheumatoid arthritis,Initial treatment - Initial 4 (Temporary listing - change of treatment from another biological medicine to tocilizumab after resolution of the critical shortage of tocilizumab),,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+12796L,tocilizumab,Actemra,Concentrate for injection 200 mg in 10 mL,juvenile idiopathic arthritis,Initial treatment - Initial 4 (Temporary listing - change of treatment from another biological medicine to tocilzumab after resolution of the critical shortage of tocilizumab),,True,AUTHORITY_REQUIRED,Public,4030,2024,AUGUST
+12796L,tocilizumab,Actemra,Concentrate for injection 200 mg in 10 mL,juvenile idiopathic arthritis,Initial treatment - Initial 4 (Temporary listing - change of treatment from another biological medicine to tocilizumab after resolution of the critical shortage of tocilizumab),,True,AUTHORITY_REQUIRED,Public,4030,2024,AUGUST
+13295R,etanercept,Enbrel,Injection set containing 4 vials powder for injection 25 mg and 4 pre-filled syringes solvent 1 mL,juvenile idiopathic arthritis,Continuing treatment,14155,True,STREAMLINED,Private,4030,2024,AUGUST
+11489Q,infliximab,Remicade,Powder for I.V. infusion 100 mg,ankylosing spondylitis,Subsequent continuing treatment,,False,AUTHORITY_REQUIRED,Private,4030,2024,AUGUST
+11489Q,infliximab,Inflectra,Powder for I.V. infusion 100 mg,ankylosing spondylitis,Subsequent continuing treatment,,False,AUTHORITY_REQUIRED,Private,4030,2024,AUGUST
+11489Q,infliximab,Renflexis,Powder for I.V. infusion 100 mg,ankylosing spondylitis,Subsequent continuing treatment,,False,AUTHORITY_REQUIRED,Private,4030,2024,AUGUST
+13339C,tocilizumab,Actemra,Concentrate for injection 400 mg in 20 mL,juvenile idiopathic arthritis,Continuing treatment,14164,True,STREAMLINED,Public,4030,2024,AUGUST
+13699B,golimumab,Simponi,Injection 50 mg in 0.5 mL single use pre-filled syringe,rheumatoid arthritis,Subsequent continuing treatment,14604,True,STREAMLINED,Any,4030,2024,AUGUST
+13722F,adalimumab,Abrilada,Injection 40 mg in 0.8 mL pre-filled syringe,rheumatoid arthritis,Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 24 months),,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+13722F,adalimumab,Hadlima,Injection 40 mg in 0.8 mL pre-filled syringe,rheumatoid arthritis,Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 24 months),,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+13722F,adalimumab,Idacio,Injection 40 mg in 0.8 mL pre-filled syringe,rheumatoid arthritis,Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 24 months),,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+13722F,adalimumab,Amgevita,Injection 40 mg in 0.8 mL pre-filled syringe,rheumatoid arthritis,Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 24 months),,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+13722F,adalimumab,Hyrimoz,Injection 40 mg in 0.8 mL pre-filled syringe,rheumatoid arthritis,Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 24 months),,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+13722F,adalimumab,Abrilada,Injection 40 mg in 0.8 mL pre-filled syringe,rheumatoid arthritis,Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months),,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+13722F,adalimumab,Hadlima,Injection 40 mg in 0.8 mL pre-filled syringe,rheumatoid arthritis,Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months),,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+13722F,adalimumab,Idacio,Injection 40 mg in 0.8 mL pre-filled syringe,rheumatoid arthritis,Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months),,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+13722F,adalimumab,Amgevita,Injection 40 mg in 0.8 mL pre-filled syringe,rheumatoid arthritis,Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months),,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+13722F,adalimumab,Hyrimoz,Injection 40 mg in 0.8 mL pre-filled syringe,rheumatoid arthritis,Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months),,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+13722F,adalimumab,Abrilada,Injection 40 mg in 0.8 mL pre-filled syringe,rheumatoid arthritis,Initial treatment - Initial 1 (new patient),,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+13722F,adalimumab,Hadlima,Injection 40 mg in 0.8 mL pre-filled syringe,rheumatoid arthritis,Initial treatment - Initial 1 (new patient),,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+13722F,adalimumab,Idacio,Injection 40 mg in 0.8 mL pre-filled syringe,rheumatoid arthritis,Initial treatment - Initial 1 (new patient),,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+13722F,adalimumab,Amgevita,Injection 40 mg in 0.8 mL pre-filled syringe,rheumatoid arthritis,Initial treatment - Initial 1 (new patient),,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+13722F,adalimumab,Hyrimoz,Injection 40 mg in 0.8 mL pre-filled syringe,rheumatoid arthritis,Initial treatment - Initial 1 (new patient),,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+10897M,certolizumab pegol,Cimzia,Injection 200 mg in 1 mL single use pre-filled syringe,ankylosing spondylitis,"Initial treatment - Initial 1 (new patient), Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years) - balance of supply",,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+13214L,adalimumab,Yuflyma,Injection 40 mg in 0.4 mL pre-filled pen,psoriatic arthritis,Subsequent continuing treatment,11523,True,STREAMLINED,Any,4030,2024,AUGUST
+13214L,adalimumab,Adalicip,Injection 40 mg in 0.4 mL pre-filled pen,psoriatic arthritis,Subsequent continuing treatment,11523,True,STREAMLINED,Any,4030,2024,AUGUST
+12444Y,adalimumab,Humira,Injection 40 mg in 0.4 mL pre-filled pen,juvenile idiopathic arthritis,Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 12 months) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 12 months) - balance of supply,,True,AUTHORITY_REQUIRED,Public,4030,2024,AUGUST
+12444Y,adalimumab,Adalicip,Injection 40 mg in 0.4 mL pre-filled pen,juvenile idiopathic arthritis,Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 12 months) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 12 months) - balance of supply,,True,AUTHORITY_REQUIRED,Public,4030,2024,AUGUST
+12444Y,adalimumab,Yuflyma,Injection 40 mg in 0.4 mL pre-filled pen,juvenile idiopathic arthritis,Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 12 months) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 12 months) - balance of supply,,True,AUTHORITY_REQUIRED,Public,4030,2024,AUGUST
+12444Y,adalimumab,Humira,Injection 40 mg in 0.4 mL pre-filled pen,juvenile idiopathic arthritis,Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 12 months),,True,AUTHORITY_REQUIRED,Public,4030,2024,AUGUST
+12444Y,adalimumab,Adalicip,Injection 40 mg in 0.4 mL pre-filled pen,juvenile idiopathic arthritis,Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 12 months),,True,AUTHORITY_REQUIRED,Public,4030,2024,AUGUST
+12444Y,adalimumab,Yuflyma,Injection 40 mg in 0.4 mL pre-filled pen,juvenile idiopathic arthritis,Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 12 months),,True,AUTHORITY_REQUIRED,Public,4030,2024,AUGUST
+12444Y,adalimumab,Humira,Injection 40 mg in 0.4 mL pre-filled pen,juvenile idiopathic arthritis,Initial treatment - Initial 1 (new patient),,True,AUTHORITY_REQUIRED,Public,4030,2024,AUGUST
+12444Y,adalimumab,Adalicip,Injection 40 mg in 0.4 mL pre-filled pen,juvenile idiopathic arthritis,Initial treatment - Initial 1 (new patient),,True,AUTHORITY_REQUIRED,Public,4030,2024,AUGUST
+12444Y,adalimumab,Yuflyma,Injection 40 mg in 0.4 mL pre-filled pen,juvenile idiopathic arthritis,Initial treatment - Initial 1 (new patient),,True,AUTHORITY_REQUIRED,Public,4030,2024,AUGUST
+12444Y,adalimumab,Humira,Injection 40 mg in 0.4 mL pre-filled pen,juvenile idiopathic arthritis,Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 12 months),,True,AUTHORITY_REQUIRED,Public,4030,2024,AUGUST
+12444Y,adalimumab,Adalicip,Injection 40 mg in 0.4 mL pre-filled pen,juvenile idiopathic arthritis,Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 12 months),,True,AUTHORITY_REQUIRED,Public,4030,2024,AUGUST
+12444Y,adalimumab,Yuflyma,Injection 40 mg in 0.4 mL pre-filled pen,juvenile idiopathic arthritis,Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 12 months),,True,AUTHORITY_REQUIRED,Public,4030,2024,AUGUST
+11560K,golimumab,Simponi,Injection 50 mg in 0.5 mL single use pre-filled syringe,non-radiographic axial spondyloarthritis,Initial treatment - Initial 1 (New patient),,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+11560K,golimumab,Simponi,Injection 50 mg in 0.5 mL single use pre-filled syringe,non-radiographic axial spondyloarthritis,"Initial 1 (New patient), Initial 2 (Change or re-commencement of treatment after a break in biological medicine of less than 5 years) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years) - balance of supply",,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+11560K,golimumab,Simponi,Injection 50 mg in 0.5 mL single use pre-filled syringe,non-radiographic axial spondyloarthritis,Initial treatment - Initial 2 (Change or re-commencement of treatment after a break of less than 5 years),,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+11560K,golimumab,Simponi,Injection 50 mg in 0.5 mL single use pre-filled syringe,non-radiographic axial spondyloarthritis,Initial treatment - Initial 3 (Recommencement of treatment after a break in biological medicine of more than 5 years),,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+12425Y,adalimumab,Humira,Injection 40 mg in 0.4 mL pre-filled pen,juvenile idiopathic arthritis,Continuing treatment - balance of supply,,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+12425Y,adalimumab,Yuflyma,Injection 40 mg in 0.4 mL pre-filled pen,juvenile idiopathic arthritis,Continuing treatment - balance of supply,,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+12425Y,adalimumab,Adalicip,Injection 40 mg in 0.4 mL pre-filled pen,juvenile idiopathic arthritis,Continuing treatment - balance of supply,,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+12425Y,adalimumab,Humira,Injection 40 mg in 0.4 mL pre-filled pen,juvenile idiopathic arthritis,Subsequent continuing treatment,,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+12425Y,adalimumab,Yuflyma,Injection 40 mg in 0.4 mL pre-filled pen,juvenile idiopathic arthritis,Subsequent continuing treatment,,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+12425Y,adalimumab,Adalicip,Injection 40 mg in 0.4 mL pre-filled pen,juvenile idiopathic arthritis,Subsequent continuing treatment,,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+12425Y,adalimumab,Humira,Injection 40 mg in 0.4 mL pre-filled pen,juvenile idiopathic arthritis,First continuing treatment,,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+12425Y,adalimumab,Yuflyma,Injection 40 mg in 0.4 mL pre-filled pen,juvenile idiopathic arthritis,First continuing treatment,,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+12425Y,adalimumab,Adalicip,Injection 40 mg in 0.4 mL pre-filled pen,juvenile idiopathic arthritis,First continuing treatment,,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+13725J,abatacept,Orencia,Powder for I.V. infusion 250 mg,rheumatoid arthritis,Subsequent continuing treatment,14604,True,STREAMLINED,Public,4030,2024,AUGUST
+12417M,adalimumab,Amgevita,Injection 20 mg in 0.4 mL pre-filled syringe,juvenile idiopathic arthritis,Continuing treatment,14136,True,STREAMLINED,Public,4030,2024,AUGUST
+10890E,secukinumab,Cosentyx,Injection 150 mg in 1 mL pre-filled pen,ankylosing spondylitis,Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years),,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+10890E,secukinumab,Cosentyx,Injection 150 mg in 1 mL pre-filled pen,ankylosing spondylitis,Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years),,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+10890E,secukinumab,Cosentyx,Injection 150 mg in 1 mL pre-filled pen,ankylosing spondylitis,Initial treatment - Initial 1 (new patient),,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+10892G,certolizumab pegol,Cimzia,Injection 200 mg in 1 mL single use pre-filled syringe,rheumatoid arthritis,Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 24 months) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months) - balance of supply,,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+12328W,adalimumab,Amgevita,Injection 40 mg in 0.8 mL pre-filled pen,ankylosing spondylitis,First continuing treatment,14683,True,STREAMLINED,Any,4030,2024,AUGUST
+12328W,adalimumab,Hadlima,Injection 40 mg in 0.8 mL pre-filled pen,ankylosing spondylitis,First continuing treatment,14683,True,STREAMLINED,Any,4030,2024,AUGUST
+12328W,adalimumab,Abrilada,Injection 40 mg in 0.8 mL pre-filled pen,ankylosing spondylitis,First continuing treatment,14683,True,STREAMLINED,Any,4030,2024,AUGUST
+12328W,adalimumab,Hyrimoz,Injection 40 mg in 0.8 mL pre-filled pen,ankylosing spondylitis,First continuing treatment,14683,True,STREAMLINED,Any,4030,2024,AUGUST
+12328W,adalimumab,Idacio,Injection 40 mg in 0.8 mL pre-filled pen,ankylosing spondylitis,First continuing treatment,14683,True,STREAMLINED,Any,4030,2024,AUGUST
+12328W,adalimumab,Amgevita,Injection 40 mg in 0.8 mL pre-filled pen,ankylosing spondylitis,Subsequent continuing treatment,14701,True,STREAMLINED,Any,4030,2024,AUGUST
+12328W,adalimumab,Hadlima,Injection 40 mg in 0.8 mL pre-filled pen,ankylosing spondylitis,Subsequent continuing treatment,14701,True,STREAMLINED,Any,4030,2024,AUGUST
+12328W,adalimumab,Abrilada,Injection 40 mg in 0.8 mL pre-filled pen,ankylosing spondylitis,Subsequent continuing treatment,14701,True,STREAMLINED,Any,4030,2024,AUGUST
+12328W,adalimumab,Hyrimoz,Injection 40 mg in 0.8 mL pre-filled pen,ankylosing spondylitis,Subsequent continuing treatment,14701,True,STREAMLINED,Any,4030,2024,AUGUST
+12328W,adalimumab,Idacio,Injection 40 mg in 0.8 mL pre-filled pen,ankylosing spondylitis,Subsequent continuing treatment,14701,True,STREAMLINED,Any,4030,2024,AUGUST
+12415K,adalimumab,Hadlima,Injection 40 mg in 0.8 mL pre-filled pen,psoriatic arthritis,Subsequent continuing treatment,11523,True,STREAMLINED,Any,4030,2024,AUGUST
+12415K,adalimumab,Amgevita,Injection 40 mg in 0.8 mL pre-filled pen,psoriatic arthritis,Subsequent continuing treatment,11523,True,STREAMLINED,Any,4030,2024,AUGUST
+12415K,adalimumab,Hyrimoz,Injection 40 mg in 0.8 mL pre-filled pen,psoriatic arthritis,Subsequent continuing treatment,11523,True,STREAMLINED,Any,4030,2024,AUGUST
+12415K,adalimumab,Idacio,Injection 40 mg in 0.8 mL pre-filled pen,psoriatic arthritis,Subsequent continuing treatment,11523,True,STREAMLINED,Any,4030,2024,AUGUST
+12415K,adalimumab,Abrilada,Injection 40 mg in 0.8 mL pre-filled pen,psoriatic arthritis,Subsequent continuing treatment,11523,True,STREAMLINED,Any,4030,2024,AUGUST
+12576X,infliximab,Remsima SC,Solution for injection 120 mg in 1 mL pre-filled syringe,rheumatoid arthritis,Initial treatment with the subcutaneous form where a concurrent PBS authority application for the intravenously (IV) administered formulation is being made,,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+13216N,adalimumab,Yuflyma,Injection 40 mg in 0.4 mL pre-filled syringe,psoriatic arthritis,Subsequent continuing treatment,11523,True,STREAMLINED,Any,4030,2024,AUGUST
+13216N,adalimumab,Adalicip,Injection 40 mg in 0.4 mL pre-filled syringe,psoriatic arthritis,Subsequent continuing treatment,11523,True,STREAMLINED,Any,4030,2024,AUGUST
+11748H,tocilizumab,Actemra Subcutaneous Injection,Injection 162 mg in 0.9 mL single use pre-filled syringe,juvenile idiopathic arthritis,Initial treatment - Initial 1 (new patient),,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+11748H,tocilizumab,Actemra Subcutaneous Injection,Injection 162 mg in 0.9 mL single use pre-filled syringe,juvenile idiopathic arthritis,Initial treatment - Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 12 months) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 12 months) - balance of supply,,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+11748H,tocilizumab,Actemra Subcutaneous Injection,Injection 162 mg in 0.9 mL single use pre-filled syringe,juvenile idiopathic arthritis,Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 12 months),,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+11748H,tocilizumab,Actemra Subcutaneous Injection,Injection 162 mg in 0.9 mL single use pre-filled syringe,juvenile idiopathic arthritis,Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 12 months),,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+12102Y,tocilizumab,Actemra Subcutaneous Injection,Injection 162 mg in 0.9 mL single use pre-filled syringe,juvenile idiopathic arthritis,Balance of supply for Initial treatment - Initial 1 (new patient) or Initial 2 (retrial or recommencement of treatment after a break of less than 12 months) or Initial 3 (recommencement of treatment after a break of more than 12 months) - in a patient of any weight being administered a subcutaneous form of this biological medicine,,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+13209F,adalimumab,Adalicip,Injection 40 mg in 0.4 mL pre-filled syringe,juvenile idiopathic arthritis,Subsequent continuing treatment,11604,True,STREAMLINED,Any,4030,2024,AUGUST
+13209F,adalimumab,Yuflyma,Injection 40 mg in 0.4 mL pre-filled syringe,juvenile idiopathic arthritis,Subsequent continuing treatment,11604,True,STREAMLINED,Any,4030,2024,AUGUST
+13770R,tofacitinib,Xeljanz,"Oral solution 1 mg per mL, 240 mL",juvenile idiopathic arthritis,Initial treatment - Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 12 months) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 12 months) - balance of supply,,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+13770R,tofacitinib,Xeljanz,"Oral solution 1 mg per mL, 240 mL",juvenile idiopathic arthritis,Initial treatment - Initial 1 (new patient),,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+13770R,tofacitinib,Xeljanz,"Oral solution 1 mg per mL, 240 mL",juvenile idiopathic arthritis,Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 12 months),,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+13770R,tofacitinib,Xeljanz,"Oral solution 1 mg per mL, 240 mL",juvenile idiopathic arthritis,Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 12 months),,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+11324B,certolizumab pegol,Cimzia,Solution for injection 200 mg in 1 mL pre-filled pen,psoriatic arthritis,Continuing treatment - balance of supply,,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+11324B,certolizumab pegol,Cimzia,Solution for injection 200 mg in 1 mL pre-filled pen,psoriatic arthritis,Continuing treatment,,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+13696W,tocilizumab,Actemra,Concentrate for injection 80 mg in 4 mL,rheumatoid arthritis,Subsequent continuing treatment,14485,True,STREAMLINED,Private,4030,2024,AUGUST
+10909E,certolizumab pegol,Cimzia,Injection 200 mg in 1 mL single use pre-filled syringe,psoriatic arthritis,Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years),,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+10909E,certolizumab pegol,Cimzia,Injection 200 mg in 1 mL single use pre-filled syringe,psoriatic arthritis,Initial treatment - Initial 1 (new patient),,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+10909E,certolizumab pegol,Cimzia,Injection 200 mg in 1 mL single use pre-filled syringe,psoriatic arthritis,Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years),,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+13077G,infliximab,Remsima SC,Solution for injection 120 mg in 1 mL pre-filled pen,psoriatic arthritis,Initial treatment with the subcutaneous form where a concurrent PBS authority application for the intravenously (IV) administered formulation is being made,,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+12390D,adalimumab,Humira,Injection 40 mg in 0.4 mL pre-filled pen,rheumatoid arthritis,First continuing treatment - balance of supply,,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+12390D,adalimumab,Yuflyma,Injection 40 mg in 0.4 mL pre-filled pen,rheumatoid arthritis,First continuing treatment - balance of supply,,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+12390D,adalimumab,Adalicip,Injection 40 mg in 0.4 mL pre-filled pen,rheumatoid arthritis,First continuing treatment - balance of supply,,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+12390D,adalimumab,Humira,Injection 40 mg in 0.4 mL pre-filled pen,rheumatoid arthritis,First continuing treatment,,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+12390D,adalimumab,Yuflyma,Injection 40 mg in 0.4 mL pre-filled pen,rheumatoid arthritis,First continuing treatment,,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+12390D,adalimumab,Adalicip,Injection 40 mg in 0.4 mL pre-filled pen,rheumatoid arthritis,First continuing treatment,,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+9458T,etanercept,Brenzys,"Injection 50 mg in 1 mL single use auto-injector, 4",psoriatic arthritis,First continuing treatment,,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+9458T,etanercept,Enbrel,"Injection 50 mg in 1 mL single use auto-injector, 4",psoriatic arthritis,First continuing treatment,,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+9458T,etanercept,Brenzys,"Injection 50 mg in 1 mL single use auto-injector, 4",psoriatic arthritis,Continuing treatment - balance of supply,,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+9458T,etanercept,Enbrel,"Injection 50 mg in 1 mL single use auto-injector, 4",psoriatic arthritis,Continuing treatment - balance of supply,,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+12577Y,infliximab,Remsima SC,Solution for injection 120 mg in 1 mL pre-filled pen,rheumatoid arthritis,Initial treatment with the subcutaneous form where a concurrent PBS authority application for the intravenously (IV) administered formulation is being made,,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+10900Q,secukinumab,Cosentyx,Injection 150 mg in 1 mL pre-filled pen,psoriatic arthritis,Initial treatment - Initial 1 (new patient),,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+10900Q,secukinumab,Cosentyx,Injection 150 mg in 1 mL pre-filled pen,psoriatic arthritis,Initial treatment - Initial 2 (change or recommencement of treatment after a break in in biological medicine of less than 5 years),,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+10900Q,secukinumab,Cosentyx,Injection 150 mg in 1 mL pre-filled pen,psoriatic arthritis,Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years),,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+9104E,adalimumab,Hyrimoz,Injection 40 mg in 0.8 mL pre-filled pen,ankylosing spondylitis,First continuing treatment,,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+9104E,adalimumab,Hadlima,Injection 40 mg in 0.8 mL pre-filled pen,ankylosing spondylitis,First continuing treatment,,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+9104E,adalimumab,Abrilada,Injection 40 mg in 0.8 mL pre-filled pen,ankylosing spondylitis,First continuing treatment,,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+9104E,adalimumab,Idacio,Injection 40 mg in 0.8 mL pre-filled pen,ankylosing spondylitis,First continuing treatment,,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+9104E,adalimumab,Amgevita,Injection 40 mg in 0.8 mL pre-filled pen,ankylosing spondylitis,First continuing treatment,,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+9104E,adalimumab,Hyrimoz,Injection 40 mg in 0.8 mL pre-filled pen,ankylosing spondylitis,Subsequent continuing treatment,,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+9104E,adalimumab,Hadlima,Injection 40 mg in 0.8 mL pre-filled pen,ankylosing spondylitis,Subsequent continuing treatment,,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+9104E,adalimumab,Abrilada,Injection 40 mg in 0.8 mL pre-filled pen,ankylosing spondylitis,Subsequent continuing treatment,,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+9104E,adalimumab,Idacio,Injection 40 mg in 0.8 mL pre-filled pen,ankylosing spondylitis,Subsequent continuing treatment,,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+9104E,adalimumab,Amgevita,Injection 40 mg in 0.8 mL pre-filled pen,ankylosing spondylitis,Subsequent continuing treatment,,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+9104E,adalimumab,Hyrimoz,Injection 40 mg in 0.8 mL pre-filled pen,ankylosing spondylitis,Continuing treatment - balance of supply,,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+9104E,adalimumab,Hadlima,Injection 40 mg in 0.8 mL pre-filled pen,ankylosing spondylitis,Continuing treatment - balance of supply,,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+9104E,adalimumab,Abrilada,Injection 40 mg in 0.8 mL pre-filled pen,ankylosing spondylitis,Continuing treatment - balance of supply,,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+9104E,adalimumab,Idacio,Injection 40 mg in 0.8 mL pre-filled pen,ankylosing spondylitis,Continuing treatment - balance of supply,,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+9104E,adalimumab,Amgevita,Injection 40 mg in 0.8 mL pre-filled pen,ankylosing spondylitis,Continuing treatment - balance of supply,,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+13293P,adalimumab,Humira,Injection 20 mg in 0.2 mL pre-filled syringe,juvenile idiopathic arthritis,Continuing treatment,14136,True,STREAMLINED,Public,4030,2024,AUGUST
+11521J,golimumab,Simponi,Injection 50 mg in 0.5 mL single use pre-filled pen,non-radiographic axial spondyloarthritis,Continuing treatment,,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+11521J,golimumab,Simponi,Injection 50 mg in 0.5 mL single use pre-filled pen,non-radiographic axial spondyloarthritis,Continuing treatment - balance of supply,,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+1423X,tocilizumab,Actemra,Concentrate for injection 200 mg in 10 mL,juvenile idiopathic arthritis,Initial treatment - Initial 1 (new patient),,True,AUTHORITY_REQUIRED,Private,4030,2024,AUGUST
+1423X,tocilizumab,Actemra,Concentrate for injection 200 mg in 10 mL,juvenile idiopathic arthritis,Initial treatment - Initial 3 (recommencement of treatment after a break of more than 12 months),,True,AUTHORITY_REQUIRED,Private,4030,2024,AUGUST
+1423X,tocilizumab,Actemra,Concentrate for injection 200 mg in 10 mL,juvenile idiopathic arthritis,Initial treatment - Initial 2 (retrial or recommencement of treatment after a break of less than 12 months),,True,AUTHORITY_REQUIRED,Private,4030,2024,AUGUST
+1423X,tocilizumab,Actemra,Concentrate for injection 200 mg in 10 mL,juvenile idiopathic arthritis,Balance of supply for Initial treatment - Initial 1 (new patient) or Initial 2 (retrial or recommencement of treatment after a break of less than 12 months) or Initial 3 (recommencement of treatment after a break of more than 12 months),,True,AUTHORITY_REQUIRED,Private,4030,2024,AUGUST
+11743C,tocilizumab,Actemra Subcutaneous Injection,Injection 162 mg in 0.9 mL single use pre-filled syringe,giant cell arteritis,Initial treatment,,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+12084B,tocilizumab,Actemra ACTPen,Injection 162 mg in 0.9 mL single use pre-filled pen,juvenile idiopathic arthritis,Continuing treatment in a patient weighing at least 30 kg,14088,True,STREAMLINED,Any,4030,2024,AUGUST
+13345J,tofacitinib,Xeljanz,Tablet 5 mg,ankylosing spondylitis,Continuing treatment,,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+13345J,tofacitinib,Xeljanz,Tablet 5 mg,ankylosing spondylitis,Continuing treatment - balance of supply,,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+13345J,tofacitinib,Xeljanz,Tablet 5 mg,ankylosing spondylitis,Transitioning from non-PBS to PBS-subsidised supply - Grandfather arrangements,,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+12795K,tocilizumab,Actemra,Concentrate for injection 200 mg in 10 mL,juvenile idiopathic arthritis,Initial treatment - Initial 4 (Temporary listing - change of treatment from another biological medicine to tocilzumab after resolution of the critical shortage of tocilizumab),,True,AUTHORITY_REQUIRED,Private,4030,2024,AUGUST
+12795K,tocilizumab,Actemra,Concentrate for injection 200 mg in 10 mL,juvenile idiopathic arthritis,Initial treatment - Initial 4 (Temporary listing - change of treatment from another biological medicine to tocilizumab after resolution of the critical shortage of tocilizumab),,True,AUTHORITY_REQUIRED,Private,4030,2024,AUGUST
+13685G,tocilizumab,Actemra Subcutaneous Injection,Injection 162 mg in 0.9 mL single use pre-filled syringe,rheumatoid arthritis,Subsequent continuing treatment,14499,True,STREAMLINED,Any,4030,2024,AUGUST
+13763J,adalimumab,Yuflyma,Injection 40 mg in 0.4 mL pre-filled syringe,ankylosing spondylitis,Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years),,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+13763J,adalimumab,Adalicip,Injection 40 mg in 0.4 mL pre-filled syringe,ankylosing spondylitis,Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years),,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+13763J,adalimumab,Yuflyma,Injection 40 mg in 0.4 mL pre-filled syringe,ankylosing spondylitis,Initial treatment - Initial 1 (new patient),,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+13763J,adalimumab,Adalicip,Injection 40 mg in 0.4 mL pre-filled syringe,ankylosing spondylitis,Initial treatment - Initial 1 (new patient),,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+13763J,adalimumab,Yuflyma,Injection 40 mg in 0.4 mL pre-filled syringe,ankylosing spondylitis,Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years),,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+13763J,adalimumab,Adalicip,Injection 40 mg in 0.4 mL pre-filled syringe,ankylosing spondylitis,Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years),,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+12364R,adalimumab,Humira,Injection 40 mg in 0.4 mL pre-filled syringe,juvenile idiopathic arthritis,Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months),,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+12364R,adalimumab,Adalicip,Injection 40 mg in 0.4 mL pre-filled syringe,juvenile idiopathic arthritis,Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months),,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+12364R,adalimumab,Yuflyma,Injection 40 mg in 0.4 mL pre-filled syringe,juvenile idiopathic arthritis,Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months),,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+12364R,adalimumab,Humira,Injection 40 mg in 0.4 mL pre-filled syringe,juvenile idiopathic arthritis,Initial treatment - Initial 2 (change or recommencement of treatment after break in biological medicine of less than 24 months),,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+12364R,adalimumab,Adalicip,Injection 40 mg in 0.4 mL pre-filled syringe,juvenile idiopathic arthritis,Initial treatment - Initial 2 (change or recommencement of treatment after break in biological medicine of less than 24 months),,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+12364R,adalimumab,Yuflyma,Injection 40 mg in 0.4 mL pre-filled syringe,juvenile idiopathic arthritis,Initial treatment - Initial 2 (change or recommencement of treatment after break in biological medicine of less than 24 months),,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+12364R,adalimumab,Humira,Injection 40 mg in 0.4 mL pre-filled syringe,juvenile idiopathic arthritis,Initial treatment - Initial 1 (new patient),,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+12364R,adalimumab,Adalicip,Injection 40 mg in 0.4 mL pre-filled syringe,juvenile idiopathic arthritis,Initial treatment - Initial 1 (new patient),,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+12364R,adalimumab,Yuflyma,Injection 40 mg in 0.4 mL pre-filled syringe,juvenile idiopathic arthritis,Initial treatment - Initial 1 (new patient),,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+12364R,adalimumab,Humira,Injection 40 mg in 0.4 mL pre-filled syringe,juvenile idiopathic arthritis,Initial treatment - Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after break of less than 24 months) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months) -  balance of supply,,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+12364R,adalimumab,Adalicip,Injection 40 mg in 0.4 mL pre-filled syringe,juvenile idiopathic arthritis,Initial treatment - Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after break of less than 24 months) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months) -  balance of supply,,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+12364R,adalimumab,Yuflyma,Injection 40 mg in 0.4 mL pre-filled syringe,juvenile idiopathic arthritis,Initial treatment - Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after break of less than 24 months) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months) -  balance of supply,,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+13332Q,etanercept,Enbrel,"Injections 50 mg in 1 mL single use pre-filled syringes, 4",juvenile idiopathic arthritis,Continuing treatment,14155,True,STREAMLINED,Private,4030,2024,AUGUST
+12625L,upadacitinib,Rinvoq,Tablet 15 mg,ankylosing spondylitis,Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years),,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+12625L,upadacitinib,Rinvoq,Tablet 15 mg,ankylosing spondylitis,Initial treatment - Initial 1 (new patient),,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+12625L,upadacitinib,Rinvoq,Tablet 15 mg,ankylosing spondylitis,Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years),,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+12625L,upadacitinib,Rinvoq,Tablet 15 mg,ankylosing spondylitis,Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years) - balance of supply,,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+9659J,tocilizumab,Actemra,Concentrate for injection 400 mg in 20 mL,rheumatoid arthritis,First continuing treatment - balance of supply,,True,AUTHORITY_REQUIRED,Public,4030,2024,AUGUST
+9659J,tocilizumab,Actemra,Concentrate for injection 400 mg in 20 mL,rheumatoid arthritis,Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 24 months) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months) - balance of supply,,True,AUTHORITY_REQUIRED,Public,4030,2024,AUGUST
+9659J,tocilizumab,Actemra,Concentrate for injection 400 mg in 20 mL,rheumatoid arthritis,Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months),,False,AUTHORITY_REQUIRED,Public,4030,2024,AUGUST
+9659J,tocilizumab,Actemra,Concentrate for injection 400 mg in 20 mL,rheumatoid arthritis,Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 24 months),,False,AUTHORITY_REQUIRED,Public,4030,2024,AUGUST
+9659J,tocilizumab,Actemra,Concentrate for injection 400 mg in 20 mL,rheumatoid arthritis,First continuing treatment,,False,AUTHORITY_REQUIRED,Public,4030,2024,AUGUST
+9659J,tocilizumab,Actemra,Concentrate for injection 400 mg in 20 mL,rheumatoid arthritis,Initial treatment - Initial 1 (new patient),,False,AUTHORITY_REQUIRED,Public,4030,2024,AUGUST
+11481G,infliximab,Inflectra,Powder for I.V. infusion 100 mg,rheumatoid arthritis,Subsequent continuing treatment,,False,AUTHORITY_REQUIRED,Public,4030,2024,AUGUST
+11481G,infliximab,Renflexis,Powder for I.V. infusion 100 mg,rheumatoid arthritis,Subsequent continuing treatment,,False,AUTHORITY_REQUIRED,Public,4030,2024,AUGUST
+11481G,infliximab,Remicade,Powder for I.V. infusion 100 mg,rheumatoid arthritis,Subsequent continuing treatment,,False,AUTHORITY_REQUIRED,Public,4030,2024,AUGUST
+1476Q,tocilizumab,Actemra,Concentrate for injection 80 mg in 4 mL,juvenile idiopathic arthritis,Initial treatment - Initial 1 (new patient),,True,AUTHORITY_REQUIRED,Public,4030,2024,AUGUST
+1476Q,tocilizumab,Actemra,Concentrate for injection 80 mg in 4 mL,juvenile idiopathic arthritis,Balance of supply for Initial treatment - Initial 1 (new patient) or Initial 2 (retrial or recommencement of treatment after a break of less than 12 months) or Initial 3 (recommencement of treatment after a break of more than 12 months),,True,AUTHORITY_REQUIRED,Public,4030,2024,AUGUST
+1476Q,tocilizumab,Actemra,Concentrate for injection 80 mg in 4 mL,juvenile idiopathic arthritis,Initial treatment - Initial 2 (retrial or recommencement of treatment after a break of less than 12 months),,True,AUTHORITY_REQUIRED,Public,4030,2024,AUGUST
+1476Q,tocilizumab,Actemra,Concentrate for injection 80 mg in 4 mL,juvenile idiopathic arthritis,Initial treatment - Initial 3 (recommencement of treatment after a break of more than 12 months),,True,AUTHORITY_REQUIRED,Public,4030,2024,AUGUST
+10895K,secukinumab,Cosentyx,Injection 150 mg in 1 mL pre-filled pen,psoriatic arthritis,Continuing treatment,,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+10895K,secukinumab,Cosentyx,Injection 150 mg in 1 mL pre-filled pen,psoriatic arthritis,Continuing treatment - balance of supply,,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+6496X,infliximab,Inflectra,Powder for I.V. infusion 100 mg,psoriatic arthritis,First continuing treatment,,False,AUTHORITY_REQUIRED,Private,4030,2024,AUGUST
+6496X,infliximab,Remicade,Powder for I.V. infusion 100 mg,psoriatic arthritis,First continuing treatment,,False,AUTHORITY_REQUIRED,Private,4030,2024,AUGUST
+6496X,infliximab,Renflexis,Powder for I.V. infusion 100 mg,psoriatic arthritis,First continuing treatment,,False,AUTHORITY_REQUIRED,Private,4030,2024,AUGUST
+6496X,infliximab,Inflectra,Powder for I.V. infusion 100 mg,psoriatic arthritis,Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years),,False,AUTHORITY_REQUIRED,Private,4030,2024,AUGUST
+6496X,infliximab,Remicade,Powder for I.V. infusion 100 mg,psoriatic arthritis,Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years),,False,AUTHORITY_REQUIRED,Private,4030,2024,AUGUST
+6496X,infliximab,Renflexis,Powder for I.V. infusion 100 mg,psoriatic arthritis,Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years),,False,AUTHORITY_REQUIRED,Private,4030,2024,AUGUST
+6496X,infliximab,Inflectra,Powder for I.V. infusion 100 mg,psoriatic arthritis,Initial treatment - Initial 1 (new patient),,False,AUTHORITY_REQUIRED,Private,4030,2024,AUGUST
+6496X,infliximab,Remicade,Powder for I.V. infusion 100 mg,psoriatic arthritis,Initial treatment - Initial 1 (new patient),,False,AUTHORITY_REQUIRED,Private,4030,2024,AUGUST
+6496X,infliximab,Renflexis,Powder for I.V. infusion 100 mg,psoriatic arthritis,Initial treatment - Initial 1 (new patient),,False,AUTHORITY_REQUIRED,Private,4030,2024,AUGUST
+6496X,infliximab,Inflectra,Powder for I.V. infusion 100 mg,psoriatic arthritis,Continuing treatment - balance of supply,,True,AUTHORITY_REQUIRED,Private,4030,2024,AUGUST
+6496X,infliximab,Remicade,Powder for I.V. infusion 100 mg,psoriatic arthritis,Continuing treatment - balance of supply,,True,AUTHORITY_REQUIRED,Private,4030,2024,AUGUST
+6496X,infliximab,Renflexis,Powder for I.V. infusion 100 mg,psoriatic arthritis,Continuing treatment - balance of supply,,True,AUTHORITY_REQUIRED,Private,4030,2024,AUGUST
+6496X,infliximab,Inflectra,Powder for I.V. infusion 100 mg,psoriatic arthritis,Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years),,False,AUTHORITY_REQUIRED,Private,4030,2024,AUGUST
+6496X,infliximab,Remicade,Powder for I.V. infusion 100 mg,psoriatic arthritis,Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years),,False,AUTHORITY_REQUIRED,Private,4030,2024,AUGUST
+6496X,infliximab,Renflexis,Powder for I.V. infusion 100 mg,psoriatic arthritis,Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years),,False,AUTHORITY_REQUIRED,Private,4030,2024,AUGUST
+6496X,infliximab,Inflectra,Powder for I.V. infusion 100 mg,psoriatic arthritis,Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years) - balance of supply,,True,AUTHORITY_REQUIRED,Private,4030,2024,AUGUST
+6496X,infliximab,Remicade,Powder for I.V. infusion 100 mg,psoriatic arthritis,Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years) - balance of supply,,True,AUTHORITY_REQUIRED,Private,4030,2024,AUGUST
+6496X,infliximab,Renflexis,Powder for I.V. infusion 100 mg,psoriatic arthritis,Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years) - balance of supply,,True,AUTHORITY_REQUIRED,Private,4030,2024,AUGUST
+11320T,certolizumab pegol,Cimzia,Solution for injection 200 mg in 1 mL pre-filled pen,ankylosing spondylitis,Continuing treatment - balance of supply,,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+11320T,certolizumab pegol,Cimzia,Solution for injection 200 mg in 1 mL pre-filled pen,ankylosing spondylitis,Continuing treatment,,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+11721X,tocilizumab,Actemra Subcutaneous Injection,Injection 162 mg in 0.9 mL single use pre-filled syringe,giant cell arteritis,Continuing treatment,,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+9615C,etanercept,Enbrel,"Injections 50 mg in 1 mL single use pre-filled syringes, 4",juvenile idiopathic arthritis,Initial treatment - Initial 1 (new patient),,True,AUTHORITY_REQUIRED,Private,4030,2024,AUGUST
+9615C,etanercept,Enbrel,"Injections 50 mg in 1 mL single use pre-filled syringes, 4",juvenile idiopathic arthritis,Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 12 months),,True,AUTHORITY_REQUIRED,Private,4030,2024,AUGUST
+9615C,etanercept,Enbrel,"Injections 50 mg in 1 mL single use pre-filled syringes, 4",juvenile idiopathic arthritis,Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 12 months),,True,AUTHORITY_REQUIRED,Private,4030,2024,AUGUST
+9615C,etanercept,Enbrel,"Injections 50 mg in 1 mL single use pre-filled syringes, 4",juvenile idiopathic arthritis,Initial treatment - Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 12 months) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 12 months) - balance of supply,,True,AUTHORITY_REQUIRED,Private,4030,2024,AUGUST
+9077R,adalimumab,Amgevita,Injection 40 mg in 0.8 mL pre-filled syringe,ankylosing spondylitis,Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years),,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+9077R,adalimumab,Hadlima,Injection 40 mg in 0.8 mL pre-filled syringe,ankylosing spondylitis,Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years),,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+9077R,adalimumab,Idacio,Injection 40 mg in 0.8 mL pre-filled syringe,ankylosing spondylitis,Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years),,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+9077R,adalimumab,Abrilada,Injection 40 mg in 0.8 mL pre-filled syringe,ankylosing spondylitis,Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years),,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+9077R,adalimumab,Hyrimoz,Injection 40 mg in 0.8 mL pre-filled syringe,ankylosing spondylitis,Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years),,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+9077R,adalimumab,Amgevita,Injection 40 mg in 0.8 mL pre-filled syringe,ankylosing spondylitis,Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years) - balance of supply,,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+9077R,adalimumab,Hadlima,Injection 40 mg in 0.8 mL pre-filled syringe,ankylosing spondylitis,Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years) - balance of supply,,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+9077R,adalimumab,Idacio,Injection 40 mg in 0.8 mL pre-filled syringe,ankylosing spondylitis,Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years) - balance of supply,,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+9077R,adalimumab,Abrilada,Injection 40 mg in 0.8 mL pre-filled syringe,ankylosing spondylitis,Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years) - balance of supply,,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+9077R,adalimumab,Hyrimoz,Injection 40 mg in 0.8 mL pre-filled syringe,ankylosing spondylitis,Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years) - balance of supply,,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+9077R,adalimumab,Amgevita,Injection 40 mg in 0.8 mL pre-filled syringe,ankylosing spondylitis,Initial treatment - Initial 1 (new patient),,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+9077R,adalimumab,Hadlima,Injection 40 mg in 0.8 mL pre-filled syringe,ankylosing spondylitis,Initial treatment - Initial 1 (new patient),,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+9077R,adalimumab,Idacio,Injection 40 mg in 0.8 mL pre-filled syringe,ankylosing spondylitis,Initial treatment - Initial 1 (new patient),,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+9077R,adalimumab,Abrilada,Injection 40 mg in 0.8 mL pre-filled syringe,ankylosing spondylitis,Initial treatment - Initial 1 (new patient),,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+9077R,adalimumab,Hyrimoz,Injection 40 mg in 0.8 mL pre-filled syringe,ankylosing spondylitis,Initial treatment - Initial 1 (new patient),,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+9077R,adalimumab,Amgevita,Injection 40 mg in 0.8 mL pre-filled syringe,ankylosing spondylitis,Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years),,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+9077R,adalimumab,Hadlima,Injection 40 mg in 0.8 mL pre-filled syringe,ankylosing spondylitis,Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years),,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+9077R,adalimumab,Idacio,Injection 40 mg in 0.8 mL pre-filled syringe,ankylosing spondylitis,Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years),,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+9077R,adalimumab,Abrilada,Injection 40 mg in 0.8 mL pre-filled syringe,ankylosing spondylitis,Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years),,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+9077R,adalimumab,Hyrimoz,Injection 40 mg in 0.8 mL pre-filled syringe,ankylosing spondylitis,Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years),,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+5284D,adalimumab,Idacio,Injection 40 mg in 0.8 mL pre-filled pen,juvenile idiopathic arthritis,Continuing treatment - balance of supply,,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+5284D,adalimumab,Hyrimoz,Injection 40 mg in 0.8 mL pre-filled pen,juvenile idiopathic arthritis,Continuing treatment - balance of supply,,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+5284D,adalimumab,Hadlima,Injection 40 mg in 0.8 mL pre-filled pen,juvenile idiopathic arthritis,Continuing treatment - balance of supply,,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+5284D,adalimumab,Abrilada,Injection 40 mg in 0.8 mL pre-filled pen,juvenile idiopathic arthritis,Continuing treatment - balance of supply,,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+5284D,adalimumab,Amgevita,Injection 40 mg in 0.8 mL pre-filled pen,juvenile idiopathic arthritis,Continuing treatment - balance of supply,,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+5284D,adalimumab,Idacio,Injection 40 mg in 0.8 mL pre-filled pen,juvenile idiopathic arthritis,Subsequent continuing treatment,,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+5284D,adalimumab,Hyrimoz,Injection 40 mg in 0.8 mL pre-filled pen,juvenile idiopathic arthritis,Subsequent continuing treatment,,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+5284D,adalimumab,Hadlima,Injection 40 mg in 0.8 mL pre-filled pen,juvenile idiopathic arthritis,Subsequent continuing treatment,,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+5284D,adalimumab,Abrilada,Injection 40 mg in 0.8 mL pre-filled pen,juvenile idiopathic arthritis,Subsequent continuing treatment,,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+5284D,adalimumab,Amgevita,Injection 40 mg in 0.8 mL pre-filled pen,juvenile idiopathic arthritis,Subsequent continuing treatment,,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+5284D,adalimumab,Idacio,Injection 40 mg in 0.8 mL pre-filled pen,juvenile idiopathic arthritis,First continuing treatment,,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+5284D,adalimumab,Hyrimoz,Injection 40 mg in 0.8 mL pre-filled pen,juvenile idiopathic arthritis,First continuing treatment,,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+5284D,adalimumab,Hadlima,Injection 40 mg in 0.8 mL pre-filled pen,juvenile idiopathic arthritis,First continuing treatment,,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+5284D,adalimumab,Abrilada,Injection 40 mg in 0.8 mL pre-filled pen,juvenile idiopathic arthritis,First continuing treatment,,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+5284D,adalimumab,Amgevita,Injection 40 mg in 0.8 mL pre-filled pen,juvenile idiopathic arthritis,First continuing treatment,,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+12321L,secukinumab,Cosentyx,Injection 150 mg in 1 mL pre-filled pen,non-radiographic axial spondyloarthritis,Initial treatment - Initial 1 (New patient),,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+12321L,secukinumab,Cosentyx,Injection 150 mg in 1 mL pre-filled pen,non-radiographic axial spondyloarthritis,Initial treatment - Initial 2 (Change or recommencement of treatment after a break in biological medicine of less than 5 years),,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+12321L,secukinumab,Cosentyx,Injection 150 mg in 1 mL pre-filled pen,non-radiographic axial spondyloarthritis,Initial treatment - Initial 3 (Recommencement of treatment after a break in biological medicine of more than 5 years),,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+12806B,tocilizumab,Actemra Subcutaneous Injection,Injection 162 mg in 0.9 mL single use pre-filled syringe,rheumatoid arthritis,Initial treatment - Initial 4 (Temporary listing - change of treatment from another biological medicine to tocilizumab after resolution of the critical shortage of tocilizumab),,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+9089J,etanercept,Brenzys,"Injections 50 mg in 1 mL single use pre-filled syringes, 4",rheumatoid arthritis,Initial treatment - Initial 1 (new patient),,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+9089J,etanercept,Enbrel,"Injections 50 mg in 1 mL single use pre-filled syringes, 4",rheumatoid arthritis,Initial treatment - Initial 1 (new patient),,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+9089J,etanercept,Brenzys,"Injections 50 mg in 1 mL single use pre-filled syringes, 4",rheumatoid arthritis,Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 24 months),,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+9089J,etanercept,Enbrel,"Injections 50 mg in 1 mL single use pre-filled syringes, 4",rheumatoid arthritis,Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 24 months),,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+9089J,etanercept,Brenzys,"Injections 50 mg in 1 mL single use pre-filled syringes, 4",rheumatoid arthritis,Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months),,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+9089J,etanercept,Enbrel,"Injections 50 mg in 1 mL single use pre-filled syringes, 4",rheumatoid arthritis,Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months),,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+9089J,etanercept,Brenzys,"Injections 50 mg in 1 mL single use pre-filled syringes, 4",rheumatoid arthritis,Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 24 months) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months) - balance of supply,,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+9089J,etanercept,Enbrel,"Injections 50 mg in 1 mL single use pre-filled syringes, 4",rheumatoid arthritis,Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 24 months) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months) - balance of supply,,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+5282B,adalimumab,Idacio,Injection 40 mg in 0.8 mL pre-filled pen,juvenile idiopathic arthritis,Initial treatment - Initial 1 (new patient),,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+5282B,adalimumab,Abrilada,Injection 40 mg in 0.8 mL pre-filled pen,juvenile idiopathic arthritis,Initial treatment - Initial 1 (new patient),,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+5282B,adalimumab,Hadlima,Injection 40 mg in 0.8 mL pre-filled pen,juvenile idiopathic arthritis,Initial treatment - Initial 1 (new patient),,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+5282B,adalimumab,Hyrimoz,Injection 40 mg in 0.8 mL pre-filled pen,juvenile idiopathic arthritis,Initial treatment - Initial 1 (new patient),,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+5282B,adalimumab,Amgevita,Injection 40 mg in 0.8 mL pre-filled pen,juvenile idiopathic arthritis,Initial treatment - Initial 1 (new patient),,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+5282B,adalimumab,Idacio,Injection 40 mg in 0.8 mL pre-filled pen,juvenile idiopathic arthritis,Initial treatment - Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after break of less than 24 months) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months) -  balance of supply,,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+5282B,adalimumab,Abrilada,Injection 40 mg in 0.8 mL pre-filled pen,juvenile idiopathic arthritis,Initial treatment - Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after break of less than 24 months) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months) -  balance of supply,,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+5282B,adalimumab,Hadlima,Injection 40 mg in 0.8 mL pre-filled pen,juvenile idiopathic arthritis,Initial treatment - Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after break of less than 24 months) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months) -  balance of supply,,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+5282B,adalimumab,Hyrimoz,Injection 40 mg in 0.8 mL pre-filled pen,juvenile idiopathic arthritis,Initial treatment - Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after break of less than 24 months) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months) -  balance of supply,,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+5282B,adalimumab,Amgevita,Injection 40 mg in 0.8 mL pre-filled pen,juvenile idiopathic arthritis,Initial treatment - Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after break of less than 24 months) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months) -  balance of supply,,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+5282B,adalimumab,Idacio,Injection 40 mg in 0.8 mL pre-filled pen,juvenile idiopathic arthritis,Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months),,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+5282B,adalimumab,Abrilada,Injection 40 mg in 0.8 mL pre-filled pen,juvenile idiopathic arthritis,Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months),,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+5282B,adalimumab,Hadlima,Injection 40 mg in 0.8 mL pre-filled pen,juvenile idiopathic arthritis,Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months),,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+5282B,adalimumab,Hyrimoz,Injection 40 mg in 0.8 mL pre-filled pen,juvenile idiopathic arthritis,Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months),,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+5282B,adalimumab,Amgevita,Injection 40 mg in 0.8 mL pre-filled pen,juvenile idiopathic arthritis,Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months),,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+5282B,adalimumab,Idacio,Injection 40 mg in 0.8 mL pre-filled pen,juvenile idiopathic arthritis,Initial treatment - Initial 2 (change or recommencement of treatment after break in biological medicine of less than 24 months),,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+5282B,adalimumab,Abrilada,Injection 40 mg in 0.8 mL pre-filled pen,juvenile idiopathic arthritis,Initial treatment - Initial 2 (change or recommencement of treatment after break in biological medicine of less than 24 months),,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+5282B,adalimumab,Hadlima,Injection 40 mg in 0.8 mL pre-filled pen,juvenile idiopathic arthritis,Initial treatment - Initial 2 (change or recommencement of treatment after break in biological medicine of less than 24 months),,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+5282B,adalimumab,Hyrimoz,Injection 40 mg in 0.8 mL pre-filled pen,juvenile idiopathic arthritis,Initial treatment - Initial 2 (change or recommencement of treatment after break in biological medicine of less than 24 months),,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+5282B,adalimumab,Amgevita,Injection 40 mg in 0.8 mL pre-filled pen,juvenile idiopathic arthritis,Initial treatment - Initial 2 (change or recommencement of treatment after break in biological medicine of less than 24 months),,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+11979L,upadacitinib,Rinvoq,Tablet 15 mg,rheumatoid arthritis,First Continuing treatment,,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+11979L,upadacitinib,Rinvoq,Tablet 15 mg,rheumatoid arthritis,First Continuing treatment - balance of supply,,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+9090K,etanercept,Brenzys,"Injections 50 mg in 1 mL single use pre-filled syringes, 4",rheumatoid arthritis,First continuing treatment,,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+9090K,etanercept,Enbrel,"Injections 50 mg in 1 mL single use pre-filled syringes, 4",rheumatoid arthritis,First continuing treatment,,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+9090K,etanercept,Brenzys,"Injections 50 mg in 1 mL single use pre-filled syringes, 4",rheumatoid arthritis,First continuing treatment - balance of supply,,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+9090K,etanercept,Enbrel,"Injections 50 mg in 1 mL single use pre-filled syringes, 4",rheumatoid arthritis,First continuing treatment - balance of supply,,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+12810F,tocilizumab,Actemra,Concentrate for injection 400 mg in 20 mL,juvenile idiopathic arthritis,Initial treatment - Initial 4 (Temporary listing - change of treatment from another biological medicine to tocilzumab after resolution of the critical shortage of tocilizumab),,True,AUTHORITY_REQUIRED,Private,4030,2024,AUGUST
+12810F,tocilizumab,Actemra,Concentrate for injection 400 mg in 20 mL,juvenile idiopathic arthritis,Initial treatment - Initial 4 (Temporary listing - change of treatment from another biological medicine to tocilizumab after resolution of the critical shortage of tocilizumab),,True,AUTHORITY_REQUIRED,Private,4030,2024,AUGUST
+12568L,guselkumab,Tremfya,Injection 100 mg in 1 mL single use pre-filled pen,psoriatic arthritis,Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years) - balance of supply,,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+12568L,guselkumab,Tremfya,Injection 100 mg in 1 mL single use pre-filled pen,psoriatic arthritis,Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years),,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+12568L,guselkumab,Tremfya,Injection 100 mg in 1 mL single use pre-filled pen,psoriatic arthritis,Continuing treatment - balance of supply,,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+12568L,guselkumab,Tremfya,Injection 100 mg in 1 mL single use pre-filled pen,psoriatic arthritis,Initial treatment - Initial 1 (new patient),,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+12568L,guselkumab,Tremfya,Injection 100 mg in 1 mL single use pre-filled pen,psoriatic arthritis,Continuing treatment,,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+12568L,guselkumab,Tremfya,Injection 100 mg in 1 mL single use pre-filled pen,psoriatic arthritis,Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years),,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+13706J,golimumab,Simponi,Injection 50 mg in 0.5 mL single use pre-filled pen,rheumatoid arthritis,Subsequent continuing treatment,14604,True,STREAMLINED,Any,4030,2024,AUGUST
+12761P,tocilizumab,Actemra ACTPen,Injection 162 mg in 0.9 mL single use pre-filled pen,juvenile idiopathic arthritis,Initial treatment - Initial 4 (Temporary listing - change of treatment from another biological medicine to tocilizumab after resolution of the critical shortage of tocilizumab),,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+12396K,adalimumab,Humira,Injection 40 mg in 0.4 mL pre-filled syringe,juvenile idiopathic arthritis,Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 12 months),,True,AUTHORITY_REQUIRED,Private,4030,2024,AUGUST
+12396K,adalimumab,Yuflyma,Injection 40 mg in 0.4 mL pre-filled syringe,juvenile idiopathic arthritis,Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 12 months),,True,AUTHORITY_REQUIRED,Private,4030,2024,AUGUST
+12396K,adalimumab,Adalicip,Injection 40 mg in 0.4 mL pre-filled syringe,juvenile idiopathic arthritis,Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 12 months),,True,AUTHORITY_REQUIRED,Private,4030,2024,AUGUST
+12396K,adalimumab,Humira,Injection 40 mg in 0.4 mL pre-filled syringe,juvenile idiopathic arthritis,Initial treatment - Initial 1 (new patient),,True,AUTHORITY_REQUIRED,Private,4030,2024,AUGUST
+12396K,adalimumab,Yuflyma,Injection 40 mg in 0.4 mL pre-filled syringe,juvenile idiopathic arthritis,Initial treatment - Initial 1 (new patient),,True,AUTHORITY_REQUIRED,Private,4030,2024,AUGUST
+12396K,adalimumab,Adalicip,Injection 40 mg in 0.4 mL pre-filled syringe,juvenile idiopathic arthritis,Initial treatment - Initial 1 (new patient),,True,AUTHORITY_REQUIRED,Private,4030,2024,AUGUST
+12396K,adalimumab,Humira,Injection 40 mg in 0.4 mL pre-filled syringe,juvenile idiopathic arthritis,Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 12 months),,True,AUTHORITY_REQUIRED,Private,4030,2024,AUGUST
+12396K,adalimumab,Yuflyma,Injection 40 mg in 0.4 mL pre-filled syringe,juvenile idiopathic arthritis,Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 12 months),,True,AUTHORITY_REQUIRED,Private,4030,2024,AUGUST
+12396K,adalimumab,Adalicip,Injection 40 mg in 0.4 mL pre-filled syringe,juvenile idiopathic arthritis,Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 12 months),,True,AUTHORITY_REQUIRED,Private,4030,2024,AUGUST
+12396K,adalimumab,Humira,Injection 40 mg in 0.4 mL pre-filled syringe,juvenile idiopathic arthritis,Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 12 months) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 12 months) - balance of supply,,True,AUTHORITY_REQUIRED,Private,4030,2024,AUGUST
+12396K,adalimumab,Yuflyma,Injection 40 mg in 0.4 mL pre-filled syringe,juvenile idiopathic arthritis,Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 12 months) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 12 months) - balance of supply,,True,AUTHORITY_REQUIRED,Private,4030,2024,AUGUST
+12396K,adalimumab,Adalicip,Injection 40 mg in 0.4 mL pre-filled syringe,juvenile idiopathic arthritis,Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 12 months) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 12 months) - balance of supply,,True,AUTHORITY_REQUIRED,Private,4030,2024,AUGUST
+9460X,etanercept,Brenzys,"Injection 50 mg in 1 mL single use auto-injector, 4",rheumatoid arthritis,First continuing treatment - balance of supply,,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+9460X,etanercept,Enbrel,"Injection 50 mg in 1 mL single use auto-injector, 4",rheumatoid arthritis,First continuing treatment - balance of supply,,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+9460X,etanercept,Brenzys,"Injection 50 mg in 1 mL single use auto-injector, 4",rheumatoid arthritis,First continuing treatment,,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+9460X,etanercept,Enbrel,"Injection 50 mg in 1 mL single use auto-injector, 4",rheumatoid arthritis,First continuing treatment,,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+1482B,tocilizumab,Actemra,Concentrate for injection 400 mg in 20 mL,juvenile idiopathic arthritis,Balance of supply for Initial treatment - Initial 1 (new patient) or Initial 2 (retrial or recommencement of treatment after a break of less than 12 months) or Initial 3 (recommencement of treatment after a break of more than 12 months),,True,AUTHORITY_REQUIRED,Public,4030,2024,AUGUST
+1482B,tocilizumab,Actemra,Concentrate for injection 400 mg in 20 mL,juvenile idiopathic arthritis,Initial treatment - Initial 3 (recommencement of treatment after a break of more than 12 months),,True,AUTHORITY_REQUIRED,Public,4030,2024,AUGUST
+1482B,tocilizumab,Actemra,Concentrate for injection 400 mg in 20 mL,juvenile idiopathic arthritis,Initial treatment - Initial 2 (retrial or recommencement of treatment after a break of less than 12 months),,True,AUTHORITY_REQUIRED,Public,4030,2024,AUGUST
+1482B,tocilizumab,Actemra,Concentrate for injection 400 mg in 20 mL,juvenile idiopathic arthritis,Initial treatment - Initial 1 (new patient),,True,AUTHORITY_REQUIRED,Public,4030,2024,AUGUST
+10898N,secukinumab,Cosentyx,Injection 150 mg in 1 mL pre-filled pen,psoriatic arthritis,Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years) - balance of supply,,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+9658H,tocilizumab,Actemra,Concentrate for injection 200 mg in 10 mL,rheumatoid arthritis,Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 24 months),,False,AUTHORITY_REQUIRED,Public,4030,2024,AUGUST
+9658H,tocilizumab,Actemra,Concentrate for injection 200 mg in 10 mL,rheumatoid arthritis,Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months),,False,AUTHORITY_REQUIRED,Public,4030,2024,AUGUST
+9658H,tocilizumab,Actemra,Concentrate for injection 200 mg in 10 mL,rheumatoid arthritis,First continuing treatment,,False,AUTHORITY_REQUIRED,Public,4030,2024,AUGUST
+9658H,tocilizumab,Actemra,Concentrate for injection 200 mg in 10 mL,rheumatoid arthritis,First continuing treatment - balance of supply,,True,AUTHORITY_REQUIRED,Public,4030,2024,AUGUST
+9658H,tocilizumab,Actemra,Concentrate for injection 200 mg in 10 mL,rheumatoid arthritis,Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 24 months) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months) - balance of supply,,True,AUTHORITY_REQUIRED,Public,4030,2024,AUGUST
+9658H,tocilizumab,Actemra,Concentrate for injection 200 mg in 10 mL,rheumatoid arthritis,Initial treatment - Initial 1 (new patient),,False,AUTHORITY_REQUIRED,Public,4030,2024,AUGUST
+1419Q,tocilizumab,Actemra,Concentrate for injection 80 mg in 4 mL,juvenile idiopathic arthritis,Balance of supply for Initial treatment - Initial 1 (new patient) or Initial 2 (retrial or recommencement of treatment after a break of less than 12 months) or Initial 3 (recommencement of treatment after a break of more than 12 months),,True,AUTHORITY_REQUIRED,Private,4030,2024,AUGUST
+1419Q,tocilizumab,Actemra,Concentrate for injection 80 mg in 4 mL,juvenile idiopathic arthritis,Initial treatment - Initial 1 (new patient),,True,AUTHORITY_REQUIRED,Private,4030,2024,AUGUST
+1419Q,tocilizumab,Actemra,Concentrate for injection 80 mg in 4 mL,juvenile idiopathic arthritis,Initial treatment - Initial 3 (recommencement of treatment after a break of more than 12 months),,True,AUTHORITY_REQUIRED,Private,4030,2024,AUGUST
+1419Q,tocilizumab,Actemra,Concentrate for injection 80 mg in 4 mL,juvenile idiopathic arthritis,Initial treatment - Initial 2 (retrial or recommencement of treatment after a break of less than 12 months),,True,AUTHORITY_REQUIRED,Private,4030,2024,AUGUST
+14195D,anifrolumab,Saphnelo,Solution concentrate for I.V. infusion 300 mg in 2 mL,systemic lupus erythematosus,Initial treatment,,False,AUTHORITY_REQUIRED,Public,4030,2024,AUGUST
+14195D,anifrolumab,Saphnelo,Solution concentrate for I.V. infusion 300 mg in 2 mL,systemic lupus erythematosus,Transitioning from non-PBS to PBS-subsidised supply - Grandfather arrangements,,False,AUTHORITY_REQUIRED,Public,4030,2024,AUGUST
+14195D,anifrolumab,Saphnelo,Solution concentrate for I.V. infusion 300 mg in 2 mL,systemic lupus erythematosus,Continuing or recommencement of treatment (within 12 months of a treatment break),,True,AUTHORITY_REQUIRED,Public,4030,2024,AUGUST
+10517M,tofacitinib,Xeljanz,Tablet 5 mg,rheumatoid arthritis,Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months),,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+10517M,tofacitinib,Xeljanz,Tablet 5 mg,rheumatoid arthritis,Initial treatment - Initial 1 (new patient),,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+10517M,tofacitinib,Xeljanz,Tablet 5 mg,rheumatoid arthritis,Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 24 months),,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+10517M,tofacitinib,Xeljanz,Tablet 5 mg,rheumatoid arthritis,Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 24 months) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months) - balance of supply,,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+13737B,tofacitinib,Xeljanz,Tablet 5 mg,juvenile idiopathic arthritis,Continuing treatment,14697,True,STREAMLINED,Any,4030,2024,AUGUST
+13304F,tocilizumab,Actemra,Concentrate for injection 80 mg in 4 mL,juvenile idiopathic arthritis,Continuing treatment,14093,True,STREAMLINED,Public,4030,2024,AUGUST
+11323Y,certolizumab pegol,Cimzia,Solution for injection 200 mg in 1 mL pre-filled pen,psoriatic arthritis,Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years),,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+11323Y,certolizumab pegol,Cimzia,Solution for injection 200 mg in 1 mL pre-filled pen,psoriatic arthritis,Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years),,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+11323Y,certolizumab pegol,Cimzia,Solution for injection 200 mg in 1 mL pre-filled pen,psoriatic arthritis,Initial treatment - Initial 1 (new patient),,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+8779C,etanercept,Enbrel,Injection set containing 4 vials powder for injection 25 mg and 4 pre-filled syringes solvent 1 mL,ankylosing spondylitis,First continuing treatment,,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+8779C,etanercept,Enbrel,Injection set containing 4 vials powder for injection 25 mg and 4 pre-filled syringes solvent 1 mL,ankylosing spondylitis,Continuing treatment - balance of supply,,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+5283C,adalimumab,Amgevita,Injection 40 mg in 0.8 mL pre-filled syringe,juvenile idiopathic arthritis,First continuing treatment,,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+5283C,adalimumab,Hadlima,Injection 40 mg in 0.8 mL pre-filled syringe,juvenile idiopathic arthritis,First continuing treatment,,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+5283C,adalimumab,Idacio,Injection 40 mg in 0.8 mL pre-filled syringe,juvenile idiopathic arthritis,First continuing treatment,,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+5283C,adalimumab,Hyrimoz,Injection 40 mg in 0.8 mL pre-filled syringe,juvenile idiopathic arthritis,First continuing treatment,,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+5283C,adalimumab,Abrilada,Injection 40 mg in 0.8 mL pre-filled syringe,juvenile idiopathic arthritis,First continuing treatment,,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+5283C,adalimumab,Amgevita,Injection 40 mg in 0.8 mL pre-filled syringe,juvenile idiopathic arthritis,Continuing treatment - balance of supply,,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+5283C,adalimumab,Hadlima,Injection 40 mg in 0.8 mL pre-filled syringe,juvenile idiopathic arthritis,Continuing treatment - balance of supply,,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+5283C,adalimumab,Idacio,Injection 40 mg in 0.8 mL pre-filled syringe,juvenile idiopathic arthritis,Continuing treatment - balance of supply,,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+5283C,adalimumab,Hyrimoz,Injection 40 mg in 0.8 mL pre-filled syringe,juvenile idiopathic arthritis,Continuing treatment - balance of supply,,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+5283C,adalimumab,Abrilada,Injection 40 mg in 0.8 mL pre-filled syringe,juvenile idiopathic arthritis,Continuing treatment - balance of supply,,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+5283C,adalimumab,Amgevita,Injection 40 mg in 0.8 mL pre-filled syringe,juvenile idiopathic arthritis,Subsequent continuing treatment,,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+5283C,adalimumab,Hadlima,Injection 40 mg in 0.8 mL pre-filled syringe,juvenile idiopathic arthritis,Subsequent continuing treatment,,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+5283C,adalimumab,Idacio,Injection 40 mg in 0.8 mL pre-filled syringe,juvenile idiopathic arthritis,Subsequent continuing treatment,,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+5283C,adalimumab,Hyrimoz,Injection 40 mg in 0.8 mL pre-filled syringe,juvenile idiopathic arthritis,Subsequent continuing treatment,,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+5283C,adalimumab,Abrilada,Injection 40 mg in 0.8 mL pre-filled syringe,juvenile idiopathic arthritis,Subsequent continuing treatment,,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+9101B,adalimumab,Hadlima,Injection 40 mg in 0.8 mL pre-filled pen,psoriatic arthritis,Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years),,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+9101B,adalimumab,Abrilada,Injection 40 mg in 0.8 mL pre-filled pen,psoriatic arthritis,Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years),,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+9101B,adalimumab,Hyrimoz,Injection 40 mg in 0.8 mL pre-filled pen,psoriatic arthritis,Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years),,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+9101B,adalimumab,Amgevita,Injection 40 mg in 0.8 mL pre-filled pen,psoriatic arthritis,Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years),,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+9101B,adalimumab,Idacio,Injection 40 mg in 0.8 mL pre-filled pen,psoriatic arthritis,Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years),,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+9101B,adalimumab,Hadlima,Injection 40 mg in 0.8 mL pre-filled pen,psoriatic arthritis,Initial treatment - Initial 1 (new patient),,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+9101B,adalimumab,Abrilada,Injection 40 mg in 0.8 mL pre-filled pen,psoriatic arthritis,Initial treatment - Initial 1 (new patient),,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+9101B,adalimumab,Hyrimoz,Injection 40 mg in 0.8 mL pre-filled pen,psoriatic arthritis,Initial treatment - Initial 1 (new patient),,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+9101B,adalimumab,Amgevita,Injection 40 mg in 0.8 mL pre-filled pen,psoriatic arthritis,Initial treatment - Initial 1 (new patient),,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+9101B,adalimumab,Idacio,Injection 40 mg in 0.8 mL pre-filled pen,psoriatic arthritis,Initial treatment - Initial 1 (new patient),,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+9101B,adalimumab,Hadlima,Injection 40 mg in 0.8 mL pre-filled pen,psoriatic arthritis,Initial treatment - Initial 2 (change or recommencement of treatment after a break in in biological medicine of less than 5 years),,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+9101B,adalimumab,Abrilada,Injection 40 mg in 0.8 mL pre-filled pen,psoriatic arthritis,Initial treatment - Initial 2 (change or recommencement of treatment after a break in in biological medicine of less than 5 years),,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+9101B,adalimumab,Hyrimoz,Injection 40 mg in 0.8 mL pre-filled pen,psoriatic arthritis,Initial treatment - Initial 2 (change or recommencement of treatment after a break in in biological medicine of less than 5 years),,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+9101B,adalimumab,Amgevita,Injection 40 mg in 0.8 mL pre-filled pen,psoriatic arthritis,Initial treatment - Initial 2 (change or recommencement of treatment after a break in in biological medicine of less than 5 years),,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+9101B,adalimumab,Idacio,Injection 40 mg in 0.8 mL pre-filled pen,psoriatic arthritis,Initial treatment - Initial 2 (change or recommencement of treatment after a break in in biological medicine of less than 5 years),,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+9101B,adalimumab,Hadlima,Injection 40 mg in 0.8 mL pre-filled pen,psoriatic arthritis,Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years) - balance of supply,,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+9101B,adalimumab,Abrilada,Injection 40 mg in 0.8 mL pre-filled pen,psoriatic arthritis,Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years) - balance of supply,,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+9101B,adalimumab,Hyrimoz,Injection 40 mg in 0.8 mL pre-filled pen,psoriatic arthritis,Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years) - balance of supply,,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+9101B,adalimumab,Amgevita,Injection 40 mg in 0.8 mL pre-filled pen,psoriatic arthritis,Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years) - balance of supply,,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+9101B,adalimumab,Idacio,Injection 40 mg in 0.8 mL pre-filled pen,psoriatic arthritis,Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years) - balance of supply,,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+12811G,tocilizumab,Actemra,Concentrate for injection 80 mg in 4 mL,juvenile idiopathic arthritis,Initial treatment - Initial 4 (Temporary listing - change of treatment from another biological medicine to tocilzumab after resolution of the critical shortage of tocilizumab),,True,AUTHORITY_REQUIRED,Private,4030,2024,AUGUST
+12811G,tocilizumab,Actemra,Concentrate for injection 80 mg in 4 mL,juvenile idiopathic arthritis,Initial treatment - Initial 4 (Temporary listing - change of treatment from another biological medicine to tocilizumab after resolution of the critical shortage of tocilizumab),,True,AUTHORITY_REQUIRED,Private,4030,2024,AUGUST
+13054C,infliximab,Remsima SC,Solution for injection 120 mg in 1 mL pre-filled pen,psoriatic arthritis,Continuing treatment with subcutaneous form or switching from intravenous form to subcutaneous form,,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+12429E,adalimumab,Humira,Injection 40 mg in 0.4 mL pre-filled pen,rheumatoid arthritis,Initial treatment - Initial 1 (new patient),,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+12429E,adalimumab,Yuflyma,Injection 40 mg in 0.4 mL pre-filled pen,rheumatoid arthritis,Initial treatment - Initial 1 (new patient),,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+12429E,adalimumab,Adalicip,Injection 40 mg in 0.4 mL pre-filled pen,rheumatoid arthritis,Initial treatment - Initial 1 (new patient),,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+12429E,adalimumab,Humira,Injection 40 mg in 0.4 mL pre-filled pen,rheumatoid arthritis,Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 24 months),,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+12429E,adalimumab,Yuflyma,Injection 40 mg in 0.4 mL pre-filled pen,rheumatoid arthritis,Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 24 months),,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+12429E,adalimumab,Adalicip,Injection 40 mg in 0.4 mL pre-filled pen,rheumatoid arthritis,Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 24 months),,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+12429E,adalimumab,Humira,Injection 40 mg in 0.4 mL pre-filled pen,rheumatoid arthritis,Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months),,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+12429E,adalimumab,Yuflyma,Injection 40 mg in 0.4 mL pre-filled pen,rheumatoid arthritis,Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months),,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+12429E,adalimumab,Adalicip,Injection 40 mg in 0.4 mL pre-filled pen,rheumatoid arthritis,Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months),,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+12429E,adalimumab,Humira,Injection 40 mg in 0.4 mL pre-filled pen,rheumatoid arthritis,Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 24 months) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months) - balance of supply,,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+12429E,adalimumab,Yuflyma,Injection 40 mg in 0.4 mL pre-filled pen,rheumatoid arthritis,Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 24 months) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months) - balance of supply,,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+12429E,adalimumab,Adalicip,Injection 40 mg in 0.4 mL pre-filled pen,rheumatoid arthritis,Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 24 months) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months) - balance of supply,,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+11376R,golimumab,Simponi,Injection 50 mg in 0.5 mL single use pre-filled pen,ankylosing spondylitis,Continuing treatment - balance of supply,,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+11376R,golimumab,Simponi,Injection 50 mg in 0.5 mL single use pre-filled pen,ankylosing spondylitis,Continuing treatment,,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+12554R,infliximab,Remsima SC,Solution for injection 120 mg in 1 mL pre-filled pen,rheumatoid arthritis,Continuing treatment with subcutaneous form or switching from intravenous form to subcutaneous form,,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+11208X,etanercept,Brenzys,"Injections 50 mg in 1 mL single use pre-filled syringes, 4",psoriatic arthritis,Continuing treatment - balance of supply,,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+11208X,etanercept,Enbrel,"Injections 50 mg in 1 mL single use pre-filled syringes, 4",psoriatic arthritis,Continuing treatment - balance of supply,,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+11208X,etanercept,Brenzys,"Injections 50 mg in 1 mL single use pre-filled syringes, 4",psoriatic arthritis,Subsequent continuing treatment,,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+11208X,etanercept,Enbrel,"Injections 50 mg in 1 mL single use pre-filled syringes, 4",psoriatic arthritis,Subsequent continuing treatment,,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+12363Q,adalimumab,Yuflyma,Injection 40 mg in 0.4 mL pre-filled pen,ankylosing spondylitis,Continuing treatment - balance of supply,,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+12363Q,adalimumab,Adalicip,Injection 40 mg in 0.4 mL pre-filled pen,ankylosing spondylitis,Continuing treatment - balance of supply,,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+12363Q,adalimumab,Humira,Injection 40 mg in 0.4 mL pre-filled pen,ankylosing spondylitis,Continuing treatment - balance of supply,,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+12363Q,adalimumab,Yuflyma,Injection 40 mg in 0.4 mL pre-filled pen,ankylosing spondylitis,Subsequent continuing treatment,,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+12363Q,adalimumab,Adalicip,Injection 40 mg in 0.4 mL pre-filled pen,ankylosing spondylitis,Subsequent continuing treatment,,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+12363Q,adalimumab,Humira,Injection 40 mg in 0.4 mL pre-filled pen,ankylosing spondylitis,Subsequent continuing treatment,,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+12363Q,adalimumab,Yuflyma,Injection 40 mg in 0.4 mL pre-filled pen,ankylosing spondylitis,First continuing treatment,,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+12363Q,adalimumab,Adalicip,Injection 40 mg in 0.4 mL pre-filled pen,ankylosing spondylitis,First continuing treatment,,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+12363Q,adalimumab,Humira,Injection 40 mg in 0.4 mL pre-filled pen,ankylosing spondylitis,First continuing treatment,,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+13774Y,etanercept,Brenzys,"Injection 50 mg in 1 mL single use auto-injector, 4",ankylosing spondylitis,Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years),,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+13774Y,etanercept,Brenzys,"Injection 50 mg in 1 mL single use auto-injector, 4",ankylosing spondylitis,Initial treatment - Initial 1 (new patient),,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+13774Y,etanercept,Brenzys,"Injection 50 mg in 1 mL single use auto-injector, 4",ankylosing spondylitis,Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years),,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+9663N,adalimumab,Abrilada,Injection 40 mg in 0.8 mL pre-filled pen,juvenile idiopathic arthritis,Initial treatment - Initial 1 (new patient),,True,AUTHORITY_REQUIRED,Public,4030,2024,AUGUST
+9663N,adalimumab,Hadlima,Injection 40 mg in 0.8 mL pre-filled pen,juvenile idiopathic arthritis,Initial treatment - Initial 1 (new patient),,True,AUTHORITY_REQUIRED,Public,4030,2024,AUGUST
+9663N,adalimumab,Hyrimoz,Injection 40 mg in 0.8 mL pre-filled pen,juvenile idiopathic arthritis,Initial treatment - Initial 1 (new patient),,True,AUTHORITY_REQUIRED,Public,4030,2024,AUGUST
+9663N,adalimumab,Amgevita,Injection 40 mg in 0.8 mL pre-filled pen,juvenile idiopathic arthritis,Initial treatment - Initial 1 (new patient),,True,AUTHORITY_REQUIRED,Public,4030,2024,AUGUST
+9663N,adalimumab,Idacio,Injection 40 mg in 0.8 mL pre-filled pen,juvenile idiopathic arthritis,Initial treatment - Initial 1 (new patient),,True,AUTHORITY_REQUIRED,Public,4030,2024,AUGUST
+9663N,adalimumab,Abrilada,Injection 40 mg in 0.8 mL pre-filled pen,juvenile idiopathic arthritis,Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 12 months),,True,AUTHORITY_REQUIRED,Public,4030,2024,AUGUST
+9663N,adalimumab,Hadlima,Injection 40 mg in 0.8 mL pre-filled pen,juvenile idiopathic arthritis,Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 12 months),,True,AUTHORITY_REQUIRED,Public,4030,2024,AUGUST
+9663N,adalimumab,Hyrimoz,Injection 40 mg in 0.8 mL pre-filled pen,juvenile idiopathic arthritis,Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 12 months),,True,AUTHORITY_REQUIRED,Public,4030,2024,AUGUST
+9663N,adalimumab,Amgevita,Injection 40 mg in 0.8 mL pre-filled pen,juvenile idiopathic arthritis,Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 12 months),,True,AUTHORITY_REQUIRED,Public,4030,2024,AUGUST
+9663N,adalimumab,Idacio,Injection 40 mg in 0.8 mL pre-filled pen,juvenile idiopathic arthritis,Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 12 months),,True,AUTHORITY_REQUIRED,Public,4030,2024,AUGUST
+9663N,adalimumab,Abrilada,Injection 40 mg in 0.8 mL pre-filled pen,juvenile idiopathic arthritis,Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 12 months) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 12 months) - balance of supply,,True,AUTHORITY_REQUIRED,Public,4030,2024,AUGUST
+9663N,adalimumab,Hadlima,Injection 40 mg in 0.8 mL pre-filled pen,juvenile idiopathic arthritis,Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 12 months) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 12 months) - balance of supply,,True,AUTHORITY_REQUIRED,Public,4030,2024,AUGUST
+9663N,adalimumab,Hyrimoz,Injection 40 mg in 0.8 mL pre-filled pen,juvenile idiopathic arthritis,Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 12 months) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 12 months) - balance of supply,,True,AUTHORITY_REQUIRED,Public,4030,2024,AUGUST
+9663N,adalimumab,Amgevita,Injection 40 mg in 0.8 mL pre-filled pen,juvenile idiopathic arthritis,Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 12 months) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 12 months) - balance of supply,,True,AUTHORITY_REQUIRED,Public,4030,2024,AUGUST
+9663N,adalimumab,Idacio,Injection 40 mg in 0.8 mL pre-filled pen,juvenile idiopathic arthritis,Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 12 months) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 12 months) - balance of supply,,True,AUTHORITY_REQUIRED,Public,4030,2024,AUGUST
+9663N,adalimumab,Abrilada,Injection 40 mg in 0.8 mL pre-filled pen,juvenile idiopathic arthritis,Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 12 months),,True,AUTHORITY_REQUIRED,Public,4030,2024,AUGUST
+9663N,adalimumab,Hadlima,Injection 40 mg in 0.8 mL pre-filled pen,juvenile idiopathic arthritis,Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 12 months),,True,AUTHORITY_REQUIRED,Public,4030,2024,AUGUST
+9663N,adalimumab,Hyrimoz,Injection 40 mg in 0.8 mL pre-filled pen,juvenile idiopathic arthritis,Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 12 months),,True,AUTHORITY_REQUIRED,Public,4030,2024,AUGUST
+9663N,adalimumab,Amgevita,Injection 40 mg in 0.8 mL pre-filled pen,juvenile idiopathic arthritis,Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 12 months),,True,AUTHORITY_REQUIRED,Public,4030,2024,AUGUST
+9663N,adalimumab,Idacio,Injection 40 mg in 0.8 mL pre-filled pen,juvenile idiopathic arthritis,Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 12 months),,True,AUTHORITY_REQUIRED,Public,4030,2024,AUGUST
+12040Q,certolizumab pegol,Cimzia,Injection 200 mg in 1 mL single use pre-filled syringe,non-radiographic axial spondyloarthritis,Continuing treatment - balance of supply,,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+12040Q,certolizumab pegol,Cimzia,Injection 200 mg in 1 mL single use pre-filled syringe,non-radiographic axial spondyloarthritis,"Initial 1 (New patient), Initial 2 (Change or re-commencement of treatment after a break in biological medicine of less than 5 years) or Initial 3 (Recommencement of treatment after a break in biological medicine of more than 5 years) - balance of supply",,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+13323F,tocilizumab,Actemra,Concentrate for injection 400 mg in 20 mL,juvenile idiopathic arthritis,Continuing treatment,14179,True,STREAMLINED,Private,4030,2024,AUGUST
+10077J,tocilizumab,Actemra,Concentrate for injection 80 mg in 4 mL,juvenile idiopathic arthritis,Initial treatment - Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 12 months) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 12 months) - balance of supply,,True,AUTHORITY_REQUIRED,Public,4030,2024,AUGUST
+10077J,tocilizumab,Actemra,Concentrate for injection 80 mg in 4 mL,juvenile idiopathic arthritis,Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 12 months),,True,AUTHORITY_REQUIRED,Public,4030,2024,AUGUST
+10077J,tocilizumab,Actemra,Concentrate for injection 80 mg in 4 mL,juvenile idiopathic arthritis,Initial treatment - Initial 1 (new patient),,True,AUTHORITY_REQUIRED,Public,4030,2024,AUGUST
+10077J,tocilizumab,Actemra,Concentrate for injection 80 mg in 4 mL,juvenile idiopathic arthritis,Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 12 months),,True,AUTHORITY_REQUIRED,Public,4030,2024,AUGUST
+11211C,etanercept,Brenzys,"Injections 50 mg in 1 mL single use pre-filled syringes, 4",rheumatoid arthritis,Subsequent continuing treatment,14499,True,STREAMLINED,Any,4030,2024,AUGUST
+11211C,etanercept,Enbrel,"Injections 50 mg in 1 mL single use pre-filled syringes, 4",rheumatoid arthritis,Subsequent continuing treatment,14499,True,STREAMLINED,Any,4030,2024,AUGUST
+12590P,guselkumab,Tremfya,Injection 100 mg in 1 mL single use pre-filled syringe,psoriatic arthritis,Continuing treatment - balance of supply,,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+12590P,guselkumab,Tremfya,Injection 100 mg in 1 mL single use pre-filled syringe,psoriatic arthritis,Initial treatment - Initial 1 (new patient),,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+12590P,guselkumab,Tremfya,Injection 100 mg in 1 mL single use pre-filled syringe,psoriatic arthritis,Continuing treatment,,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+12590P,guselkumab,Tremfya,Injection 100 mg in 1 mL single use pre-filled syringe,psoriatic arthritis,Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years),,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+12590P,guselkumab,Tremfya,Injection 100 mg in 1 mL single use pre-filled syringe,psoriatic arthritis,Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years),,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+12590P,guselkumab,Tremfya,Injection 100 mg in 1 mL single use pre-filled syringe,psoriatic arthritis,Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years) - balance of supply,,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+12099T,tocilizumab,Actemra Subcutaneous Injection,Injection 162 mg in 0.9 mL single use pre-filled syringe,juvenile idiopathic arthritis,Continuing treatment in a patient weighing at least 30 kg,14088,True,STREAMLINED,Any,4030,2024,AUGUST
+11204Q,etanercept,Enbrel,Injection set containing 4 vials powder for injection 25 mg and 4 pre-filled syringes solvent 1 mL,ankylosing spondylitis,Subsequent continuing treatment,,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+12435L,adalimumab,Amgevita,Injection 20 mg in 0.4 mL pre-filled syringe,juvenile idiopathic arthritis,Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 12 months),,True,AUTHORITY_REQUIRED,Public,4030,2024,AUGUST
+12435L,adalimumab,Amgevita,Injection 20 mg in 0.4 mL pre-filled syringe,juvenile idiopathic arthritis,Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 12 months),,True,AUTHORITY_REQUIRED,Public,4030,2024,AUGUST
+12435L,adalimumab,Amgevita,Injection 20 mg in 0.4 mL pre-filled syringe,juvenile idiopathic arthritis,Initial treatment - Initial 1 (new patient),,True,AUTHORITY_REQUIRED,Public,4030,2024,AUGUST
+12435L,adalimumab,Amgevita,Injection 20 mg in 0.4 mL pre-filled syringe,juvenile idiopathic arthritis,Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 12 months) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 12 months) - balance of supply,,True,AUTHORITY_REQUIRED,Public,4030,2024,AUGUST
+9455P,etanercept,Brenzys,"Injection 50 mg in 1 mL single use auto-injector, 4",ankylosing spondylitis,Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years) - balance of supply,,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+9455P,etanercept,Enbrel,"Injection 50 mg in 1 mL single use auto-injector, 4",ankylosing spondylitis,Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years) - balance of supply,,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+9455P,etanercept,Brenzys,"Injection 50 mg in 1 mL single use auto-injector, 4",ankylosing spondylitis,Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years),,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+9455P,etanercept,Enbrel,"Injection 50 mg in 1 mL single use auto-injector, 4",ankylosing spondylitis,Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years),,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+9455P,etanercept,Brenzys,"Injection 50 mg in 1 mL single use auto-injector, 4",ankylosing spondylitis,Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years),,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+9455P,etanercept,Enbrel,"Injection 50 mg in 1 mL single use auto-injector, 4",ankylosing spondylitis,Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years),,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+9455P,etanercept,Brenzys,"Injection 50 mg in 1 mL single use auto-injector, 4",ankylosing spondylitis,Initial treatment - Initial 1 (new patient),,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+9455P,etanercept,Enbrel,"Injection 50 mg in 1 mL single use auto-injector, 4",ankylosing spondylitis,Initial treatment - Initial 1 (new patient),,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+12648Q,upadacitinib,Rinvoq,Tablet 15 mg,psoriatic arthritis,Continuing treatment,,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+12648Q,upadacitinib,Rinvoq,Tablet 15 mg,psoriatic arthritis,Continuing treatment - balance of supply,,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+10238W,certolizumab pegol,Cimzia,Injection 200 mg in 1 mL single use pre-filled syringe,psoriatic arthritis,Continuing treatment - balance of supply,,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+10238W,certolizumab pegol,Cimzia,Injection 200 mg in 1 mL single use pre-filled syringe,psoriatic arthritis,Continuing treatment,,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+13698Y,etanercept,Brenzys,"Injections 50 mg in 1 mL single use pre-filled syringes, 4",rheumatoid arthritis,Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 24 months),,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+13698Y,etanercept,Brenzys,"Injections 50 mg in 1 mL single use pre-filled syringes, 4",rheumatoid arthritis,Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 24 months) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months) - balance of supply,,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+13698Y,etanercept,Brenzys,"Injections 50 mg in 1 mL single use pre-filled syringes, 4",rheumatoid arthritis,Initial treatment - Initial 1 (new patient),,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+13698Y,etanercept,Brenzys,"Injections 50 mg in 1 mL single use pre-filled syringes, 4",rheumatoid arthritis,Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months),,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+13738C,tofacitinib,Xeljanz,"Oral solution 1 mg per mL, 240 mL",juvenile idiopathic arthritis,Continuing treatment,14697,True,STREAMLINED,Any,4030,2024,AUGUST
+13684F,tocilizumab,Actemra,Concentrate for injection 200 mg in 10 mL,rheumatoid arthritis,Subsequent continuing treatment,14621,True,STREAMLINED,Public,4030,2024,AUGUST
+13226D,adalimumab,Adalicip,Injection 40 mg in 0.4 mL pre-filled pen,ankylosing spondylitis,First continuing treatment,14683,True,STREAMLINED,Any,4030,2024,AUGUST
+13226D,adalimumab,Yuflyma,Injection 40 mg in 0.4 mL pre-filled pen,ankylosing spondylitis,First continuing treatment,14683,True,STREAMLINED,Any,4030,2024,AUGUST
+13226D,adalimumab,Adalicip,Injection 40 mg in 0.4 mL pre-filled pen,ankylosing spondylitis,Subsequent continuing treatment,14701,True,STREAMLINED,Any,4030,2024,AUGUST
+13226D,adalimumab,Yuflyma,Injection 40 mg in 0.4 mL pre-filled pen,ankylosing spondylitis,Subsequent continuing treatment,14701,True,STREAMLINED,Any,4030,2024,AUGUST
+12335F,adalimumab,Yuflyma,Injection 40 mg in 0.4 mL pre-filled pen,juvenile idiopathic arthritis,Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 12 months),,True,AUTHORITY_REQUIRED,Private,4030,2024,AUGUST
+12335F,adalimumab,Adalicip,Injection 40 mg in 0.4 mL pre-filled pen,juvenile idiopathic arthritis,Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 12 months),,True,AUTHORITY_REQUIRED,Private,4030,2024,AUGUST
+12335F,adalimumab,Humira,Injection 40 mg in 0.4 mL pre-filled pen,juvenile idiopathic arthritis,Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 12 months),,True,AUTHORITY_REQUIRED,Private,4030,2024,AUGUST
+12335F,adalimumab,Yuflyma,Injection 40 mg in 0.4 mL pre-filled pen,juvenile idiopathic arthritis,Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 12 months),,True,AUTHORITY_REQUIRED,Private,4030,2024,AUGUST
+12335F,adalimumab,Adalicip,Injection 40 mg in 0.4 mL pre-filled pen,juvenile idiopathic arthritis,Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 12 months),,True,AUTHORITY_REQUIRED,Private,4030,2024,AUGUST
+12335F,adalimumab,Humira,Injection 40 mg in 0.4 mL pre-filled pen,juvenile idiopathic arthritis,Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 12 months),,True,AUTHORITY_REQUIRED,Private,4030,2024,AUGUST
+12335F,adalimumab,Yuflyma,Injection 40 mg in 0.4 mL pre-filled pen,juvenile idiopathic arthritis,Initial treatment - Initial 1 (new patient),,True,AUTHORITY_REQUIRED,Private,4030,2024,AUGUST
+12335F,adalimumab,Adalicip,Injection 40 mg in 0.4 mL pre-filled pen,juvenile idiopathic arthritis,Initial treatment - Initial 1 (new patient),,True,AUTHORITY_REQUIRED,Private,4030,2024,AUGUST
+12335F,adalimumab,Humira,Injection 40 mg in 0.4 mL pre-filled pen,juvenile idiopathic arthritis,Initial treatment - Initial 1 (new patient),,True,AUTHORITY_REQUIRED,Private,4030,2024,AUGUST
+12335F,adalimumab,Yuflyma,Injection 40 mg in 0.4 mL pre-filled pen,juvenile idiopathic arthritis,Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 12 months) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 12 months) - balance of supply,,True,AUTHORITY_REQUIRED,Private,4030,2024,AUGUST
+12335F,adalimumab,Adalicip,Injection 40 mg in 0.4 mL pre-filled pen,juvenile idiopathic arthritis,Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 12 months) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 12 months) - balance of supply,,True,AUTHORITY_REQUIRED,Private,4030,2024,AUGUST
+12335F,adalimumab,Humira,Injection 40 mg in 0.4 mL pre-filled pen,juvenile idiopathic arthritis,Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 12 months) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 12 months) - balance of supply,,True,AUTHORITY_REQUIRED,Private,4030,2024,AUGUST
+5733R,etanercept,Enbrel,"Injections 50 mg in 1 mL single use pre-filled syringes, 4",juvenile idiopathic arthritis,Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 12 months),,True,AUTHORITY_REQUIRED,Public,4030,2024,AUGUST
+5733R,etanercept,Enbrel,"Injections 50 mg in 1 mL single use pre-filled syringes, 4",juvenile idiopathic arthritis,Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 12 months),,True,AUTHORITY_REQUIRED,Public,4030,2024,AUGUST
+5733R,etanercept,Enbrel,"Injections 50 mg in 1 mL single use pre-filled syringes, 4",juvenile idiopathic arthritis,Initial treatment - Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 12 months) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 12 months) - balance of supply,,True,AUTHORITY_REQUIRED,Public,4030,2024,AUGUST
+5733R,etanercept,Enbrel,"Injections 50 mg in 1 mL single use pre-filled syringes, 4",juvenile idiopathic arthritis,Initial treatment - Initial 1 (new patient),,True,AUTHORITY_REQUIRED,Public,4030,2024,AUGUST
+1481Y,tocilizumab,Actemra,Concentrate for injection 200 mg in 10 mL,juvenile idiopathic arthritis,Balance of supply for Initial treatment - Initial 1 (new patient) or Initial 2 (retrial or recommencement of treatment after a break of less than 12 months) or Initial 3 (recommencement of treatment after a break of more than 12 months),,True,AUTHORITY_REQUIRED,Public,4030,2024,AUGUST
+1481Y,tocilizumab,Actemra,Concentrate for injection 200 mg in 10 mL,juvenile idiopathic arthritis,Initial treatment - Initial 1 (new patient),,True,AUTHORITY_REQUIRED,Public,4030,2024,AUGUST
+1481Y,tocilizumab,Actemra,Concentrate for injection 200 mg in 10 mL,juvenile idiopathic arthritis,Initial treatment - Initial 2 (retrial or recommencement of treatment after a break of less than 12 months),,True,AUTHORITY_REQUIRED,Public,4030,2024,AUGUST
+1481Y,tocilizumab,Actemra,Concentrate for injection 200 mg in 10 mL,juvenile idiopathic arthritis,Initial treatment - Initial 3 (recommencement of treatment after a break of more than 12 months),,True,AUTHORITY_REQUIRED,Public,4030,2024,AUGUST
+12624K,upadacitinib,Rinvoq,Tablet 15 mg,psoriatic arthritis,Initial treatment - Initial 2 (change or recommencement of treatment after a break in in biological medicine of less than 5 years),,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+12624K,upadacitinib,Rinvoq,Tablet 15 mg,psoriatic arthritis,Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years),,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+12624K,upadacitinib,Rinvoq,Tablet 15 mg,psoriatic arthritis,Initial treatment - Initial 1 (new patient),,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+12624K,upadacitinib,Rinvoq,Tablet 15 mg,psoriatic arthritis,Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years) - balance of supply,,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+11437Y,baricitinib,Olumiant,Tablet 2 mg,rheumatoid arthritis,Initial treatment - Initial 1 (new patient),,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+11437Y,baricitinib,Olumiant,Tablet 2 mg,rheumatoid arthritis,Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 24 months),,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+11437Y,baricitinib,Olumiant,Tablet 2 mg,rheumatoid arthritis,Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months),,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+11437Y,baricitinib,Olumiant,Tablet 2 mg,rheumatoid arthritis,Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 24 months) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months) - balance of supply,,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+11565Q,tocilizumab,Actemra ACTPen,Injection 162 mg in 0.9 mL single use pre-filled pen,rheumatoid arthritis,Initial treatment - Initial 1 (new patient),,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+11565Q,tocilizumab,Actemra ACTPen,Injection 162 mg in 0.9 mL single use pre-filled pen,rheumatoid arthritis,Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 24 months),,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+11565Q,tocilizumab,Actemra ACTPen,Injection 162 mg in 0.9 mL single use pre-filled pen,rheumatoid arthritis,Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months),,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+11565Q,tocilizumab,Actemra ACTPen,Injection 162 mg in 0.9 mL single use pre-filled pen,rheumatoid arthritis,Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 24 months) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months) - balance of supply,,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+4284L,infliximab,Remicade,Powder for I.V. infusion 100 mg,rheumatoid arthritis,Initial treatment,,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+4284L,infliximab,Remicade,Powder for I.V. infusion 100 mg,rheumatoid arthritis,Continuing treatment,,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+12105D,tocilizumab,Actemra Subcutaneous Injection,Injection 162 mg in 0.9 mL single use pre-filled syringe,juvenile idiopathic arthritis,Initial treatment - Initial 3 (recommencement of a new treatment cycle after a break of more than 12 months in a patient weighing less than 30 kg),,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+12105D,tocilizumab,Actemra Subcutaneous Injection,Injection 162 mg in 0.9 mL single use pre-filled syringe,juvenile idiopathic arthritis,Initial treatment - Initial 1 (new patient weighing less than 30 kg),,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+12105D,tocilizumab,Actemra Subcutaneous Injection,Injection 162 mg in 0.9 mL single use pre-filled syringe,juvenile idiopathic arthritis,Initial treatment - Initial 2 (retrial or recommencement of treatment after a break of less than 12 months in a patient weighing less than 30 kg),,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+12384T,adalimumab,Idacio,Injection 40 mg in 0.8 mL pre-filled syringe,juvenile idiopathic arthritis,Continuing treatment,14107,True,STREAMLINED,Private,4030,2024,AUGUST
+12384T,adalimumab,Amgevita,Injection 40 mg in 0.8 mL pre-filled syringe,juvenile idiopathic arthritis,Continuing treatment,14107,True,STREAMLINED,Private,4030,2024,AUGUST
+12384T,adalimumab,Hyrimoz,Injection 40 mg in 0.8 mL pre-filled syringe,juvenile idiopathic arthritis,Continuing treatment,14107,True,STREAMLINED,Private,4030,2024,AUGUST
+12384T,adalimumab,Hadlima,Injection 40 mg in 0.8 mL pre-filled syringe,juvenile idiopathic arthritis,Continuing treatment,14107,True,STREAMLINED,Private,4030,2024,AUGUST
+12384T,adalimumab,Abrilada,Injection 40 mg in 0.8 mL pre-filled syringe,juvenile idiopathic arthritis,Continuing treatment,14107,True,STREAMLINED,Private,4030,2024,AUGUST
+3446J,etanercept,Enbrel,"Injections 50 mg in 1 mL single use pre-filled syringes, 4",juvenile idiopathic arthritis,Initial treatment - Initial 1 (new patient),,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+3446J,etanercept,Enbrel,"Injections 50 mg in 1 mL single use pre-filled syringes, 4",juvenile idiopathic arthritis,Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 24 months),,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+3446J,etanercept,Enbrel,"Injections 50 mg in 1 mL single use pre-filled syringes, 4",juvenile idiopathic arthritis,Initial treatment - Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after break of less than 24 months) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months) -  balance of supply,,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+3446J,etanercept,Enbrel,"Injections 50 mg in 1 mL single use pre-filled syringes, 4",juvenile idiopathic arthritis,Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months),,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+11744D,tocilizumab,Actemra ACTPen,Injection 162 mg in 0.9 mL single use pre-filled pen,giant cell arteritis,Initial treatment,,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+11486M,infliximab,Inflectra,Powder for I.V. infusion 100 mg,ankylosing spondylitis,First continuing treatment,14683,True,STREAMLINED,Public,4030,2024,AUGUST
+11486M,infliximab,Renflexis,Powder for I.V. infusion 100 mg,ankylosing spondylitis,First continuing treatment,14683,True,STREAMLINED,Public,4030,2024,AUGUST
+11486M,infliximab,Inflectra,Powder for I.V. infusion 100 mg,ankylosing spondylitis,Subsequent continuing treatment,14701,True,STREAMLINED,Public,4030,2024,AUGUST
+11486M,infliximab,Renflexis,Powder for I.V. infusion 100 mg,ankylosing spondylitis,Subsequent continuing treatment,14701,True,STREAMLINED,Public,4030,2024,AUGUST
+11734N,tocilizumab,Actemra ACTPen,Injection 162 mg in 0.9 mL single use pre-filled pen,juvenile idiopathic arthritis,Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 12 months),,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+11734N,tocilizumab,Actemra ACTPen,Injection 162 mg in 0.9 mL single use pre-filled pen,juvenile idiopathic arthritis,Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 12 months),,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+11734N,tocilizumab,Actemra ACTPen,Injection 162 mg in 0.9 mL single use pre-filled pen,juvenile idiopathic arthritis,Initial treatment - Initial 1 (new patient),,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+11734N,tocilizumab,Actemra ACTPen,Injection 162 mg in 0.9 mL single use pre-filled pen,juvenile idiopathic arthritis,Initial treatment - Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 12 months) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 12 months) - balance of supply,,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+12297F,secukinumab,Cosentyx,Injection 150 mg in 1 mL pre-filled pen,non-radiographic axial spondyloarthritis,"Initial 1 (New patient), Initial 2 (Change or recommencement of treatment after a break in biological medicine of less than 5 years) or Initial 3 (Recommencement of treatment after a break in biological medicine of more than 5 years) - balance of supply",,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+12297F,secukinumab,Cosentyx,Injection 150 mg in 1 mL pre-filled pen,non-radiographic axial spondyloarthritis,Continuing treatment - balance of supply,,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+14125K,upadacitinib,Rinvoq,Tablet 15 mg,rheumatoid arthritis,Subsequent continuing treatment,14499,True,STREAMLINED,Any,4030,2024,AUGUST
+9100Y,adalimumab,Hadlima,Injection 40 mg in 0.8 mL pre-filled pen,rheumatoid arthritis,First continuing treatment,,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+9100Y,adalimumab,Hyrimoz,Injection 40 mg in 0.8 mL pre-filled pen,rheumatoid arthritis,First continuing treatment,,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+9100Y,adalimumab,Idacio,Injection 40 mg in 0.8 mL pre-filled pen,rheumatoid arthritis,First continuing treatment,,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+9100Y,adalimumab,Abrilada,Injection 40 mg in 0.8 mL pre-filled pen,rheumatoid arthritis,First continuing treatment,,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+9100Y,adalimumab,Amgevita,Injection 40 mg in 0.8 mL pre-filled pen,rheumatoid arthritis,First continuing treatment,,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+9100Y,adalimumab,Hadlima,Injection 40 mg in 0.8 mL pre-filled pen,rheumatoid arthritis,First continuing treatment - balance of supply,,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+9100Y,adalimumab,Hyrimoz,Injection 40 mg in 0.8 mL pre-filled pen,rheumatoid arthritis,First continuing treatment - balance of supply,,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+9100Y,adalimumab,Idacio,Injection 40 mg in 0.8 mL pre-filled pen,rheumatoid arthritis,First continuing treatment - balance of supply,,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+9100Y,adalimumab,Abrilada,Injection 40 mg in 0.8 mL pre-filled pen,rheumatoid arthritis,First continuing treatment - balance of supply,,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+9100Y,adalimumab,Amgevita,Injection 40 mg in 0.8 mL pre-filled pen,rheumatoid arthritis,First continuing treatment - balance of supply,,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+10904X,certolizumab pegol,Cimzia,Injection 200 mg in 1 mL single use pre-filled syringe,ankylosing spondylitis,Initial treatment - Initial 1 (new patient),,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+10904X,certolizumab pegol,Cimzia,Injection 200 mg in 1 mL single use pre-filled syringe,ankylosing spondylitis,Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years),,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+10904X,certolizumab pegol,Cimzia,Injection 200 mg in 1 mL single use pre-filled syringe,ankylosing spondylitis,Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years),,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+9680L,adalimumab,Amgevita,Injection 40 mg in 0.8 mL pre-filled pen,juvenile idiopathic arthritis,Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 12 months),,True,AUTHORITY_REQUIRED,Private,4030,2024,AUGUST
+9680L,adalimumab,Abrilada,Injection 40 mg in 0.8 mL pre-filled pen,juvenile idiopathic arthritis,Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 12 months),,True,AUTHORITY_REQUIRED,Private,4030,2024,AUGUST
+9680L,adalimumab,Hadlima,Injection 40 mg in 0.8 mL pre-filled pen,juvenile idiopathic arthritis,Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 12 months),,True,AUTHORITY_REQUIRED,Private,4030,2024,AUGUST
+9680L,adalimumab,Hyrimoz,Injection 40 mg in 0.8 mL pre-filled pen,juvenile idiopathic arthritis,Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 12 months),,True,AUTHORITY_REQUIRED,Private,4030,2024,AUGUST
+9680L,adalimumab,Idacio,Injection 40 mg in 0.8 mL pre-filled pen,juvenile idiopathic arthritis,Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 12 months),,True,AUTHORITY_REQUIRED,Private,4030,2024,AUGUST
+9680L,adalimumab,Amgevita,Injection 40 mg in 0.8 mL pre-filled pen,juvenile idiopathic arthritis,Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 12 months) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 12 months) - balance of supply,,True,AUTHORITY_REQUIRED,Private,4030,2024,AUGUST
+9680L,adalimumab,Abrilada,Injection 40 mg in 0.8 mL pre-filled pen,juvenile idiopathic arthritis,Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 12 months) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 12 months) - balance of supply,,True,AUTHORITY_REQUIRED,Private,4030,2024,AUGUST
+9680L,adalimumab,Hadlima,Injection 40 mg in 0.8 mL pre-filled pen,juvenile idiopathic arthritis,Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 12 months) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 12 months) - balance of supply,,True,AUTHORITY_REQUIRED,Private,4030,2024,AUGUST
+9680L,adalimumab,Hyrimoz,Injection 40 mg in 0.8 mL pre-filled pen,juvenile idiopathic arthritis,Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 12 months) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 12 months) - balance of supply,,True,AUTHORITY_REQUIRED,Private,4030,2024,AUGUST
+9680L,adalimumab,Idacio,Injection 40 mg in 0.8 mL pre-filled pen,juvenile idiopathic arthritis,Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 12 months) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 12 months) - balance of supply,,True,AUTHORITY_REQUIRED,Private,4030,2024,AUGUST
+9680L,adalimumab,Amgevita,Injection 40 mg in 0.8 mL pre-filled pen,juvenile idiopathic arthritis,Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 12 months),,True,AUTHORITY_REQUIRED,Private,4030,2024,AUGUST
+9680L,adalimumab,Abrilada,Injection 40 mg in 0.8 mL pre-filled pen,juvenile idiopathic arthritis,Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 12 months),,True,AUTHORITY_REQUIRED,Private,4030,2024,AUGUST
+9680L,adalimumab,Hadlima,Injection 40 mg in 0.8 mL pre-filled pen,juvenile idiopathic arthritis,Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 12 months),,True,AUTHORITY_REQUIRED,Private,4030,2024,AUGUST
+9680L,adalimumab,Hyrimoz,Injection 40 mg in 0.8 mL pre-filled pen,juvenile idiopathic arthritis,Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 12 months),,True,AUTHORITY_REQUIRED,Private,4030,2024,AUGUST
+9680L,adalimumab,Idacio,Injection 40 mg in 0.8 mL pre-filled pen,juvenile idiopathic arthritis,Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 12 months),,True,AUTHORITY_REQUIRED,Private,4030,2024,AUGUST
+9680L,adalimumab,Amgevita,Injection 40 mg in 0.8 mL pre-filled pen,juvenile idiopathic arthritis,Initial treatment - Initial 1 (new patient),,True,AUTHORITY_REQUIRED,Private,4030,2024,AUGUST
+9680L,adalimumab,Abrilada,Injection 40 mg in 0.8 mL pre-filled pen,juvenile idiopathic arthritis,Initial treatment - Initial 1 (new patient),,True,AUTHORITY_REQUIRED,Private,4030,2024,AUGUST
+9680L,adalimumab,Hadlima,Injection 40 mg in 0.8 mL pre-filled pen,juvenile idiopathic arthritis,Initial treatment - Initial 1 (new patient),,True,AUTHORITY_REQUIRED,Private,4030,2024,AUGUST
+9680L,adalimumab,Hyrimoz,Injection 40 mg in 0.8 mL pre-filled pen,juvenile idiopathic arthritis,Initial treatment - Initial 1 (new patient),,True,AUTHORITY_REQUIRED,Private,4030,2024,AUGUST
+9680L,adalimumab,Idacio,Injection 40 mg in 0.8 mL pre-filled pen,juvenile idiopathic arthritis,Initial treatment - Initial 1 (new patient),,True,AUTHORITY_REQUIRED,Private,4030,2024,AUGUST
+13716X,tocilizumab,Actemra,Concentrate for injection 200 mg in 10 mL,rheumatoid arthritis,Subsequent continuing treatment,14485,True,STREAMLINED,Private,4030,2024,AUGUST
+12327T,adalimumab,Idacio,Injection 40 mg in 0.8 mL pre-filled syringe,ankylosing spondylitis,First continuing treatment,14683,True,STREAMLINED,Any,4030,2024,AUGUST
+12327T,adalimumab,Hadlima,Injection 40 mg in 0.8 mL pre-filled syringe,ankylosing spondylitis,First continuing treatment,14683,True,STREAMLINED,Any,4030,2024,AUGUST
+12327T,adalimumab,Abrilada,Injection 40 mg in 0.8 mL pre-filled syringe,ankylosing spondylitis,First continuing treatment,14683,True,STREAMLINED,Any,4030,2024,AUGUST
+12327T,adalimumab,Amgevita,Injection 40 mg in 0.8 mL pre-filled syringe,ankylosing spondylitis,First continuing treatment,14683,True,STREAMLINED,Any,4030,2024,AUGUST
+12327T,adalimumab,Hyrimoz,Injection 40 mg in 0.8 mL pre-filled syringe,ankylosing spondylitis,First continuing treatment,14683,True,STREAMLINED,Any,4030,2024,AUGUST
+12327T,adalimumab,Idacio,Injection 40 mg in 0.8 mL pre-filled syringe,ankylosing spondylitis,Subsequent continuing treatment,14701,True,STREAMLINED,Any,4030,2024,AUGUST
+12327T,adalimumab,Hadlima,Injection 40 mg in 0.8 mL pre-filled syringe,ankylosing spondylitis,Subsequent continuing treatment,14701,True,STREAMLINED,Any,4030,2024,AUGUST
+12327T,adalimumab,Abrilada,Injection 40 mg in 0.8 mL pre-filled syringe,ankylosing spondylitis,Subsequent continuing treatment,14701,True,STREAMLINED,Any,4030,2024,AUGUST
+12327T,adalimumab,Amgevita,Injection 40 mg in 0.8 mL pre-filled syringe,ankylosing spondylitis,Subsequent continuing treatment,14701,True,STREAMLINED,Any,4030,2024,AUGUST
+12327T,adalimumab,Hyrimoz,Injection 40 mg in 0.8 mL pre-filled syringe,ankylosing spondylitis,Subsequent continuing treatment,14701,True,STREAMLINED,Any,4030,2024,AUGUST
+11196G,etanercept,Enbrel,"Injections 50 mg in 1 mL single use pre-filled syringes, 4",ankylosing spondylitis,Subsequent continuing treatment,,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+11196G,etanercept,Brenzys,"Injections 50 mg in 1 mL single use pre-filled syringes, 4",ankylosing spondylitis,Subsequent continuing treatment,,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+10951J,tocilizumab,Actemra Subcutaneous Injection,Injection 162 mg in 0.9 mL single use pre-filled syringe,rheumatoid arthritis,Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 24 months),,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+10951J,tocilizumab,Actemra Subcutaneous Injection,Injection 162 mg in 0.9 mL single use pre-filled syringe,rheumatoid arthritis,Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months),,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+10951J,tocilizumab,Actemra Subcutaneous Injection,Injection 162 mg in 0.9 mL single use pre-filled syringe,rheumatoid arthritis,Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 24 months) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months) - balance of supply,,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+10951J,tocilizumab,Actemra Subcutaneous Injection,Injection 162 mg in 0.9 mL single use pre-filled syringe,rheumatoid arthritis,Initial treatment - Initial 1 (new patient),,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+9087G,etanercept,Brenzys,"Injections 50 mg in 1 mL single use pre-filled syringes, 4",psoriatic arthritis,Initial treatment - Initial 1 (new patient),,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+9087G,etanercept,Enbrel,"Injections 50 mg in 1 mL single use pre-filled syringes, 4",psoriatic arthritis,Initial treatment - Initial 1 (new patient),,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+9087G,etanercept,Brenzys,"Injections 50 mg in 1 mL single use pre-filled syringes, 4",psoriatic arthritis,Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years) - balance of supply,,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+9087G,etanercept,Enbrel,"Injections 50 mg in 1 mL single use pre-filled syringes, 4",psoriatic arthritis,Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years) - balance of supply,,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+9087G,etanercept,Brenzys,"Injections 50 mg in 1 mL single use pre-filled syringes, 4",psoriatic arthritis,Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years),,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+9087G,etanercept,Enbrel,"Injections 50 mg in 1 mL single use pre-filled syringes, 4",psoriatic arthritis,Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years),,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+9087G,etanercept,Brenzys,"Injections 50 mg in 1 mL single use pre-filled syringes, 4",psoriatic arthritis,Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years),,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+9087G,etanercept,Enbrel,"Injections 50 mg in 1 mL single use pre-filled syringes, 4",psoriatic arthritis,Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years),,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+13734W,infliximab,Inflectra,Powder for I.V. infusion 100 mg,rheumatoid arthritis,First continuing treatment,14638,True,STREAMLINED,Public,4030,2024,AUGUST
+13734W,infliximab,Renflexis,Powder for I.V. infusion 100 mg,rheumatoid arthritis,First continuing treatment,14638,True,STREAMLINED,Public,4030,2024,AUGUST
+9088H,etanercept,Enbrel,"Injections 50 mg in 1 mL single use pre-filled syringes, 4",psoriatic arthritis,Continuing treatment - balance of supply,,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+9088H,etanercept,Brenzys,"Injections 50 mg in 1 mL single use pre-filled syringes, 4",psoriatic arthritis,Continuing treatment - balance of supply,,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+9088H,etanercept,Enbrel,"Injections 50 mg in 1 mL single use pre-filled syringes, 4",psoriatic arthritis,First continuing treatment,,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+9088H,etanercept,Brenzys,"Injections 50 mg in 1 mL single use pre-filled syringes, 4",psoriatic arthritis,First continuing treatment,,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+13212J,adalimumab,Humira,Injection 40 mg in 0.4 mL pre-filled pen,juvenile idiopathic arthritis,Continuing treatment,14136,True,STREAMLINED,Public,4030,2024,AUGUST
+13212J,adalimumab,Yuflyma,Injection 40 mg in 0.4 mL pre-filled pen,juvenile idiopathic arthritis,Continuing treatment,14136,True,STREAMLINED,Public,4030,2024,AUGUST
+13212J,adalimumab,Adalicip,Injection 40 mg in 0.4 mL pre-filled pen,juvenile idiopathic arthritis,Continuing treatment,14136,True,STREAMLINED,Public,4030,2024,AUGUST
+12368Y,adalimumab,Amgevita,Injection 40 mg in 0.8 mL pre-filled pen,juvenile idiopathic arthritis,Continuing treatment,14107,True,STREAMLINED,Private,4030,2024,AUGUST
+12368Y,adalimumab,Hadlima,Injection 40 mg in 0.8 mL pre-filled pen,juvenile idiopathic arthritis,Continuing treatment,14107,True,STREAMLINED,Private,4030,2024,AUGUST
+12368Y,adalimumab,Hyrimoz,Injection 40 mg in 0.8 mL pre-filled pen,juvenile idiopathic arthritis,Continuing treatment,14107,True,STREAMLINED,Private,4030,2024,AUGUST
+12368Y,adalimumab,Abrilada,Injection 40 mg in 0.8 mL pre-filled pen,juvenile idiopathic arthritis,Continuing treatment,14107,True,STREAMLINED,Private,4030,2024,AUGUST
+12368Y,adalimumab,Idacio,Injection 40 mg in 0.8 mL pre-filled pen,juvenile idiopathic arthritis,Continuing treatment,14107,True,STREAMLINED,Private,4030,2024,AUGUST
+13692P,adalimumab,Hadlima,Injection 40 mg in 0.8 mL pre-filled pen,rheumatoid arthritis,Initial treatment - Initial 1 (new patient),,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+13692P,adalimumab,Idacio,Injection 40 mg in 0.8 mL pre-filled pen,rheumatoid arthritis,Initial treatment - Initial 1 (new patient),,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+13692P,adalimumab,Hyrimoz,Injection 40 mg in 0.8 mL pre-filled pen,rheumatoid arthritis,Initial treatment - Initial 1 (new patient),,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+13692P,adalimumab,Amgevita,Injection 40 mg in 0.8 mL pre-filled pen,rheumatoid arthritis,Initial treatment - Initial 1 (new patient),,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+13692P,adalimumab,Abrilada,Injection 40 mg in 0.8 mL pre-filled pen,rheumatoid arthritis,Initial treatment - Initial 1 (new patient),,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+13692P,adalimumab,Hadlima,Injection 40 mg in 0.8 mL pre-filled pen,rheumatoid arthritis,Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 24 months),,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+13692P,adalimumab,Idacio,Injection 40 mg in 0.8 mL pre-filled pen,rheumatoid arthritis,Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 24 months),,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+13692P,adalimumab,Hyrimoz,Injection 40 mg in 0.8 mL pre-filled pen,rheumatoid arthritis,Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 24 months),,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+13692P,adalimumab,Amgevita,Injection 40 mg in 0.8 mL pre-filled pen,rheumatoid arthritis,Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 24 months),,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+13692P,adalimumab,Abrilada,Injection 40 mg in 0.8 mL pre-filled pen,rheumatoid arthritis,Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 24 months),,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+13692P,adalimumab,Hadlima,Injection 40 mg in 0.8 mL pre-filled pen,rheumatoid arthritis,Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months),,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+13692P,adalimumab,Idacio,Injection 40 mg in 0.8 mL pre-filled pen,rheumatoid arthritis,Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months),,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+13692P,adalimumab,Hyrimoz,Injection 40 mg in 0.8 mL pre-filled pen,rheumatoid arthritis,Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months),,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+13692P,adalimumab,Amgevita,Injection 40 mg in 0.8 mL pre-filled pen,rheumatoid arthritis,Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months),,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+13692P,adalimumab,Abrilada,Injection 40 mg in 0.8 mL pre-filled pen,rheumatoid arthritis,Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months),,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+11720W,tocilizumab,Actemra Subcutaneous Injection,Injection 162 mg in 0.9 mL single use pre-filled syringe,juvenile idiopathic arthritis,Continuing treatment,14150,True,STREAMLINED,Any,4030,2024,AUGUST
+13311N,tocilizumab,Actemra,Concentrate for injection 80 mg in 4 mL,juvenile idiopathic arthritis,Continuing treatment,14082,True,STREAMLINED,Private,4030,2024,AUGUST
+12401Q,adalimumab,Hadlima,Injection 40 mg in 0.8 mL pre-filled pen,juvenile idiopathic arthritis,Subsequent continuing treatment,11604,True,STREAMLINED,Any,4030,2024,AUGUST
+12401Q,adalimumab,Amgevita,Injection 40 mg in 0.8 mL pre-filled pen,juvenile idiopathic arthritis,Subsequent continuing treatment,11604,True,STREAMLINED,Any,4030,2024,AUGUST
+12401Q,adalimumab,Hyrimoz,Injection 40 mg in 0.8 mL pre-filled pen,juvenile idiopathic arthritis,Subsequent continuing treatment,11604,True,STREAMLINED,Any,4030,2024,AUGUST
+12401Q,adalimumab,Idacio,Injection 40 mg in 0.8 mL pre-filled pen,juvenile idiopathic arthritis,Subsequent continuing treatment,11604,True,STREAMLINED,Any,4030,2024,AUGUST
+12401Q,adalimumab,Abrilada,Injection 40 mg in 0.8 mL pre-filled pen,juvenile idiopathic arthritis,Subsequent continuing treatment,11604,True,STREAMLINED,Any,4030,2024,AUGUST
+11361Y,golimumab,Simponi,Injection 50 mg in 0.5 mL single use pre-filled pen,ankylosing spondylitis,Initial treatment - Initial 1 (new patient),,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+11361Y,golimumab,Simponi,Injection 50 mg in 0.5 mL single use pre-filled pen,ankylosing spondylitis,Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years),,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+11361Y,golimumab,Simponi,Injection 50 mg in 0.5 mL single use pre-filled pen,ankylosing spondylitis,"Initial treatment - Initial 1 (new patient), Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years) - balance of supply",,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+11361Y,golimumab,Simponi,Injection 50 mg in 0.5 mL single use pre-filled pen,ankylosing spondylitis,Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years),,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+8638P,etanercept,Enbrel,Injection set containing 4 vials powder for injection 25 mg and 4 pre-filled syringes solvent 1 mL,rheumatoid arthritis,First continuing treatment,,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+8638P,etanercept,Enbrel,Injection set containing 4 vials powder for injection 25 mg and 4 pre-filled syringes solvent 1 mL,rheumatoid arthritis,First continuing treatment - balance of supply,,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+12442W,adalimumab,Humira,Injection 40 mg in 0.4 mL pre-filled syringe,ankylosing spondylitis,Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years),,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+12442W,adalimumab,Adalicip,Injection 40 mg in 0.4 mL pre-filled syringe,ankylosing spondylitis,Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years),,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+12442W,adalimumab,Yuflyma,Injection 40 mg in 0.4 mL pre-filled syringe,ankylosing spondylitis,Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years),,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+12442W,adalimumab,Humira,Injection 40 mg in 0.4 mL pre-filled syringe,ankylosing spondylitis,Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years) - balance of supply,,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+12442W,adalimumab,Adalicip,Injection 40 mg in 0.4 mL pre-filled syringe,ankylosing spondylitis,Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years) - balance of supply,,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+12442W,adalimumab,Yuflyma,Injection 40 mg in 0.4 mL pre-filled syringe,ankylosing spondylitis,Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years) - balance of supply,,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+12442W,adalimumab,Humira,Injection 40 mg in 0.4 mL pre-filled syringe,ankylosing spondylitis,Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years),,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+12442W,adalimumab,Adalicip,Injection 40 mg in 0.4 mL pre-filled syringe,ankylosing spondylitis,Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years),,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+12442W,adalimumab,Yuflyma,Injection 40 mg in 0.4 mL pre-filled syringe,ankylosing spondylitis,Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years),,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+12442W,adalimumab,Humira,Injection 40 mg in 0.4 mL pre-filled syringe,ankylosing spondylitis,Initial treatment - Initial 1 (new patient),,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+12442W,adalimumab,Adalicip,Injection 40 mg in 0.4 mL pre-filled syringe,ankylosing spondylitis,Initial treatment - Initial 1 (new patient),,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+12442W,adalimumab,Yuflyma,Injection 40 mg in 0.4 mL pre-filled syringe,ankylosing spondylitis,Initial treatment - Initial 1 (new patient),,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+12767Y,tocilizumab,Actemra ACTPen,Injection 162 mg in 0.9 mL single use pre-filled pen,juvenile idiopathic arthritis,Initial treatment - Initial 4 (Temporary listing - change of treatment from another biological medicine to tocilizumab after resolution of the critical shortage of tocilizumab),,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+11216H,etanercept,Brenzys,"Injections 50 mg in 1 mL single use pre-filled syringes, 4",psoriatic arthritis,Subsequent continuing treatment,9156,True,STREAMLINED,Any,4030,2024,AUGUST
+13715W,tocilizumab,Actemra,Concentrate for injection 400 mg in 20 mL,rheumatoid arthritis,Subsequent continuing treatment,14621,True,STREAMLINED,Public,4030,2024,AUGUST
+13066Q,infliximab,Remsima SC,Solution for injection 120 mg in 1 mL pre-filled syringe,psoriatic arthritis,Initial treatment with the subcutaneous form where a concurrent PBS authority application for the intravenously (IV) administered formulation is being made,,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+11322X,certolizumab pegol,Cimzia,Solution for injection 200 mg in 1 mL pre-filled pen,rheumatoid arthritis,Initial treatment - Initial 1 (new patient),,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+11322X,certolizumab pegol,Cimzia,Solution for injection 200 mg in 1 mL pre-filled pen,rheumatoid arthritis,Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months),,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+11322X,certolizumab pegol,Cimzia,Solution for injection 200 mg in 1 mL pre-filled pen,rheumatoid arthritis,Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 24 months),,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+13075E,infliximab,Remsima SC,Solution for injection 120 mg in 1 mL pre-filled pen,ankylosing spondylitis,Balance of supply (including switching formulation) where the full duration of treatment available under a particular treatment phase was not requested in the preceding prescription,,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+12326R,adalimumab,Hadlima,Injection 40 mg in 0.8 mL pre-filled syringe,rheumatoid arthritis,Subsequent continuing treatment,14499,True,STREAMLINED,Any,4030,2024,AUGUST
+12326R,adalimumab,Abrilada,Injection 40 mg in 0.8 mL pre-filled syringe,rheumatoid arthritis,Subsequent continuing treatment,14499,True,STREAMLINED,Any,4030,2024,AUGUST
+12326R,adalimumab,Idacio,Injection 40 mg in 0.8 mL pre-filled syringe,rheumatoid arthritis,Subsequent continuing treatment,14499,True,STREAMLINED,Any,4030,2024,AUGUST
+12326R,adalimumab,Amgevita,Injection 40 mg in 0.8 mL pre-filled syringe,rheumatoid arthritis,Subsequent continuing treatment,14499,True,STREAMLINED,Any,4030,2024,AUGUST
+12326R,adalimumab,Hyrimoz,Injection 40 mg in 0.8 mL pre-filled syringe,rheumatoid arthritis,Subsequent continuing treatment,14499,True,STREAMLINED,Any,4030,2024,AUGUST
+11750K,tocilizumab,Actemra ACTPen,Injection 162 mg in 0.9 mL single use pre-filled pen,juvenile idiopathic arthritis,Continuing treatment,,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+11750K,tocilizumab,Actemra ACTPen,Injection 162 mg in 0.9 mL single use pre-filled pen,juvenile idiopathic arthritis,Continuing Treatment - balance of supply,,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+10073E,tocilizumab,Actemra,Concentrate for injection 80 mg in 4 mL,juvenile idiopathic arthritis,Continuing Treatment - balance of supply,,True,AUTHORITY_REQUIRED,Private,4030,2024,AUGUST
+10073E,tocilizumab,Actemra,Concentrate for injection 80 mg in 4 mL,juvenile idiopathic arthritis,Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 24 months),,False,AUTHORITY_REQUIRED,Private,4030,2024,AUGUST
+10073E,tocilizumab,Actemra,Concentrate for injection 80 mg in 4 mL,juvenile idiopathic arthritis,Initial treatment - Initial 1 (new patient),,False,AUTHORITY_REQUIRED,Private,4030,2024,AUGUST
+10073E,tocilizumab,Actemra,Concentrate for injection 80 mg in 4 mL,juvenile idiopathic arthritis,Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months),,False,AUTHORITY_REQUIRED,Private,4030,2024,AUGUST
+10073E,tocilizumab,Actemra,Concentrate for injection 80 mg in 4 mL,juvenile idiopathic arthritis,Initial treatment - Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after break of less than 24 months) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months) -  balance of supply,,True,AUTHORITY_REQUIRED,Private,4030,2024,AUGUST
+10073E,tocilizumab,Actemra,Concentrate for injection 80 mg in 4 mL,juvenile idiopathic arthritis,Continuing treatment,,False,AUTHORITY_REQUIRED,Private,4030,2024,AUGUST
+12428D,adalimumab,Yuflyma,Injection 40 mg in 0.4 mL pre-filled pen,juvenile idiopathic arthritis,Initial treatment - Initial 2 (change or recommencement of treatment after break in biological medicine of less than 24 months),,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+12428D,adalimumab,Adalicip,Injection 40 mg in 0.4 mL pre-filled pen,juvenile idiopathic arthritis,Initial treatment - Initial 2 (change or recommencement of treatment after break in biological medicine of less than 24 months),,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+12428D,adalimumab,Humira,Injection 40 mg in 0.4 mL pre-filled pen,juvenile idiopathic arthritis,Initial treatment - Initial 2 (change or recommencement of treatment after break in biological medicine of less than 24 months),,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+12428D,adalimumab,Yuflyma,Injection 40 mg in 0.4 mL pre-filled pen,juvenile idiopathic arthritis,Initial treatment - Initial 1 (new patient),,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+12428D,adalimumab,Adalicip,Injection 40 mg in 0.4 mL pre-filled pen,juvenile idiopathic arthritis,Initial treatment - Initial 1 (new patient),,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+12428D,adalimumab,Humira,Injection 40 mg in 0.4 mL pre-filled pen,juvenile idiopathic arthritis,Initial treatment - Initial 1 (new patient),,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+12428D,adalimumab,Yuflyma,Injection 40 mg in 0.4 mL pre-filled pen,juvenile idiopathic arthritis,Initial treatment - Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after break of less than 24 months) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months) -  balance of supply,,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+12428D,adalimumab,Adalicip,Injection 40 mg in 0.4 mL pre-filled pen,juvenile idiopathic arthritis,Initial treatment - Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after break of less than 24 months) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months) -  balance of supply,,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+12428D,adalimumab,Humira,Injection 40 mg in 0.4 mL pre-filled pen,juvenile idiopathic arthritis,Initial treatment - Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after break of less than 24 months) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months) -  balance of supply,,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+12428D,adalimumab,Yuflyma,Injection 40 mg in 0.4 mL pre-filled pen,juvenile idiopathic arthritis,Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months),,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+12428D,adalimumab,Adalicip,Injection 40 mg in 0.4 mL pre-filled pen,juvenile idiopathic arthritis,Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months),,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+12428D,adalimumab,Humira,Injection 40 mg in 0.4 mL pre-filled pen,juvenile idiopathic arthritis,Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months),,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+3434R,golimumab,Simponi,Injection 50 mg in 0.5 mL single use pre-filled syringe,ankylosing spondylitis,Initial treatment - Initial 1 (new patient),,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+3434R,golimumab,Simponi,Injection 50 mg in 0.5 mL single use pre-filled syringe,ankylosing spondylitis,Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years),,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+3434R,golimumab,Simponi,Injection 50 mg in 0.5 mL single use pre-filled syringe,ankylosing spondylitis,Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years),,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+3434R,golimumab,Simponi,Injection 50 mg in 0.5 mL single use pre-filled syringe,ankylosing spondylitis,"Initial treatment - Initial 1 (new patient), Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years) - balance of supply",,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+11321W,certolizumab pegol,Cimzia,Solution for injection 200 mg in 1 mL pre-filled pen,rheumatoid arthritis,Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 24 months) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months) - balance of supply,,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+13324G,tocilizumab,Actemra,Concentrate for injection 80 mg in 4 mL,juvenile idiopathic arthritis,Continuing treatment,14164,True,STREAMLINED,Public,4030,2024,AUGUST
+5605B,abatacept,Orencia,Powder for I.V. infusion 250 mg,rheumatoid arthritis,Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months),,False,AUTHORITY_REQUIRED,Public,4030,2024,AUGUST
+5605B,abatacept,Orencia,Powder for I.V. infusion 250 mg,rheumatoid arthritis,First continuing treatment,,False,AUTHORITY_REQUIRED,Public,4030,2024,AUGUST
+5605B,abatacept,Orencia,Powder for I.V. infusion 250 mg,rheumatoid arthritis,Initial treatment - Initial 1 (new patient),,False,AUTHORITY_REQUIRED,Public,4030,2024,AUGUST
+5605B,abatacept,Orencia,Powder for I.V. infusion 250 mg,rheumatoid arthritis,First continuing treatment - balance of supply,,True,AUTHORITY_REQUIRED,Public,4030,2024,AUGUST
+5605B,abatacept,Orencia,Powder for I.V. infusion 250 mg,rheumatoid arthritis,Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 24 months),,False,AUTHORITY_REQUIRED,Public,4030,2024,AUGUST
+5605B,abatacept,Orencia,Powder for I.V. infusion 250 mg,rheumatoid arthritis,Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 24 months) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months) - balance of supply,,True,AUTHORITY_REQUIRED,Public,4030,2024,AUGUST
+11514B,infliximab,Inflectra,Powder for I.V. infusion 100 mg,psoriatic arthritis,Subsequent continuing treatment,9188,True,STREAMLINED,Public,4030,2024,AUGUST
+11514B,infliximab,Renflexis,Powder for I.V. infusion 100 mg,psoriatic arthritis,Subsequent continuing treatment,9188,True,STREAMLINED,Public,4030,2024,AUGUST
+13350P,upadacitinib,Rinvoq,Tablet 15 mg,non-radiographic axial spondyloarthritis,Initial treatment - Initial 1 (New patient),,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+13350P,upadacitinib,Rinvoq,Tablet 15 mg,non-radiographic axial spondyloarthritis,Initial treatment - Initial 2 (Change or recommencement of treatment after a break in biological medicine of less than 5 years),,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+13350P,upadacitinib,Rinvoq,Tablet 15 mg,non-radiographic axial spondyloarthritis,Initial treatment - Initial 3 (Recommencement of treatment after a break in biological medicine of more than 5 years),,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+13350P,upadacitinib,Rinvoq,Tablet 15 mg,non-radiographic axial spondyloarthritis,"Initial 1 (New patient), Initial 2 (Change or recommencement of treatment after a break in biological medicine of less than 5 years) or Initial 3 (Recommencement of treatment after a break in biological medicine of more than 5 years) - balance of supply",,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+13343G,upadacitinib,Rinvoq,Tablet 15 mg,non-radiographic axial spondyloarthritis,Transitioning from non-PBS to PBS-subsidised supply - Grandfather arrangements,,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+13343G,upadacitinib,Rinvoq,Tablet 15 mg,non-radiographic axial spondyloarthritis,Continuing treatment - balance of supply,,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+13343G,upadacitinib,Rinvoq,Tablet 15 mg,non-radiographic axial spondyloarthritis,Continuing treatment,,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+11447L,baricitinib,Olumiant,Tablet 4 mg,rheumatoid arthritis,Initial treatment - Initial 1 (new patient),,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+11447L,baricitinib,Olumiant,Tablet 4 mg,rheumatoid arthritis,Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months),,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+11447L,baricitinib,Olumiant,Tablet 4 mg,rheumatoid arthritis,Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 24 months) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months) - balance of supply,,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+11447L,baricitinib,Olumiant,Tablet 4 mg,rheumatoid arthritis,Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 24 months),,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+9641K,etanercept,Enbrel,"Injection 50 mg in 1 mL single use auto-injector, 4",juvenile idiopathic arthritis,Initial treatment - Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 12 months) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 12 months) - balance of supply,,True,AUTHORITY_REQUIRED,Private,4030,2024,AUGUST
+9641K,etanercept,Enbrel,"Injection 50 mg in 1 mL single use auto-injector, 4",juvenile idiopathic arthritis,Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 12 months),,True,AUTHORITY_REQUIRED,Private,4030,2024,AUGUST
+9641K,etanercept,Enbrel,"Injection 50 mg in 1 mL single use auto-injector, 4",juvenile idiopathic arthritis,Initial treatment - Initial 1 (new patient),,True,AUTHORITY_REQUIRED,Private,4030,2024,AUGUST
+9641K,etanercept,Enbrel,"Injection 50 mg in 1 mL single use auto-injector, 4",juvenile idiopathic arthritis,Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 12 months),,True,AUTHORITY_REQUIRED,Private,4030,2024,AUGUST
+13776C,tofacitinib,Xeljanz,"Oral solution 1 mg per mL, 240 mL",juvenile idiopathic arthritis,Transitioning from non-PBS to PBS-subsidised supply - Grandfather arrangements,,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+13778E,infliximab,Inflectra,Powder for I.V. infusion 100 mg,ankylosing spondylitis,Initial treatment - Initial 1 (new patient),,True,AUTHORITY_REQUIRED,Private,4030,2024,AUGUST
+13778E,infliximab,Renflexis,Powder for I.V. infusion 100 mg,ankylosing spondylitis,Initial treatment - Initial 1 (new patient),,True,AUTHORITY_REQUIRED,Private,4030,2024,AUGUST
+13778E,infliximab,Inflectra,Powder for I.V. infusion 100 mg,ankylosing spondylitis,Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years),,True,AUTHORITY_REQUIRED,Private,4030,2024,AUGUST
+13778E,infliximab,Renflexis,Powder for I.V. infusion 100 mg,ankylosing spondylitis,Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years),,True,AUTHORITY_REQUIRED,Private,4030,2024,AUGUST
+13778E,infliximab,Inflectra,Powder for I.V. infusion 100 mg,ankylosing spondylitis,Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years),,True,AUTHORITY_REQUIRED,Private,4030,2024,AUGUST
+13778E,infliximab,Renflexis,Powder for I.V. infusion 100 mg,ankylosing spondylitis,Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years),,True,AUTHORITY_REQUIRED,Private,4030,2024,AUGUST
+13726K,abatacept,Orencia,Injection 125 mg in 1 mL single dose pre-filled syringe,rheumatoid arthritis,Subsequent continuing treatment,14604,True,STREAMLINED,Any,4030,2024,AUGUST
+11201M,etanercept,Brenzys,"Injection 50 mg in 1 mL single use auto-injector, 4",ankylosing spondylitis,Subsequent continuing treatment,,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+11201M,etanercept,Enbrel,"Injection 50 mg in 1 mL single use auto-injector, 4",ankylosing spondylitis,Subsequent continuing treatment,,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+1220F,abatacept,Orencia,Injection 125 mg in 1 mL single dose pre-filled syringe,rheumatoid arthritis,Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 24 months),,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+1220F,abatacept,Orencia,Injection 125 mg in 1 mL single dose pre-filled syringe,rheumatoid arthritis,Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months),,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+1220F,abatacept,Orencia,Injection 125 mg in 1 mL single dose pre-filled syringe,rheumatoid arthritis,Initial treatment - Initial 1 (new patient),,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+1220F,abatacept,Orencia,Injection 125 mg in 1 mL single dose pre-filled syringe,rheumatoid arthritis,Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 24 months) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months) - balance of supply,,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+13732R,adalimumab,Yuflyma,Injection 40 mg in 0.4 mL pre-filled syringe,rheumatoid arthritis,First continuing treatment,14567,True,STREAMLINED,Any,4030,2024,AUGUST
+13732R,adalimumab,Adalicip,Injection 40 mg in 0.4 mL pre-filled syringe,rheumatoid arthritis,First continuing treatment,14567,True,STREAMLINED,Any,4030,2024,AUGUST
+13222X,adalimumab,Humira,Injection 40 mg in 0.4 mL pre-filled syringe,rheumatoid arthritis,Subsequent continuing treatment,14499,True,STREAMLINED,Any,4030,2024,AUGUST
+13222X,adalimumab,Yuflyma,Injection 40 mg in 0.4 mL pre-filled syringe,rheumatoid arthritis,Subsequent continuing treatment,14499,True,STREAMLINED,Any,4030,2024,AUGUST
+13222X,adalimumab,Adalicip,Injection 40 mg in 0.4 mL pre-filled syringe,rheumatoid arthritis,Subsequent continuing treatment,14499,True,STREAMLINED,Any,4030,2024,AUGUST
+13751R,etanercept,Brenzys,"Injections 50 mg in 1 mL single use pre-filled syringes, 4",ankylosing spondylitis,Initial treatment - Initial 1 (new patient),,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+13751R,etanercept,Brenzys,"Injections 50 mg in 1 mL single use pre-filled syringes, 4",ankylosing spondylitis,Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years),,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+13751R,etanercept,Brenzys,"Injections 50 mg in 1 mL single use pre-filled syringes, 4",ankylosing spondylitis,Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years),,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+12762Q,tocilizumab,Actemra Subcutaneous Injection,Injection 162 mg in 0.9 mL single use pre-filled syringe,juvenile idiopathic arthritis,Initial treatment - Initial 4 (Temporary listing - change of treatment from another biological medicine to tocilizumab after resolution of the critical shortage of tocilizumab),,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+11538G,golimumab,Simponi,Injection 50 mg in 0.5 mL single use pre-filled pen,non-radiographic axial spondyloarthritis,"Initial 1 (New patient), Initial 2 (Change or re-commencement of treatment after a break in biological medicine of less than 5 years) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years) - balance of supply",,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+11538G,golimumab,Simponi,Injection 50 mg in 0.5 mL single use pre-filled pen,non-radiographic axial spondyloarthritis,Initial treatment - Initial 3 (Recommencement of treatment after a break in biological medicine of more than 5 years),,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+11538G,golimumab,Simponi,Injection 50 mg in 0.5 mL single use pre-filled pen,non-radiographic axial spondyloarthritis,Initial treatment - Initial 1 (New patient),,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+11538G,golimumab,Simponi,Injection 50 mg in 0.5 mL single use pre-filled pen,non-radiographic axial spondyloarthritis,Initial treatment - Initial 2 (Change or re-commencement of treatment after a break of less than 5 years),,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+11490R,infliximab,Inflectra,Powder for I.V. infusion 100 mg,rheumatoid arthritis,Subsequent continuing treatment,14504,True,STREAMLINED,Public,4030,2024,AUGUST
+11490R,infliximab,Remicade,Powder for I.V. infusion 100 mg,rheumatoid arthritis,Subsequent continuing treatment,14504,True,STREAMLINED,Public,4030,2024,AUGUST
+11490R,infliximab,Renflexis,Powder for I.V. infusion 100 mg,rheumatoid arthritis,Subsequent continuing treatment,14504,True,STREAMLINED,Public,4030,2024,AUGUST
+12791F,tocilizumab,Actemra,Concentrate for injection 200 mg in 10 mL,rheumatoid arthritis,Initial treatment - Initial 4 (Temporary listing - change of treatment from another biological medicine to tocilizumab after resolution of the critical shortage of tocilizumab),,True,AUTHORITY_REQUIRED,Public,4030,2024,AUGUST
+13312P,tocilizumab,Actemra,Concentrate for injection 200 mg in 10 mL,juvenile idiopathic arthritis,Continuing treatment,14082,True,STREAMLINED,Private,4030,2024,AUGUST
+3447K,etanercept,Enbrel,"Injection 50 mg in 1 mL single use auto-injector, 4",juvenile idiopathic arthritis,Initial treatment - Initial 1 (new patient),,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+3447K,etanercept,Enbrel,"Injection 50 mg in 1 mL single use auto-injector, 4",juvenile idiopathic arthritis,Initial treatment - Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after break of less than 24 months) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months) -  balance of supply,,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+3447K,etanercept,Enbrel,"Injection 50 mg in 1 mL single use auto-injector, 4",juvenile idiopathic arthritis,Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 24 months),,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+3447K,etanercept,Enbrel,"Injection 50 mg in 1 mL single use auto-injector, 4",juvenile idiopathic arthritis,Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months),,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+11684Y,abatacept,Orencia ClickJect,Injection 125 mg in 1 mL single dose autoinjector,rheumatoid arthritis,First continuing treatment,,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+11684Y,abatacept,Orencia ClickJect,Injection 125 mg in 1 mL single dose autoinjector,rheumatoid arthritis,First continuing treatment - balance of supply,,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+12361N,adalimumab,Humira,Injection 40 mg in 0.4 mL pre-filled syringe,ankylosing spondylitis,Subsequent continuing treatment,,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+12361N,adalimumab,Yuflyma,Injection 40 mg in 0.4 mL pre-filled syringe,ankylosing spondylitis,Subsequent continuing treatment,,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+12361N,adalimumab,Adalicip,Injection 40 mg in 0.4 mL pre-filled syringe,ankylosing spondylitis,Subsequent continuing treatment,,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+12361N,adalimumab,Humira,Injection 40 mg in 0.4 mL pre-filled syringe,ankylosing spondylitis,First continuing treatment,,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+12361N,adalimumab,Yuflyma,Injection 40 mg in 0.4 mL pre-filled syringe,ankylosing spondylitis,First continuing treatment,,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+12361N,adalimumab,Adalicip,Injection 40 mg in 0.4 mL pre-filled syringe,ankylosing spondylitis,First continuing treatment,,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+12361N,adalimumab,Humira,Injection 40 mg in 0.4 mL pre-filled syringe,ankylosing spondylitis,Continuing treatment - balance of supply,,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+12361N,adalimumab,Yuflyma,Injection 40 mg in 0.4 mL pre-filled syringe,ankylosing spondylitis,Continuing treatment - balance of supply,,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+12361N,adalimumab,Adalicip,Injection 40 mg in 0.4 mL pre-filled syringe,ankylosing spondylitis,Continuing treatment - balance of supply,,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+11722Y,tocilizumab,Actemra ACTPen,Injection 162 mg in 0.9 mL single use pre-filled pen,giant cell arteritis,Continuing treatment,,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+12787B,tocilizumab,Actemra,Concentrate for injection 80 mg in 4 mL,rheumatoid arthritis,Initial treatment - Initial 4 (Temporary listing - change of treatment from another biological medicine to tocilizumab after resolution of the critical shortage of tocilizumab),,True,AUTHORITY_REQUIRED,Private,4030,2024,AUGUST
+9102C,adalimumab,Amgevita,Injection 40 mg in 0.8 mL pre-filled pen,psoriatic arthritis,Subsequent continuing treatment,,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+9102C,adalimumab,Abrilada,Injection 40 mg in 0.8 mL pre-filled pen,psoriatic arthritis,Subsequent continuing treatment,,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+9102C,adalimumab,Idacio,Injection 40 mg in 0.8 mL pre-filled pen,psoriatic arthritis,Subsequent continuing treatment,,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+9102C,adalimumab,Hyrimoz,Injection 40 mg in 0.8 mL pre-filled pen,psoriatic arthritis,Subsequent continuing treatment,,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+9102C,adalimumab,Hadlima,Injection 40 mg in 0.8 mL pre-filled pen,psoriatic arthritis,Subsequent continuing treatment,,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+9102C,adalimumab,Amgevita,Injection 40 mg in 0.8 mL pre-filled pen,psoriatic arthritis,First continuing treatment,,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+9102C,adalimumab,Abrilada,Injection 40 mg in 0.8 mL pre-filled pen,psoriatic arthritis,First continuing treatment,,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+9102C,adalimumab,Idacio,Injection 40 mg in 0.8 mL pre-filled pen,psoriatic arthritis,First continuing treatment,,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+9102C,adalimumab,Hyrimoz,Injection 40 mg in 0.8 mL pre-filled pen,psoriatic arthritis,First continuing treatment,,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+9102C,adalimumab,Hadlima,Injection 40 mg in 0.8 mL pre-filled pen,psoriatic arthritis,First continuing treatment,,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+9102C,adalimumab,Amgevita,Injection 40 mg in 0.8 mL pre-filled pen,psoriatic arthritis,Continuing treatment - balance of supply,,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+9102C,adalimumab,Abrilada,Injection 40 mg in 0.8 mL pre-filled pen,psoriatic arthritis,Continuing treatment - balance of supply,,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+9102C,adalimumab,Idacio,Injection 40 mg in 0.8 mL pre-filled pen,psoriatic arthritis,Continuing treatment - balance of supply,,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+9102C,adalimumab,Hyrimoz,Injection 40 mg in 0.8 mL pre-filled pen,psoriatic arthritis,Continuing treatment - balance of supply,,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+9102C,adalimumab,Hadlima,Injection 40 mg in 0.8 mL pre-filled pen,psoriatic arthritis,Continuing treatment - balance of supply,,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+13292N,adalimumab,Humira,Injection 20 mg in 0.2 mL pre-filled syringe,juvenile idiopathic arthritis,Continuing treatment,14107,True,STREAMLINED,Private,4030,2024,AUGUST
+13754X,adalimumab,Idacio,Injection 40 mg in 0.8 mL pre-filled pen,ankylosing spondylitis,Initial treatment - Initial 1 (new patient),,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+13754X,adalimumab,Hyrimoz,Injection 40 mg in 0.8 mL pre-filled pen,ankylosing spondylitis,Initial treatment - Initial 1 (new patient),,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+13754X,adalimumab,Abrilada,Injection 40 mg in 0.8 mL pre-filled pen,ankylosing spondylitis,Initial treatment - Initial 1 (new patient),,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+13754X,adalimumab,Hadlima,Injection 40 mg in 0.8 mL pre-filled pen,ankylosing spondylitis,Initial treatment - Initial 1 (new patient),,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+13754X,adalimumab,Amgevita,Injection 40 mg in 0.8 mL pre-filled pen,ankylosing spondylitis,Initial treatment - Initial 1 (new patient),,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+13754X,adalimumab,Idacio,Injection 40 mg in 0.8 mL pre-filled pen,ankylosing spondylitis,Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years),,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+13754X,adalimumab,Hyrimoz,Injection 40 mg in 0.8 mL pre-filled pen,ankylosing spondylitis,Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years),,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+13754X,adalimumab,Abrilada,Injection 40 mg in 0.8 mL pre-filled pen,ankylosing spondylitis,Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years),,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+13754X,adalimumab,Hadlima,Injection 40 mg in 0.8 mL pre-filled pen,ankylosing spondylitis,Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years),,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+13754X,adalimumab,Amgevita,Injection 40 mg in 0.8 mL pre-filled pen,ankylosing spondylitis,Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years),,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+13754X,adalimumab,Idacio,Injection 40 mg in 0.8 mL pre-filled pen,ankylosing spondylitis,Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years),,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+13754X,adalimumab,Hyrimoz,Injection 40 mg in 0.8 mL pre-filled pen,ankylosing spondylitis,Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years),,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+13754X,adalimumab,Abrilada,Injection 40 mg in 0.8 mL pre-filled pen,ankylosing spondylitis,Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years),,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+13754X,adalimumab,Hadlima,Injection 40 mg in 0.8 mL pre-filled pen,ankylosing spondylitis,Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years),,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+13754X,adalimumab,Amgevita,Injection 40 mg in 0.8 mL pre-filled pen,ankylosing spondylitis,Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years),,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+9033K,adalimumab,Idacio,Injection 40 mg in 0.8 mL pre-filled syringe,psoriatic arthritis,Initial treatment - Initial 2 (change or recommencement of treatment after a break in in biological medicine of less than 5 years),,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+9033K,adalimumab,Amgevita,Injection 40 mg in 0.8 mL pre-filled syringe,psoriatic arthritis,Initial treatment - Initial 2 (change or recommencement of treatment after a break in in biological medicine of less than 5 years),,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+9033K,adalimumab,Hadlima,Injection 40 mg in 0.8 mL pre-filled syringe,psoriatic arthritis,Initial treatment - Initial 2 (change or recommencement of treatment after a break in in biological medicine of less than 5 years),,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+9033K,adalimumab,Hyrimoz,Injection 40 mg in 0.8 mL pre-filled syringe,psoriatic arthritis,Initial treatment - Initial 2 (change or recommencement of treatment after a break in in biological medicine of less than 5 years),,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+9033K,adalimumab,Idacio,Injection 40 mg in 0.8 mL pre-filled syringe,psoriatic arthritis,Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years) - balance of supply,,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+9033K,adalimumab,Amgevita,Injection 40 mg in 0.8 mL pre-filled syringe,psoriatic arthritis,Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years) - balance of supply,,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+9033K,adalimumab,Hadlima,Injection 40 mg in 0.8 mL pre-filled syringe,psoriatic arthritis,Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years) - balance of supply,,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+9033K,adalimumab,Hyrimoz,Injection 40 mg in 0.8 mL pre-filled syringe,psoriatic arthritis,Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years) - balance of supply,,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+9033K,adalimumab,Idacio,Injection 40 mg in 0.8 mL pre-filled syringe,psoriatic arthritis,Initial treatment - Initial 1 (new patient),,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+9033K,adalimumab,Amgevita,Injection 40 mg in 0.8 mL pre-filled syringe,psoriatic arthritis,Initial treatment - Initial 1 (new patient),,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+9033K,adalimumab,Hadlima,Injection 40 mg in 0.8 mL pre-filled syringe,psoriatic arthritis,Initial treatment - Initial 1 (new patient),,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+9033K,adalimumab,Hyrimoz,Injection 40 mg in 0.8 mL pre-filled syringe,psoriatic arthritis,Initial treatment - Initial 1 (new patient),,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+9033K,adalimumab,Idacio,Injection 40 mg in 0.8 mL pre-filled syringe,psoriatic arthritis,Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years),,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+9033K,adalimumab,Amgevita,Injection 40 mg in 0.8 mL pre-filled syringe,psoriatic arthritis,Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years),,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+9033K,adalimumab,Hadlima,Injection 40 mg in 0.8 mL pre-filled syringe,psoriatic arthritis,Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years),,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+9033K,adalimumab,Hyrimoz,Injection 40 mg in 0.8 mL pre-filled syringe,psoriatic arthritis,Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years),,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+12406Y,adalimumab,Humira,Injection 20 mg in 0.2 mL pre-filled syringe,juvenile idiopathic arthritis,Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 12 months),,True,AUTHORITY_REQUIRED,Public,4030,2024,AUGUST
+12406Y,adalimumab,Humira,Injection 20 mg in 0.2 mL pre-filled syringe,juvenile idiopathic arthritis,Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 12 months),,True,AUTHORITY_REQUIRED,Public,4030,2024,AUGUST
+12406Y,adalimumab,Humira,Injection 20 mg in 0.2 mL pre-filled syringe,juvenile idiopathic arthritis,Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 12 months) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 12 months) - balance of supply,,True,AUTHORITY_REQUIRED,Public,4030,2024,AUGUST
+12406Y,adalimumab,Humira,Injection 20 mg in 0.2 mL pre-filled syringe,juvenile idiopathic arthritis,Initial treatment - Initial 1 (new patient),,True,AUTHORITY_REQUIRED,Public,4030,2024,AUGUST
+11220M,etanercept,Enbrel,"Injection 50 mg in 1 mL single use auto-injector, 4",rheumatoid arthritis,Continuing treatment - balance of supply,,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+11220M,etanercept,Brenzys,"Injection 50 mg in 1 mL single use auto-injector, 4",rheumatoid arthritis,Continuing treatment - balance of supply,,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+11220M,etanercept,Enbrel,"Injection 50 mg in 1 mL single use auto-injector, 4",rheumatoid arthritis,Subsequent continuing treatment,,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+11220M,etanercept,Brenzys,"Injection 50 mg in 1 mL single use auto-injector, 4",rheumatoid arthritis,Subsequent continuing treatment,,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+12307R,secukinumab,Cosentyx,Injection 150 mg in 1 mL pre-filled pen,non-radiographic axial spondyloarthritis,Continuing treatment,,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+13701D,certolizumab pegol,Cimzia,Solution for injection 200 mg in 1 mL pre-filled pen,rheumatoid arthritis,Subsequent continuing treatment,14499,True,STREAMLINED,Any,4030,2024,AUGUST
+11326D,certolizumab pegol,Cimzia,Solution for injection 200 mg in 1 mL pre-filled pen,psoriatic arthritis,Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years) - balance of supply,,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+13056E,infliximab,Remsima SC,Solution for injection 120 mg in 1 mL pre-filled pen,psoriatic arthritis,Balance of supply (including switching formulation) where the full duration of treatment available under a particular treatment phase was not requested in the preceding prescription,,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+13703F,adalimumab,Yuflyma,Injection 40 mg in 0.4 mL pre-filled pen,rheumatoid arthritis,First continuing treatment,14567,True,STREAMLINED,Any,4030,2024,AUGUST
+13703F,adalimumab,Adalicip,Injection 40 mg in 0.4 mL pre-filled pen,rheumatoid arthritis,First continuing treatment,14567,True,STREAMLINED,Any,4030,2024,AUGUST
+11198J,etanercept,Brenzys,"Injection 50 mg in 1 mL single use auto-injector, 4",psoriatic arthritis,Subsequent continuing treatment,,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+11198J,etanercept,Enbrel,"Injection 50 mg in 1 mL single use auto-injector, 4",psoriatic arthritis,Subsequent continuing treatment,,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+11198J,etanercept,Brenzys,"Injection 50 mg in 1 mL single use auto-injector, 4",psoriatic arthritis,Continuing treatment - balance of supply,,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+11198J,etanercept,Enbrel,"Injection 50 mg in 1 mL single use auto-injector, 4",psoriatic arthritis,Continuing treatment - balance of supply,,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+11365E,golimumab,Simponi,Injection 50 mg in 0.5 mL single use pre-filled pen,psoriatic arthritis,Initial treatment - Initial 2 (change or recommencement of treatment after a break in in biological medicine of less than 5 years),,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+11365E,golimumab,Simponi,Injection 50 mg in 0.5 mL single use pre-filled pen,psoriatic arthritis,Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years) - balance of supply,,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+11365E,golimumab,Simponi,Injection 50 mg in 0.5 mL single use pre-filled pen,psoriatic arthritis,Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years),,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+11365E,golimumab,Simponi,Injection 50 mg in 0.5 mL single use pre-filled pen,psoriatic arthritis,Initial treatment - Initial 1 (new patient),,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+13227E,adalimumab,Humira,Injection 40 mg in 0.4 mL pre-filled pen,rheumatoid arthritis,Subsequent continuing treatment,14499,True,STREAMLINED,Any,4030,2024,AUGUST
+13227E,adalimumab,Yuflyma,Injection 40 mg in 0.4 mL pre-filled pen,rheumatoid arthritis,Subsequent continuing treatment,14499,True,STREAMLINED,Any,4030,2024,AUGUST
+13227E,adalimumab,Adalicip,Injection 40 mg in 0.4 mL pre-filled pen,rheumatoid arthritis,Subsequent continuing treatment,14499,True,STREAMLINED,Any,4030,2024,AUGUST
+5281Y,adalimumab,Hyrimoz,Injection 40 mg in 0.8 mL pre-filled syringe,juvenile idiopathic arthritis,Initial treatment - Initial 2 (change or recommencement of treatment after break in biological medicine of less than 24 months),,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+5281Y,adalimumab,Idacio,Injection 40 mg in 0.8 mL pre-filled syringe,juvenile idiopathic arthritis,Initial treatment - Initial 2 (change or recommencement of treatment after break in biological medicine of less than 24 months),,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+5281Y,adalimumab,Abrilada,Injection 40 mg in 0.8 mL pre-filled syringe,juvenile idiopathic arthritis,Initial treatment - Initial 2 (change or recommencement of treatment after break in biological medicine of less than 24 months),,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+5281Y,adalimumab,Hadlima,Injection 40 mg in 0.8 mL pre-filled syringe,juvenile idiopathic arthritis,Initial treatment - Initial 2 (change or recommencement of treatment after break in biological medicine of less than 24 months),,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+5281Y,adalimumab,Amgevita,Injection 40 mg in 0.8 mL pre-filled syringe,juvenile idiopathic arthritis,Initial treatment - Initial 2 (change or recommencement of treatment after break in biological medicine of less than 24 months),,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+5281Y,adalimumab,Hyrimoz,Injection 40 mg in 0.8 mL pre-filled syringe,juvenile idiopathic arthritis,Initial treatment - Initial 1 (new patient),,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+5281Y,adalimumab,Idacio,Injection 40 mg in 0.8 mL pre-filled syringe,juvenile idiopathic arthritis,Initial treatment - Initial 1 (new patient),,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+5281Y,adalimumab,Abrilada,Injection 40 mg in 0.8 mL pre-filled syringe,juvenile idiopathic arthritis,Initial treatment - Initial 1 (new patient),,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+5281Y,adalimumab,Hadlima,Injection 40 mg in 0.8 mL pre-filled syringe,juvenile idiopathic arthritis,Initial treatment - Initial 1 (new patient),,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+5281Y,adalimumab,Amgevita,Injection 40 mg in 0.8 mL pre-filled syringe,juvenile idiopathic arthritis,Initial treatment - Initial 1 (new patient),,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+5281Y,adalimumab,Hyrimoz,Injection 40 mg in 0.8 mL pre-filled syringe,juvenile idiopathic arthritis,Initial treatment - Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after break of less than 24 months) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months) -  balance of supply,,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+5281Y,adalimumab,Idacio,Injection 40 mg in 0.8 mL pre-filled syringe,juvenile idiopathic arthritis,Initial treatment - Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after break of less than 24 months) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months) -  balance of supply,,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+5281Y,adalimumab,Abrilada,Injection 40 mg in 0.8 mL pre-filled syringe,juvenile idiopathic arthritis,Initial treatment - Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after break of less than 24 months) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months) -  balance of supply,,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+5281Y,adalimumab,Hadlima,Injection 40 mg in 0.8 mL pre-filled syringe,juvenile idiopathic arthritis,Initial treatment - Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after break of less than 24 months) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months) -  balance of supply,,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+5281Y,adalimumab,Amgevita,Injection 40 mg in 0.8 mL pre-filled syringe,juvenile idiopathic arthritis,Initial treatment - Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after break of less than 24 months) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months) -  balance of supply,,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+5281Y,adalimumab,Hyrimoz,Injection 40 mg in 0.8 mL pre-filled syringe,juvenile idiopathic arthritis,Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months),,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+5281Y,adalimumab,Idacio,Injection 40 mg in 0.8 mL pre-filled syringe,juvenile idiopathic arthritis,Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months),,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+5281Y,adalimumab,Abrilada,Injection 40 mg in 0.8 mL pre-filled syringe,juvenile idiopathic arthritis,Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months),,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+5281Y,adalimumab,Hadlima,Injection 40 mg in 0.8 mL pre-filled syringe,juvenile idiopathic arthritis,Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months),,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+5281Y,adalimumab,Amgevita,Injection 40 mg in 0.8 mL pre-filled syringe,juvenile idiopathic arthritis,Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months),,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+12027B,certolizumab pegol,Cimzia,Solution for injection 200 mg in 1 mL pre-filled pen,non-radiographic axial spondyloarthritis,Initial treatment - Initial 3 (Recommencement of treatment after a break in biological medicine of more than 5 years),,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+12027B,certolizumab pegol,Cimzia,Solution for injection 200 mg in 1 mL pre-filled pen,non-radiographic axial spondyloarthritis,Initial treatment - Initial 1 (New patient),,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+12027B,certolizumab pegol,Cimzia,Solution for injection 200 mg in 1 mL pre-filled pen,non-radiographic axial spondyloarthritis,Initial treatment - Initial 2 (Change or re-commencement of treatment after a break in biological medicine of less than 5 years),,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+14276J,adalimumab,Abrilada,Injection 20 mg in 0.4 mL pre-filled syringe,juvenile idiopathic arthritis,Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 12 months),,True,AUTHORITY_REQUIRED,Private,4030,2024,AUGUST
+14276J,adalimumab,Abrilada,Injection 20 mg in 0.4 mL pre-filled syringe,juvenile idiopathic arthritis,Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 12 months),,True,AUTHORITY_REQUIRED,Private,4030,2024,AUGUST
+14276J,adalimumab,Abrilada,Injection 20 mg in 0.4 mL pre-filled syringe,juvenile idiopathic arthritis,Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 12 months) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 12 months) - balance of supply,,True,AUTHORITY_REQUIRED,Private,4030,2024,AUGUST
+14276J,adalimumab,Abrilada,Injection 20 mg in 0.4 mL pre-filled syringe,juvenile idiopathic arthritis,Initial treatment - Initial 1 (new patient),,True,AUTHORITY_REQUIRED,Private,4030,2024,AUGUST
+10078K,tocilizumab,Actemra,Concentrate for injection 400 mg in 20 mL,juvenile idiopathic arthritis,Initial treatment - Initial 1 (new patient),,False,AUTHORITY_REQUIRED,Private,4030,2024,AUGUST
+10078K,tocilizumab,Actemra,Concentrate for injection 400 mg in 20 mL,juvenile idiopathic arthritis,Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months),,False,AUTHORITY_REQUIRED,Private,4030,2024,AUGUST
+10078K,tocilizumab,Actemra,Concentrate for injection 400 mg in 20 mL,juvenile idiopathic arthritis,Initial treatment - Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after break of less than 24 months) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months) -  balance of supply,,True,AUTHORITY_REQUIRED,Private,4030,2024,AUGUST
+10078K,tocilizumab,Actemra,Concentrate for injection 400 mg in 20 mL,juvenile idiopathic arthritis,Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 24 months),,False,AUTHORITY_REQUIRED,Private,4030,2024,AUGUST
+10078K,tocilizumab,Actemra,Concentrate for injection 400 mg in 20 mL,juvenile idiopathic arthritis,Continuing Treatment - balance of supply,,True,AUTHORITY_REQUIRED,Private,4030,2024,AUGUST
+10078K,tocilizumab,Actemra,Concentrate for injection 400 mg in 20 mL,juvenile idiopathic arthritis,Continuing treatment,,False,AUTHORITY_REQUIRED,Private,4030,2024,AUGUST
+13755Y,tofacitinib,Xeljanz,Tablet 5 mg,juvenile idiopathic arthritis,Initial treatment - Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 12 months) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 12 months) - balance of supply,,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+13755Y,tofacitinib,Xeljanz,Tablet 5 mg,juvenile idiopathic arthritis,Initial treatment - Initial 1 (new patient),,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+13755Y,tofacitinib,Xeljanz,Tablet 5 mg,juvenile idiopathic arthritis,Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 12 months),,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+13755Y,tofacitinib,Xeljanz,Tablet 5 mg,juvenile idiopathic arthritis,Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 12 months),,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+1221G,abatacept,Orencia,Injection 125 mg in 1 mL single dose pre-filled syringe,rheumatoid arthritis,First continuing treatment,,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+1221G,abatacept,Orencia,Injection 125 mg in 1 mL single dose pre-filled syringe,rheumatoid arthritis,First continuing treatment - balance of supply,,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+11693K,abatacept,Orencia ClickJect,Injection 125 mg in 1 mL single dose autoinjector,rheumatoid arthritis,Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 24 months),,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+11693K,abatacept,Orencia ClickJect,Injection 125 mg in 1 mL single dose autoinjector,rheumatoid arthritis,Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months),,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+11693K,abatacept,Orencia ClickJect,Injection 125 mg in 1 mL single dose autoinjector,rheumatoid arthritis,Initial treatment - Initial 1 (new patient),,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+11693K,abatacept,Orencia ClickJect,Injection 125 mg in 1 mL single dose autoinjector,rheumatoid arthritis,Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 24 months) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months) - balance of supply,,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+11567T,tocilizumab,Actemra ACTPen,Injection 162 mg in 0.9 mL single use pre-filled pen,rheumatoid arthritis,First continuing treatment,,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+11567T,tocilizumab,Actemra ACTPen,Injection 162 mg in 0.9 mL single use pre-filled pen,rheumatoid arthritis,First continuing treatment - balance of supply,,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+13048R,infliximab,Remsima SC,Solution for injection 120 mg in 1 mL pre-filled pen,ankylosing spondylitis,Continuing treatment with subcutaneous form or switching from intravenous form to subcutaneous form,,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+8737W,adalimumab,Hadlima,Injection 40 mg in 0.8 mL pre-filled syringe,rheumatoid arthritis,Initial treatment - Initial 1 (new patient),,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+8737W,adalimumab,Idacio,Injection 40 mg in 0.8 mL pre-filled syringe,rheumatoid arthritis,Initial treatment - Initial 1 (new patient),,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+8737W,adalimumab,Amgevita,Injection 40 mg in 0.8 mL pre-filled syringe,rheumatoid arthritis,Initial treatment - Initial 1 (new patient),,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+8737W,adalimumab,Hyrimoz,Injection 40 mg in 0.8 mL pre-filled syringe,rheumatoid arthritis,Initial treatment - Initial 1 (new patient),,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+8737W,adalimumab,Abrilada,Injection 40 mg in 0.8 mL pre-filled syringe,rheumatoid arthritis,Initial treatment - Initial 1 (new patient),,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+8737W,adalimumab,Hadlima,Injection 40 mg in 0.8 mL pre-filled syringe,rheumatoid arthritis,Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 24 months),,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+8737W,adalimumab,Idacio,Injection 40 mg in 0.8 mL pre-filled syringe,rheumatoid arthritis,Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 24 months),,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+8737W,adalimumab,Amgevita,Injection 40 mg in 0.8 mL pre-filled syringe,rheumatoid arthritis,Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 24 months),,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+8737W,adalimumab,Hyrimoz,Injection 40 mg in 0.8 mL pre-filled syringe,rheumatoid arthritis,Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 24 months),,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+8737W,adalimumab,Abrilada,Injection 40 mg in 0.8 mL pre-filled syringe,rheumatoid arthritis,Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 24 months),,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+8737W,adalimumab,Hadlima,Injection 40 mg in 0.8 mL pre-filled syringe,rheumatoid arthritis,Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months),,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+8737W,adalimumab,Idacio,Injection 40 mg in 0.8 mL pre-filled syringe,rheumatoid arthritis,Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months),,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+8737W,adalimumab,Amgevita,Injection 40 mg in 0.8 mL pre-filled syringe,rheumatoid arthritis,Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months),,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+8737W,adalimumab,Hyrimoz,Injection 40 mg in 0.8 mL pre-filled syringe,rheumatoid arthritis,Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months),,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+8737W,adalimumab,Abrilada,Injection 40 mg in 0.8 mL pre-filled syringe,rheumatoid arthritis,Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months),,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+8737W,adalimumab,Hadlima,Injection 40 mg in 0.8 mL pre-filled syringe,rheumatoid arthritis,Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 24 months) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months) - balance of supply,,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+8737W,adalimumab,Idacio,Injection 40 mg in 0.8 mL pre-filled syringe,rheumatoid arthritis,Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 24 months) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months) - balance of supply,,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+8737W,adalimumab,Amgevita,Injection 40 mg in 0.8 mL pre-filled syringe,rheumatoid arthritis,Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 24 months) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months) - balance of supply,,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+8737W,adalimumab,Hyrimoz,Injection 40 mg in 0.8 mL pre-filled syringe,rheumatoid arthritis,Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 24 months) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months) - balance of supply,,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+8737W,adalimumab,Abrilada,Injection 40 mg in 0.8 mL pre-filled syringe,rheumatoid arthritis,Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 24 months) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months) - balance of supply,,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+3445H,etanercept,Enbrel,Injection set containing 4 vials powder for injection 25 mg and 4 pre-filled syringes solvent 1 mL,juvenile idiopathic arthritis,Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 24 months),,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+3445H,etanercept,Enbrel,Injection set containing 4 vials powder for injection 25 mg and 4 pre-filled syringes solvent 1 mL,juvenile idiopathic arthritis,Initial treatment - Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after break of less than 24 months) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months) -  balance of supply,,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+3445H,etanercept,Enbrel,Injection set containing 4 vials powder for injection 25 mg and 4 pre-filled syringes solvent 1 mL,juvenile idiopathic arthritis,Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months),,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+3445H,etanercept,Enbrel,Injection set containing 4 vials powder for injection 25 mg and 4 pre-filled syringes solvent 1 mL,juvenile idiopathic arthritis,Initial treatment - Initial 1 (new patient),,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+11623R,ixekizumab,Taltz,Injection 80 mg in 1 mL single dose pre-filled pen,psoriatic arthritis,Continuing treatment - balance of supply,,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+11623R,ixekizumab,Taltz,Injection 80 mg in 1 mL single dose pre-filled pen,psoriatic arthritis,Continuing treatment,,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+11623R,ixekizumab,Taltz,Injection 80 mg in 1 mL single dose pre-filled pen,psoriatic arthritis,Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years),,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+11623R,ixekizumab,Taltz,Injection 80 mg in 1 mL single dose pre-filled pen,psoriatic arthritis,Initial treatment - Initial 1 (new patient),,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+11623R,ixekizumab,Taltz,Injection 80 mg in 1 mL single dose pre-filled pen,psoriatic arthritis,Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years),,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+11623R,ixekizumab,Taltz,Injection 80 mg in 1 mL single dose pre-filled pen,psoriatic arthritis,Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years) - balance of supply,,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+11725D,tocilizumab,Actemra ACTPen,Injection 162 mg in 0.9 mL single use pre-filled pen,juvenile idiopathic arthritis,Initial treatment - Initial 1 (new patient),,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+11725D,tocilizumab,Actemra ACTPen,Injection 162 mg in 0.9 mL single use pre-filled pen,juvenile idiopathic arthritis,Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months),,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+11725D,tocilizumab,Actemra ACTPen,Injection 162 mg in 0.9 mL single use pre-filled pen,juvenile idiopathic arthritis,Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 24 months),,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+11725D,tocilizumab,Actemra ACTPen,Injection 162 mg in 0.9 mL single use pre-filled pen,juvenile idiopathic arthritis,Initial treatment - Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after break of less than 24 months) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months) -  balance of supply,,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+13724H,infliximab,Inflectra,Powder for I.V. infusion 100 mg,rheumatoid arthritis,Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months),,True,AUTHORITY_REQUIRED,Private,4030,2024,AUGUST
+13724H,infliximab,Renflexis,Powder for I.V. infusion 100 mg,rheumatoid arthritis,Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months),,True,AUTHORITY_REQUIRED,Private,4030,2024,AUGUST
+13724H,infliximab,Inflectra,Powder for I.V. infusion 100 mg,rheumatoid arthritis,Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 24 months) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months) - balance of supply,,True,AUTHORITY_REQUIRED,Private,4030,2024,AUGUST
+13724H,infliximab,Renflexis,Powder for I.V. infusion 100 mg,rheumatoid arthritis,Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 24 months) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months) - balance of supply,,True,AUTHORITY_REQUIRED,Private,4030,2024,AUGUST
+13724H,infliximab,Inflectra,Powder for I.V. infusion 100 mg,rheumatoid arthritis,Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 24 months),,True,AUTHORITY_REQUIRED,Private,4030,2024,AUGUST
+13724H,infliximab,Renflexis,Powder for I.V. infusion 100 mg,rheumatoid arthritis,Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 24 months),,True,AUTHORITY_REQUIRED,Private,4030,2024,AUGUST
+13724H,infliximab,Inflectra,Powder for I.V. infusion 100 mg,rheumatoid arthritis,Initial treatment - Initial 1 (new patient),,True,AUTHORITY_REQUIRED,Private,4030,2024,AUGUST
+13724H,infliximab,Renflexis,Powder for I.V. infusion 100 mg,rheumatoid arthritis,Initial treatment - Initial 1 (new patient),,True,AUTHORITY_REQUIRED,Private,4030,2024,AUGUST
+12438P,adalimumab,Hadlima,Injection 40 mg in 0.8 mL pre-filled syringe,psoriatic arthritis,Subsequent continuing treatment,11523,True,STREAMLINED,Any,4030,2024,AUGUST
+12438P,adalimumab,Idacio,Injection 40 mg in 0.8 mL pre-filled syringe,psoriatic arthritis,Subsequent continuing treatment,11523,True,STREAMLINED,Any,4030,2024,AUGUST
+12438P,adalimumab,Hyrimoz,Injection 40 mg in 0.8 mL pre-filled syringe,psoriatic arthritis,Subsequent continuing treatment,11523,True,STREAMLINED,Any,4030,2024,AUGUST
+12438P,adalimumab,Abrilada,Injection 40 mg in 0.8 mL pre-filled syringe,psoriatic arthritis,Subsequent continuing treatment,11523,True,STREAMLINED,Any,4030,2024,AUGUST
+12438P,adalimumab,Amgevita,Injection 40 mg in 0.8 mL pre-filled syringe,psoriatic arthritis,Subsequent continuing treatment,11523,True,STREAMLINED,Any,4030,2024,AUGUST
+10060L,tocilizumab,Actemra,Concentrate for injection 400 mg in 20 mL,juvenile idiopathic arthritis,Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 12 months),,True,AUTHORITY_REQUIRED,Private,4030,2024,AUGUST
+10060L,tocilizumab,Actemra,Concentrate for injection 400 mg in 20 mL,juvenile idiopathic arthritis,Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 12 months),,True,AUTHORITY_REQUIRED,Private,4030,2024,AUGUST
+10060L,tocilizumab,Actemra,Concentrate for injection 400 mg in 20 mL,juvenile idiopathic arthritis,Initial treatment - Initial 1 (new patient),,True,AUTHORITY_REQUIRED,Private,4030,2024,AUGUST
+10060L,tocilizumab,Actemra,Concentrate for injection 400 mg in 20 mL,juvenile idiopathic arthritis,Initial treatment - Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 12 months) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 12 months) - balance of supply,,True,AUTHORITY_REQUIRED,Private,4030,2024,AUGUST
+11741Y,tocilizumab,Actemra Subcutaneous Injection,Injection 162 mg in 0.9 mL single use pre-filled syringe,juvenile idiopathic arthritis,Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 24 months),,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+11741Y,tocilizumab,Actemra Subcutaneous Injection,Injection 162 mg in 0.9 mL single use pre-filled syringe,juvenile idiopathic arthritis,Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months),,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+11741Y,tocilizumab,Actemra Subcutaneous Injection,Injection 162 mg in 0.9 mL single use pre-filled syringe,juvenile idiopathic arthritis,Initial treatment - Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after break of less than 24 months) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months) -  balance of supply,,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+11741Y,tocilizumab,Actemra Subcutaneous Injection,Injection 162 mg in 0.9 mL single use pre-filled syringe,juvenile idiopathic arthritis,Initial treatment - Initial 1 (new patient),,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+12362P,adalimumab,Yuflyma,Injection 40 mg in 0.4 mL pre-filled pen,psoriatic arthritis,Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years),,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+12362P,adalimumab,Humira,Injection 40 mg in 0.4 mL pre-filled pen,psoriatic arthritis,Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years),,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+12362P,adalimumab,Adalicip,Injection 40 mg in 0.4 mL pre-filled pen,psoriatic arthritis,Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years),,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+12362P,adalimumab,Yuflyma,Injection 40 mg in 0.4 mL pre-filled pen,psoriatic arthritis,Initial treatment - Initial 1 (new patient),,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+12362P,adalimumab,Humira,Injection 40 mg in 0.4 mL pre-filled pen,psoriatic arthritis,Initial treatment - Initial 1 (new patient),,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+12362P,adalimumab,Adalicip,Injection 40 mg in 0.4 mL pre-filled pen,psoriatic arthritis,Initial treatment - Initial 1 (new patient),,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+12362P,adalimumab,Yuflyma,Injection 40 mg in 0.4 mL pre-filled pen,psoriatic arthritis,Initial treatment - Initial 2 (change or recommencement of treatment after a break in in biological medicine of less than 5 years),,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+12362P,adalimumab,Humira,Injection 40 mg in 0.4 mL pre-filled pen,psoriatic arthritis,Initial treatment - Initial 2 (change or recommencement of treatment after a break in in biological medicine of less than 5 years),,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+12362P,adalimumab,Adalicip,Injection 40 mg in 0.4 mL pre-filled pen,psoriatic arthritis,Initial treatment - Initial 2 (change or recommencement of treatment after a break in in biological medicine of less than 5 years),,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+12362P,adalimumab,Yuflyma,Injection 40 mg in 0.4 mL pre-filled pen,psoriatic arthritis,Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years) - balance of supply,,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+12362P,adalimumab,Humira,Injection 40 mg in 0.4 mL pre-filled pen,psoriatic arthritis,Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years) - balance of supply,,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+12362P,adalimumab,Adalicip,Injection 40 mg in 0.4 mL pre-filled pen,psoriatic arthritis,Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years) - balance of supply,,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+13708L,etanercept,Brenzys,"Injection 50 mg in 1 mL single use auto-injector, 4",rheumatoid arthritis,First continuing treatment,14629,True,STREAMLINED,Any,4030,2024,AUGUST
+11318Q,certolizumab pegol,Cimzia,Solution for injection 200 mg in 1 mL pre-filled pen,ankylosing spondylitis,"Initial treatment - Initial 1 (new patient), Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years) - balance of supply",,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+13330N,tocilizumab,Actemra,Concentrate for injection 200 mg in 10 mL,juvenile idiopathic arthritis,Continuing treatment,14093,True,STREAMLINED,Public,4030,2024,AUGUST
+12805Y,tocilizumab,Actemra,Concentrate for injection 400 mg in 20 mL,rheumatoid arthritis,Initial treatment - Initial 4 (Temporary listing - change of treatment from another biological medicine to tocilizumab after resolution of the critical shortage of tocilizumab),,True,AUTHORITY_REQUIRED,Private,4030,2024,AUGUST
+13301C,tocilizumab,Actemra Subcutaneous Injection,Injection 162 mg in 0.9 mL single use pre-filled syringe,juvenile idiopathic arthritis,Continuing treatment,14104,True,STREAMLINED,Any,4030,2024,AUGUST
+9671B,tocilizumab,Actemra,Concentrate for injection 80 mg in 4 mL,rheumatoid arthritis,Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 24 months) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months) - balance of supply,,True,AUTHORITY_REQUIRED,Private,4030,2024,AUGUST
+9671B,tocilizumab,Actemra,Concentrate for injection 80 mg in 4 mL,rheumatoid arthritis,Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months),,False,AUTHORITY_REQUIRED,Private,4030,2024,AUGUST
+9671B,tocilizumab,Actemra,Concentrate for injection 80 mg in 4 mL,rheumatoid arthritis,Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 24 months),,False,AUTHORITY_REQUIRED,Private,4030,2024,AUGUST
+9671B,tocilizumab,Actemra,Concentrate for injection 80 mg in 4 mL,rheumatoid arthritis,First continuing treatment,,False,AUTHORITY_REQUIRED,Private,4030,2024,AUGUST
+9671B,tocilizumab,Actemra,Concentrate for injection 80 mg in 4 mL,rheumatoid arthritis,First continuing treatment - balance of supply,,True,AUTHORITY_REQUIRED,Private,4030,2024,AUGUST
+9671B,tocilizumab,Actemra,Concentrate for injection 80 mg in 4 mL,rheumatoid arthritis,Initial treatment - Initial 1 (new patient),,False,AUTHORITY_REQUIRED,Private,4030,2024,AUGUST
+3450N,etanercept,Enbrel,"Injection 50 mg in 1 mL single use auto-injector, 4",juvenile idiopathic arthritis,Continuing Treatment - balance of supply,,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+3450N,etanercept,Enbrel,"Injection 50 mg in 1 mL single use auto-injector, 4",juvenile idiopathic arthritis,Continuing treatment,,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+11487N,infliximab,Inflectra,Powder for I.V. infusion 100 mg,rheumatoid arthritis,Subsequent continuing treatment,,False,AUTHORITY_REQUIRED,Private,4030,2024,AUGUST
+11487N,infliximab,Remicade,Powder for I.V. infusion 100 mg,rheumatoid arthritis,Subsequent continuing treatment,,False,AUTHORITY_REQUIRED,Private,4030,2024,AUGUST
+11487N,infliximab,Renflexis,Powder for I.V. infusion 100 mg,rheumatoid arthritis,Subsequent continuing treatment,,False,AUTHORITY_REQUIRED,Private,4030,2024,AUGUST
+9456Q,etanercept,Brenzys,"Injection 50 mg in 1 mL single use auto-injector, 4",ankylosing spondylitis,First continuing treatment,,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+9456Q,etanercept,Enbrel,"Injection 50 mg in 1 mL single use auto-injector, 4",ankylosing spondylitis,First continuing treatment,,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+9456Q,etanercept,Brenzys,"Injection 50 mg in 1 mL single use auto-injector, 4",ankylosing spondylitis,Continuing treatment - balance of supply,,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+9456Q,etanercept,Enbrel,"Injection 50 mg in 1 mL single use auto-injector, 4",ankylosing spondylitis,Continuing treatment - balance of supply,,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+12398M,adalimumab,Adalicip,Injection 40 mg in 0.4 mL pre-filled syringe,psoriatic arthritis,First continuing treatment,,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+12398M,adalimumab,Humira,Injection 40 mg in 0.4 mL pre-filled syringe,psoriatic arthritis,First continuing treatment,,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+12398M,adalimumab,Yuflyma,Injection 40 mg in 0.4 mL pre-filled syringe,psoriatic arthritis,First continuing treatment,,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+12398M,adalimumab,Adalicip,Injection 40 mg in 0.4 mL pre-filled syringe,psoriatic arthritis,Subsequent continuing treatment,,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+12398M,adalimumab,Humira,Injection 40 mg in 0.4 mL pre-filled syringe,psoriatic arthritis,Subsequent continuing treatment,,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+12398M,adalimumab,Yuflyma,Injection 40 mg in 0.4 mL pre-filled syringe,psoriatic arthritis,Subsequent continuing treatment,,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+12398M,adalimumab,Adalicip,Injection 40 mg in 0.4 mL pre-filled syringe,psoriatic arthritis,Continuing treatment - balance of supply,,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+12398M,adalimumab,Humira,Injection 40 mg in 0.4 mL pre-filled syringe,psoriatic arthritis,Continuing treatment - balance of supply,,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+12398M,adalimumab,Yuflyma,Injection 40 mg in 0.4 mL pre-filled syringe,psoriatic arthritis,Continuing treatment - balance of supply,,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+3425G,certolizumab pegol,Cimzia,Injection 200 mg in 1 mL single use pre-filled syringe,rheumatoid arthritis,First continuing treatment,,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+3425G,certolizumab pegol,Cimzia,Injection 200 mg in 1 mL single use pre-filled syringe,rheumatoid arthritis,First continuing treatment - balance of supply,,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+9621J,abatacept,Orencia,Powder for I.V. infusion 250 mg,rheumatoid arthritis,First continuing treatment,,False,AUTHORITY_REQUIRED,Private,4030,2024,AUGUST
+9621J,abatacept,Orencia,Powder for I.V. infusion 250 mg,rheumatoid arthritis,Initial treatment - Initial 1 (new patient),,False,AUTHORITY_REQUIRED,Private,4030,2024,AUGUST
+9621J,abatacept,Orencia,Powder for I.V. infusion 250 mg,rheumatoid arthritis,Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months),,False,AUTHORITY_REQUIRED,Private,4030,2024,AUGUST
+9621J,abatacept,Orencia,Powder for I.V. infusion 250 mg,rheumatoid arthritis,Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 24 months) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months) - balance of supply,,True,AUTHORITY_REQUIRED,Private,4030,2024,AUGUST
+9621J,abatacept,Orencia,Powder for I.V. infusion 250 mg,rheumatoid arthritis,Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 24 months),,False,AUTHORITY_REQUIRED,Private,4030,2024,AUGUST
+9621J,abatacept,Orencia,Powder for I.V. infusion 250 mg,rheumatoid arthritis,First continuing treatment - balance of supply,,True,AUTHORITY_REQUIRED,Private,4030,2024,AUGUST
+13306H,tocilizumab,Actemra ACTPen,Injection 162 mg in 0.9 mL single use pre-filled pen,juvenile idiopathic arthritis,Continuing treatment,14104,True,STREAMLINED,Any,4030,2024,AUGUST
+12063X,certolizumab pegol,Cimzia,Injection 200 mg in 1 mL single use pre-filled syringe,non-radiographic axial spondyloarthritis,Initial treatment - Initial 2 (Change or re-commencement of treatment after a break in biological medicine of less than 5 years),,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+12063X,certolizumab pegol,Cimzia,Injection 200 mg in 1 mL single use pre-filled syringe,non-radiographic axial spondyloarthritis,Initial treatment - Initial 1 (New patient),,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+12063X,certolizumab pegol,Cimzia,Injection 200 mg in 1 mL single use pre-filled syringe,non-radiographic axial spondyloarthritis,Initial treatment - Initial 3 (Recommencement of treatment after a break in biological medicine of more than 5 years),,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+13700C,infliximab,Inflectra,Powder for I.V. infusion 100 mg,rheumatoid arthritis,First continuing treatment,14585,True,STREAMLINED,Private,4030,2024,AUGUST
+13700C,infliximab,Renflexis,Powder for I.V. infusion 100 mg,rheumatoid arthritis,First continuing treatment,14585,True,STREAMLINED,Private,4030,2024,AUGUST
+9457R,etanercept,Brenzys,"Injection 50 mg in 1 mL single use auto-injector, 4",psoriatic arthritis,Initial treatment - Initial 1 (new patient),,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+9457R,etanercept,Enbrel,"Injection 50 mg in 1 mL single use auto-injector, 4",psoriatic arthritis,Initial treatment - Initial 1 (new patient),,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+9457R,etanercept,Brenzys,"Injection 50 mg in 1 mL single use auto-injector, 4",psoriatic arthritis,Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years),,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+9457R,etanercept,Enbrel,"Injection 50 mg in 1 mL single use auto-injector, 4",psoriatic arthritis,Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years),,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+9457R,etanercept,Brenzys,"Injection 50 mg in 1 mL single use auto-injector, 4",psoriatic arthritis,Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years),,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+9457R,etanercept,Enbrel,"Injection 50 mg in 1 mL single use auto-injector, 4",psoriatic arthritis,Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years),,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+9457R,etanercept,Brenzys,"Injection 50 mg in 1 mL single use auto-injector, 4",psoriatic arthritis,Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years) - balance of supply,,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+9457R,etanercept,Enbrel,"Injection 50 mg in 1 mL single use auto-injector, 4",psoriatic arthritis,Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years) - balance of supply,,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+11215G,etanercept,Brenzys,"Injection 50 mg in 1 mL single use auto-injector, 4",ankylosing spondylitis,First continuing treatment,14683,True,STREAMLINED,Any,4030,2024,AUGUST
+11215G,etanercept,Brenzys,"Injection 50 mg in 1 mL single use auto-injector, 4",ankylosing spondylitis,Subsequent continuing treatment,14701,True,STREAMLINED,Any,4030,2024,AUGUST
+10899P,secukinumab,Cosentyx,Injection 150 mg in 1 mL pre-filled pen,psoriatic arthritis,Continuing treatment,,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+10899P,secukinumab,Cosentyx,Injection 150 mg in 1 mL pre-filled pen,psoriatic arthritis,Continuing treatment - balance of supply,,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+14286X,adalimumab,Abrilada,Injection 20 mg in 0.4 mL pre-filled syringe,juvenile idiopathic arthritis,Continuing treatment,14136,True,STREAMLINED,Public,4030,2024,AUGUST
+12028C,certolizumab pegol,Cimzia,Solution for injection 200 mg in 1 mL pre-filled pen,non-radiographic axial spondyloarthritis,Continuing treatment,,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+11319R,certolizumab pegol,Cimzia,Solution for injection 200 mg in 1 mL pre-filled pen,ankylosing spondylitis,Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years),,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+11319R,certolizumab pegol,Cimzia,Solution for injection 200 mg in 1 mL pre-filled pen,ankylosing spondylitis,Initial treatment - Initial 1 (new patient),,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+11319R,certolizumab pegol,Cimzia,Solution for injection 200 mg in 1 mL pre-filled pen,ankylosing spondylitis,Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years),,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+12768B,tocilizumab,Actemra Subcutaneous Injection,Injection 162 mg in 0.9 mL single use pre-filled syringe,juvenile idiopathic arthritis,Initial treatment - Initial 4 (Temporary listing - change of treatment from another biological medicine to tocilizumab after resolution of the critical shortage of tocilizumab),,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+13329M,tocilizumab,Actemra,Concentrate for injection 200 mg in 10 mL,juvenile idiopathic arthritis,Continuing treatment,14179,True,STREAMLINED,Private,4030,2024,AUGUST
+11372M,golimumab,Simponi,Injection 50 mg in 0.5 mL single use pre-filled pen,rheumatoid arthritis,Initial treatment - Initial 1 (new patient),,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+11372M,golimumab,Simponi,Injection 50 mg in 0.5 mL single use pre-filled pen,rheumatoid arthritis,Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months),,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+11372M,golimumab,Simponi,Injection 50 mg in 0.5 mL single use pre-filled pen,rheumatoid arthritis,Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 24 months),,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+11372M,golimumab,Simponi,Injection 50 mg in 0.5 mL single use pre-filled pen,rheumatoid arthritis,Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 24 months) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months) - balance of supply,,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+12766X,tocilizumab,Actemra,Concentrate for injection 200 mg in 10 mL,rheumatoid arthritis,Initial treatment - Initial 4 (Temporary listing - change of treatment from another biological medicine to tocilizumab after resolution of the critical shortage of tocilizumab),,True,AUTHORITY_REQUIRED,Private,4030,2024,AUGUST
+12083Y,tocilizumab,Actemra ACTPen,Injection 162 mg in 0.9 mL single use pre-filled pen,juvenile idiopathic arthritis,Initial treatment - Initial 2 (retrial or recommencement of treatment after a break of less than 12 months in a patient weighing at least 30 kg),,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+12083Y,tocilizumab,Actemra ACTPen,Injection 162 mg in 0.9 mL single use pre-filled pen,juvenile idiopathic arthritis,Initial treatment - Initial 1 (new patient weighing at least 30 kg),,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+12083Y,tocilizumab,Actemra ACTPen,Injection 162 mg in 0.9 mL single use pre-filled pen,juvenile idiopathic arthritis,Initial treatment - Initial 3 (recommencement of treatment after a break of more than 12 months in a patient weighing at least 30 kg),,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+13049T,infliximab,Remsima SC,Solution for injection 120 mg in 1 mL pre-filled pen,ankylosing spondylitis,Initial treatment with the subcutaneous form where a concurrent PBS authority application for the intravenously (IV) administered formulation is being made,,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+11373N,golimumab,Simponi,Injection 50 mg in 0.5 mL single use pre-filled pen,psoriatic arthritis,Continuing treatment,,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+11373N,golimumab,Simponi,Injection 50 mg in 0.5 mL single use pre-filled pen,psoriatic arthritis,Continuing treatment - balance of supply,,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+13730P,tofacitinib,Xeljanz,Tablet 5 mg,rheumatoid arthritis,Subsequent continuing treatment,14499,True,STREAMLINED,Any,4030,2024,AUGUST
+3432P,golimumab,Simponi,Injection 50 mg in 0.5 mL single use pre-filled syringe,psoriatic arthritis,Continuing treatment - balance of supply,,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+3432P,golimumab,Simponi,Injection 50 mg in 0.5 mL single use pre-filled syringe,psoriatic arthritis,Continuing treatment,,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+12431G,adalimumab,Yuflyma,Injection 40 mg in 0.4 mL pre-filled syringe,juvenile idiopathic arthritis,Initial treatment - Initial 1 (new patient),,True,AUTHORITY_REQUIRED,Public,4030,2024,AUGUST
+12431G,adalimumab,Humira,Injection 40 mg in 0.4 mL pre-filled syringe,juvenile idiopathic arthritis,Initial treatment - Initial 1 (new patient),,True,AUTHORITY_REQUIRED,Public,4030,2024,AUGUST
+12431G,adalimumab,Adalicip,Injection 40 mg in 0.4 mL pre-filled syringe,juvenile idiopathic arthritis,Initial treatment - Initial 1 (new patient),,True,AUTHORITY_REQUIRED,Public,4030,2024,AUGUST
+12431G,adalimumab,Yuflyma,Injection 40 mg in 0.4 mL pre-filled syringe,juvenile idiopathic arthritis,Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 12 months),,True,AUTHORITY_REQUIRED,Public,4030,2024,AUGUST
+12431G,adalimumab,Humira,Injection 40 mg in 0.4 mL pre-filled syringe,juvenile idiopathic arthritis,Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 12 months),,True,AUTHORITY_REQUIRED,Public,4030,2024,AUGUST
+12431G,adalimumab,Adalicip,Injection 40 mg in 0.4 mL pre-filled syringe,juvenile idiopathic arthritis,Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 12 months),,True,AUTHORITY_REQUIRED,Public,4030,2024,AUGUST
+12431G,adalimumab,Yuflyma,Injection 40 mg in 0.4 mL pre-filled syringe,juvenile idiopathic arthritis,Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 12 months) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 12 months) - balance of supply,,True,AUTHORITY_REQUIRED,Public,4030,2024,AUGUST
+12431G,adalimumab,Humira,Injection 40 mg in 0.4 mL pre-filled syringe,juvenile idiopathic arthritis,Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 12 months) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 12 months) - balance of supply,,True,AUTHORITY_REQUIRED,Public,4030,2024,AUGUST
+12431G,adalimumab,Adalicip,Injection 40 mg in 0.4 mL pre-filled syringe,juvenile idiopathic arthritis,Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 12 months) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 12 months) - balance of supply,,True,AUTHORITY_REQUIRED,Public,4030,2024,AUGUST
+12431G,adalimumab,Yuflyma,Injection 40 mg in 0.4 mL pre-filled syringe,juvenile idiopathic arthritis,Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 12 months),,True,AUTHORITY_REQUIRED,Public,4030,2024,AUGUST
+12431G,adalimumab,Humira,Injection 40 mg in 0.4 mL pre-filled syringe,juvenile idiopathic arthritis,Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 12 months),,True,AUTHORITY_REQUIRED,Public,4030,2024,AUGUST
+12431G,adalimumab,Adalicip,Injection 40 mg in 0.4 mL pre-filled syringe,juvenile idiopathic arthritis,Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 12 months),,True,AUTHORITY_REQUIRED,Public,4030,2024,AUGUST
+3436W,golimumab,Simponi,Injection 50 mg in 0.5 mL single use pre-filled syringe,ankylosing spondylitis,Continuing treatment - balance of supply,,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+3436W,golimumab,Simponi,Injection 50 mg in 0.5 mL single use pre-filled syringe,ankylosing spondylitis,Continuing treatment,,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+14189T,anifrolumab,Saphnelo,Solution concentrate for I.V. infusion 300 mg in 2 mL,systemic lupus erythematosus,Continuing or recommencement of treatment (within 12 months of a treatment break),,True,AUTHORITY_REQUIRED,Private,4030,2024,AUGUST
+14189T,anifrolumab,Saphnelo,Solution concentrate for I.V. infusion 300 mg in 2 mL,systemic lupus erythematosus,Initial treatment,,False,AUTHORITY_REQUIRED,Private,4030,2024,AUGUST
+14189T,anifrolumab,Saphnelo,Solution concentrate for I.V. infusion 300 mg in 2 mL,systemic lupus erythematosus,Transitioning from non-PBS to PBS-subsidised supply - Grandfather arrangements,,False,AUTHORITY_REQUIRED,Private,4030,2024,AUGUST
+13764K,adalimumab,Yuflyma,Injection 40 mg in 0.4 mL pre-filled pen,ankylosing spondylitis,Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years),,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+13764K,adalimumab,Adalicip,Injection 40 mg in 0.4 mL pre-filled pen,ankylosing spondylitis,Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years),,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+13764K,adalimumab,Yuflyma,Injection 40 mg in 0.4 mL pre-filled pen,ankylosing spondylitis,Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years),,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+13764K,adalimumab,Adalicip,Injection 40 mg in 0.4 mL pre-filled pen,ankylosing spondylitis,Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years),,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+13764K,adalimumab,Yuflyma,Injection 40 mg in 0.4 mL pre-filled pen,ankylosing spondylitis,Initial treatment - Initial 1 (new patient),,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+13764K,adalimumab,Adalicip,Injection 40 mg in 0.4 mL pre-filled pen,ankylosing spondylitis,Initial treatment - Initial 1 (new patient),,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+10905Y,certolizumab pegol,Cimzia,Injection 200 mg in 1 mL single use pre-filled syringe,rheumatoid arthritis,Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 24 months),,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+10905Y,certolizumab pegol,Cimzia,Injection 200 mg in 1 mL single use pre-filled syringe,rheumatoid arthritis,Initial treatment - Initial 1 (new patient),,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+10905Y,certolizumab pegol,Cimzia,Injection 200 mg in 1 mL single use pre-filled syringe,rheumatoid arthritis,Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months),,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+13319B,etanercept,Enbrel,"Injection 50 mg in 1 mL single use auto-injector, 4",juvenile idiopathic arthritis,Continuing treatment,14154,True,STREAMLINED,Public,4030,2024,AUGUST
+10954M,tocilizumab,Actemra Subcutaneous Injection,Injection 162 mg in 0.9 mL single use pre-filled syringe,rheumatoid arthritis,First continuing treatment - balance of supply,,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+10954M,tocilizumab,Actemra Subcutaneous Injection,Injection 162 mg in 0.9 mL single use pre-filled syringe,rheumatoid arthritis,First continuing treatment,,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+13078H,infliximab,Remsima SC,Solution for injection 120 mg in 1 mL pre-filled syringe,psoriatic arthritis,Balance of supply (including switching formulation) where the full duration of treatment available under a particular treatment phase was not requested in the preceding prescription,,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+13690M,tocilizumab,Actemra,Concentrate for injection 80 mg in 4 mL,rheumatoid arthritis,Subsequent continuing treatment,14621,True,STREAMLINED,Public,4030,2024,AUGUST
+13721E,adalimumab,Abrilada,Injection 40 mg in 0.8 mL pre-filled syringe,rheumatoid arthritis,First continuing treatment,14567,True,STREAMLINED,Any,4030,2024,AUGUST
+13721E,adalimumab,Hadlima,Injection 40 mg in 0.8 mL pre-filled syringe,rheumatoid arthritis,First continuing treatment,14567,True,STREAMLINED,Any,4030,2024,AUGUST
+13721E,adalimumab,Idacio,Injection 40 mg in 0.8 mL pre-filled syringe,rheumatoid arthritis,First continuing treatment,14567,True,STREAMLINED,Any,4030,2024,AUGUST
+13721E,adalimumab,Amgevita,Injection 40 mg in 0.8 mL pre-filled syringe,rheumatoid arthritis,First continuing treatment,14567,True,STREAMLINED,Any,4030,2024,AUGUST
+13721E,adalimumab,Hyrimoz,Injection 40 mg in 0.8 mL pre-filled syringe,rheumatoid arthritis,First continuing treatment,14567,True,STREAMLINED,Any,4030,2024,AUGUST
+12555T,infliximab,Remsima SC,Solution for injection 120 mg in 1 mL pre-filled syringe,rheumatoid arthritis,"Balance of supply for Initial treatment, Continuing treatment - subcutaneous form",,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+12439Q,adalimumab,Amgevita,Injection 20 mg in 0.4 mL pre-filled syringe,juvenile idiopathic arthritis,Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 12 months),,True,AUTHORITY_REQUIRED,Private,4030,2024,AUGUST
+12439Q,adalimumab,Amgevita,Injection 20 mg in 0.4 mL pre-filled syringe,juvenile idiopathic arthritis,Initial treatment - Initial 1 (new patient),,True,AUTHORITY_REQUIRED,Private,4030,2024,AUGUST
+12439Q,adalimumab,Amgevita,Injection 20 mg in 0.4 mL pre-filled syringe,juvenile idiopathic arthritis,Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 12 months) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 12 months) - balance of supply,,True,AUTHORITY_REQUIRED,Private,4030,2024,AUGUST
+12439Q,adalimumab,Amgevita,Injection 20 mg in 0.4 mL pre-filled syringe,juvenile idiopathic arthritis,Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 12 months),,True,AUTHORITY_REQUIRED,Private,4030,2024,AUGUST
+10071C,tocilizumab,Actemra,Concentrate for injection 200 mg in 10 mL,juvenile idiopathic arthritis,Continuing Treatment - balance of supply,,True,AUTHORITY_REQUIRED,Private,4030,2024,AUGUST
+10071C,tocilizumab,Actemra,Concentrate for injection 200 mg in 10 mL,juvenile idiopathic arthritis,Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months),,False,AUTHORITY_REQUIRED,Private,4030,2024,AUGUST
+10071C,tocilizumab,Actemra,Concentrate for injection 200 mg in 10 mL,juvenile idiopathic arthritis,Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 24 months),,False,AUTHORITY_REQUIRED,Private,4030,2024,AUGUST
+10071C,tocilizumab,Actemra,Concentrate for injection 200 mg in 10 mL,juvenile idiopathic arthritis,Continuing treatment,,False,AUTHORITY_REQUIRED,Private,4030,2024,AUGUST
+10071C,tocilizumab,Actemra,Concentrate for injection 200 mg in 10 mL,juvenile idiopathic arthritis,Initial treatment - Initial 1 (new patient),,False,AUTHORITY_REQUIRED,Private,4030,2024,AUGUST
+10071C,tocilizumab,Actemra,Concentrate for injection 200 mg in 10 mL,juvenile idiopathic arthritis,Initial treatment - Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after break of less than 24 months) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months) -  balance of supply,,True,AUTHORITY_REQUIRED,Private,4030,2024,AUGUST
+13326J,etanercept,Enbrel,"Injection 50 mg in 1 mL single use auto-injector, 4",juvenile idiopathic arthritis,Continuing treatment,14155,True,STREAMLINED,Private,4030,2024,AUGUST
+12095N,tocilizumab,Actemra Subcutaneous Injection,Injection 162 mg in 0.9 mL single use pre-filled syringe,juvenile idiopathic arthritis,Initial treatment - Initial 1 (new patient weighing at least 30 kg),,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+12095N,tocilizumab,Actemra Subcutaneous Injection,Injection 162 mg in 0.9 mL single use pre-filled syringe,juvenile idiopathic arthritis,Initial treatment - Initial 3 (recommencement of treatment after a break of more than 12 months in a patient weighing at least 30 kg),,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+12095N,tocilizumab,Actemra Subcutaneous Injection,Injection 162 mg in 0.9 mL single use pre-filled syringe,juvenile idiopathic arthritis,Initial treatment - Initial 2 (retrial or recommencement of treatment after a break of less than 12 months in a patient weighing at least 30 kg),,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+13229G,adalimumab,Humira,Injection 40 mg in 0.4 mL pre-filled pen,juvenile idiopathic arthritis,Continuing treatment,14107,True,STREAMLINED,Private,4030,2024,AUGUST
+13229G,adalimumab,Yuflyma,Injection 40 mg in 0.4 mL pre-filled pen,juvenile idiopathic arthritis,Continuing treatment,14107,True,STREAMLINED,Private,4030,2024,AUGUST
+13229G,adalimumab,Adalicip,Injection 40 mg in 0.4 mL pre-filled pen,juvenile idiopathic arthritis,Continuing treatment,14107,True,STREAMLINED,Private,4030,2024,AUGUST
+10081N,tocilizumab,Actemra,Concentrate for injection 80 mg in 4 mL,juvenile idiopathic arthritis,Continuing Treatment - balance of supply,,True,AUTHORITY_REQUIRED,Public,4030,2024,AUGUST
+10081N,tocilizumab,Actemra,Concentrate for injection 80 mg in 4 mL,juvenile idiopathic arthritis,Initial treatment - Initial 1 (new patient),,False,AUTHORITY_REQUIRED,Public,4030,2024,AUGUST
+10081N,tocilizumab,Actemra,Concentrate for injection 80 mg in 4 mL,juvenile idiopathic arthritis,Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months),,False,AUTHORITY_REQUIRED,Public,4030,2024,AUGUST
+10081N,tocilizumab,Actemra,Concentrate for injection 80 mg in 4 mL,juvenile idiopathic arthritis,Continuing treatment,,False,AUTHORITY_REQUIRED,Public,4030,2024,AUGUST
+10081N,tocilizumab,Actemra,Concentrate for injection 80 mg in 4 mL,juvenile idiopathic arthritis,Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 24 months),,False,AUTHORITY_REQUIRED,Public,4030,2024,AUGUST
+10081N,tocilizumab,Actemra,Concentrate for injection 80 mg in 4 mL,juvenile idiopathic arthritis,Initial treatment - Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after break of less than 24 months) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months) -  balance of supply,,True,AUTHORITY_REQUIRED,Public,4030,2024,AUGUST
+12005W,certolizumab pegol,Cimzia,Injection 200 mg in 1 mL single use pre-filled syringe,non-radiographic axial spondyloarthritis,Continuing treatment,,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+10906B,secukinumab,Cosentyx,Injection 150 mg in 1 mL pre-filled pen,ankylosing spondylitis,Continuing treatment - balance of supply,,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+10906B,secukinumab,Cosentyx,Injection 150 mg in 1 mL pre-filled pen,ankylosing spondylitis,Continuing treatment,,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+11219L,etanercept,Enbrel,"Injections 50 mg in 1 mL single use pre-filled syringes, 4",rheumatoid arthritis,Subsequent continuing treatment,,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+11219L,etanercept,Brenzys,"Injections 50 mg in 1 mL single use pre-filled syringes, 4",rheumatoid arthritis,Subsequent continuing treatment,,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+11219L,etanercept,Enbrel,"Injections 50 mg in 1 mL single use pre-filled syringes, 4",rheumatoid arthritis,Continuing treatment - balance of supply,,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+11219L,etanercept,Brenzys,"Injections 50 mg in 1 mL single use pre-filled syringes, 4",rheumatoid arthritis,Continuing treatment - balance of supply,,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+1464C,tocilizumab,Actemra,Concentrate for injection 400 mg in 20 mL,juvenile idiopathic arthritis,Balance of supply for Initial treatment - Initial 1 (new patient) or Initial 2 (retrial or recommencement of treatment after a break of less than 12 months) or Initial 3 (recommencement of treatment after a break of more than 12 months),,True,AUTHORITY_REQUIRED,Private,4030,2024,AUGUST
+1464C,tocilizumab,Actemra,Concentrate for injection 400 mg in 20 mL,juvenile idiopathic arthritis,Initial treatment - Initial 3 (recommencement of treatment after a break of more than 12 months),,True,AUTHORITY_REQUIRED,Private,4030,2024,AUGUST
+1464C,tocilizumab,Actemra,Concentrate for injection 400 mg in 20 mL,juvenile idiopathic arthritis,Initial treatment - Initial 2 (retrial or recommencement of treatment after a break of less than 12 months),,True,AUTHORITY_REQUIRED,Private,4030,2024,AUGUST
+1464C,tocilizumab,Actemra,Concentrate for injection 400 mg in 20 mL,juvenile idiopathic arthritis,Initial treatment - Initial 1 (new patient),,True,AUTHORITY_REQUIRED,Private,4030,2024,AUGUST
+12375H,adalimumab,Humira,Injection 40 mg in 0.4 mL pre-filled pen,psoriatic arthritis,Continuing treatment - balance of supply,,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+12375H,adalimumab,Yuflyma,Injection 40 mg in 0.4 mL pre-filled pen,psoriatic arthritis,Continuing treatment - balance of supply,,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+12375H,adalimumab,Adalicip,Injection 40 mg in 0.4 mL pre-filled pen,psoriatic arthritis,Continuing treatment - balance of supply,,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+12375H,adalimumab,Humira,Injection 40 mg in 0.4 mL pre-filled pen,psoriatic arthritis,Subsequent continuing treatment,,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+12375H,adalimumab,Yuflyma,Injection 40 mg in 0.4 mL pre-filled pen,psoriatic arthritis,Subsequent continuing treatment,,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+12375H,adalimumab,Adalicip,Injection 40 mg in 0.4 mL pre-filled pen,psoriatic arthritis,Subsequent continuing treatment,,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+12375H,adalimumab,Humira,Injection 40 mg in 0.4 mL pre-filled pen,psoriatic arthritis,First continuing treatment,,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+12375H,adalimumab,Yuflyma,Injection 40 mg in 0.4 mL pre-filled pen,psoriatic arthritis,First continuing treatment,,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+12375H,adalimumab,Adalicip,Injection 40 mg in 0.4 mL pre-filled pen,psoriatic arthritis,First continuing treatment,,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+9679K,adalimumab,Idacio,Injection 40 mg in 0.8 mL pre-filled syringe,juvenile idiopathic arthritis,Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 12 months),,True,AUTHORITY_REQUIRED,Private,4030,2024,AUGUST
+9679K,adalimumab,Hyrimoz,Injection 40 mg in 0.8 mL pre-filled syringe,juvenile idiopathic arthritis,Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 12 months),,True,AUTHORITY_REQUIRED,Private,4030,2024,AUGUST
+9679K,adalimumab,Hadlima,Injection 40 mg in 0.8 mL pre-filled syringe,juvenile idiopathic arthritis,Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 12 months),,True,AUTHORITY_REQUIRED,Private,4030,2024,AUGUST
+9679K,adalimumab,Amgevita,Injection 40 mg in 0.8 mL pre-filled syringe,juvenile idiopathic arthritis,Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 12 months),,True,AUTHORITY_REQUIRED,Private,4030,2024,AUGUST
+9679K,adalimumab,Abrilada,Injection 40 mg in 0.8 mL pre-filled syringe,juvenile idiopathic arthritis,Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 12 months),,True,AUTHORITY_REQUIRED,Private,4030,2024,AUGUST
+9679K,adalimumab,Idacio,Injection 40 mg in 0.8 mL pre-filled syringe,juvenile idiopathic arthritis,Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 12 months) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 12 months) - balance of supply,,True,AUTHORITY_REQUIRED,Private,4030,2024,AUGUST
+9679K,adalimumab,Hyrimoz,Injection 40 mg in 0.8 mL pre-filled syringe,juvenile idiopathic arthritis,Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 12 months) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 12 months) - balance of supply,,True,AUTHORITY_REQUIRED,Private,4030,2024,AUGUST
+9679K,adalimumab,Hadlima,Injection 40 mg in 0.8 mL pre-filled syringe,juvenile idiopathic arthritis,Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 12 months) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 12 months) - balance of supply,,True,AUTHORITY_REQUIRED,Private,4030,2024,AUGUST
+9679K,adalimumab,Amgevita,Injection 40 mg in 0.8 mL pre-filled syringe,juvenile idiopathic arthritis,Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 12 months) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 12 months) - balance of supply,,True,AUTHORITY_REQUIRED,Private,4030,2024,AUGUST
+9679K,adalimumab,Abrilada,Injection 40 mg in 0.8 mL pre-filled syringe,juvenile idiopathic arthritis,Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 12 months) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 12 months) - balance of supply,,True,AUTHORITY_REQUIRED,Private,4030,2024,AUGUST
+9679K,adalimumab,Idacio,Injection 40 mg in 0.8 mL pre-filled syringe,juvenile idiopathic arthritis,Initial treatment - Initial 1 (new patient),,True,AUTHORITY_REQUIRED,Private,4030,2024,AUGUST
+9679K,adalimumab,Hyrimoz,Injection 40 mg in 0.8 mL pre-filled syringe,juvenile idiopathic arthritis,Initial treatment - Initial 1 (new patient),,True,AUTHORITY_REQUIRED,Private,4030,2024,AUGUST
+9679K,adalimumab,Hadlima,Injection 40 mg in 0.8 mL pre-filled syringe,juvenile idiopathic arthritis,Initial treatment - Initial 1 (new patient),,True,AUTHORITY_REQUIRED,Private,4030,2024,AUGUST
+9679K,adalimumab,Amgevita,Injection 40 mg in 0.8 mL pre-filled syringe,juvenile idiopathic arthritis,Initial treatment - Initial 1 (new patient),,True,AUTHORITY_REQUIRED,Private,4030,2024,AUGUST
+9679K,adalimumab,Abrilada,Injection 40 mg in 0.8 mL pre-filled syringe,juvenile idiopathic arthritis,Initial treatment - Initial 1 (new patient),,True,AUTHORITY_REQUIRED,Private,4030,2024,AUGUST
+9679K,adalimumab,Idacio,Injection 40 mg in 0.8 mL pre-filled syringe,juvenile idiopathic arthritis,Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 12 months),,True,AUTHORITY_REQUIRED,Private,4030,2024,AUGUST
+9679K,adalimumab,Hyrimoz,Injection 40 mg in 0.8 mL pre-filled syringe,juvenile idiopathic arthritis,Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 12 months),,True,AUTHORITY_REQUIRED,Private,4030,2024,AUGUST
+9679K,adalimumab,Hadlima,Injection 40 mg in 0.8 mL pre-filled syringe,juvenile idiopathic arthritis,Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 12 months),,True,AUTHORITY_REQUIRED,Private,4030,2024,AUGUST
+9679K,adalimumab,Amgevita,Injection 40 mg in 0.8 mL pre-filled syringe,juvenile idiopathic arthritis,Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 12 months),,True,AUTHORITY_REQUIRED,Private,4030,2024,AUGUST
+9679K,adalimumab,Abrilada,Injection 40 mg in 0.8 mL pre-filled syringe,juvenile idiopathic arthritis,Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 12 months),,True,AUTHORITY_REQUIRED,Private,4030,2024,AUGUST
+10056G,tocilizumab,Actemra,Concentrate for injection 200 mg in 10 mL,juvenile idiopathic arthritis,Initial treatment - Initial 1 (new patient),,True,AUTHORITY_REQUIRED,Public,4030,2024,AUGUST
+10056G,tocilizumab,Actemra,Concentrate for injection 200 mg in 10 mL,juvenile idiopathic arthritis,Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 12 months),,True,AUTHORITY_REQUIRED,Public,4030,2024,AUGUST
+10056G,tocilizumab,Actemra,Concentrate for injection 200 mg in 10 mL,juvenile idiopathic arthritis,Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 12 months),,True,AUTHORITY_REQUIRED,Public,4030,2024,AUGUST
+10056G,tocilizumab,Actemra,Concentrate for injection 200 mg in 10 mL,juvenile idiopathic arthritis,Initial treatment - Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 12 months) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 12 months) - balance of supply,,True,AUTHORITY_REQUIRED,Public,4030,2024,AUGUST
+12802T,tocilizumab,Actemra,Concentrate for injection 400 mg in 20 mL,juvenile idiopathic arthritis,Initial treatment - Initial 4 (Temporary listing - change of treatment from another biological medicine to tocilizumab after resolution of the critical shortage of tocilizumab),,True,AUTHORITY_REQUIRED,Public,4030,2024,AUGUST
+12802T,tocilizumab,Actemra,Concentrate for injection 400 mg in 20 mL,juvenile idiopathic arthritis,Initial treatment - Initial 4 (Temporary listing - change of treatment from another biological medicine to tocilzumab after resolution of the critical shortage of tocilizumab),,True,AUTHORITY_REQUIRED,Public,4030,2024,AUGUST
+10894J,secukinumab,Cosentyx,Injection 150 mg in 1 mL pre-filled pen,psoriatic arthritis,Initial treatment - Initial 1 (new patient),,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+10894J,secukinumab,Cosentyx,Injection 150 mg in 1 mL pre-filled pen,psoriatic arthritis,Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years),,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+10894J,secukinumab,Cosentyx,Injection 150 mg in 1 mL pre-filled pen,psoriatic arthritis,Initial treatment - Initial 2 (change or recommencement of treatment after a break in in biological medicine of less than 5 years),,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+13069W,infliximab,Remsima SC,Solution for injection 120 mg in 1 mL pre-filled syringe,ankylosing spondylitis,Continuing treatment with subcutaneous form or switching from intravenous form to subcutaneous form,,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+12430F,adalimumab,Humira,Injection 40 mg in 0.4 mL pre-filled syringe,rheumatoid arthritis,First continuing treatment,,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+12430F,adalimumab,Yuflyma,Injection 40 mg in 0.4 mL pre-filled syringe,rheumatoid arthritis,First continuing treatment,,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+12430F,adalimumab,Adalicip,Injection 40 mg in 0.4 mL pre-filled syringe,rheumatoid arthritis,First continuing treatment,,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+12430F,adalimumab,Humira,Injection 40 mg in 0.4 mL pre-filled syringe,rheumatoid arthritis,First continuing treatment - balance of supply,,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+12430F,adalimumab,Yuflyma,Injection 40 mg in 0.4 mL pre-filled syringe,rheumatoid arthritis,First continuing treatment - balance of supply,,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+12430F,adalimumab,Adalicip,Injection 40 mg in 0.4 mL pre-filled syringe,rheumatoid arthritis,First continuing treatment - balance of supply,,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+10511F,tofacitinib,Xeljanz,Tablet 5 mg,rheumatoid arthritis,First continuing treatment,,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+10511F,tofacitinib,Xeljanz,Tablet 5 mg,rheumatoid arthritis,First continuing treatment - balance of supply,,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+11482H,infliximab,Inflectra,Powder for I.V. infusion 100 mg,ankylosing spondylitis,Subsequent continuing treatment,,False,AUTHORITY_REQUIRED,Public,4030,2024,AUGUST
+11482H,infliximab,Renflexis,Powder for I.V. infusion 100 mg,ankylosing spondylitis,Subsequent continuing treatment,,False,AUTHORITY_REQUIRED,Public,4030,2024,AUGUST
+11482H,infliximab,Remicade,Powder for I.V. infusion 100 mg,ankylosing spondylitis,Subsequent continuing treatment,,False,AUTHORITY_REQUIRED,Public,4030,2024,AUGUST
+8741C,adalimumab,Idacio,Injection 40 mg in 0.8 mL pre-filled syringe,rheumatoid arthritis,First continuing treatment,,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+8741C,adalimumab,Hadlima,Injection 40 mg in 0.8 mL pre-filled syringe,rheumatoid arthritis,First continuing treatment,,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+8741C,adalimumab,Abrilada,Injection 40 mg in 0.8 mL pre-filled syringe,rheumatoid arthritis,First continuing treatment,,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+8741C,adalimumab,Amgevita,Injection 40 mg in 0.8 mL pre-filled syringe,rheumatoid arthritis,First continuing treatment,,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+8741C,adalimumab,Hyrimoz,Injection 40 mg in 0.8 mL pre-filled syringe,rheumatoid arthritis,First continuing treatment,,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+8741C,adalimumab,Idacio,Injection 40 mg in 0.8 mL pre-filled syringe,rheumatoid arthritis,First continuing treatment - balance of supply,,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+8741C,adalimumab,Hadlima,Injection 40 mg in 0.8 mL pre-filled syringe,rheumatoid arthritis,First continuing treatment - balance of supply,,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+8741C,adalimumab,Abrilada,Injection 40 mg in 0.8 mL pre-filled syringe,rheumatoid arthritis,First continuing treatment - balance of supply,,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+8741C,adalimumab,Amgevita,Injection 40 mg in 0.8 mL pre-filled syringe,rheumatoid arthritis,First continuing treatment - balance of supply,,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+8741C,adalimumab,Hyrimoz,Injection 40 mg in 0.8 mL pre-filled syringe,rheumatoid arthritis,First continuing treatment - balance of supply,,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+9672C,tocilizumab,Actemra,Concentrate for injection 200 mg in 10 mL,rheumatoid arthritis,Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 24 months),,False,AUTHORITY_REQUIRED,Private,4030,2024,AUGUST
+9672C,tocilizumab,Actemra,Concentrate for injection 200 mg in 10 mL,rheumatoid arthritis,Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 24 months) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months) - balance of supply,,True,AUTHORITY_REQUIRED,Private,4030,2024,AUGUST
+9672C,tocilizumab,Actemra,Concentrate for injection 200 mg in 10 mL,rheumatoid arthritis,First continuing treatment,,False,AUTHORITY_REQUIRED,Private,4030,2024,AUGUST
+9672C,tocilizumab,Actemra,Concentrate for injection 200 mg in 10 mL,rheumatoid arthritis,Initial treatment - Initial 1 (new patient),,False,AUTHORITY_REQUIRED,Private,4030,2024,AUGUST
+9672C,tocilizumab,Actemra,Concentrate for injection 200 mg in 10 mL,rheumatoid arthritis,First continuing treatment - balance of supply,,True,AUTHORITY_REQUIRED,Private,4030,2024,AUGUST
+9672C,tocilizumab,Actemra,Concentrate for injection 200 mg in 10 mL,rheumatoid arthritis,Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months),,False,AUTHORITY_REQUIRED,Private,4030,2024,AUGUST
+9099X,adalimumab,Abrilada,Injection 40 mg in 0.8 mL pre-filled pen,rheumatoid arthritis,Initial treatment - Initial 1 (new patient),,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+9099X,adalimumab,Hadlima,Injection 40 mg in 0.8 mL pre-filled pen,rheumatoid arthritis,Initial treatment - Initial 1 (new patient),,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+9099X,adalimumab,Hyrimoz,Injection 40 mg in 0.8 mL pre-filled pen,rheumatoid arthritis,Initial treatment - Initial 1 (new patient),,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+9099X,adalimumab,Idacio,Injection 40 mg in 0.8 mL pre-filled pen,rheumatoid arthritis,Initial treatment - Initial 1 (new patient),,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+9099X,adalimumab,Amgevita,Injection 40 mg in 0.8 mL pre-filled pen,rheumatoid arthritis,Initial treatment - Initial 1 (new patient),,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+9099X,adalimumab,Abrilada,Injection 40 mg in 0.8 mL pre-filled pen,rheumatoid arthritis,Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 24 months),,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+9099X,adalimumab,Hadlima,Injection 40 mg in 0.8 mL pre-filled pen,rheumatoid arthritis,Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 24 months),,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+9099X,adalimumab,Hyrimoz,Injection 40 mg in 0.8 mL pre-filled pen,rheumatoid arthritis,Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 24 months),,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+9099X,adalimumab,Idacio,Injection 40 mg in 0.8 mL pre-filled pen,rheumatoid arthritis,Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 24 months),,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+9099X,adalimumab,Amgevita,Injection 40 mg in 0.8 mL pre-filled pen,rheumatoid arthritis,Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 24 months),,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+9099X,adalimumab,Abrilada,Injection 40 mg in 0.8 mL pre-filled pen,rheumatoid arthritis,Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months),,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+9099X,adalimumab,Hadlima,Injection 40 mg in 0.8 mL pre-filled pen,rheumatoid arthritis,Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months),,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+9099X,adalimumab,Hyrimoz,Injection 40 mg in 0.8 mL pre-filled pen,rheumatoid arthritis,Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months),,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+9099X,adalimumab,Idacio,Injection 40 mg in 0.8 mL pre-filled pen,rheumatoid arthritis,Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months),,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+9099X,adalimumab,Amgevita,Injection 40 mg in 0.8 mL pre-filled pen,rheumatoid arthritis,Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months),,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+9099X,adalimumab,Abrilada,Injection 40 mg in 0.8 mL pre-filled pen,rheumatoid arthritis,Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 24 months) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months) - balance of supply,,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+9099X,adalimumab,Hadlima,Injection 40 mg in 0.8 mL pre-filled pen,rheumatoid arthritis,Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 24 months) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months) - balance of supply,,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+9099X,adalimumab,Hyrimoz,Injection 40 mg in 0.8 mL pre-filled pen,rheumatoid arthritis,Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 24 months) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months) - balance of supply,,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+9099X,adalimumab,Idacio,Injection 40 mg in 0.8 mL pre-filled pen,rheumatoid arthritis,Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 24 months) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months) - balance of supply,,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+9099X,adalimumab,Amgevita,Injection 40 mg in 0.8 mL pre-filled pen,rheumatoid arthritis,Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 24 months) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months) - balance of supply,,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+13727L,abatacept,Orencia ClickJect,Injection 125 mg in 1 mL single dose autoinjector,rheumatoid arthritis,Subsequent continuing treatment,14604,True,STREAMLINED,Any,4030,2024,AUGUST
+9459W,etanercept,Brenzys,"Injection 50 mg in 1 mL single use auto-injector, 4",rheumatoid arthritis,Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 24 months) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months) - balance of supply,,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+9459W,etanercept,Enbrel,"Injection 50 mg in 1 mL single use auto-injector, 4",rheumatoid arthritis,Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 24 months) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months) - balance of supply,,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+9459W,etanercept,Brenzys,"Injection 50 mg in 1 mL single use auto-injector, 4",rheumatoid arthritis,Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months),,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+9459W,etanercept,Enbrel,"Injection 50 mg in 1 mL single use auto-injector, 4",rheumatoid arthritis,Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months),,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+9459W,etanercept,Brenzys,"Injection 50 mg in 1 mL single use auto-injector, 4",rheumatoid arthritis,Initial treatment - Initial 1 (new patient),,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+9459W,etanercept,Enbrel,"Injection 50 mg in 1 mL single use auto-injector, 4",rheumatoid arthritis,Initial treatment - Initial 1 (new patient),,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+9459W,etanercept,Brenzys,"Injection 50 mg in 1 mL single use auto-injector, 4",rheumatoid arthritis,Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 24 months),,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+9459W,etanercept,Enbrel,"Injection 50 mg in 1 mL single use auto-injector, 4",rheumatoid arthritis,Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 24 months),,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+10774C,ustekinumab,Stelara,Injection 45 mg in 0.5 mL,psoriatic arthritis,"Initial treatment - Initial 1 (new patient), Initial 2 (change or recommencement of treatment after a break in medicine of less than 5 years) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years) - balance of supply",,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+10774C,ustekinumab,Stelara,Injection 45 mg in 0.5 mL,psoriatic arthritis,Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years),,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+10774C,ustekinumab,Stelara,Injection 45 mg in 0.5 mL,psoriatic arthritis,Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years),,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+10774C,ustekinumab,Stelara,Injection 45 mg in 0.5 mL,psoriatic arthritis,Initial treatment - Initial 1 (new patient),,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+12085C,tocilizumab,Actemra ACTPen,Injection 162 mg in 0.9 mL single use pre-filled pen,juvenile idiopathic arthritis,Initial treatment - Initial 3 (recommencement of a new treatment cycle after a break of more than 12 months in a patient weighing less than 30 kg),,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+12085C,tocilizumab,Actemra ACTPen,Injection 162 mg in 0.9 mL single use pre-filled pen,juvenile idiopathic arthritis,Initial treatment - Initial 1 (new patient weighing less than 30 kg),,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+12085C,tocilizumab,Actemra ACTPen,Injection 162 mg in 0.9 mL single use pre-filled pen,juvenile idiopathic arthritis,Initial treatment - Initial 2 (retrial or recommencement of treatment after a break of less than 12 months in a patient weighing less than 30 kg),,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+9086F,etanercept,Brenzys,"Injections 50 mg in 1 mL single use pre-filled syringes, 4",ankylosing spondylitis,First continuing treatment,,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+9086F,etanercept,Enbrel,"Injections 50 mg in 1 mL single use pre-filled syringes, 4",ankylosing spondylitis,First continuing treatment,,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+9086F,etanercept,Brenzys,"Injections 50 mg in 1 mL single use pre-filled syringes, 4",ankylosing spondylitis,Continuing treatment - balance of supply,,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+9086F,etanercept,Enbrel,"Injections 50 mg in 1 mL single use pre-filled syringes, 4",ankylosing spondylitis,Continuing treatment - balance of supply,,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+8637N,etanercept,Enbrel,Injection set containing 4 vials powder for injection 25 mg and 4 pre-filled syringes solvent 1 mL,rheumatoid arthritis,Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months),,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+8637N,etanercept,Enbrel,Injection set containing 4 vials powder for injection 25 mg and 4 pre-filled syringes solvent 1 mL,rheumatoid arthritis,Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 24 months) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months) - balance of supply,,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+8637N,etanercept,Enbrel,Injection set containing 4 vials powder for injection 25 mg and 4 pre-filled syringes solvent 1 mL,rheumatoid arthritis,Initial treatment - Initial 1 (new patient),,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+8637N,etanercept,Enbrel,Injection set containing 4 vials powder for injection 25 mg and 4 pre-filled syringes solvent 1 mL,rheumatoid arthritis,Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 24 months),,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+11218K,etanercept,Brenzys,"Injection 50 mg in 1 mL single use auto-injector, 4",rheumatoid arthritis,Subsequent continuing treatment,14499,True,STREAMLINED,Any,4030,2024,AUGUST
+11218K,etanercept,Enbrel,"Injection 50 mg in 1 mL single use auto-injector, 4",rheumatoid arthritis,Subsequent continuing treatment,14499,True,STREAMLINED,Any,4030,2024,AUGUST
+10901R,secukinumab,Cosentyx,Injection 150 mg in 1 mL pre-filled pen,psoriatic arthritis,Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years) - balance of supply,,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+13208E,adalimumab,Yuflyma,Injection 40 mg in 0.4 mL pre-filled syringe,ankylosing spondylitis,Subsequent continuing treatment,14701,True,STREAMLINED,Any,4030,2024,AUGUST
+13208E,adalimumab,Adalicip,Injection 40 mg in 0.4 mL pre-filled syringe,ankylosing spondylitis,Subsequent continuing treatment,14701,True,STREAMLINED,Any,4030,2024,AUGUST
+13208E,adalimumab,Yuflyma,Injection 40 mg in 0.4 mL pre-filled syringe,ankylosing spondylitis,First continuing treatment,14683,True,STREAMLINED,Any,4030,2024,AUGUST
+13208E,adalimumab,Adalicip,Injection 40 mg in 0.4 mL pre-filled syringe,ankylosing spondylitis,First continuing treatment,14683,True,STREAMLINED,Any,4030,2024,AUGUST
+13294Q,etanercept,Enbrel,Injection set containing 4 vials powder for injection 25 mg and 4 pre-filled syringes solvent 1 mL,juvenile idiopathic arthritis,Continuing treatment,14154,True,STREAMLINED,Public,4030,2024,AUGUST
+10068X,tocilizumab,Actemra,Concentrate for injection 80 mg in 4 mL,juvenile idiopathic arthritis,Initial treatment - Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 12 months) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 12 months) - balance of supply,,True,AUTHORITY_REQUIRED,Private,4030,2024,AUGUST
+10068X,tocilizumab,Actemra,Concentrate for injection 80 mg in 4 mL,juvenile idiopathic arthritis,Initial treatment - Initial 1 (new patient),,True,AUTHORITY_REQUIRED,Private,4030,2024,AUGUST
+10068X,tocilizumab,Actemra,Concentrate for injection 80 mg in 4 mL,juvenile idiopathic arthritis,Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 12 months),,True,AUTHORITY_REQUIRED,Private,4030,2024,AUGUST
+10068X,tocilizumab,Actemra,Concentrate for injection 80 mg in 4 mL,juvenile idiopathic arthritis,Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 12 months),,True,AUTHORITY_REQUIRED,Private,4030,2024,AUGUST
+11325C,certolizumab pegol,Cimzia,Solution for injection 200 mg in 1 mL pre-filled pen,rheumatoid arthritis,First continuing treatment - balance of supply,,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+11325C,certolizumab pegol,Cimzia,Solution for injection 200 mg in 1 mL pre-filled pen,rheumatoid arthritis,First continuing treatment,,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+13210G,adalimumab,Humira,Injection 40 mg in 0.4 mL pre-filled syringe,juvenile idiopathic arthritis,Continuing treatment,14107,True,STREAMLINED,Private,4030,2024,AUGUST
+13210G,adalimumab,Yuflyma,Injection 40 mg in 0.4 mL pre-filled syringe,juvenile idiopathic arthritis,Continuing treatment,14107,True,STREAMLINED,Private,4030,2024,AUGUST
+13210G,adalimumab,Adalicip,Injection 40 mg in 0.4 mL pre-filled syringe,juvenile idiopathic arthritis,Continuing treatment,14107,True,STREAMLINED,Private,4030,2024,AUGUST
+11730J,tocilizumab,Actemra Subcutaneous Injection,Injection 162 mg in 0.9 mL single use pre-filled syringe,juvenile idiopathic arthritis,Continuing treatment,,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+11730J,tocilizumab,Actemra Subcutaneous Injection,Injection 162 mg in 0.9 mL single use pre-filled syringe,juvenile idiopathic arthritis,Continuing Treatment - balance of supply,,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+9662M,adalimumab,Abrilada,Injection 40 mg in 0.8 mL pre-filled syringe,juvenile idiopathic arthritis,Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 12 months),,True,AUTHORITY_REQUIRED,Public,4030,2024,AUGUST
+9662M,adalimumab,Hadlima,Injection 40 mg in 0.8 mL pre-filled syringe,juvenile idiopathic arthritis,Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 12 months),,True,AUTHORITY_REQUIRED,Public,4030,2024,AUGUST
+9662M,adalimumab,Idacio,Injection 40 mg in 0.8 mL pre-filled syringe,juvenile idiopathic arthritis,Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 12 months),,True,AUTHORITY_REQUIRED,Public,4030,2024,AUGUST
+9662M,adalimumab,Amgevita,Injection 40 mg in 0.8 mL pre-filled syringe,juvenile idiopathic arthritis,Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 12 months),,True,AUTHORITY_REQUIRED,Public,4030,2024,AUGUST
+9662M,adalimumab,Hyrimoz,Injection 40 mg in 0.8 mL pre-filled syringe,juvenile idiopathic arthritis,Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 12 months),,True,AUTHORITY_REQUIRED,Public,4030,2024,AUGUST
+9662M,adalimumab,Abrilada,Injection 40 mg in 0.8 mL pre-filled syringe,juvenile idiopathic arthritis,Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 12 months) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 12 months) - balance of supply,,True,AUTHORITY_REQUIRED,Public,4030,2024,AUGUST
+9662M,adalimumab,Hadlima,Injection 40 mg in 0.8 mL pre-filled syringe,juvenile idiopathic arthritis,Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 12 months) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 12 months) - balance of supply,,True,AUTHORITY_REQUIRED,Public,4030,2024,AUGUST
+9662M,adalimumab,Idacio,Injection 40 mg in 0.8 mL pre-filled syringe,juvenile idiopathic arthritis,Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 12 months) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 12 months) - balance of supply,,True,AUTHORITY_REQUIRED,Public,4030,2024,AUGUST
+9662M,adalimumab,Amgevita,Injection 40 mg in 0.8 mL pre-filled syringe,juvenile idiopathic arthritis,Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 12 months) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 12 months) - balance of supply,,True,AUTHORITY_REQUIRED,Public,4030,2024,AUGUST
+9662M,adalimumab,Hyrimoz,Injection 40 mg in 0.8 mL pre-filled syringe,juvenile idiopathic arthritis,Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 12 months) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 12 months) - balance of supply,,True,AUTHORITY_REQUIRED,Public,4030,2024,AUGUST
+9662M,adalimumab,Abrilada,Injection 40 mg in 0.8 mL pre-filled syringe,juvenile idiopathic arthritis,Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 12 months),,True,AUTHORITY_REQUIRED,Public,4030,2024,AUGUST
+9662M,adalimumab,Hadlima,Injection 40 mg in 0.8 mL pre-filled syringe,juvenile idiopathic arthritis,Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 12 months),,True,AUTHORITY_REQUIRED,Public,4030,2024,AUGUST
+9662M,adalimumab,Idacio,Injection 40 mg in 0.8 mL pre-filled syringe,juvenile idiopathic arthritis,Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 12 months),,True,AUTHORITY_REQUIRED,Public,4030,2024,AUGUST
+9662M,adalimumab,Amgevita,Injection 40 mg in 0.8 mL pre-filled syringe,juvenile idiopathic arthritis,Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 12 months),,True,AUTHORITY_REQUIRED,Public,4030,2024,AUGUST
+9662M,adalimumab,Hyrimoz,Injection 40 mg in 0.8 mL pre-filled syringe,juvenile idiopathic arthritis,Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 12 months),,True,AUTHORITY_REQUIRED,Public,4030,2024,AUGUST
+9662M,adalimumab,Abrilada,Injection 40 mg in 0.8 mL pre-filled syringe,juvenile idiopathic arthritis,Initial treatment - Initial 1 (new patient),,True,AUTHORITY_REQUIRED,Public,4030,2024,AUGUST
+9662M,adalimumab,Hadlima,Injection 40 mg in 0.8 mL pre-filled syringe,juvenile idiopathic arthritis,Initial treatment - Initial 1 (new patient),,True,AUTHORITY_REQUIRED,Public,4030,2024,AUGUST
+9662M,adalimumab,Idacio,Injection 40 mg in 0.8 mL pre-filled syringe,juvenile idiopathic arthritis,Initial treatment - Initial 1 (new patient),,True,AUTHORITY_REQUIRED,Public,4030,2024,AUGUST
+9662M,adalimumab,Amgevita,Injection 40 mg in 0.8 mL pre-filled syringe,juvenile idiopathic arthritis,Initial treatment - Initial 1 (new patient),,True,AUTHORITY_REQUIRED,Public,4030,2024,AUGUST
+9662M,adalimumab,Hyrimoz,Injection 40 mg in 0.8 mL pre-filled syringe,juvenile idiopathic arthritis,Initial treatment - Initial 1 (new patient),,True,AUTHORITY_REQUIRED,Public,4030,2024,AUGUST
+13765L,infliximab,Inflectra,Powder for I.V. infusion 100 mg,ankylosing spondylitis,Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years),,True,AUTHORITY_REQUIRED,Public,4030,2024,AUGUST
+13765L,infliximab,Renflexis,Powder for I.V. infusion 100 mg,ankylosing spondylitis,Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years),,True,AUTHORITY_REQUIRED,Public,4030,2024,AUGUST
+13765L,infliximab,Inflectra,Powder for I.V. infusion 100 mg,ankylosing spondylitis,Initial treatment - Initial 1 (new patient),,True,AUTHORITY_REQUIRED,Public,4030,2024,AUGUST
+13765L,infliximab,Renflexis,Powder for I.V. infusion 100 mg,ankylosing spondylitis,Initial treatment - Initial 1 (new patient),,True,AUTHORITY_REQUIRED,Public,4030,2024,AUGUST
+13765L,infliximab,Inflectra,Powder for I.V. infusion 100 mg,ankylosing spondylitis,Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years),,True,AUTHORITY_REQUIRED,Public,4030,2024,AUGUST
+13765L,infliximab,Renflexis,Powder for I.V. infusion 100 mg,ankylosing spondylitis,Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years),,True,AUTHORITY_REQUIRED,Public,4030,2024,AUGUST
+13702E,baricitinib,Olumiant,Tablet 4 mg,rheumatoid arthritis,Subsequent continuing treatment,14499,True,STREAMLINED,Any,4030,2024,AUGUST
+10896L,certolizumab pegol,Cimzia,Injection 200 mg in 1 mL single use pre-filled syringe,psoriatic arthritis,Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years) - balance of supply,,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+11488P,infliximab,Inflectra,Powder for I.V. infusion 100 mg,ankylosing spondylitis,First continuing treatment,14689,True,STREAMLINED,Private,4030,2024,AUGUST
+11488P,infliximab,Renflexis,Powder for I.V. infusion 100 mg,ankylosing spondylitis,First continuing treatment,14689,True,STREAMLINED,Private,4030,2024,AUGUST
+11488P,infliximab,Inflectra,Powder for I.V. infusion 100 mg,ankylosing spondylitis,Subsequent continuing treatment,14723,True,STREAMLINED,Private,4030,2024,AUGUST
+11488P,infliximab,Renflexis,Powder for I.V. infusion 100 mg,ankylosing spondylitis,Subsequent continuing treatment,14723,True,STREAMLINED,Private,4030,2024,AUGUST
+5734T,etanercept,Enbrel,Injection set containing 4 vials powder for injection 25 mg and 4 pre-filled syringes solvent 1 mL,juvenile idiopathic arthritis,Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 12 months),,True,AUTHORITY_REQUIRED,Public,4030,2024,AUGUST
+5734T,etanercept,Enbrel,Injection set containing 4 vials powder for injection 25 mg and 4 pre-filled syringes solvent 1 mL,juvenile idiopathic arthritis,Initial treatment - Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 12 months) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 12 months) - balance of supply,,True,AUTHORITY_REQUIRED,Public,4030,2024,AUGUST
+5734T,etanercept,Enbrel,Injection set containing 4 vials powder for injection 25 mg and 4 pre-filled syringes solvent 1 mL,juvenile idiopathic arthritis,Initial treatment - Initial 1 (new patient),,True,AUTHORITY_REQUIRED,Public,4030,2024,AUGUST
+5734T,etanercept,Enbrel,Injection set containing 4 vials powder for injection 25 mg and 4 pre-filled syringes solvent 1 mL,juvenile idiopathic arthritis,Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 12 months),,True,AUTHORITY_REQUIRED,Public,4030,2024,AUGUST
+11442F,baricitinib,Olumiant,Tablet 2 mg,rheumatoid arthritis,First continuing treatment - balance of supply,,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+11442F,baricitinib,Olumiant,Tablet 2 mg,rheumatoid arthritis,First continuing treatment,,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+5756Y,infliximab,Inflectra,Powder for I.V. infusion 100 mg,psoriatic arthritis,Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years),,False,AUTHORITY_REQUIRED,Public,4030,2024,AUGUST
+5756Y,infliximab,Remicade,Powder for I.V. infusion 100 mg,psoriatic arthritis,Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years),,False,AUTHORITY_REQUIRED,Public,4030,2024,AUGUST
+5756Y,infliximab,Renflexis,Powder for I.V. infusion 100 mg,psoriatic arthritis,Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years),,False,AUTHORITY_REQUIRED,Public,4030,2024,AUGUST
+5756Y,infliximab,Inflectra,Powder for I.V. infusion 100 mg,psoriatic arthritis,First continuing treatment,,False,AUTHORITY_REQUIRED,Public,4030,2024,AUGUST
+5756Y,infliximab,Remicade,Powder for I.V. infusion 100 mg,psoriatic arthritis,First continuing treatment,,False,AUTHORITY_REQUIRED,Public,4030,2024,AUGUST
+5756Y,infliximab,Renflexis,Powder for I.V. infusion 100 mg,psoriatic arthritis,First continuing treatment,,False,AUTHORITY_REQUIRED,Public,4030,2024,AUGUST
+5756Y,infliximab,Inflectra,Powder for I.V. infusion 100 mg,psoriatic arthritis,Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years),,False,AUTHORITY_REQUIRED,Public,4030,2024,AUGUST
+5756Y,infliximab,Remicade,Powder for I.V. infusion 100 mg,psoriatic arthritis,Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years),,False,AUTHORITY_REQUIRED,Public,4030,2024,AUGUST
+5756Y,infliximab,Renflexis,Powder for I.V. infusion 100 mg,psoriatic arthritis,Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years),,False,AUTHORITY_REQUIRED,Public,4030,2024,AUGUST
+5756Y,infliximab,Inflectra,Powder for I.V. infusion 100 mg,psoriatic arthritis,Continuing treatment - balance of supply,,True,AUTHORITY_REQUIRED,Public,4030,2024,AUGUST
+5756Y,infliximab,Remicade,Powder for I.V. infusion 100 mg,psoriatic arthritis,Continuing treatment - balance of supply,,True,AUTHORITY_REQUIRED,Public,4030,2024,AUGUST
+5756Y,infliximab,Renflexis,Powder for I.V. infusion 100 mg,psoriatic arthritis,Continuing treatment - balance of supply,,True,AUTHORITY_REQUIRED,Public,4030,2024,AUGUST
+5756Y,infliximab,Inflectra,Powder for I.V. infusion 100 mg,psoriatic arthritis,Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years) - balance of supply,,True,AUTHORITY_REQUIRED,Public,4030,2024,AUGUST
+5756Y,infliximab,Remicade,Powder for I.V. infusion 100 mg,psoriatic arthritis,Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years) - balance of supply,,True,AUTHORITY_REQUIRED,Public,4030,2024,AUGUST
+5756Y,infliximab,Renflexis,Powder for I.V. infusion 100 mg,psoriatic arthritis,Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years) - balance of supply,,True,AUTHORITY_REQUIRED,Public,4030,2024,AUGUST
+5756Y,infliximab,Inflectra,Powder for I.V. infusion 100 mg,psoriatic arthritis,Initial treatment - Initial 1 (new patient),,False,AUTHORITY_REQUIRED,Public,4030,2024,AUGUST
+5756Y,infliximab,Remicade,Powder for I.V. infusion 100 mg,psoriatic arthritis,Initial treatment - Initial 1 (new patient),,False,AUTHORITY_REQUIRED,Public,4030,2024,AUGUST
+5756Y,infliximab,Renflexis,Powder for I.V. infusion 100 mg,psoriatic arthritis,Initial treatment - Initial 1 (new patient),,False,AUTHORITY_REQUIRED,Public,4030,2024,AUGUST
+11515C,infliximab,Inflectra,Powder for I.V. infusion 100 mg,psoriatic arthritis,Subsequent continuing treatment,9472,True,STREAMLINED,Private,4030,2024,AUGUST
+11515C,infliximab,Renflexis,Powder for I.V. infusion 100 mg,psoriatic arthritis,Subsequent continuing treatment,9472,True,STREAMLINED,Private,4030,2024,AUGUST
+11217J,etanercept,Brenzys,"Injections 50 mg in 1 mL single use pre-filled syringes, 4",ankylosing spondylitis,Subsequent continuing treatment,14701,True,STREAMLINED,Any,4030,2024,AUGUST
+11217J,etanercept,Brenzys,"Injections 50 mg in 1 mL single use pre-filled syringes, 4",ankylosing spondylitis,First continuing treatment,14683,True,STREAMLINED,Any,4030,2024,AUGUST
+10072D,tocilizumab,Actemra,Concentrate for injection 400 mg in 20 mL,juvenile idiopathic arthritis,Initial treatment - Initial 1 (new patient),,False,AUTHORITY_REQUIRED,Public,4030,2024,AUGUST
+10072D,tocilizumab,Actemra,Concentrate for injection 400 mg in 20 mL,juvenile idiopathic arthritis,Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months),,False,AUTHORITY_REQUIRED,Public,4030,2024,AUGUST
+10072D,tocilizumab,Actemra,Concentrate for injection 400 mg in 20 mL,juvenile idiopathic arthritis,Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 24 months),,False,AUTHORITY_REQUIRED,Public,4030,2024,AUGUST
+10072D,tocilizumab,Actemra,Concentrate for injection 400 mg in 20 mL,juvenile idiopathic arthritis,Initial treatment - Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after break of less than 24 months) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months) -  balance of supply,,True,AUTHORITY_REQUIRED,Public,4030,2024,AUGUST
+10072D,tocilizumab,Actemra,Concentrate for injection 400 mg in 20 mL,juvenile idiopathic arthritis,Continuing treatment,,False,AUTHORITY_REQUIRED,Public,4030,2024,AUGUST
+10072D,tocilizumab,Actemra,Concentrate for injection 400 mg in 20 mL,juvenile idiopathic arthritis,Continuing Treatment - balance of supply,,True,AUTHORITY_REQUIRED,Public,4030,2024,AUGUST
+9657G,tocilizumab,Actemra,Concentrate for injection 80 mg in 4 mL,rheumatoid arthritis,First continuing treatment,,False,AUTHORITY_REQUIRED,Public,4030,2024,AUGUST
+9657G,tocilizumab,Actemra,Concentrate for injection 80 mg in 4 mL,rheumatoid arthritis,First continuing treatment - balance of supply,,True,AUTHORITY_REQUIRED,Public,4030,2024,AUGUST
+9657G,tocilizumab,Actemra,Concentrate for injection 80 mg in 4 mL,rheumatoid arthritis,Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months),,False,AUTHORITY_REQUIRED,Public,4030,2024,AUGUST
+9657G,tocilizumab,Actemra,Concentrate for injection 80 mg in 4 mL,rheumatoid arthritis,Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 24 months),,False,AUTHORITY_REQUIRED,Public,4030,2024,AUGUST
+9657G,tocilizumab,Actemra,Concentrate for injection 80 mg in 4 mL,rheumatoid arthritis,Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 24 months) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months) - balance of supply,,True,AUTHORITY_REQUIRED,Public,4030,2024,AUGUST
+9657G,tocilizumab,Actemra,Concentrate for injection 80 mg in 4 mL,rheumatoid arthritis,Initial treatment - Initial 1 (new patient),,False,AUTHORITY_REQUIRED,Public,4030,2024,AUGUST
+12794J,tocilizumab,Actemra,Concentrate for injection 80 mg in 4 mL,juvenile idiopathic arthritis,Initial treatment - Initial 4 (Temporary listing - change of treatment from another biological medicine to tocilizumab after resolution of the critical shortage of tocilizumab),,True,AUTHORITY_REQUIRED,Public,4030,2024,AUGUST
+12794J,tocilizumab,Actemra,Concentrate for injection 80 mg in 4 mL,juvenile idiopathic arthritis,Initial treatment - Initial 4 (Temporary listing - change of treatment from another biological medicine to tocilzumab after resolution of the critical shortage of tocilizumab),,True,AUTHORITY_REQUIRED,Public,4030,2024,AUGUST
+11207W,etanercept,Enbrel,Injection set containing 4 vials powder for injection 25 mg and 4 pre-filled syringes solvent 1 mL,psoriatic arthritis,Continuing treatment - balance of supply,,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+11207W,etanercept,Enbrel,Injection set containing 4 vials powder for injection 25 mg and 4 pre-filled syringes solvent 1 mL,psoriatic arthritis,Subsequent continuing treatment,,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+3426H,golimumab,Simponi,Injection 50 mg in 0.5 mL single use pre-filled syringe,rheumatoid arthritis,Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 24 months),,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+3426H,golimumab,Simponi,Injection 50 mg in 0.5 mL single use pre-filled syringe,rheumatoid arthritis,Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months),,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+3426H,golimumab,Simponi,Injection 50 mg in 0.5 mL single use pre-filled syringe,rheumatoid arthritis,Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 24 months) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months) - balance of supply,,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+3426H,golimumab,Simponi,Injection 50 mg in 0.5 mL single use pre-filled syringe,rheumatoid arthritis,Initial treatment - Initial 1 (new patient),,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+12376J,adalimumab,Yuflyma,Injection 40 mg in 0.4 mL pre-filled pen,ankylosing spondylitis,Initial treatment - Initial 1 (new patient),,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+12376J,adalimumab,Adalicip,Injection 40 mg in 0.4 mL pre-filled pen,ankylosing spondylitis,Initial treatment - Initial 1 (new patient),,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+12376J,adalimumab,Humira,Injection 40 mg in 0.4 mL pre-filled pen,ankylosing spondylitis,Initial treatment - Initial 1 (new patient),,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+12376J,adalimumab,Yuflyma,Injection 40 mg in 0.4 mL pre-filled pen,ankylosing spondylitis,Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years),,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+12376J,adalimumab,Adalicip,Injection 40 mg in 0.4 mL pre-filled pen,ankylosing spondylitis,Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years),,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+12376J,adalimumab,Humira,Injection 40 mg in 0.4 mL pre-filled pen,ankylosing spondylitis,Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years),,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+12376J,adalimumab,Yuflyma,Injection 40 mg in 0.4 mL pre-filled pen,ankylosing spondylitis,Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years) - balance of supply,,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+12376J,adalimumab,Adalicip,Injection 40 mg in 0.4 mL pre-filled pen,ankylosing spondylitis,Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years) - balance of supply,,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+12376J,adalimumab,Humira,Injection 40 mg in 0.4 mL pre-filled pen,ankylosing spondylitis,Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years) - balance of supply,,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+12376J,adalimumab,Yuflyma,Injection 40 mg in 0.4 mL pre-filled pen,ankylosing spondylitis,Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years),,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+12376J,adalimumab,Adalicip,Injection 40 mg in 0.4 mL pre-filled pen,ankylosing spondylitis,Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years),,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+12376J,adalimumab,Humira,Injection 40 mg in 0.4 mL pre-filled pen,ankylosing spondylitis,Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years),,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+13691N,adalimumab,Adalicip,Injection 40 mg in 0.4 mL pre-filled pen,rheumatoid arthritis,Initial treatment - Initial 1 (new patient),,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+13691N,adalimumab,Yuflyma,Injection 40 mg in 0.4 mL pre-filled pen,rheumatoid arthritis,Initial treatment - Initial 1 (new patient),,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+13691N,adalimumab,Adalicip,Injection 40 mg in 0.4 mL pre-filled pen,rheumatoid arthritis,Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months),,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+13691N,adalimumab,Yuflyma,Injection 40 mg in 0.4 mL pre-filled pen,rheumatoid arthritis,Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months),,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+13691N,adalimumab,Adalicip,Injection 40 mg in 0.4 mL pre-filled pen,rheumatoid arthritis,Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 24 months),,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+13691N,adalimumab,Yuflyma,Injection 40 mg in 0.4 mL pre-filled pen,rheumatoid arthritis,Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 24 months),,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+12086D,tocilizumab,Actemra Subcutaneous Injection,Injection 162 mg in 0.9 mL single use pre-filled syringe,juvenile idiopathic arthritis,Continuing treatment in a patient weighing less than 30 kg,14084,True,STREAMLINED,Any,4030,2024,AUGUST
+12348X,adalimumab,Idacio,Injection 40 mg in 0.8 mL pre-filled syringe,juvenile idiopathic arthritis,Continuing treatment,14136,True,STREAMLINED,Public,4030,2024,AUGUST
+12348X,adalimumab,Hadlima,Injection 40 mg in 0.8 mL pre-filled syringe,juvenile idiopathic arthritis,Continuing treatment,14136,True,STREAMLINED,Public,4030,2024,AUGUST
+12348X,adalimumab,Amgevita,Injection 40 mg in 0.8 mL pre-filled syringe,juvenile idiopathic arthritis,Continuing treatment,14136,True,STREAMLINED,Public,4030,2024,AUGUST
+12348X,adalimumab,Hyrimoz,Injection 40 mg in 0.8 mL pre-filled syringe,juvenile idiopathic arthritis,Continuing treatment,14136,True,STREAMLINED,Public,4030,2024,AUGUST
+12348X,adalimumab,Abrilada,Injection 40 mg in 0.8 mL pre-filled syringe,juvenile idiopathic arthritis,Continuing treatment,14136,True,STREAMLINED,Public,4030,2024,AUGUST
+13689L,baricitinib,Olumiant,Tablet 2 mg,rheumatoid arthritis,Subsequent continuing treatment,14499,True,STREAMLINED,Any,4030,2024,AUGUST
+13731Q,tocilizumab,Actemra,Concentrate for injection 400 mg in 20 mL,rheumatoid arthritis,Subsequent continuing treatment,14485,True,STREAMLINED,Private,4030,2024,AUGUST
+11742B,tocilizumab,Actemra ACTPen,Injection 162 mg in 0.9 mL single use pre-filled pen,juvenile idiopathic arthritis,Continuing treatment,14150,True,STREAMLINED,Any,4030,2024,AUGUST
+12621G,upadacitinib,Rinvoq,Tablet 15 mg,ankylosing spondylitis,Continuing treatment - balance of supply,,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+12621G,upadacitinib,Rinvoq,Tablet 15 mg,ankylosing spondylitis,Continuing treatment,,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+12400P,adalimumab,Humira,Injection 40 mg in 0.4 mL pre-filled syringe,rheumatoid arthritis,Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months),,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+12400P,adalimumab,Yuflyma,Injection 40 mg in 0.4 mL pre-filled syringe,rheumatoid arthritis,Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months),,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+12400P,adalimumab,Adalicip,Injection 40 mg in 0.4 mL pre-filled syringe,rheumatoid arthritis,Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months),,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+12400P,adalimumab,Humira,Injection 40 mg in 0.4 mL pre-filled syringe,rheumatoid arthritis,Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 24 months),,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+12400P,adalimumab,Yuflyma,Injection 40 mg in 0.4 mL pre-filled syringe,rheumatoid arthritis,Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 24 months),,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+12400P,adalimumab,Adalicip,Injection 40 mg in 0.4 mL pre-filled syringe,rheumatoid arthritis,Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 24 months),,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+12400P,adalimumab,Humira,Injection 40 mg in 0.4 mL pre-filled syringe,rheumatoid arthritis,Initial treatment - Initial 1 (new patient),,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+12400P,adalimumab,Yuflyma,Injection 40 mg in 0.4 mL pre-filled syringe,rheumatoid arthritis,Initial treatment - Initial 1 (new patient),,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+12400P,adalimumab,Adalicip,Injection 40 mg in 0.4 mL pre-filled syringe,rheumatoid arthritis,Initial treatment - Initial 1 (new patient),,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+12400P,adalimumab,Humira,Injection 40 mg in 0.4 mL pre-filled syringe,rheumatoid arthritis,Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 24 months) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months) - balance of supply,,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+12400P,adalimumab,Yuflyma,Injection 40 mg in 0.4 mL pre-filled syringe,rheumatoid arthritis,Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 24 months) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months) - balance of supply,,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+12400P,adalimumab,Adalicip,Injection 40 mg in 0.4 mL pre-filled syringe,rheumatoid arthritis,Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 24 months) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months) - balance of supply,,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+12209N,ixekizumab,Taltz,Injection 80 mg in 1 mL single dose pre-filled pen,ankylosing spondylitis,Continuing treatment,,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+12209N,ixekizumab,Taltz,Injection 80 mg in 1 mL single dose pre-filled pen,ankylosing spondylitis,Continuing treatment - balance of supply,,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+12365T,adalimumab,Amgevita,Injection 40 mg in 0.8 mL pre-filled syringe,juvenile idiopathic arthritis,Subsequent continuing treatment,11604,True,STREAMLINED,Any,4030,2024,AUGUST
+12365T,adalimumab,Abrilada,Injection 40 mg in 0.8 mL pre-filled syringe,juvenile idiopathic arthritis,Subsequent continuing treatment,11604,True,STREAMLINED,Any,4030,2024,AUGUST
+12365T,adalimumab,Hadlima,Injection 40 mg in 0.8 mL pre-filled syringe,juvenile idiopathic arthritis,Subsequent continuing treatment,11604,True,STREAMLINED,Any,4030,2024,AUGUST
+12365T,adalimumab,Idacio,Injection 40 mg in 0.8 mL pre-filled syringe,juvenile idiopathic arthritis,Subsequent continuing treatment,11604,True,STREAMLINED,Any,4030,2024,AUGUST
+12365T,adalimumab,Hyrimoz,Injection 40 mg in 0.8 mL pre-filled syringe,juvenile idiopathic arthritis,Subsequent continuing treatment,11604,True,STREAMLINED,Any,4030,2024,AUGUST
+13057F,infliximab,Remsima SC,Solution for injection 120 mg in 1 mL pre-filled syringe,ankylosing spondylitis,Initial treatment with the subcutaneous form where a concurrent PBS authority application for the intravenously (IV) administered formulation is being made,,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+12399N,adalimumab,Yuflyma,Injection 40 mg in 0.4 mL pre-filled syringe,juvenile idiopathic arthritis,First continuing treatment,,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+12399N,adalimumab,Adalicip,Injection 40 mg in 0.4 mL pre-filled syringe,juvenile idiopathic arthritis,First continuing treatment,,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+12399N,adalimumab,Humira,Injection 40 mg in 0.4 mL pre-filled syringe,juvenile idiopathic arthritis,First continuing treatment,,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+12399N,adalimumab,Yuflyma,Injection 40 mg in 0.4 mL pre-filled syringe,juvenile idiopathic arthritis,Subsequent continuing treatment,,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+12399N,adalimumab,Adalicip,Injection 40 mg in 0.4 mL pre-filled syringe,juvenile idiopathic arthritis,Subsequent continuing treatment,,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+12399N,adalimumab,Humira,Injection 40 mg in 0.4 mL pre-filled syringe,juvenile idiopathic arthritis,Subsequent continuing treatment,,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+12399N,adalimumab,Yuflyma,Injection 40 mg in 0.4 mL pre-filled syringe,juvenile idiopathic arthritis,Continuing treatment - balance of supply,,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+12399N,adalimumab,Adalicip,Injection 40 mg in 0.4 mL pre-filled syringe,juvenile idiopathic arthritis,Continuing treatment - balance of supply,,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+12399N,adalimumab,Humira,Injection 40 mg in 0.4 mL pre-filled syringe,juvenile idiopathic arthritis,Continuing treatment - balance of supply,,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+12378L,adalimumab,Humira,Injection 40 mg in 0.4 mL pre-filled syringe,psoriatic arthritis,Initial treatment - Initial 1 (new patient),,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+12378L,adalimumab,Yuflyma,Injection 40 mg in 0.4 mL pre-filled syringe,psoriatic arthritis,Initial treatment - Initial 1 (new patient),,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+12378L,adalimumab,Adalicip,Injection 40 mg in 0.4 mL pre-filled syringe,psoriatic arthritis,Initial treatment - Initial 1 (new patient),,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+12378L,adalimumab,Humira,Injection 40 mg in 0.4 mL pre-filled syringe,psoriatic arthritis,Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years),,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+12378L,adalimumab,Yuflyma,Injection 40 mg in 0.4 mL pre-filled syringe,psoriatic arthritis,Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years),,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+12378L,adalimumab,Adalicip,Injection 40 mg in 0.4 mL pre-filled syringe,psoriatic arthritis,Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years),,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+12378L,adalimumab,Humira,Injection 40 mg in 0.4 mL pre-filled syringe,psoriatic arthritis,Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years) - balance of supply,,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+12378L,adalimumab,Yuflyma,Injection 40 mg in 0.4 mL pre-filled syringe,psoriatic arthritis,Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years) - balance of supply,,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+12378L,adalimumab,Adalicip,Injection 40 mg in 0.4 mL pre-filled syringe,psoriatic arthritis,Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years) - balance of supply,,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+12378L,adalimumab,Humira,Injection 40 mg in 0.4 mL pre-filled syringe,psoriatic arthritis,Initial treatment - Initial 2 (change or recommencement of treatment after a break in in biological medicine of less than 5 years),,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+12378L,adalimumab,Yuflyma,Injection 40 mg in 0.4 mL pre-filled syringe,psoriatic arthritis,Initial treatment - Initial 2 (change or recommencement of treatment after a break in in biological medicine of less than 5 years),,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+12378L,adalimumab,Adalicip,Injection 40 mg in 0.4 mL pre-filled syringe,psoriatic arthritis,Initial treatment - Initial 2 (change or recommencement of treatment after a break in in biological medicine of less than 5 years),,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+12013G,certolizumab pegol,Cimzia,Solution for injection 200 mg in 1 mL pre-filled pen,non-radiographic axial spondyloarthritis,Continuing treatment - balance of supply,,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+12013G,certolizumab pegol,Cimzia,Solution for injection 200 mg in 1 mL pre-filled pen,non-radiographic axial spondyloarthritis,"Initial 1 (New patient), Initial 2 (Change or re-commencement of treatment after a break in biological medicine of less than 5 years) or Initial 3 (Recommencement of treatment after a break in biological medicine of more than 5 years) - balance of supply",,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+12443X,adalimumab,Humira,Injection 20 mg in 0.2 mL pre-filled syringe,juvenile idiopathic arthritis,Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 12 months) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 12 months) - balance of supply,,True,AUTHORITY_REQUIRED,Private,4030,2024,AUGUST
+12443X,adalimumab,Humira,Injection 20 mg in 0.2 mL pre-filled syringe,juvenile idiopathic arthritis,Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 12 months),,True,AUTHORITY_REQUIRED,Private,4030,2024,AUGUST
+12443X,adalimumab,Humira,Injection 20 mg in 0.2 mL pre-filled syringe,juvenile idiopathic arthritis,Initial treatment - Initial 1 (new patient),,True,AUTHORITY_REQUIRED,Private,4030,2024,AUGUST
+12443X,adalimumab,Humira,Injection 20 mg in 0.2 mL pre-filled syringe,juvenile idiopathic arthritis,Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 12 months),,True,AUTHORITY_REQUIRED,Private,4030,2024,AUGUST
+13349N,tofacitinib,Xeljanz,Tablet 5 mg,ankylosing spondylitis,Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years),,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+13349N,tofacitinib,Xeljanz,Tablet 5 mg,ankylosing spondylitis,Initial treatment - Initial 1 (new patient),,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+13349N,tofacitinib,Xeljanz,Tablet 5 mg,ankylosing spondylitis,Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years) - balance of supply,,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+13349N,tofacitinib,Xeljanz,Tablet 5 mg,ankylosing spondylitis,Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years),,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+9036N,etanercept,Enbrel,Injection set containing 4 vials powder for injection 25 mg and 4 pre-filled syringes solvent 1 mL,psoriatic arthritis,First continuing treatment,,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+9036N,etanercept,Enbrel,Injection set containing 4 vials powder for injection 25 mg and 4 pre-filled syringes solvent 1 mL,psoriatic arthritis,Continuing treatment - balance of supply,,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+10893H,secukinumab,Cosentyx,Injection 150 mg in 1 mL pre-filled pen,ankylosing spondylitis,"Initial treatment - Initial 1 (new patient), Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years) - balance of supply",,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+13707K,etanercept,Brenzys,"Injections 50 mg in 1 mL single use pre-filled syringes, 4",rheumatoid arthritis,First continuing treatment,14629,True,STREAMLINED,Any,4030,2024,AUGUST
+9035M,etanercept,Enbrel,Injection set containing 4 vials powder for injection 25 mg and 4 pre-filled syringes solvent 1 mL,psoriatic arthritis,Initial treatment - Initial 1 (new patient),,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+9035M,etanercept,Enbrel,Injection set containing 4 vials powder for injection 25 mg and 4 pre-filled syringes solvent 1 mL,psoriatic arthritis,Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years) - balance of supply,,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+9035M,etanercept,Enbrel,Injection set containing 4 vials powder for injection 25 mg and 4 pre-filled syringes solvent 1 mL,psoriatic arthritis,Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years),,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+9035M,etanercept,Enbrel,Injection set containing 4 vials powder for injection 25 mg and 4 pre-filled syringes solvent 1 mL,psoriatic arthritis,Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years),,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+13705H,abatacept,Orencia,Powder for I.V. infusion 250 mg,rheumatoid arthritis,Subsequent continuing treatment,14555,True,STREAMLINED,Private,4030,2024,AUGUST
+13744J,adalimumab,Hadlima,Injection 40 mg in 0.8 mL pre-filled syringe,ankylosing spondylitis,Initial treatment - Initial 1 (new patient),,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+13744J,adalimumab,Idacio,Injection 40 mg in 0.8 mL pre-filled syringe,ankylosing spondylitis,Initial treatment - Initial 1 (new patient),,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+13744J,adalimumab,Abrilada,Injection 40 mg in 0.8 mL pre-filled syringe,ankylosing spondylitis,Initial treatment - Initial 1 (new patient),,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+13744J,adalimumab,Hyrimoz,Injection 40 mg in 0.8 mL pre-filled syringe,ankylosing spondylitis,Initial treatment - Initial 1 (new patient),,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+13744J,adalimumab,Amgevita,Injection 40 mg in 0.8 mL pre-filled syringe,ankylosing spondylitis,Initial treatment - Initial 1 (new patient),,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+13744J,adalimumab,Hadlima,Injection 40 mg in 0.8 mL pre-filled syringe,ankylosing spondylitis,Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years),,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+13744J,adalimumab,Idacio,Injection 40 mg in 0.8 mL pre-filled syringe,ankylosing spondylitis,Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years),,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+13744J,adalimumab,Abrilada,Injection 40 mg in 0.8 mL pre-filled syringe,ankylosing spondylitis,Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years),,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+13744J,adalimumab,Hyrimoz,Injection 40 mg in 0.8 mL pre-filled syringe,ankylosing spondylitis,Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years),,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+13744J,adalimumab,Amgevita,Injection 40 mg in 0.8 mL pre-filled syringe,ankylosing spondylitis,Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years),,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+13744J,adalimumab,Hadlima,Injection 40 mg in 0.8 mL pre-filled syringe,ankylosing spondylitis,Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years),,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+13744J,adalimumab,Idacio,Injection 40 mg in 0.8 mL pre-filled syringe,ankylosing spondylitis,Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years),,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+13744J,adalimumab,Abrilada,Injection 40 mg in 0.8 mL pre-filled syringe,ankylosing spondylitis,Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years),,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+13744J,adalimumab,Hyrimoz,Injection 40 mg in 0.8 mL pre-filled syringe,ankylosing spondylitis,Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years),,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+13744J,adalimumab,Amgevita,Injection 40 mg in 0.8 mL pre-filled syringe,ankylosing spondylitis,Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years),,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+9078T,adalimumab,Hadlima,Injection 40 mg in 0.8 mL pre-filled syringe,ankylosing spondylitis,First continuing treatment,,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+9078T,adalimumab,Idacio,Injection 40 mg in 0.8 mL pre-filled syringe,ankylosing spondylitis,First continuing treatment,,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+9078T,adalimumab,Amgevita,Injection 40 mg in 0.8 mL pre-filled syringe,ankylosing spondylitis,First continuing treatment,,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+9078T,adalimumab,Hyrimoz,Injection 40 mg in 0.8 mL pre-filled syringe,ankylosing spondylitis,First continuing treatment,,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+9078T,adalimumab,Abrilada,Injection 40 mg in 0.8 mL pre-filled syringe,ankylosing spondylitis,First continuing treatment,,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+9078T,adalimumab,Hadlima,Injection 40 mg in 0.8 mL pre-filled syringe,ankylosing spondylitis,Continuing treatment - balance of supply,,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+9078T,adalimumab,Idacio,Injection 40 mg in 0.8 mL pre-filled syringe,ankylosing spondylitis,Continuing treatment - balance of supply,,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+9078T,adalimumab,Amgevita,Injection 40 mg in 0.8 mL pre-filled syringe,ankylosing spondylitis,Continuing treatment - balance of supply,,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+9078T,adalimumab,Hyrimoz,Injection 40 mg in 0.8 mL pre-filled syringe,ankylosing spondylitis,Continuing treatment - balance of supply,,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+9078T,adalimumab,Abrilada,Injection 40 mg in 0.8 mL pre-filled syringe,ankylosing spondylitis,Continuing treatment - balance of supply,,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+9078T,adalimumab,Hadlima,Injection 40 mg in 0.8 mL pre-filled syringe,ankylosing spondylitis,Subsequent continuing treatment,,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+9078T,adalimumab,Idacio,Injection 40 mg in 0.8 mL pre-filled syringe,ankylosing spondylitis,Subsequent continuing treatment,,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+9078T,adalimumab,Amgevita,Injection 40 mg in 0.8 mL pre-filled syringe,ankylosing spondylitis,Subsequent continuing treatment,,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+9078T,adalimumab,Hyrimoz,Injection 40 mg in 0.8 mL pre-filled syringe,ankylosing spondylitis,Subsequent continuing treatment,,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+9078T,adalimumab,Abrilada,Injection 40 mg in 0.8 mL pre-filled syringe,ankylosing spondylitis,Subsequent continuing treatment,,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+11989B,upadacitinib,Rinvoq,Tablet 15 mg,rheumatoid arthritis,Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 24 months) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months) - balance of supply,,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+11989B,upadacitinib,Rinvoq,Tablet 15 mg,rheumatoid arthritis,Initial treatment - Initial 1 (new patient),,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+11989B,upadacitinib,Rinvoq,Tablet 15 mg,rheumatoid arthritis,Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 24 months),,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+11989B,upadacitinib,Rinvoq,Tablet 15 mg,rheumatoid arthritis,Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months),,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+5753T,infliximab,Inflectra,Powder for I.V. infusion 100 mg,ankylosing spondylitis,Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years),,False,AUTHORITY_REQUIRED,Public,4030,2024,AUGUST
+5753T,infliximab,Remicade,Powder for I.V. infusion 100 mg,ankylosing spondylitis,Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years),,False,AUTHORITY_REQUIRED,Public,4030,2024,AUGUST
+5753T,infliximab,Renflexis,Powder for I.V. infusion 100 mg,ankylosing spondylitis,Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years),,False,AUTHORITY_REQUIRED,Public,4030,2024,AUGUST
+5753T,infliximab,Inflectra,Powder for I.V. infusion 100 mg,ankylosing spondylitis,Initial treatment - Initial 1 (new patient),,False,AUTHORITY_REQUIRED,Public,4030,2024,AUGUST
+5753T,infliximab,Remicade,Powder for I.V. infusion 100 mg,ankylosing spondylitis,Initial treatment - Initial 1 (new patient),,False,AUTHORITY_REQUIRED,Public,4030,2024,AUGUST
+5753T,infliximab,Renflexis,Powder for I.V. infusion 100 mg,ankylosing spondylitis,Initial treatment - Initial 1 (new patient),,False,AUTHORITY_REQUIRED,Public,4030,2024,AUGUST
+5753T,infliximab,Inflectra,Powder for I.V. infusion 100 mg,ankylosing spondylitis,Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years),,False,AUTHORITY_REQUIRED,Public,4030,2024,AUGUST
+5753T,infliximab,Remicade,Powder for I.V. infusion 100 mg,ankylosing spondylitis,Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years),,False,AUTHORITY_REQUIRED,Public,4030,2024,AUGUST
+5753T,infliximab,Renflexis,Powder for I.V. infusion 100 mg,ankylosing spondylitis,Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years),,False,AUTHORITY_REQUIRED,Public,4030,2024,AUGUST
+5753T,infliximab,Inflectra,Powder for I.V. infusion 100 mg,ankylosing spondylitis,Continuing treatment - balance of supply,,True,AUTHORITY_REQUIRED,Public,4030,2024,AUGUST
+5753T,infliximab,Remicade,Powder for I.V. infusion 100 mg,ankylosing spondylitis,Continuing treatment - balance of supply,,True,AUTHORITY_REQUIRED,Public,4030,2024,AUGUST
+5753T,infliximab,Renflexis,Powder for I.V. infusion 100 mg,ankylosing spondylitis,Continuing treatment - balance of supply,,True,AUTHORITY_REQUIRED,Public,4030,2024,AUGUST
+5753T,infliximab,Inflectra,Powder for I.V. infusion 100 mg,ankylosing spondylitis,First continuing treatment,,False,AUTHORITY_REQUIRED,Public,4030,2024,AUGUST
+5753T,infliximab,Remicade,Powder for I.V. infusion 100 mg,ankylosing spondylitis,First continuing treatment,,False,AUTHORITY_REQUIRED,Public,4030,2024,AUGUST
+5753T,infliximab,Renflexis,Powder for I.V. infusion 100 mg,ankylosing spondylitis,First continuing treatment,,False,AUTHORITY_REQUIRED,Public,4030,2024,AUGUST
+5753T,infliximab,Inflectra,Powder for I.V. infusion 100 mg,ankylosing spondylitis,"Initial treatment - Initial 1 (new patient), Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years) - balance of supply",,True,AUTHORITY_REQUIRED,Public,4030,2024,AUGUST
+5753T,infliximab,Remicade,Powder for I.V. infusion 100 mg,ankylosing spondylitis,"Initial treatment - Initial 1 (new patient), Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years) - balance of supply",,True,AUTHORITY_REQUIRED,Public,4030,2024,AUGUST
+5753T,infliximab,Renflexis,Powder for I.V. infusion 100 mg,ankylosing spondylitis,"Initial treatment - Initial 1 (new patient), Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years) - balance of supply",,True,AUTHORITY_REQUIRED,Public,4030,2024,AUGUST
+9673D,tocilizumab,Actemra,Concentrate for injection 400 mg in 20 mL,rheumatoid arthritis,Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 24 months) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months) - balance of supply,,True,AUTHORITY_REQUIRED,Private,4030,2024,AUGUST
+9673D,tocilizumab,Actemra,Concentrate for injection 400 mg in 20 mL,rheumatoid arthritis,First continuing treatment - balance of supply,,True,AUTHORITY_REQUIRED,Private,4030,2024,AUGUST
+9673D,tocilizumab,Actemra,Concentrate for injection 400 mg in 20 mL,rheumatoid arthritis,Initial treatment - Initial 1 (new patient),,False,AUTHORITY_REQUIRED,Private,4030,2024,AUGUST
+9673D,tocilizumab,Actemra,Concentrate for injection 400 mg in 20 mL,rheumatoid arthritis,Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 24 months),,False,AUTHORITY_REQUIRED,Private,4030,2024,AUGUST
+9673D,tocilizumab,Actemra,Concentrate for injection 400 mg in 20 mL,rheumatoid arthritis,First continuing treatment,,False,AUTHORITY_REQUIRED,Private,4030,2024,AUGUST
+9673D,tocilizumab,Actemra,Concentrate for injection 400 mg in 20 mL,rheumatoid arthritis,Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months),,False,AUTHORITY_REQUIRED,Private,4030,2024,AUGUST
+10064Q,tocilizumab,Actemra,Concentrate for injection 400 mg in 20 mL,juvenile idiopathic arthritis,Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 12 months),,True,AUTHORITY_REQUIRED,Public,4030,2024,AUGUST
+10064Q,tocilizumab,Actemra,Concentrate for injection 400 mg in 20 mL,juvenile idiopathic arthritis,Initial treatment - Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 12 months) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 12 months) - balance of supply,,True,AUTHORITY_REQUIRED,Public,4030,2024,AUGUST
+10064Q,tocilizumab,Actemra,Concentrate for injection 400 mg in 20 mL,juvenile idiopathic arthritis,Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 12 months),,True,AUTHORITY_REQUIRED,Public,4030,2024,AUGUST
+10064Q,tocilizumab,Actemra,Concentrate for injection 400 mg in 20 mL,juvenile idiopathic arthritis,Initial treatment - Initial 1 (new patient),,True,AUTHORITY_REQUIRED,Public,4030,2024,AUGUST
+12553Q,infliximab,Remsima SC,Solution for injection 120 mg in 1 mL pre-filled syringe,rheumatoid arthritis,Continuing treatment with subcutaneous form or switching from intravenous form to subcutaneous form,,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+11443G,baricitinib,Olumiant,Tablet 4 mg,rheumatoid arthritis,First continuing treatment,,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+11443G,baricitinib,Olumiant,Tablet 4 mg,rheumatoid arthritis,First continuing treatment - balance of supply,,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+9085E,etanercept,Brenzys,"Injections 50 mg in 1 mL single use pre-filled syringes, 4",ankylosing spondylitis,Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years),,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+9085E,etanercept,Enbrel,"Injections 50 mg in 1 mL single use pre-filled syringes, 4",ankylosing spondylitis,Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years),,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+9085E,etanercept,Brenzys,"Injections 50 mg in 1 mL single use pre-filled syringes, 4",ankylosing spondylitis,Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years),,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+9085E,etanercept,Enbrel,"Injections 50 mg in 1 mL single use pre-filled syringes, 4",ankylosing spondylitis,Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years),,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+9085E,etanercept,Brenzys,"Injections 50 mg in 1 mL single use pre-filled syringes, 4",ankylosing spondylitis,Initial treatment - Initial 1 (new patient),,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+9085E,etanercept,Enbrel,"Injections 50 mg in 1 mL single use pre-filled syringes, 4",ankylosing spondylitis,Initial treatment - Initial 1 (new patient),,False,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+9085E,etanercept,Brenzys,"Injections 50 mg in 1 mL single use pre-filled syringes, 4",ankylosing spondylitis,Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years) - balance of supply,,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+9085E,etanercept,Enbrel,"Injections 50 mg in 1 mL single use pre-filled syringes, 4",ankylosing spondylitis,Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years) - balance of supply,,True,AUTHORITY_REQUIRED,Any,4030,2024,AUGUST
+5735W,etanercept,Enbrel,"Injection 50 mg in 1 mL single use auto-injector, 4",juvenile idiopathic arthritis,Initial treatment - Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 12 months) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 12 months) - balance of supply,,True,AUTHORITY_REQUIRED,Public,4030,2024,AUGUST
+5735W,etanercept,Enbrel,"Injection 50 mg in 1 mL single use auto-injector, 4",juvenile idiopathic arthritis,Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 12 months),,True,AUTHORITY_REQUIRED,Public,4030,2024,AUGUST
+5735W,etanercept,Enbrel,"Injection 50 mg in 1 mL single use auto-injector, 4",juvenile idiopathic arthritis,Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 12 months),,True,AUTHORITY_REQUIRED,Public,4030,2024,AUGUST
+5735W,etanercept,Enbrel,"Injection 50 mg in 1 mL single use auto-injector, 4",juvenile idiopathic arthritis,Initial treatment - Initial 1 (new patient),,True,AUTHORITY_REQUIRED,Public,4030,2024,AUGUST
+11497D,infliximab,Inflectra,Powder for I.V. infusion 100 mg,psoriatic arthritis,Subsequent continuing treatment,,False,AUTHORITY_REQUIRED,Public,4030,2024,AUGUST
+11497D,infliximab,Renflexis,Powder for I.V. infusion 100 mg,psoriatic arthritis,Subsequent continuing treatment,,False,AUTHORITY_REQUIRED,Public,4030,2024,AUGUST
+11497D,infliximab,Remicade,Powder for I.V. infusion 100 mg,psoriatic arthritis,Subsequent continuing treatment,,False,AUTHORITY_REQUIRED,Public,4030,2024,AUGUST
+11483J,infliximab,Inflectra,Powder for I.V. infusion 100 mg,rheumatoid arthritis,Subsequent continuing treatment,14505,True,STREAMLINED,Private,4030,2024,AUGUST
+11483J,infliximab,Remicade,Powder for I.V. infusion 100 mg,rheumatoid arthritis,Subsequent continuing treatment,14505,True,STREAMLINED,Private,4030,2024,AUGUST
+11483J,infliximab,Renflexis,Powder for I.V. infusion 100 mg,rheumatoid arthritis,Subsequent continuing treatment,14505,True,STREAMLINED,Private,4030,2024,AUGUST
+13338B,tocilizumab,Actemra,Concentrate for injection 400 mg in 20 mL,juvenile idiopathic arthritis,Continuing treatment,14082,True,STREAMLINED,Private,4030,2024,AUGUST